PT J
AU de Tilques, MD
   Tribouillard-Tanvier, D
   Tétaud, E
   Testet, E
   di Rago, JP
   Lasserre, JP
AF de Tilques, Maxence de Taffin
   Tribouillard-Tanvier, Deborah
   Tetaud, Emmanuel
   Testet, Eric
   di Rago, Jean-Paul
   Lasserre, Jean-Paul
TI Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Human mitochondrial disease; Oxidative phosphorylation; Barth syndrome; Oxodicarboxylic acid transport; Cardiolipin remodeling; Tafazzin
ID linked cardioskeletal myopathy; substrate-level phosphorylation; membrane-protein complexes; transfer-rna synthetase; respiratory-chain; atp synthase; saccharomyces-cerevisiae; supramolecular organization; cardiolipin biosynthesis; essential requirement
AB Cardiolipin (CL) is a diglycerol phospholipid mostly found in mitochondria where it optimizes numerous processes, including oxidative phosphorylation (OXPHOS). To function properly, CL needs to be unsaturated, which requires the acyltransferase tafazzin. Loss-of-function mutations in this protein are responsible for Barth syndrome (BTHS), presumably because of a diminished OXPHOS capacity. Here, we show that overexpressing Odc1p, a conserved oxodicarboxylic acid carrier located in the mitochondrial inner membrane, fully restores oxidative phosphorylation in a yeast model (taz1.) of BTHS. The rescuing activity involves the recovery of normal expression of key components that sustain oxidative phosphorylation, including cytochrome c and electron transport chain complexes IV and III, which are strongly downregulated in taz1. yeast. Interestingly, overexpression of Odc1p was also shown previously to rescue yeast models of mitochondrial diseases caused by defects in the assembly of ATP synthase and by mutations in the MPV17 protein that result in hepatocerebral mitochondrial DNA depletion syndrome. These findings define the transport of oxodicarboxylic acids across the inner membrane as a potential therapeutic target for a large spectrum of mitochondrial diseases, including BTHS.
C1 [de Tilques, Maxence de Taffin; Tribouillard-Tanvier, Deborah; Tetaud, Emmanuel; di Rago, Jean-Paul; Lasserre, Jean-Paul] Univ Bordeaux, Inst Biochim & Genet Cellulaires, CNRS, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.
   [Testet, Eric] Univ Bordeaux, Lab Biogenese Membranaire, CNRS, UMR 5200,INRA Bordeaux Aquitaine, BP81, F-33883 Villenave Dornon, France.
C3 Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Bordeaux
RP Tribouillard-Tanvier, D; Lasserre, JP (corresponding author), Univ Bordeaux, Inst Biochim & Genet Cellulaires, CNRS, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.
EM tribouillard@ibgc.cnrs.fr; lasserre@ibgc.cnrs.fr
FU Association Francaise contre les Myopathies (AFM); Ministere de l'Enseignement et de la Recherche
CR Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031
   ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309
   Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284
   Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008
   Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733
   Baile MG, 2013, FRONT BIOSCI-LANDMRK, V18, P241, DOI 10.2741/4098
   Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418
   Bazán S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   BLIGNY R, 1980, BIOCHIM BIOPHYS ACTA, V617, P254, DOI 10.1016/0005-2760(80)90168-X
   BOLHUIS PA, 1991, AM J HUM GENET, V48, P481
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x
   Chen XJ, 2000, INT REV CYTOL, V194, P197
   Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896
   Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098
   Dudek J, 2016, EMBO MOL MED, V8, P139, DOI 10.15252/emmm.201505644
   Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Ferri L, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-27
   Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200
   Francisci S, 2011, MITOCHONDRION, V11, P919, DOI 10.1016/j.mito.2011.08.006
   Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720
   Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074
   GEDEON AK, 1995, J MED GENET, V32, P383, DOI 10.1136/jmg.32.5.383
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005
   GrandierVazeille X, 1996, ANAL BIOCHEM, V242, P248, DOI 10.1006/abio.1996.0460
   Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x
   Guerin B, 1979, METHODS ENZYMOL, V55, P149
   Hatch GM, 1998, INT J MOL MED, V1, P33
   Heit B, 2011, AM J PHYSIOL-CELL PH, V300, PC33, DOI 10.1152/ajpcell.00139.2010
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3
   Hsu P, 2015, AUTOPHAGY, V11, P643, DOI 10.1080/15548627.2015.1023984
   Ikon N, 2015, BIOCHEM BIOPH RES CO, V464, P580, DOI 10.1016/j.bbrc.2015.07.012
   Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167
   Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024
   KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5
   Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375
   Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864
   Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317
   Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Lasserre JP, 2015, DIS MODEL MECH, V8, P509, DOI 10.1242/dmm.020438
   Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x
   Li XX, 2015, J HISTOCHEM CYTOCHEM, V63, P301, DOI 10.1369/0022155415574818
   LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manganelli V, 2015, J IMMUNOL RES, V2015, P0, DOI 10.1155/2015/847985
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3
   Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   Montanari A, 2010, BBA-MOL CELL RES, V1803, P1050, DOI 10.1016/j.bbamcr.2010.05.003
   MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767
   Neuwald AF, 1997, CURR BIOL, V7, P0
   NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x
   Orrenius S, 2005, NAT CHEM BIOL, V1, P188, DOI 10.1038/nchembio0905-188
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   REAUME SE, 1949, ARCH BIOCHEM, V22, P331
   RIGOULET M, 1985, EUR J BIOCHEM, V153, P601, DOI 10.1111/j.1432-1033.1985.tb09343.x
   RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9
   ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SCHLAME M, 1993, J BIOL CHEM, V268, P74
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007
   Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064
   Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491
   Tibbetts AS, 2002, ARCH BIOCHEM BIOPHYS, V406, P96, DOI 10.1016/S0003-9861(02)00419-8
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   VITIELLO F, 1978, J CHROMATOGR, V166, P637, DOI 10.1016/S0021-9673(00)95654-1
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103
   Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200
NR 105
TC 13
Z9 13
U1 1
U2 11
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD APR 1
PY 2017
VL 10
IS 4
BP 439
EP 450
DI 10.1242/dmm.027540
PG 12
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA ER6FA
UT WOS:000398899500009
PM 28188263
DA 2024-11-01
ER

PT J
AU Zhang, RY
   Wang, YQ
   Ye, KX
   Picard, M
   Gu, ZL
AF Zhang, Ruoyu
   Wang, Yiqin
   Ye, Kaixiong
   Picard, Martin
   Gu, Zhenglong
TI Independent impacts of aging on mitochondrial DNA quantity and quality in humans
SO BMC GENOMICS
LA English
DT Article
DE Aging; Heteroplasmy; mtDNA copy number; Whole genome sequencing
ID copy number; mtdna heteroplasmy; apolipoprotein-b; skeletal-muscle; mutations; association; disease; health; risk; contamination
AB Background: The accumulation of mitochondrial DNA (mtDNA) mutations, and the reduction of mtDNA copy number, both disrupt mitochondrial energetics, and may contribute to aging and age-associated phenotypes. However, there are few genetic and epidemiological studies on the spectra of blood mtDNA heteroplasmies, and the distribution of mtDNA copy numbers in different age groups and their impact on age-related phenotypes. In this work, we used whole-genome sequencing data of isolated peripheral blood mononuclear cells (PBMCs) from the UK10K project to investigate in parallel mtDNA heteroplasmy and copy number in 1511 women, between 17 and 85 years old, recruited in the TwinsUK cohorts. Results: We report a high prevalence of pathogenic mtDNA heteroplasmies in this population. We also find an increase in mtDNA heteroplasmies with age (beta = 0.011, P = 5.77e-6), and showed that, on average, individuals aged 70-years or older had 58.5% more mtDNA heteroplasmies than those under 40-years old. Conversely, mtDNA copy number decreased by an average of 0.4 copies per year (beta = -0.395, P = 0.0097). Multiple regression analyses also showed that age had independent effects on mtDNA copy number decrease and heteroplasmy accumulation. Finally, mtDNA copy number was positively associated with serum bicarbonate level (P = 4.46e-5), and inversely correlated with white blood cell count (P = 0.0006). Moreover, the aggregated heteroplasmy load was associated with blood apolipoprotein B level (P = 1.33e-5), linking the accumulation of mtDNA mutations to age-related physiological markers. Conclusions: Our population-based study indicates that both mtDNA quality and quantity are influenced by age. An open question for the future is whether interventions that would contribute to maintain optimal mtDNA copy number and prevent the expansion of heteroplasmy could promote healthy aging.
C1 [Zhang, Ruoyu; Wang, Yiqin; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Ye, Kaixiong] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.
   [Picard, Martin] Columbia Univ, Div Behav Med, Dept Psychiat, Med Ctr,Columbia Aging Ctr,Dept Neurol, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Columbia Translat Neurosci Initiat, Columbia Aging Ctr, Med Ctr, New York, NY 10032 USA.
C3 Cornell University; Cornell University; Columbia University; Columbia University
RP Gu, ZL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
EM zg27@cornell.edu
FU Cornell University; National Science Foundation [MCB-1243588]; National Institute of Health [1R01AI085286]; ENN Science and Technology Development
CR Andrikoula M, 2008, DIABETES OBES METAB, V10, P271, DOI 10.1111/j.1463-1326.2007.00714.x
   [Anonymous], 2007, ORIGINS GENOME ARCHI, V0, P0
   Arnedo J, 2015, AM J PSYCHIAT, V172, P139, DOI 10.1176/appi.ajp.2014.14040435
   Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x
   Barati M, 2008, BURNS, V34, P770, DOI 10.1016/j.burns.2008.01.014
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004
   Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, PE225, DOI 10.1152/ajpendo.00738.2009
   Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366
   Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carré JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC
   Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Durand T, 1999, CRYOBIOLOGY, V38, P68, DOI 10.1006/cryo.1999.2152
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kwak SH, 2010, J DIABETES INVEST, V1, P161, DOI 10.1111/j.2040-1124.2010.00047.x
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Langmead B, 2012, NAT METHODS, V9, P357, DOI 10.1038/NMETH.1923
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liu SF, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0138716
   Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MAHLEY RW, 1984, J LIPID RES, V25, P1277
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Niccoli T, 2012, CURR BIOL, V22, PR741, DOI 10.1016/j.cub.2012.07.024
   Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007
   Reiling E, 2010, J CLIN ENDOCR METAB, V95, P1909, DOI 10.1210/jc.2009-1775
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Ridge PG, 2014, BMC BIOINFORMATICS, V15, P0, DOI 10.1186/1471-2105-15-S7-S6
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SIMPSON DP, 1984, AM J PHYSIOL, V247, PF440, DOI 10.1152/ajprenal.1984.247.3.F440
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Su QZ, 2014, AM J PHYSIOL-ENDOC M, V306, PE1264, DOI 10.1152/ajpendo.00438.2013
   Suissa S, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000474
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Stormo Gary D, 2013, CURR PROTOC BIOINFORMATICS, V43, P0, DOI 10.1002/0471250953.bi1110s43
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW58, DOI 10.1093/nar/gkw233
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yoon CY, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000002717
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 83
TC 113
Z9 124
U1 7
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
EI 
J9 BMC GENOMICS
JI BMC Genomics
PD NOV 21
PY 2017
VL 18
IS 
BP 
EP 
DI 10.1186/s12864-017-4287-0
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FN5NA
UT WOS:000416053400004
PM 29157198
DA 2024-11-01
ER

PT J
AU Kudin, AP
   Baron, G
   Zsurka, G
   Hampel, KG
   Elger, CE
   Grote, A
   Weber, Y
   Lerche, H
   Thiele, H
   Nürnberg, P
   Schulz, H
   Ruppert, AK
   Sander, T
   Cheng, Q
   Arnér, ESJ
   Schomburg, L
   Seeher, S
   Fradejas-Villar, N
   Schweizer, U
   Kunz, WS
AF Kudin, Alexei P.
   Baron, Gregor
   Zsurka, Gabor
   Hampel, Kevin G.
   Elger, Christian E.
   Grote, Alexander
   Weber, Yvonne
   Lerche, Holger
   Thiele, Holger
   Nuernberg, Peter
   Schulz, Herbert
   Ruppert, Ann-Kathrin
   Sander, Thomas
   Cheng, Qing
   Arner, Elias S. J.
   Schomburg, Lutz
   Seeher, Sandra
   Fradejas-Villar, Noelia
   Schweizer, Ulrich
   Kunz, Wolfram S.
TI Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Generalized seizures; Epilepsy; Oxidative stress; TXNRD1
ID early embryonic lethality; thioredoxin reductase; selenoprotein biosynthesis; mitochondrial dysfunction; deficiency; penetrance; disruption; expression; survival; seizures
AB Increased oxidative stress has been widely implicated in the pathogenesis in various forms of human epilepsy. Here, we report a homozygous mutation in TXNRD1 (thioredoxin reductase 1) in a family with genetic generalized epilepsy. TXNRD1 is an essential selenium-containing enzyme involved in detoxification of reactive oxygen species (ROS) and redox signaling. The TXNRD1 mutation p.Pro190Leu affecting a highly conserved amino acid residue was identified by whole-exome sequencing of blood DNA from the index patient. The detected mutation and its segregation within the family- all siblings of the index patient were homozygous and the parents heterozygous-were confirmed by Sanger sequencing. TXNRD1 activity was determined in subcellular fractions from a skeletal muscle biopsy and skin fibroblasts of the index patient and the expression levels of the mutated protein were assessed by Se-75 labeling and Western blot analysis. As result of the mutation, the activity of TXNRD1 was reduced in the patient's fibroblasts and skeletal muscle (to 34 +/- 3% and 16 +/- 8% of controls, respectively). In fibroblasts, we detected reduced Se-75-labeling of the enzyme (41 +/- 3% of controls). An in-depth in vitro kinetic analysis of the recombinant mutated TXNRD1 indicated 30-40% lowered k(cat)/Se values. Therefore, a reduced activity of the enzyme in the patient's tissue samples is explained by (i) lower enzyme turnover and (ii) reduced abundance of the mutated enzyme as confirmed by Western blotting and Se-75 labeling. The mutant fibroblasts were also found to be less resistant to a hydrogen peroxide challenge. Our data agree with a potential role of insufficient ROS detoxification for disease manifestation in genetic generalized epilepsy.
C1 [Kudin, Alexei P.; Baron, Gregor; Zsurka, Gabor; Hampel, Kevin G.; Elger, Christian E.; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Kudin, Alexei P.; Baron, Gregor; Zsurka, Gabor; Hampel, Kevin G.; Elger, Christian E.; Kunz, Wolfram S.] Univ Bonn, Life & Brain Ctr, Bonn, Germany.
   [Grote, Alexander] Univ Bonn, Dept Neurosurg, Bonn, Germany.
   [Weber, Yvonne; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany.
   [Thiele, Holger; Nuernberg, Peter; Schulz, Herbert; Ruppert, Ann-Kathrin; Sander, Thomas] Univ Cologne, Cologne Ctr Genom, Cologne, Germany.
   [Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys MBB, Div Biochem, Stockholm, Sweden.
   [Schomburg, Lutz] Charite, Inst Biochem & Mol Biol, Berlin, Germany.
   [Seeher, Sandra; Fradejas-Villar, Noelia; Schweizer, Ulrich] Rheinische Friedrich Wilhelms Univ, Inst Biochem & Mol Biol, Bonn, Germany.
   [Hampel, Kevin G.] Hosp Univ & Politecn La Fe, Neurol Serv, Multidisciplinary Epilepsy Unit, Valencia, Spain.
C3 University of Bonn; University of Bonn; University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Cologne; Karolinska Institutet; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; Hospital Universitari i Politecnic La Fe
RP Kunz, WS (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.; Kunz, WS (corresponding author), Univ Bonn, Life & Brain Ctr, Bonn, Germany.; Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Div Neurochem, Dept Epileptol, Sigmund Freud Str 25, D-53105 Bonn, Germany.; Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Life & Brain Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM alexei_kudin@yahoo.com; brain21@gmx.net; gabor.zsurka@ukb.uni-bonn.de; kevin.hampel@gmx.de; christian.elger@ukb.uni-bonn.de; alexander.grote@ukb.uni-bonn.de; yvonne.weber@uni-tuebingen.de; holger.lerche@uni-tuebingen.de; holger.thiele@uni-koeln.de; nuemberg@uni-koeln.de; herbert.schulz@uni-koeln.de; sandert@uni-koeln.de; Qing.Cheng@ki.se; elias.arner@ki.se; lutz.schomburg@charite.de; seeher@gmx.de; nfradejas@uni-bonn.de; uschweiz@uni-bonn.de; wolfram.kunz@ukb.uni-bonn.de
CR Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007
   Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787
   Arner ES, 2001, CURR PROTOC TOXICOL, V0, P0
   Arnér ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014
   Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003
   Bragin DE, 2010, J CEREBR BLOOD F MET, V30, P734, DOI 10.1038/jcbfm.2010.9
   Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304
   Cheng Q, 2010, J BIOL CHEM, V285, P21708, DOI 10.1074/jbc.M110.117259
   Chiueh CC, 2005, ANN NY ACAD SCI, V1042, P403, DOI 10.1196/annals.1338.034
   Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013
   Cologne Center for Genomics, 2016, VARBANK DAT AN TOOL, V0, P0
   Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Exome Aggregation Consortium, 2016, EXAC BROWS, V0, P0
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155
   Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350
   Hybsier S, 2017, REDOX BIOL, V11, P403, DOI 10.1016/j.redox.2016.12.025
   Iverson SV, 2013, FREE RADICAL BIO MED, V63, P369, DOI 10.1016/j.freeradbiomed.2013.05.028
   Kean WF, 2008, INFLAMMOPHARMACOLOGY, V16, P112, DOI 10.1007/s10787-007-0021-x
   Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516
   Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003
   Peng X, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.209
   Prasad R, 2014, J CLIN ENDOCR METAB, V99, PE1556, DOI 10.1210/jc.2013-3844
   RAMAEKERS VT, 1994, NEUROPEDIATRICS, V25, P217, DOI 10.1055/s-2008-1073025
   Riveiro-Alvarez R, 2009, BRIT J OPHTHALMOL, V93, P1359, DOI 10.1136/bjo.2008.148155
   Romá-Mateo C, 2015, FREE RADICAL BIO MED, V88, P30, DOI 10.1016/j.freeradbiomed.2015.01.034
   Rossi E, 2008, EXPERT REV HEMATOL, V1, P205, DOI 10.1586/17474086.1.2.205
   Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853
   Schweizer U, 2016, FASEB J, V30, P3669, DOI 10.1096/fj.201600424
   Seelow D, 2009, NUCLEIC ACIDS RES, V37, PW593, DOI 10.1093/nar/gkp369
   Sibbing D, 2011, EUR HEART J, V32, P1121, DOI 10.1093/eurheartj/ehq507
   Soerensen J, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001813
   Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612
   Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004
   Valentine WM, 2005, TOXICOL PATHOL, V33, P570, DOI 10.1080/01926230500243045
   Volmering E, 2016, ACTA NEUROPATHOL, V132, P277, DOI 10.1007/s00401-016-1561-1
   WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2
   Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z
   Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974
   WISNIEWSKI E, 1993, J BIOL CHEM, V268, P9343
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
   Zuckerman S, 2007, JAMA-J AM MED ASSOC, V298, P1281, DOI 10.1001/jama.298.11.1281
NR 45
TC 32
Z9 33
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY 15
PY 2017
VL 106
IS 
BP 270
EP 277
DI 10.1016/j.freeradbiomed.2017.02.040
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EU0TN
UT WOS:000400724500025
PM 28232204
DA 2024-11-01
ER

PT J
AU Rothwell, S
   Lilleker, JB
   Lamb, JA
AF Rothwell, Simon
   Lilleker, James B.
   Lamb, Janine A.
TI Genetics in inclusion body myositis
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE degeneration; genetic association study; genetics; inclusion body myositis; mitochondria; sequencing
ID cytosolic 5'-nucleotidase 1a; mitochondrial-dna deletions; association; myopathy; diseases; alleles; mhc; polymorphisms; arthritis; proteins
AB Purpose of review To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year. Recent findings One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen (HLA) region to HLA-DRB1 alleles, and identified certain amino acid positions in HLA-DRB1 that may explain this risk. A suggestive association with CCR5 may indicate genetic overlap with other autoimmune diseases. Sequencing studies of candidate genes involved in related neuromuscular or neurodegenerative diseases have identified rare variants in VCP and SQSTM1. Proteomic studies of rimmed vacuoles in IBM and subsequent genetic analyses of candidate genes identified rare missense variants in FYCO1. Complex, large-scale mitochondrial deletions in cytochrome c oxidase-deficient muscle fibres expand our understanding of mitochondrial abnormalities in IBM. Summary The pathogenesis of IBM is likely multifactorial, including inflammatory and degenerative changes, and mitochondrial abnormalities. There has been considerable progress in our understanding of the genetic architecture of IBM, using complementary genetic approaches to investigate these different pathways.
C1 [Rothwell, Simon; Lilleker, James B.] Univ Manchester, Ctr Musculoskeletal Res, Div Musculoskeletal & Dermatol Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9PT, Lancs, England.
   [Lilleker, James B.] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Greater Manchester Neurosci Ctr, Stott Lane, Salford, Lancs, England.
   [Lamb, Janine A.] Univ Manchester, Ctr Epidemiol, Manchester Acad Hlth Sci Ctr,Div Populat Hlth, Hlth Serv Res & Primary Care,Fac Biol Med & Hlth, Manchester, Lancs, England.
C3 University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester
RP Rothwell, S (corresponding author), Univ Manchester, Ctr Musculoskeletal Res, Div Musculoskeletal & Dermatol Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9PT, Lancs, England.
EM s.rothwell@manchester.ac.uk
FU MRC [MR/N003322/1]; MRC [MR/N003322/1] Funding Source: UKRI
CR Ahmed M, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad4583
   Benveniste O, 2015, ACTA NEUROPATHOL, V129, P611, DOI 10.1007/s00401-015-1384-5
   Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chinoy H, 2007, RHEUMATOLOGY, V46, P1411, DOI 10.1093/rheumatology/kem145
   Chinoy H, 2012, RHEUMATOLOGY, V51, P794, DOI 10.1093/rheumatology/ker379
   Evilä A, 2016, NEUROMUSCULAR DISORD, V26, P7, DOI 10.1016/j.nmd.2015.10.003
   Gang Q, 2016, NEUROBIOL AGING, V47, P0, DOI 10.1016/j.neurobiolaging.2016.07.024
   Gang Q, 2015, CURR OPIN RHEUMATOL, V27, P586, DOI 10.1097/BOR.0000000000000213
   Gang Q, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.12.039
   Gang Q, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-88
   Garlepp MJ, 1995, ANN NEUROL, V38, P957, DOI 10.1002/ana.410380619
   Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614
   Johari M, 2017, EUR J NEUROL, V24, P572, DOI 10.1111/ene.13244
   Kirino Y, 2015, NAT REV RHEUMATOL, V11, P401, DOI 10.1038/nrrheum.2015.41
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   Liley J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1004926
   Limaye VS, 2016, MUSCLE NERVE, V53, P654, DOI 10.1002/mus.24989
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P150, DOI 10.1016/j.nmd.2007.09.005
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   Price AL, 2015, P ROY SOC B-BIOL SCI, V282, P0, DOI 10.1098/rspb.2015.1684
   Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Rothwell S, 2017, ARTHRITIS RHEUMATOL, V69, P1090, DOI 10.1002/art.40045
   Rothwell S, 2016, ANN RHEUM DIS, V75, P1558, DOI 10.1136/annrheumdis-2015-208119
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Salajegheh M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020266
   Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148
   Scott AP, 2012, J NEUROIMMUNOL, V250, P66, DOI 10.1016/j.jneuroim.2012.04.021
   SIVAKUMAR K, 1995, ANN NEUROL, V38, P267, DOI 10.1002/ana.410380222
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
NR 45
TC 10
Z9 10
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV 15
PY 2017
VL 29
IS 6
BP 639
EP 644
DI 10.1097/BOR.0000000000000431
PG 6
WC Rheumatology
SC Rheumatology
GA FJ2IK
UT WOS:000412548600013
PM 28777108
DA 2024-11-01
ER

PT J
AU Alila-Fersi, O
   Chamkha, I
   Majdoub, I
   Gargouri, L
   Mkaouar-Rebai, E
   Tabebi, M
   Tlili, A
   Keskes, L
   Mahfoudh, A
   Fakhfakh, F
AF Alila-Fersi, Olfa
   Chamkha, Imen
   Majdoub, Imen
   Gargouri, Lamia
   Mkaouar-Rebai, Emna
   Tabebi, Mouna
   Tlili, Abdelaziz
   Keskes, Leila
   Mahfoudh, Abdelmajid
   Fakhfakh, Faiza
TI Co segregation of the m.1555A>G mutation in the MT-RNR1 gene and mutations in MT-ATP6 gene in a family with dilated mitochondrial cardiomyopathy and hearing loss: A whole mitochondrial genome screening
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Dilated mitochondrial cardiomyopathy; Hearing loss; m.1555A>G; m.8605C>T; m.8527A>G; m.8932C>T
ID proline residues; prediction; patient; helix
AB Mitochondrial disease refers to a heterogeneous group of disorders resulting in defective cellular energy production due to dysfunction of the mitochondrial respiratory chain, which is responsible for the generation of most cellular energy. Because cardiac muscles are one of the high energy demanding tissues, mitochondrial cardiomyopathies is one of the most frequent mitochondria disorders. Mitochondrial cardiomyopathy has been associated with several point mutations of mtDNA in both genes encoded mitochondrial proteins and mitochondrial tRNA and rRNA. We reported here the first description of mutations in MT-ATP6 gene in two patients with clinical features of dilated mitochondrial cardiomyopathy. The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A>G mutation in MT-RNR1 gene associated to the m.8527A>G (p.M>V) and the m.8392C>T (p.136P>S) variations in the mitochondrial MT-ATP6 gene in patient) and his family members with variable phenotype including hearing impairment. The second patient with isolated mitochondrial cardiomyopathy presented the m.8605C>T (p.27P>S) mutation in the MT-ATP6 gene. The three mutations p.M1V, p.P27S and p.P136S detected in MT-ATP6 affected well conserved residues of the mitochondrial protein ATPase 6. In addition, the substitution of proline residue at position 27 and 136 effect hydrophobicity and structure flexibility conformation of the protein. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Alila-Fersi, Olfa; Mkaouar-Rebai, Emna; Fakhfakh, Faiza] Univ Sfax, Fac Sci Sfax, Sfax, Sfax, Tunisia.
   [Chamkha, Imen] Lund Univ, Dept Mitochondrial Med, S-22100 Lund, Sweden.
   [Majdoub, Imen; Gargouri, Lamia; Mahfoudh, Abdelmajid] CHU Hedi Chaker Sfax Tunisia, Serv Reanimat Pediat, Sfax, Tunisia.
   [Tabebi, Mouna; Keskes, Leila] Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Sfax, Sfax, Tunisia.
   [Mahfoudh, Abdelmajid] Univ Sharjah, Coll Sci, Dept Appl Biol, Sharjah, U Arab Emirates.
C3 Universite de Sfax; Faculty of Sciences Sfax; Lund University; Universite de Sfax; Hopital Hedi Chaker; Universite de Sfax; University of Sharjah
RP Alila-Fersi, O; Fakhfakh, F (corresponding author), Fac Sci Sfax, Lab Genet Mol & Fonct, Route Soukra Km 2-5, Sfax 3000, Tunisia.
EM alilafersiolfa@yahoo.fr; faiza.fakhfakh02@gmail.com
FU Ministry of the Higher Education; Scientific Research in Tunisia
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854
   Arnold S, 2001, FEBS LETT, V490, P70, DOI 10.1016/S0014-5793(01)02139-1
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b
   Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Brunel-Guitton C, 2015, CAN J CARDIOL, V31, P1360, DOI 10.1016/j.cjca.2015.08.017
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Cheng Zu-jian, 2009, ZHONGHUA YI XUE ZA ZHI, V89, P2536
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019
   Deschauer M, 2000, MOL GENET METAB, V70, P235, DOI 10.1006/mgme.2000.3002
   Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Felhi R, 2016, BIOCHEM BIOPH RES CO, V473, P61, DOI 10.1016/j.bbrc.2016.03.050
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Hagen CM, 2013, MOL GENET GENOM MED, V1, P54, DOI 10.1002/mgg3.5
   Hejzlarová K, 2014, PHYSIOL RES, V63, PS57, DOI 10.33549/physiolres.932643
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Marin-Garcia J, 2000, J CARD FAIL, V6, P321, DOI 10.1054/jcaf.2000.19232
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   Niedzwiecka K, 2016, MITOCHONDRION, V29, P7, DOI 10.1016/j.mito.2016.04.003
   Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217
   Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Tsai JD, 2012, PEDIATR NEONATOL, V53, P60, DOI 10.1016/j.pedneo.2011.11.012
NR 40
TC 8
Z9 9
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 26
PY 2017
VL 484
IS 1
BP 71
EP 78
DI 10.1016/j.bbrc.2017.01.070
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA EL1VW
UT WOS:000394410500012
PM 28104394
DA 2024-11-01
ER

PT J
AU Panosyan, FB
   Tawil, R
   Herrmann, DN
AF Panosyan, Francis B.
   Tawil, Rabi
   Herrmann, David N.
TI EPISODIC WEAKNESS AND CHARCOT-MARIE-TOOTH DISEASE DUE TO A MITOCHONDRIAL <i>MT</i>-<i>ATP6</i> MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE Charcot-Marie-Tooth disease; episodic weakness; inherited neuropathy; mitochondrial ATPase; periodic paralysis
ID leigh-syndrome; t9176c mutation; ataxia; atpase; mtdna; gene; disorders; phenotype; subtypes; family
AB Introduction: Episodic muscle weakness is the hallmark of a heterogeneous group of disorders known as periodic paralysis. A majority are due to single nucleotide mutations causing membrane depolarization. Methods: We report 2 family members with chronic, slowly progressive, distal axonal neuropathy, or Charcot-Marie-Tooth disease type 2 (CMT2) and episodic weakness resembling periodic paralysis. Results: Next generation sequencing (NGS) identified a mitochondrial MT-ATP6 mutation m.9185T>C (p.Leu220Pro) in both patients, consistent with a previous report of an association with this phenotype. The episodic weakness has been responsive to acetazolamide therapy for a few decades. By contrast, the underlying axonal neuropathy is quite progressive despite treatment with acetazolamide. Conclusions: Mitochondrial DNA mutations should be considered in patients with a history of episodic weakness and axonal inherited neuropathy (CMT2). The episodic weakness is responsive to acetazolamide therapy, and electrophysiological testing for periodic paralysis with a long exercise protocol is negative in these cases.
C1 [Panosyan, Francis B.; Tawil, Rabi; Herrmann, David N.] Univ Rochester, Med Ctr, Dept Neurol, Box 673,601 Elmwood Ave, Rochester, NY 14642 USA.
C3 University of Rochester
RP Panosyan, FB (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Box 673,601 Elmwood Ave, Rochester, NY 14642 USA.
EM 4fbp@queensu.ca
CR Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Braathen GJ, 2012, ACTA NEUROL SCAND, V126, P0, DOI 10.1111/ane.12013
   Brum M, 2014, CASE REP NEUROL MED, V2014, P0, DOI 10.1155/2014/701761
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   CAIN BD, 1986, J BIOL CHEM, V261, P43
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Cleland JC, 2014, CLIN NEUROPHYSIOL, V125, P2134, DOI 10.1016/j.clinph.2014.02.005
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Miller TM, 2004, NEUROLOGY, V63, P1647, DOI 10.1212/01.WNL.0000143383.91137.00
   Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Rudnik-Schöneborn S, 2016, CLIN GENET, V89, P34, DOI 10.1111/cge.12594
   Sansone V, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD005045.pub2
   Sansone VA, 2016, NEUROLOGY, V86, P1408, DOI 10.1212/WNL.0000000000002416
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Takahashi S, 1998, AM J HUM GENET, V62, P717, DOI 10.1086/301751
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tengan CH, 2004, J NEUROL NEUROSUR PS, V75, P497, DOI 10.1136/jnnp.2003.013870
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
NR 39
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JUN 15
PY 2017
VL 55
IS 6
BP 922
EP +
DI 10.1002/mus.25453
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EY5TA
UT WOS:000404041600028
PM 27783406
DA 2024-11-01
ER

PT J
AU Dallabona, C
   Baruffini, E
   Goffrini, P
   Lodi, T
AF Dallabona, Cristina
   Baruffini, Enrico
   Goffrini, Paola
   Lodi, Tiziana
TI Dominance of yeast <i>aac2<SUP>R96H</SUP></i> and <i>aac2<SUP>R252G</SUP></i> mutations, equivalent to pathological mutations in ant1, is due to gain of function
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Yeast; ANT1; SLC25A4; AAC2; Mitochondrial diseases; Gain of function
ID adenine-nucleotide translocator; progressive external ophthalmoplegia; mitochondrial adp/atp carrier; saccharomyces-cerevisiae; gene mutation; myopathy; dna; cardiomyopathy; diseases; family
AB The mitochondrial ADP/ATP carrier is a nuclear encoded protein, which catalyzes the exchange of ATP generated in mitochondria with ADP produced in the cytosol. In humans, mutations in the major ADP/ATP carrier gene, ANTI, are involved in several degenerative mitochondrial pathologies, leading to instability of mitochondrial DNA. Recessive mutations have been associated with mitochondrial myopathy and cardiomyopathy whereas dominant mutations have been associated with autosomal dominant Progressive External Ophtalmoplegia (adPEO). Recently, two de novo dominant mutations, R8OH and R235G, leading to extremely severe symptoms, have been identified. In order to evaluate if the dominance is due to haploinsufficiency or to a gain of function, the two mutations have been introduced in the equivalent positions of the AAC2 gene, the yeast orthologue of human ANTI, and their dominant effect has been studied in heteroallelic strains, containing both one copy of wild type AAC2 and one copy of mutant aac2 allele. Through phenotypic characterization of these yeast models we showed that the OXPHOS phenotypes in the heteroallelic strains were more affected than in the hemiallelic strain indicating that the dominant trait of the two mutations is due to gain of function. (C) 2017 The Authors. Published by Elsevier Inc.
C1 [Dallabona, Cristina; Baruffini, Enrico; Goffrini, Paola; Lodi, Tiziana] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
C3 University of Parma
RP Lodi, T (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM tiziana.lodi@unipr.it
FU Fondazione Telethon (Italy) [GGP15041]
CR Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   KOLAROV J, 1990, J BIOL CHEM, V265, P12711
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kunji ERS, 2016, BBA-MOL CELL RES, V1863, P2379, DOI 10.1016/j.bbamcr.2016.03.015
   Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   Liu YX, 2015, MOL BIOL CELL, V26, P1985, DOI 10.1091/mbc.E15-01-0030
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
NR 29
TC 8
Z9 8
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 18
PY 2017
VL 493
IS 2
BP 909
EP 913
DI 10.1016/j.bbrc.2017.09.122
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK8YI
UT WOS:000413797200006
PM 28947214
DA 2024-11-01
ER

PT J
AU Zhang, J
   Cui, L
   Ma, J
   Chen, C
   Yang, B
   Huang, L
AF Zhang, J.
   Cui, L.
   Ma, J.
   Chen, C.
   Yang, B.
   Huang, L.
TI Transcriptome analyses reveal genes and pathways associated with fatty acid composition traits in pigs
SO ANIMAL GENETICS
LA English
DT Article
DE candidate gene; co-expression network; fatty acid contents; quantitative trait transcript; swine
ID genome-wide association; adipose-tissue; meat quality; population; insulin; cells; identification; interferon; samples; humans
AB Fatty acid composition is associated with meat quality in pigs as well as with obesity-and diabetes-related traits in humans. Liver and muscle are important tissues for fatty acid metabolism. In this study, we evaluated correlations between liver and muscle transcriptomes and fatty acid composition traits in muscle and abdominal fat tissues in 335 F-2 pigs from a White Duroc x Erhualian F-2 pig resource population. Transcripts significantly correlated with fatty acid composition traits were enriched for genes involved in the categories of triglyceride catabolic process, mitochondrial function, hematological and immune system, and disease such as Type II diabetes. Gene co-expression network analysis further identified liver network modules relevant to fatty acid unsaturation index that were enriched in platelet activation and the type I interferon signaling pathway and highlighted the connections between variations in fatty acid composition and genes involved in hematological and immune system. Integrative analysis of the expression QTL identified ELOVL6 and SCD as plausible candidate genes underlying the loci for muscle C18:1n-9/C16:1n-7 values on chromosome 8 and the loci for muscle C18:1n-9/C18:0 contents on chromosome 14 respectively.
C1 [Zhang, J.; Cui, L.; Ma, J.; Chen, C.; Yang, B.; Huang, L.] Jiangxi Agr Univ, State Key Lab Pig Genet Improvement & Prod Techno, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Yang, B (corresponding author), Jiangxi Agr Univ, State Key Lab Pig Genet Improvement & Prod Techno, Nanchang 330045, Jiangxi, Peoples R China.
EM binyang@live.cn
FU Natural Science Foundation of China [31572379]
CR Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222
   APOSTOLOV K, 1981, FEBS LETT, V126, P261, DOI 10.1016/0014-5793(81)80256-6
   Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404
   BOUGNOUX P, 1985, MOL IMMUNOL, V22, P1107, DOI 10.1016/0161-5890(85)90114-2
   Calder PC, 2002, BRIT J NUTR, V87, PS31, DOI 10.1079/BJN2001455
   Corominas J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053687
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Garaulet M, 2001, AM J CLIN NUTR, V74, P585
   Garaulet M, 2006, INT J OBESITY, V30, P899, DOI 10.1038/sj.ijo.0803219
   GOODNIGHT SH, 1981, BLOOD, V58, P880
   Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004
   Kew S, 2003, AM J CLIN NUTR, V77, P1278, DOI 10.1093/ajcn/77.5.1278
   Kriketos AD, 1996, AM J PHYSIOL-REG I, V270, PR1332, DOI 10.1152/ajpregu.1996.270.6.R1332
   Langmead B, 2009, GENOME BIOL, V10, P0, DOI 10.1186/gb-2009-10-3-r25
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900
   RENAUD S, 1970, CIRC RES, V26, P553, DOI 10.1161/01.RES.26.5.553
   Ros-Freixedes R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0152496
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Uemoto Y, 2012, ANIM GENET, V43, P27, DOI 10.1111/j.1365-2052.2011.02218.x
   Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029
   Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019
   Xiong XW, 2015, PHYSIOL GENOMICS, V47, P274, DOI 10.1152/physiolgenomics.00005.2015
   Xu P, 2016, PHYSIOL GENOMICS, V48, P573, DOI 10.1152/physiolgenomics.00123.2015
   Yang B, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065554
   Zhang B, 2005, STAT APPL GENET MOL, V4, P0, DOI 10.2202/1544-6115.1128
   Zhang WC, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24718
   Zhang WC, 2016, GENET SEL EVOL, V48, P0, DOI 10.1186/s12711-016-0184-2
NR 30
TC 16
Z9 18
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-9146
EI 1365-2052
J9 ANIM GENET
JI Anim. Genet.
PD DEC 15
PY 2017
VL 48
IS 6
BP 645
EP 652
DI 10.1111/age.12597
PG 8
WC Agriculture, Dairy & Animal Science; Genetics & Heredity
SC Agriculture; Genetics & Heredity
GA FM8VF
UT WOS:000415368600002
PM 29034492
DA 2024-11-01
ER

PT J
AU Lv, ZY
   Xu, XM
   Cao, XF
   Wang, Q
   Sun, DF
   Tian, WJ
   Yang, Y
   Wang, YZ
   Hao, YL
AF Lv, Zhan-Yun
   Xu, Xue-Mei
   Cao, Xiao-Fu
   Wang, Qian
   Sun, Da-Fang
   Tian, Wen-Jing
   Yang, Yan
   Wang, Yu-Zhong
   Hao, Yan-Lei
TI Mitochondrial mutations in 12S rRNA and 16S rRNA presenting as chronic progressive external ophthalmoplegia (CPEO) plus A case report
SO MEDICINE
LA English
DT Article
DE 12S rRNA; 16S rRNA; C2835T; C960del; chronic progressive external ophthalmoplegia plus; mitochondrial; MRI
ID diagnosis; dna; disease
AB Rationale: Chronic progressive external ophthalmoplegia (CPEO) is a classical mitochondrial ocular disorder characterized by bilateral progressive ptosis and ophthalmoplegia. Kearns-Sayre syndrome (KSS) is a multisystem disorder with PEO, cardiac conduction block, and pigmentary retinopathy. A few individuals with CPEO have other manifestations of KSS, but do not meet all the clinical diagnosis criteria, and this is called "CPEO plus." Patient concerns: We report a 48-year-old woman exhibiting limb weakness, ptosis, ophthalmoparesis, and cerebellar dysfunctions. Diagnoses: The patient was diagnosed as exhibiting CPEO plus syndrome. Interventions: The patient underwent clinical, genetic, histological, and histochemical analysis. She was treated orally with CoQ10, vitamin Bs, L-carnitine, and vitamin E. Outcomes: The patient's serum creatine kinase levels, electrocardiography, and nerve conduction study results were normal; an electromyogram revealed myopathic findings. Magnetic resonance imaging showed global brain atrophy, particularly in the brainstem and cerebellum areas. A muscle biopsy showed the presence of abundant ragged red fibers. Sequencing of the mitochondrial DNA from the skeletal muscle biopsy revealed C960del mutation in 12S rRNA and homozygous mutation C2835T in 16S rRNA. She took medicines on schedule, the clinical features were similar as 2 years ago. Lessons: This is the first report of 2 rRNA mutations in a patient with MRI findings showing global brain atrophy, particularly in brainstem and cerebellum areas. Early recognition and appropriate treatment is crucial. This case highlights the cerebellar ataxia can occur in CPEO plus.
C1 [Lv, Zhan-Yun; Xu, Xue-Mei; Cao, Xiao-Fu; Wang, Qian; Sun, Da-Fang; Tian, Wen-Jing; Yang, Yan; Wang, Yu-Zhong; Hao, Yan-Lei] Jining Med Coll, Affiliated Hosp, Dept Neurol, 89 Guhuai Rd, Jining 272000, Shandong, Peoples R China.
C3 Jining Medical University
RP Hao, YL (corresponding author), Jining Med Coll, Affiliated Hosp, Dept Neurol, 89 Guhuai Rd, Jining 272000, Shandong, Peoples R China.
EM yhao@mail.jnmc.edu.cn
FU National Natural Science Foundation of China [81401064, 81271398]; Affiliated Hospital of Jining Medical College [2013-ZD-003]
CR Bindu PS, 2015, MITOCHONDRION, V25, P6, DOI 10.1016/j.mito.2015.08.002
   Cianfaglione R, 2015, J NEURODEV DISORD, V7, P0, DOI 10.1186/s11689-015-9104-y
   Davis RL, 2011, SEMIN NEUROL, V31, P519, DOI 10.1055/s-0031-1299790
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Elstner M, 2008, BIOCHEM BIOPH RES CO, V377, P379, DOI 10.1016/j.bbrc.2008.09.134
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   KAWAI H, 1995, MUSCLE NERVE, V18, P753, DOI 10.1002/mus.880180712
   Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meyers DE, 2013, TEX HEART I J, V40, P385
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Qu J, 2009, OPHTHALMOLOGY, V116, P558, DOI 10.1016/j.ophtha.2008.10.022
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Salvatore D, 1993, MITOCHONDRIAL DNA DE, V0, P0
   Tang J, 1997, PEDIATR NEUROL, V17, P327, DOI 10.1016/S0887-8994(97)00151-3
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani Massimo, 2012, HANDB CLIN NEUROL, V103, P359, DOI 10.1016/B978-0-444-51892-7.00022-X
NR 28
TC 9
Z9 10
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC 15
PY 2017
VL 96
IS 48
BP 
EP 
DI 10.1097/MD.0000000000008869
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA FS2VD
UT WOS:000419636400049
PM 29310369
DA 2024-11-01
ER

PT J
AU Younis, S
   Hougaard, A
   Vestergaard, MB
   Larsson, HBW
   Ashina, M
AF Younis, Samaira
   Hougaard, Anders
   Vestergaard, Mark B.
   Larsson, Henrik B. W.
   Ashina, Messoud
TI Migraine and magnetic resonance spectroscopy: a systematic review
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE glutamate; magnetic resonance spectroscopy; metabolism; migraine; mitochondrial dysfunction
ID randomized controlled-trial; vivo h-1-nmr spectroscopy; muscle energy-metabolism; genome-wide association; h-1 mr spectroscopy; low brain magnesium; n-acetyl-aspartate; in-vivo; clinical-manifestations; hemiplegic migraine
AB Purpose of review To present an updated and streamlined overview of the metabolic and biochemical aspect of the migraine pathophysiology based on findings from phosphorous (P-31) and hydrogen (H-1) magnetic resonance spectroscopy (MRS) studies. Recent findings Despite of the variation in the methodology and quality of the MRS migraine studies over time, some results were consistent and reproducible. P-31-MRS studies suggested reduced availability of neuronal energy and implied a mitochondrial dysfunction in the migraine brain. H-1-MRS studies reported interictal abnormalities in the excitatory and inhibitory neurotransmitters, glutamate and gamma-aminobutyric acid (GABA), suggesting persistent altered excitability in migraine patients. N-Acetylaspartate levels were decreased in migraine, probably due to a mitochondrial dysfunction and abnormal energy metabolism. The reported abnormalities may increase the susceptibility of migraine patients to excitatory stimulation, such as migraine attack triggers. Summary Several biochemical aspects of the migraine pathophysiology remain to be elucidated using MRS, such as the migraine attack, correlation to disease severity, and medication efficacy. Nevertheless, to identify a biomarker in migraine, MRS may be a valuable noninvasive technique.
C1 [Younis, Samaira; Hougaard, Anders; Ashina, Messoud] Univ Copenhagen, Danish Headache Ctr, Copenhagen, Denmark.
   [Younis, Samaira; Hougaard, Anders; Ashina, Messoud] Univ Copenhagen, Dept Neurol, Copenhagen, Denmark.
   [Vestergaard, Mark B.; Larsson, Henrik B. W.] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Funct Imaging Unit,Dept Clin Physiol Nucl Med & P, Copenhagen, Denmark.
C3 University of Copenhagen; University of Copenhagen; University of Copenhagen
RP Ashina, M (corresponding author), Univ Copenhagen, Danish Headache Ctr, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.; Ashina, M (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.; Ashina, M (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.
EM ashina@dadlnet.dk
FU Lundbeck Foundation [R155-2014-171]
CR Aguila MER, 2015, NMR BIOMED, V28, P890, DOI 10.1002/nbm.3321
   Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652
   Arngrim N, 2016, BRAIN, V139, P723, DOI 10.1093/brain/awv359
   Assarzadegan F, 2016, INT CLIN PSYCHOPHARM, V31, P287, DOI 10.1097/YIC.0000000000000130
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
   BARBIROLI B, 1990, CEPHALALGIA, V10, P263, DOI 10.1046/j.1468-2982.1990.1005263.x
   Becerra L, 2016, NEUROIMAGE-CLIN, V11, P588, DOI 10.1016/j.nicl.2016.03.020
   BIERMANS W, 1990, BIOCHIM BIOPHYS ACTA, V1018, P225, DOI 10.1016/0005-2728(90)90254-2
   Bigal ME, 2008, NEUROLOGY, V70, P2078, DOI 10.1212/01.wnl.0000313376.07248.28
   Boska MD, 2002, NEUROLOGY, V58, P1227, DOI 10.1212/WNL.58.8.1227
   BOTTOMLEY PA, 1989, CLIN CHEM, V35, P392
   Bridge H, 2015, CEPHALALGIA, V35, P1025, DOI 10.1177/0333102414566860
   Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856
   CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D
   Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321
   de Tommaso M, 2012, J HEADACHE PAIN, V13, P389, DOI 10.1007/s10194-012-0448-3
   Dichgans M, 2005, NEUROLOGY, V64, P608, DOI 10.1212/01.WNL.0000151855.98318.50
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fayed N, 2014, ACAD RADIOL, V21, P1211, DOI 10.1016/j.acra.2014.04.009
   Goadsby PJ, 2009, NEUROL CLIN, V27, P335, DOI 10.1016/j.ncl.2008.11.012
   de la Aleja JG, 2013, HEADACHE, V53, P365, DOI 10.1111/head.12030
   Grimaldi D, 2010, CEPHALALGIA, V30, P552, DOI 10.1111/j.1468-2982.2009.01979.x
   Grubbs RD, 1987, MAGNESIUM, V6, P781
   Gu M, 2013, NMR BIOMED, V26, P164, DOI 10.1002/nbm.2831
   Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   HALVORSON HR, 1992, NMR BIOMED, V5, P53, DOI 10.1002/nbm.1940050202
   Hougaard A, 2013, NEUROLOGY, V80, P428, DOI 10.1212/WNL.0b013e31827f0f10
   Iotti S, 1996, NMR BIOMED, V9, P24, DOI 10.1002/(SICI)1099-1492(199602)9:1<24::AID-NBM392>3.0.CO;2-B
   Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314
   Jourdain P, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21250
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Lai T, 2011, J HEADACHE PAIN, V12, P295
   Landim RCG, 2016, MAGN RESON IMAGING, V34, P239, DOI 10.1016/j.mri.2015.10.038
   LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32
   Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4
   Lirng JF, 2015, CEPHALALGIA, V35, P702, DOI 10.1177/0333102414557048
   Lodi R, 1997, PEDIATR RES, V42, P866, DOI 10.1203/00006450-199712000-00024
   Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3
   Macrì MA, 2003, MAGN RESON IMAGING, V21, P1201, DOI 10.1016/j.mri.2003.08.021
   Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J
   Mohamed RE, 2013, EGYPT J RADIOL NUC M, V44, P859, DOI 10.1016/j.ejrnm.2013.08.004
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   MONTAGNA P, 1994, NEUROLOGY, V44, P666, DOI 10.1212/WNL.44.4.666
   NIOKA S, 1987, J APPL PHYSIOL, V62, P2094, DOI 10.1152/jappl.1987.62.5.2094
   Noseda R, 2013, PAIN, V154, PS44, DOI 10.1016/j.pain.2013.07.021
   OGorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520
   Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0
   Oshinsky ML, 2006, HEADACHE, V46, PS39, DOI 10.1111/j.1526-4610.2006.00489.x
   PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781
   Pradhan S, 2015, MAGN RESON IMAGING, V33, P1013, DOI 10.1016/j.mri.2015.06.003
   Prescot A, 2009, MOL PAIN, V5, P0, DOI 10.1186/1744-8069-5-34
   RAMADAN NM, 1989, HEADACHE, V29, P590, DOI 10.1111/j.1526-4610.1989.hed2909590.x
   Reyngoudt H, 2012, CEPHALALGIA, V32, P845, DOI 10.1177/0333102412452048
   Reyngoudt H, 2011, CEPHALALGIA, V31, P1243, DOI 10.1177/0333102410394675
   Reyngoudt H, 2011, J HEADACHE PAIN, V12, P295, DOI 10.1007/s10194-011-0295-7
   Reyngoudt H, 2010, MAGN RESON MATER PHY, V23, P227, DOI 10.1007/s10334-010-0221-z
   RYNER LN, 1995, MAGN RESON IMAGING, V13, P853, DOI 10.1016/0730-725X(95)00031-B
   Sándor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED
   Sándor PS, 2005, CEPHALALGIA, V25, P507, DOI 10.1111/j.1468-2982.2005.00900.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82
   Sarchielli P, 2005, NEUROIMAGE, V24, P1025, DOI 10.1016/j.neuroimage.2004.11.005
   Schaller B, 2013, J NEUROSCI RES, V91, P1076, DOI 10.1002/jnr.23194
   Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466
   Schulz UG, 2007, BRAIN, V130, P3102, DOI 10.1093/brain/awm165
   Siniatchkin M, 2012, CEREB CORTEX, V22, P2207, DOI 10.1093/cercor/bhr248
   Tkác I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213
   Tkác I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   van Dongen RM, 2017, CEPHALALGIA, V37, P49, DOI 10.1177/0333102415625614
   Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007
   VEECH RL, 1979, J BIOL CHEM, V254, P6538
   Vestergaard MB, 2016, J CEREBR BLOOD F MET, V36, P1046, DOI 10.1177/0271678X15606460
   Wang SJ, 2006, J NEUROL NEUROSUR PS, V77, P622, DOI 10.1136/jnnp.2005.081836
   Watanabe H, 1996, NEUROLOGY, V47, P1093
   WELCH KMA, 1988, CEPHALALGIA, V8, P273, DOI 10.1046/j.1468-2982.1988.0804273.x
   WELCH KMA, 1995, J NEUROL SCI, V134, P9, DOI 10.1016/0022-510X(95)00196-1
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Yang SL, 2008, MAGN RESON MED, V59, P236, DOI 10.1002/mrm.21463
   Zielman R, 2014, CEPHALALGIA, V34, P959, DOI 10.1177/0333102414527016
NR 82
TC 63
Z9 68
U1 1
U2 19
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD JUN 15
PY 2017
VL 30
IS 3
BP 246
EP 262
DI 10.1097/WCO.0000000000000436
PG 17
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EU5RC
UT WOS:000401089600008
PM 28240609
DA 2024-11-01
ER

PT J
AU Toscano, A
   Barca, E
   Musumeci, O
AF Toscano, Antonio
   Barca, Emanuele
   Musumeci, Olimpia
TI Update on diagnostics of metabolic myopathies
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE algorithm; dried blood spot; early therapy; metabolic myopathies; muscle biopsy; presymptomatic hyperckemia; rhabdomyolysis
ID polyglucosan body disease; mitochondrial-dna; pompe disease; coenzyme-q10 deficiency; molecular findings; clinical-features; mutations; gene; myoglobinuria; management
AB Purpose of review This review aims to highlight the most relevant clinical and laboratory findings, regarding acute and progressive metabolic myopathies, and to develop an algorithm addressing clinicians to clinical practice. Recent findings Although diagnosis of metabolic myopathies remains still challenging, the recent identification of new disorders has increased the number of patients requiring specific investigations. Nowadays, a more detailed characterization of the clinical spectrum of metabolic myopathies improved awareness as well as a deeper knowledge on their natural history or multisystem involvement. Diagnostic procedures, as first-line screening tests are necessary for an earlier and more accurate diagnostic work up, not only in infantile cases, but also in adults with suspected metabolic myopathies. New generation diagnostic techniques such as NGS (Next Generation Sequencing) and whole exome/genome sequencing have emerged as innovative tools to extensively evaluate either known genes variants or new candidate genes as possible causes of metabolic myopathies. Summary Diagnosis of metabolic myopathies is still challenging for clinicians because of rarity and clinical heterogeneity which is often overlapping with other neuromuscular disorders. Detailed algorithms supported by advanced laboratory investigations may be helpful to timely reach a diagnosis, so allowing an earlier therapeutic decision.
C1 [Toscano, Antonio; Barca, Emanuele; Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Via Consolare Valeria 1, I-98125 Messina, Italy.
C3 University of Messina
RP Toscano, A (corresponding author), Univ Messina, Dept Clin & Expt Med, Via Consolare Valeria 1, I-98125 Messina, Italy.
EM atoscano@unime.it
FU Department of Clinical and Experimental Medicine, University of Messina, Telethon [GUP13013]; EUROMAC project - European Commission [20121214]; Telethon GUP [13013]; Telethon GSP [16000]
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Barca E, 2015, CURR NEUROL NEUROSCI, V15, P0, DOI 10.1007/s11910-015-0590-9
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cohen BH, 1993, GENEREVIEWS R, V0, P0
   Corti S, 2008, J NEUROL SCI, V266, P97, DOI 10.1016/j.jns.2007.09.015
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   DIDONATO S, 2004, MYOLOGY, V0, P1587
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kollberg G, 2011, NEUROMUSCULAR DISORD, V21, P115, DOI 10.1016/j.nmd.2010.11.010
   Laforêt P, 2010, NEUROMUSCULAR DISORD, V20, P693, DOI 10.1016/j.nmd.2010.06.018
   Laforêt P, 2009, NEUROMUSCULAR DISORD, V19, P324, DOI 10.1016/j.nmd.2009.02.007
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   Lucchiari S, 2006, HUM MUTAT, V27, P600, DOI 10.1002/humu.9426
   Lukacs Z, 2016, NEUROLOGY, V87, P295, DOI 10.1212/WNL.0000000000002758
   Malfatti E, 2014, ANN NEUROL, V76, P891, DOI 10.1002/ana.24284
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mochel F, 2012, ANN NEUROL, V72, P433, DOI 10.1002/ana.23598
   Montagnese F, 2016, J INHERIT METAB DIS, V39, P391, DOI 10.1007/s10545-015-9913-x
   Musumeci O, 2016, J NEUROL NEUROSUR PS, V87, P5, DOI 10.1136/jnnp-2014-310164
   Musumeci O, 2014, J NEUROL, V261, P2424, DOI 10.1007/s00415-014-7512-7
   Musumeci O, 2012, NEUROMUSCULAR DISORD, V22, P325, DOI 10.1016/j.nmd.2011.10.022
   Naini A, 2009, ARCH NEUROL-CHICAGO, V66, P394, DOI 10.1001/archneurol.2008.584
   Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52
   Nilsson J, 2013, ANN NEUROL, V74, P914, DOI 10.1002/ana.23963
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ohashi Y, 2004, NEUROLOGY, V62, P2209, DOI 10.1212/01.WNL.0000130486.54839.15
   Oldfors A, 2013, CURR OPIN NEUROL, V26, P544, DOI 10.1097/WCO.0b013e328364dbdc
   Olpin SE, 2015, J CLIN PATHOL, V68, P410, DOI 10.1136/jclinpath-2014-202808
   Quinlivan R, 2010, J NEUROL NEUROSUR PS, V81, P1182, DOI 10.1136/jnnp.2009.195040
   Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317
   Ripolone M, 2018, NEUROPATH APPL NEURO, V44, P449, DOI 10.1111/nan.12414
   Sagnelli A, 2014, NEUROMUSCULAR DISORD, V24, P272, DOI 10.1016/j.nmd.2013.11.006
   Schoser B, 2017, J NEUROL, V264, P621, DOI 10.1007/s00415-016-8219-8
   Sentner CP, 2016, J INHERIT METAB DIS, V39, P697, DOI 10.1007/s10545-016-9932-2
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sukigara S, 2012, NEUROMUSCULAR DISORD, V22, P162, DOI 10.1016/j.nmd.2011.08.008
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605
   Toscano A, 2014, CURR MOL MED, V14, P1001, DOI 10.2174/1566524014666141010152340
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002
NR 47
TC 14
Z9 14
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT 15
PY 2017
VL 30
IS 5
BP 553
EP 562
DI 10.1097/WCO.0000000000000483
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF5AK
UT WOS:000408979900017
PM 28763305
DA 2024-11-01
ER

PT J
AU Paraskevaidi, M
   Martin-Hirsch, PL
   Kyrgiou, M
   Martin, FL
AF Paraskevaidi, Maria
   Martin-Hirsch, Pierre L.
   Kyrgiou, Maria
   Martin, Francis L.
TI Underlying role of mitochondrial mutagenesis in the pathogenesis of a disease and current approaches for translational research
SO MUTAGENESIS
LA English
DT Review
ID hereditary optic neuropathy; dna mutations; neurodegenerative diseases; protein-synthesis; oxidative stress; stem-cells; replication; disorders; epidemiology; dysfunction
AB Mitochondrial diseases have been extensively investigated over the last three decades, but many questions regarding their underlying aetiologies remain unanswered. Mitochondrial dysfunction is not only responsible for a range of neurological and myopathy diseases but also considered pivotal in a broader spectrum of common diseases such as epilepsy, autism and bipolar disorder. These disorders are a challenge to diagnose and treat, as their aetiology might be multifactorial. In this review, the focus is placed on potential mechanisms capable of introducing defects in mitochondria resulting in disease. Special attention is given to the influence of xenobiotics on mitochondria; environmental factors inducing mutations or epigenetic changes in the mitochondrial genome can alter its expression and impair the whole cell's functionality. Specifically, we suggest that environmental agents can cause damage in mitochondrial DNA and consequently lead to mutagenesis. Moreover, we describe current approaches for handling mitochondrial diseases, as well as available prenatal diagnostic tests, towards eliminating these maternally inherited diseases. Undoubtedly, more research is required, as current therapeutic approaches mostly employ palliative therapies rather than targeting primary mechanisms or prophylactic approaches. Much effort is needed into further unravelling the relationship between xenobiotics and mitochondria, as the extent of influence in mitochondrial pathogenesis is increasingly recognised.
C1 [Paraskevaidi, Maria; Martin, Francis L.] Univ Cent Lancashire, Sch Pharm & Biomed Sci, Preston PR1 2HE, Lancs, England.
   [Martin-Hirsch, Pierre L.] Cent Lancashire Teaching Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Preston PR5 6AW, Lancs, England.
   [Kyrgiou, Maria] Imperial Coll, Inst Reprod & Dev Biol, Fac Med, London W12 0NN, England.
C3 University of Central Lancashire; Imperial College London
RP Martin, FL (corresponding author), Univ Cent Lancashire, Sch Pharm & Biomed Sci, Preston PR1 2HE, Lancs, England.
EM flmartin@uclan.ac.uk
FU Rosemere Cancer Foundation
CR Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexeyev M, 2013, COLD SPRING HARB PERSPECT BIOL, V5, P0, DOI 10.1101/CSHPERSPECT.A012641
   ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATCHISON WD, 1994, FASEB J, V8, P622, DOI 10.1096/fasebj.8.9.7516300
   Attene-Ramos MS, 2013, CHEM RES TOXICOL, V26, P1323, DOI 10.1021/tx4001754
   Baker MJ, 2014, BRIT J PHARMACOL, V171, P1870, DOI 10.1111/bph.12430
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   CASTELLINO N, 1969, BRIT J IND MED, V26, P139
   Cavalieri E, 2000, J NATL CANCER INST MONOGR, V0, P75
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1999, J MED GENET, V36, P425
   Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6
   Chinnery PF, 2002, MITOCHONDRION, V2, P149, DOI 10.1016/S1567-7249(02)00046-6
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Cochemé HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   Cohen BH, 2010, DEV DISABIL RES REV, V16, P189, DOI 10.1002/ddrr.106
   de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2000, NEUROL SCI, V21, P0
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392
   HUTCHISOCA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0
   Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188
   Ioannides C, 2007, ENVIRONMENTAL BIOTECHNOLOGY, V3, P1
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Maurer LL, 2016, ENVIRON SCI-NANO, V3, P311, DOI 10.1039/c5en00187k
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   Omura T, 2006, CHEM-BIOL INTERACT, V163, P86, DOI 10.1016/j.cbi.2006.06.008
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Robson M, 2007, RISK ASSESSMENT ENV, V0, P0
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142
   Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, PA292, DOI 10.1289/ehp.118-a292
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   SIEKEVITZ P, 1957, SCI AM, V197, P131, DOI 10.1038/scientificamerican0757-131
   Sokolova IM, 2005, AQUAT TOXICOL, V74, P218, DOI 10.1016/j.aquatox.2005.05.012
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   WUNDERLIV, 1970, BIOCHEM J, V118, P99, DOI 10.1042/bj1180099
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 100
TC 8
Z9 8
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD MAY 15
PY 2017
VL 32
IS 3
BP 335
EP 342
DI 10.1093/mutage/gew058
PG 8
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA EU2PX
UT WOS:000400872500002
PM 27816931
DA 2024-11-01
ER

PT J
AU Punsoni, M
   Mangray, S
   Lombardo, KA
   Heath, N
   Stopa, EG
   Yakirevich, E
AF Punsoni, Michael
   Mangray, Shamlal
   Lombardo, Kara A.
   Heath, Nancy
   Stopa, Edward G.
   Yakirevich, Evgeny
TI Succinate Dehydrogenase B (SDHB) Immunohistochemistry for the Evaluation of Muscle Biopsies
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Article
DE succinate dehydrogenase B; SDHB; immunohistochemistry; muscle biopsy; mitochondrial myopathy
ID mitochondrial-dna deletions; skeletal-muscle; complex ii; mutations
AB Succinate dehydrogenase (SDH) is a key mitochondrial enzyme complex composed of 4 subunits. SDH histochemistry is routinely utilized in the assessment of muscle biopsies to reveal underlying pathology such as subsarcolemmal mitochondrial aggregates. In this study, we evaluated the utility of succinate dehydrogenase B (SDHB) immunohistochemistry (IHC) in 27 muscle biopsies, including 13 mitochondrial myopathies (MMs), 9 inflammatory myopathies, and 5 controls. SDHB IHC was performed on formalin-fixed, paraffin-embedded tissue sections with a mouse monoclonal antibody (Abcam 21A11AE7) in parallel with histochemical SDH stains on a fresh-frozen tissue. In all muscle biopsies, SDHB IHC exhibited granular immunoreactivity and highlighted the dark type 1 and lighter type 2 staining pattern observed by histochemistry. In all cases of MM, SDHB IHC showed subsarcolemmal granular aggregates involving the entire periphery of the fibers that were more distinct than those seen by SDH histochemistry. In 3 extraocular muscle biopsies, SDHB immunoreactive speckles of various sizes were distributed throughout the entire sarcoplasm that were more prominent than those seen on SDH histochemistry. Subsarcolemmal and cytoplasmic granular aggregates seen on SDHB IHC correlated with mitochondrial pathology on electron microscopy. In cases of inflammatory myopathy, there was diffuse sarcoplasmic SDHB immunoreactivity in degenerating fibers, but no evidence of subsarcolemmal aggregates. This study demonstrates that SDHB IHC is highly sensitive and specific in the identification of MM. The automation, reproducibility, and cost efficiency of SDHB IHC offer advantages over the labor-intensive histochemical method requiring frozen sections. As this technique is performed on formalin-fixed, paraffin-embedded tissues, it can be easily applied for retrospective studies.
C1 [Punsoni, Michael; Mangray, Shamlal; Lombardo, Kara A.; Heath, Nancy; Stopa, Edward G.; Yakirevich, Evgeny] Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA.
   [Punsoni, Michael; Mangray, Shamlal; Lombardo, Kara A.; Heath, Nancy; Stopa, Edward G.; Yakirevich, Evgeny] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
C3 Lifespan Health Rhode Island; Rhode Island Hospital; Brown University
RP Yakirevich, E (corresponding author), Rhode Isl Hosp, Dept Pathol, APC12,593 Eddy St, Providence, RI 02903 USA.
EM eyakirevich@lifespan.org
FU Molecular Pathology Core of the COBRE Center for Cancer Research Development - National Institute of General Medical Sciences of the National Institutes of Health [P20GM103421]
CR Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   Bancroft JD, 1990, THEORY PRACTICE HIST, V0, P0
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Chen T, 2014, INT J CLIN EXP PATHO, V7, P8887
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Gill AJ, 2012, PATHOLOGY, V44, P285, DOI 10.1097/PAT.0b013e3283539932
   HINTZ CS, 1984, J HISTOCHEM CYTOCHEM, V32, P655, DOI 10.1177/32.6.6202737
   Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005
   JAY V, 1994, ARCH PATHOL LAB MED, V118, P917
   KUN E, 1949, SCIENCE, V109, P144, DOI 10.1126/science.109.2824.144
   MALATY HA, 1953, NATURE, V171, P295, DOI 10.1038/171295a0
   Meng H, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51586
   Miles L, 2012, HUM PATHOL, V43, P1249, DOI 10.1016/j.humpath.2011.09.016
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Pytel P, 2015, ROBBINS COTRAN PATHO, V0, P1227
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rojiani AM, 1998, MODERN PATHOL, V11, P334
   RUTENBURG AM, 1950, CANCER RES, V10, P113
   Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001
   SELIGMAN AM, 1951, SCIENCE, V113, P317, DOI 10.1126/science.113.2934.317-a
   Sheehan DC, 1980, THEORY PRACTICE HIST, V0, P292
   van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0
   Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 25
TC 11
Z9 13
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD OCT 15
PY 2017
VL 25
IS 9
BP 645
EP 650
DI 10.1097/PAI.0000000000000432
PG 6
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA FO2WX
UT WOS:000416660800011
PM 27556822
DA 2024-11-01
ER

PT J
AU Alston, CL
   Rocha, MC
   Lax, NZ
   Turnbull, DM
   Taylor, RW
AF Alston, Charlotte L.
   Rocha, Mariana C.
   Lax, Nichola Z.
   Turnbull, Doug M.
   Taylor, Robert W.
TI The genetics and pathology of mitochondrial disease
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE mitochondria; mitochondrial disease; mtDNA; respiratory chain deficiency; genetic diagnosis; muscle pathology; immunohistochemistry; neuropathology
ID cytochrome-c-oxidase; complex-i deficiency; stroke-like episodes; hereditary optic neuropathy; atp synthase deficiency; kearns-sayre-syndrome; progressive external ophthalmoplegia; ragged-red fibers; respiratory-chain; leigh-syndrome
AB Mitochondria are double-membrane-bound organelles that are present in all nucleated eukaryotic cells and are responsible for the production of cellular energy in the form of ATP. Mitochondrial function is under dual genetic control-the 16.6-kb mitochondrial genome, with only 37 genes, and the nuclear genome, which encodes the remaining similar to 1300 proteins of the mitoproteome. Mitochondrial dysfunction can arise because of defects in either mitochondrial DNA or nuclear mitochondrial genes, and can present in childhood or adulthood in association with vast clinical heterogeneity, with symptoms affecting a single organ or tissue, or multisystem involvement. There is no cure for mitochondrial disease for the vast majority of mitochondrial disease patients, and a genetic diagnosis is therefore crucial for genetic counselling and recurrence risk calculation, and can impact on the clinical management of affected patients. Next-generation sequencing strategies are proving pivotal in the discovery of new disease genes and the diagnosis of clinically affected patients; mutations in > 250 genes have now been shown to cause mitochondrial disease, and the biochemical, histochemical, immunocytochemical and neuropathological characterization of these patients has led to improved diagnostic testing strategies and novel diagnostic techniques. This review focuses on the current genetic landscape associated with mitochondrial disease, before focusing on advances in studying associated mitochondrial pathology in two, clinically relevant organs-skeletal muscle and brain. (C) 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Alston, Charlotte L.; Rocha, Mariana C.; Lax, Nichola Z.; Turnbull, Doug M.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Newcastle University Centre for Ageing and Vitality [Biotechnology and Biological Sciences Research Council] [G016354/1]; Newcastle University Centre for Ageing and Vitality [Medical Research Council] [G016354/1]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases award; MRC/ESPRC Newcastle Molecular Pathology Node; UK National Health Service Highly Specialised 'Rare Mitochondrial Disorders of Adults and Children' service; Lily Foundation; National Institute for Health Research (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [MC_G0802536, G1100540, G0400074, G0502157, G0800674, G0900652, MR/K000608/1, MR/L016354/1, G0700718] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alston CL, 2016, J MED GENET, V53, P634, DOI 10.1136/jmedgenet-2015-103576
   Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021
   Alston C, 2015, HUM GENET, V134, P869, DOI 10.1007/s00439-015-1568-z
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Chung K, 2013, NAT METHODS, V10, P508, DOI 10.1038/NMETH.2481
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033
   Fukutani Y, 1996, J NEUROL SCI, V137, P103, DOI 10.1016/0022-510X(95)00303-J
   Gaignard P, 2013, AM J HUM GENET, V93, P384, DOI 10.1016/j.ajhg.2013.06.015
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hallmann K, 2016, BRAIN, V139, P338, DOI 10.1093/brain/awv357
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hartmannová H, 2016, HUM MOL GENET, V25, P4062, DOI 10.1093/hmg/ddw245
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Hensen EF, 2011, CLIN ENDOCRINOL, V75, P650, DOI 10.1111/j.1365-2265.2011.04097.x
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lim SC, 2014, AM J HUM GENET, V94, P209, DOI 10.1016/j.ajhg.2013.12.015
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Lott MT, 2013, CURR PROTOC BIOINFOR, V44, P0
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Marcu R, 2014, MOL CELL BIOL, V34, P2890, DOI 10.1128/MCB.00068-14
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Miyake N, 2013, HUM MUTAT, V34, P446, DOI 10.1002/humu.22257
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Mordaunt DA, 2015, AM J MED GENET A, V167, P1330, DOI 10.1002/ajmg.a.36968
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Ostergaard E, 2015, J MED GENET, V52, P203, DOI 10.1136/jmedgenet-2014-102914
   Ostergaard E, 2011, J MED GENET, V48, P737, DOI 10.1136/jmg.2011.088856
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P163, DOI 10.1016/j.ymgme.2011.11.188
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Phillips J, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26013
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sánchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sperl W, 2015, J INHERIT METAB DIS, V38, P391, DOI 10.1007/s10545-014-9787-3
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spiegel R, 2009, EUR J HUM GENET, V17, P1200, DOI 10.1038/ejhg.2009.24
   Stehling O, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011312
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tetreault M, 2015, HUM GENET, V134, P981, DOI 10.1007/s00439-015-1577-y
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284
   Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Tucker EJ, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1004034
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170
   van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466
   van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Wanschers BFJ, 2014, HUM MOL GENET, V23, P6356, DOI 10.1093/hmg/ddu357
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 189
TC 284
Z9 323
U1 4
U2 121
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD JAN 15
PY 2017
VL 241
IS 2
BP 236
EP 250
DI 10.1002/path.4809
PG 15
WC Oncology; Pathology
SC Oncology; Pathology
GA EI9RA
UT WOS:000392845200012
PM 27659608
DA 2024-11-01
ER

PT J
AU Morovat, A
   Weerasinghe, G
   Nesbitt, V
   Hofer, M
   Agnew, T
   Quaghebeur, G
   Sergeant, K
   Fratter, C
   Guha, N
   Mirzazadeh, M
   Poulton, J
AF Morovat, Alireza
   Weerasinghe, Gayani
   Nesbitt, Victoria
   Hofer, Monika
   Agnew, Thomas
   Quaghebeur, Geralrine
   Sergeant, Kate
   Fratter, Carl
   Guha, Nishan
   Mirzazadeh, Mehdi
   Poulton, Joanna
TI Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE fibroblast growth factor-21; FGF-21; mitochondrial disease; diagnosis
ID growth-factor 21; unfolded protein response; fatty liver-disease; fgf21 expression; skeletal-muscle; ppar-alpha; stress; prevalence; disorders; obesity
AB Recent work has suggested that fibroblast growth factor-21 (FGF-21) is a useful biomarker of mitochondrial disease (MD). We routinely measured FGF-21 levels on patients who were investigated at our centre for MD and evaluated its diagnostic performance based on detailed genetic and other laboratory findings. Patients' FGF-21 results were assessed by the use of age-adjusted z-scores based on normalised FGF-21 values from a healthy population. One hundred and fifty five patients were investigated. One hundred and four of these patients had molecular evidence for MD, 27 were deemed to have disorders other than MD (non-MD), and 24 had possible MD. Patients with defects in mitochondrial DNA (mtDNA) maintenance (n = 32) and mtDNA rearrangements (n = 17) had the highest median FGF-21 among the MD group. Other MD patients harbouring mtDNA point mutations (n = 40) or mutations in other autosomal genes (n = 7) and those with partially characterised MD had lower FGF-21 levels. The area under the receiver operating characteristic curve for distinguishing MD from non-MD patients was 0.69. No correlation between FGF-21 and creatinine, creatine kinase, or cardio-skeletal myopathy score was found. FGF-21 was significantly associated with plasma lactate and ocular myopathy. Although FGF-21 was found to have a low sensitivity for detecting MD, at a z-score of 2.8, its specificity was above 90%. We suggest that a high serum concentration of FGF-21 would be clinically useful in MD, especially in adult patients with chronic progressive external ophthalmoplegia, and may enable bypassing muscle biopsy and directly opting for genetic analysis. Availability of its assay has thus modified our diagnostic pathway.
C1 [Morovat, Alireza; Weerasinghe, Gayani; Guha, Nishan; Mirzazadeh, Mehdi] Oxford Univ Hosp, Dept Clin Biochem, Oxford OX3 9DU, England.
   [Nesbitt, Victoria] Childrens Hosp, Dept Paediat, Oxford OX3 9DU, England.
   [Hofer, Monika] Oxford Univ Hosp, Dept Neuropathol & Ocular Pathol, Oxford OX3 9DU, England.
   [Agnew, Thomas] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England.
   [Quaghebeur, Geralrine] Oxford Univ Hosp, Dept Neuroradiol, Oxford OX3 9DU, England.
   [Sergeant, Kate; Fratter, Carl] Oxford Univ Hosp, Oxford Med Genet Labs, NHS Specialised Serv Rare Mitochondrial Disorders, Oxford OX3 7LE, England.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
C3 University of Oxford; University of Oxford; University of Oxford
RP Poulton, J (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
EM reza.morovat@ouh.nhs.uk; gayani.weerasinghe@ouh.nhs.uk; victoria.nesbitt@ouh.nhs.uk; monika.hofer@ouh.nhs.uk; thomas.agnew@path.ox.ac.uk; gerardine.quaghebeur@ouh.nhs.uk; kate.sergeant@ouh.nhs.uk; carl.fratter@ouh.nhs.uk; nishan.guha@ouh.nhs.uk; mehdi.mirzazadeh@nhs.net; joanna.poulton@obs-gyn.ox.ac.uk
FU UK Rare Mitochondrial Disorders of Adults and Children (NHS Highly Specialized Services); Lily Foundation; NewLife [SG/14-15/11]; Medical Research Council [MR/J010448/1]; Wellcome Trust [0948685/Z/10/Z]; NHS; MRC [MR/J010448/1, G0800674] Funding Source: UKRI
CR Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111
   Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054
   Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008
   Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339
   Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005
   Gómez-Ambrosi J, 2017, CLIN NUTR, V36, P861, DOI 10.1016/j.clnu.2016.04.027
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713
   Jeanson Y, 2016, BIOCHEM J, V473, P685, DOI 10.1042/BJ20150808
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Lee DV, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0111767
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Li HT, 2013, J HEPATOL, V58, P557, DOI 10.1016/j.jhep.2012.10.029
   Lundåsen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068
   Luo Yongde, 2013, FRONT ENDOCRINOL (LAUSANNE), V4, P194, DOI 10.3389/fendo.2013.00194
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177
   Michel S, 2015, MITOCHONDRION, V21, P58, DOI 10.1016/j.mito.2015.01.005
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Oglesbee D, 2006, PEDIATR NEUROL, V35, P289, DOI 10.1016/j.pediatrneurol.2006.05.007
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Planavila A, 2015, FRONT ENDOCRINOL, V6, P0, DOI 10.3389/fendo.2015.00133
   Planavila A, 2015, CARDIOVASC RES, V106, P19, DOI 10.1093/cvr/cvu263
   Qin A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027155
   Rath E, 2012, GUT, V61, P1269, DOI 10.1136/gutjnl-2011-300767
   Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sonoda J, 2017, HORM MOL BIOL CLIN I, V30, P0, DOI 10.1515/hmbci-2017-0002
   Suomalainen Anu, 2013, EXPERT OPIN MED DIAGN, V7, P313, DOI 10.1517/17530059.2013.812070
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Thiessen SE, 2015, J CLIN ENDOCR METAB, V100, PE1319, DOI 10.1210/jc.2015-2700
   Tyynismaa H, 2011, J CLIN ENDOCR METAB, V96, PE351, DOI 10.1210/jc.2010-1326
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095
NR 44
TC 55
Z9 55
U1 1
U2 5
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
EI 
J9 J CLIN MED
JI J. Clin. Med.
PD AUG 15
PY 2017
VL 6
IS 8
BP 
EP 
DI 10.3390/jcm6080080
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA FF4CG
UT WOS:000408875600005
PM 28825656
DA 2024-11-01
ER

PT J
AU Gill, JS
   Hardy, SA
   Blakely, EL
   Hopton, S
   Nemeth, AH
   Fratter, C
   Poulton, J
   Taylor, RW
   Downes, SM
AF Gill, Jaidip S.
   Hardy, Steven A.
   Blakely, Emma L.
   Hopton, Sila
   Nemeth, Andrea H.
   Fratter, Carl
   Poulton, Joanna
   Taylor, Robert W.
   Downes, Susan M.
TI Pigmentary retinopathy, rod-cone dysfunction and sensorineural deafness associated with a rare mitochondrial tRNA<SUP>Lys</SUP> (m.8340G&gt;A) gene variant
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID transfer-rna mutations; dna mutations; retinal dystrophy; point mutations; human-disease; pathogenicity; prevalence; myopathy
AB Background/Aim The rare mitochondrial DNA (mtDNA) variant m.8340G>A has been previously reported in the literature in a single, sporadic case of mitochondrial myopathy. In this report, we aim to investigate the case of a 39-year-old male patient with sensorineural deafness who presented to the eye clinic with nyctalopia, retinal pigmentary changes and bilateral cortical cataracts. Methods The patient was examined clinically and investigated with autofluorescence, full-field electroretinography, electro-oculogram and dark adaptometry. Sequencing of the mitochondrial genome in blood and muscle tissue was followed by histochemical and biochemical analyses together with single fibre studies of a muscle biopsy to confirm a mitochondrial aetiology. Results Electrophysiology, colour testing and dark adaptometry showed significant photoreceptor dysfunction with macular involvement. Sequencing the complete mitochondrial genome revealed a rare mitochondrial tRNALys (MTTK) gene variantm. 8340G>A-which was heteroplasmic in blood (11%) and skeletal muscle (65%) and cosegregated with cytochrome c oxidase-deficient fibres in single-fibre studies. Conclusion We confirm the pathogenicity of the rare mitochondrial m. 8340G>A variant the basis of single-fibre segregation studies and its association with an expanded clinical phenotype. Our case expands the phenotypic spectrum of diseases associated with mitochondrial tRNA point mutations, highlighting the importance of considering a mitochondrial diagnosis in similar cases presenting to the eye clinic and the importance of further genetic testing if standard mutational analysis does not yield a result.
C1 [Gill, Jaidip S.; Downes, Susan M.] John Radcliffe Hosp, Oxford, England.
   [Hardy, Steven A.; Blakely, Emma L.; Hopton, Sila; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Nemeth, Andrea H.; Poulton, Joanna] Churchill Hosp, Dept Clin Genet, Oxford, England.
   [Nemeth, Andrea H.; Downes, Susan M.] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford, England.
   [Fratter, Carl] Churchill Hosp, Oxford Med Genet Lab, Oxford, England.
C3 University of Oxford; Newcastle University - UK; University of Oxford; University of Oxford; University of Oxford
RP Downes, SM (corresponding author), John Radcliffe Hosp, Oxford Eye Hosp, West Wing, Oxford OX3 9DU, England.
EM susan.downes@eye.ox.ac.uk
FU Medical Research Council [G0601943] Funding Source: Medline; Wellcome Trust [096919/Z/11/Z] Funding Source: Medline; MRC [G0601943] Funding Source: UKRI
CR Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   Bellmann C, 2004, INVEST OPHTH VIS SCI, V45, P2355, DOI 10.1167/iovs.03-1090
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Daruich A, 2014, BMC OPHTHALMOL, V14, P0, DOI 10.1186/1471-2415-14-77
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Jarc-Vidmar M, 2015, DOC OPHTHALMOL, V130, P179, DOI 10.1007/s10633-015-9489-7
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 20
TC 6
Z9 6
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD SEP 15
PY 2017
VL 101
IS 9
BP 1298
EP 1302
DI 10.1136/bjophthalmol-2017-310370
PG 5
WC Ophthalmology
SC Ophthalmology
GA FE5BJ
UT WOS:000408226700026
PM 28729369
DA 2024-11-01
ER

PT J
AU Van Maldergem, L
   Besse, A
   De Paepe, B
   Blakely, EL
   Appadurai, V
   Humble, MM
   Piard, J
   Craig, K
   He, LP
   Hella, P
   Debray, FG
   Martin, JJ
   Gaussen, M
   Laloux, P
   Stevanin, G
   Van Coster, R
   Taylor, RW
   Copeland, WC
   Mormont, E
   Bonnen, PE
AF Van Maldergem, Lionel
   Besse, Arnaud
   De Paepe, Boel
   Blakely, Emma L.
   Appadurai, Vivek
   Humble, Margaret M.
   Piard, Juliette
   Craig, Kate
   He, Langping
   Hella, Pierre
   Debray, Francois-Guillaume
   Martin, Jean-Jacques
   Gaussen, Marion
   Laloux, Patrice
   Stevanin, Giovanni
   Van Coster, Rudy
   Taylor, Robert W.
   Copeland, William C.
   Mormont, Eric
   Bonnen, Penelope E.
TI POLG2 deficiency causes adult-onset syndromic sensory neuropathy, ataxia and parkinsonism
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID mitochondrial-dna deletions; polymerase gamma-subunits; mutations; disease; ophthalmoplegia; maintenance; variants; dementia; patient; twinkle
AB Objective: Mitochondrial dysfunction plays a key role in the pathophysiology of neurodegenerative disorders such as ataxia and Parkinson's disease. We describe an extended Belgian pedigree where seven individuals presented with adult-onset cerebellar ataxia, axonal peripheral ataxic neuropathy, and tremor, in variable combination with parkinsonism, seizures, cognitive decline, and ophthalmoplegia. We sought to identify the underlying molecular etiology and characterize the mitochondrial pathophysiology of this neurological syndrome. Methods: Clinical, neurophysiological, and neuroradiological evaluations were conducted. Patient muscle and cultured fibroblasts underwent extensive analyses to assess mitochondrial function. Genetic studies including genome-wide sequencing were conducted. Results: Hallmarks of mitochondrial dysfunction were present in patients' tissues including ultrastructural anomalies of mitochondria, mosaic cytochrome c oxidase deficiency, and multiple mtDNA deletions. We identified a splice acceptor variant in POLG2, c.970-1G>C, segregating with disease in this family and associated with a concomitant decrease in levels of POLG2 protein in patient cells. Interpretation: This work extends the clinical spectrum of POLG2 deficiency to include an overwhelming, adult-onset neurological syndrome that includes cerebellar syndrome, peripheral neuropathy, tremor, and parkinsonism. We therefore suggest to include POLG2 sequencing in the evaluation of ataxia and sensory neuropathy in adults, especially when it is accompanied by tremor or parkinsonism with white matter disease. The demonstration that deletions of mtDNA resulting from autosomal-dominant POLG2 variant lead to a monogenic neurodegenerative multicomponent syndrome provides further evidence for a major role of mitochondrial dysfunction in the pathomechanism of nonsyndromic forms of the component neurodegenerative disorders.
C1 [Van Maldergem, Lionel; Piard, Juliette] Univ Franche Comte, Ctr Genet Humaine, Besancon, France.
   [Van Maldergem, Lionel; Debray, Francois-Guillaume] Univ Hosp, Ctr Human Genet, Metab Unit, Liege, Belgium.
   [Besse, Arnaud; Appadurai, Vivek; Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
   [De Paepe, Boel; Van Coster, Rudy] Ghent Univ Hosp, Div Child Neurol & Metab, Dept Pediat, Ghent, Belgium.
   [Blakely, Emma L.; Craig, Kate; He, Langping; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Humble, Margaret M.; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Durham, NC USA.
   [Hella, Pierre] Sambre & Meuse Reg Hosp, Dept Neurol, Namur, Belgium.
   [Martin, Jean-Jacques] Univ Antwerp, Born Bunge Fdn, Antwerp, Belgium.
   [Gaussen, Marion; Stevanin, Giovanni] Sorbonne Univ, UPMC, CNRS, INSERM,U1127,UMR7225, Paris, France.
   [Gaussen, Marion; Stevanin, Giovanni] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Paris, France.
   [Gaussen, Marion; Stevanin, Giovanni] PSL Univ, Lab Neurogenet, Ecole Prat Hautes Etud, F-75013 Paris, France.
   [Laloux, Patrice; Mormont, Eric] Catholic Univ Louvain, CHU UCL Namur, Dept Neurol, B-5530 Yvoir, Belgium.
   [Mormont, Eric; Bonnen, Penelope E.] UCL Inst Neurosci IoNS, B-1200 Brussels, Belgium.
C3 Universite de Franche-Comte; University of Liege; Baylor College of Medicine; Ghent University; Ghent University Hospital; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Universite PSL; Ecole Pratique des Hautes Etudes (EPHE); Universite Catholique Louvain
RP Van Maldergem, L (corresponding author), Univ Franche Comte, Ctr Genet Humaine, Besancon, France.; Bonnen, PE (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
EM vmald@hotmail.com; pbonnen@bcm.edu
FU Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES065078]; French National Agency for Research (SPATAX-QUEST project); Verum Foundation; European community [E12009DD]; Investissements d'Avenir program [ANR-10-IAIHU-06]; Wellcome Trust Strategic Award [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; NIH National Human Genome Research Institute [U54HG006542]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS08372]; MRC [G0601943] Funding Source: UKRI
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1001025
   DesPaepe B, 2012, PEDIATR RES, V72, P232
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   DisRe M, 2009, NUCLEIC ACIDS RES, V37, P5701
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Graham JM, 1997, SUBCELLULAR FRACTIONATION: A PRACTICAL APPROACH, V0, P0
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
NR 27
TC 15
Z9 15
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JAN 15
PY 2017
VL 4
IS 1
BP 4
EP 14
DI 10.1002/acn3.361
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EK1CY
UT WOS:000393664600001
PM 28078310
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Henriksen, E
   Miletic, H
   Bindoff, LA
AF Tzoulis, Charalampos
   Henriksen, Eilen
   Miletic, Hrvoje
   Bindoff, Laurence A.
TI No evidence of ischemia in stroke-like lesions of mitochondrial POLG encephalopathy
SO MITOCHONDRION
LA English
DT Article
DE Polymerase gamma; Mitochondria; Mitochondrial disease; Ischemia; Vessels; Infarction; Angiogenesis
ID angiogenesis; mutations; myopathy; episodes; lactate; oxygen
AB Stroke-like lesions are characteristically associated with mitochondrial encephalopathies such as those caused by mutations of polymerase gamma (POLG) and the m.3243A > G mitochondrial DNA (mtDNA) mutation. The combination of acute clinical onset, MRI and pathological abnormalities, have led to the suggestion that these lesions are ischemic. Here, we sought to determine the role of ischemia in the pathogenesis of mitochondrial stroke-like lesions. We performed a systematic study of cerebral blood vessel morphology, density and distribution in post mortem brain tissue from nine patients with POLG-encephalopathy and seven neurologically healthy controls. We found that patients had significantly higher cerebral vascular density than controls: this was more pronounced in areas of chronic neurodegeneration, where vascular density correlated with the severity of neuronal loss, but was also seen in acute lesions. Further, blood vessels were patent and, in acute lesions, dilated suggesting increased perfusion. In contrast to what would be expected in ischemia, stroke-like lesions were not pan-necrotic and were highly vascularized. Our results suggest that ischemia does not contribute to the pathogenesis of either the chronic neurodegeneration or acute lesions in POLG encephalopathy. Neovascularization and vascular dilatation does occur and suggests a compensatory response. We suggested the acute lesions are more likely to reflect energy insufficiency and our earlier studies suggest that this is driven in large part by seizure activity. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, Bergen, Norway.
   [Tzoulis, Charalampos; Henriksen, Eilen; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway.
   [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
FU Western Norway Health Trust [911650]; Meltzer Foundation
CR BARZ H, 1975, ZENTRALBLATT FUER ALLGEMEINE PATHOLOGIE UND PATHOLOGISCHE ANATOMIE, V119, P488
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hunt TK, 2008, ADV EXP MED BIOL, V614, P73, DOI 10.1007/978-0-387-74911-2_9
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
NR 15
TC 10
Z9 10
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2017
VL 32
IS 
BP 10
EP 15
DI 10.1016/j.mito.2016.11.004
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EI0LG
UT WOS:000392165400002
PM 27838477
DA 2024-11-01
ER

PT J
AU Cruz, S
   Taipa, R
   Nogueira, C
   Pereira, C
   Almeida, LS
   Neiva, R
   Geraldes, T
   Guimaraes, A
   Melo-Pires, M
   Vilarinho, L
AF Cruz, Simao
   Taipa, Ricardo
   Nogueira, Celia
   Pereira, Cristina
   Almeida, Ligia S.
   Neiva, Raquel
   Geraldes, Tiago
   Guimaraes, Antonio
   Melo-Pires, Manuel
   Vilarinho, Laura
TI CLINICAL, BIOCHEMICAL, MOLECULAR, AND HISTOLOGICAL FEATURES OF 65 PORTUGUESE PATIENTS WITH MITOCHONDRIAL DISORDERS
SO MUSCLE & NERVE
LA English
DT Article
DE chronic progressive external ophthalmoplegia; mitochondrial disorders; muscle biopsy; ragged red fibers; respiratory chain
ID respiratory-chain deficiency; transfer-rna mutations; dna; disease; melas; encephalomyopathy; phenotypes; pathology; genome; family
AB IntroductionMitochondrial disorders display remarkable genetic and phenotypic heterogeneity. MethodsWe performed a retrospective analysis of the clinical, histological, biochemical, and genetic features of 65 patients with molecular diagnoses of mitochondrial disorders. ResultsThe most common genetic diagnosis was a single large-scale mitochondrial DNA (mtDNA) deletion (41.5%), and the most frequent clinical phenotype was chronic progressive external ophthalmoplegia (CPEO). It occurred in 41.5% of all patients, primarily in those with mtDNA deletions. Histological signs of mitochondrial dysfunction were found in 73.8% of patients, and respiratory chain enzyme assay (RCEA) abnormalities were detected in 51.9%. ConclusionsThis study confirms the high relative frequency of single large-scale deletions among mitochondrial disorders as well as its particular association with CPEO. Muscle histology seems to be particularly useful in older patients and those with mtDNA deletions, whereas RCEA might be more helpful in young children or individuals with mtDNA depletion.
C1 [Cruz, Simao] Hosp Prof Doutor Fernando Fonseca, Dept Neurol, IC 19, P-2720276 Amadora, Portugal.
   [Taipa, Ricardo; Guimaraes, Antonio; Melo-Pires, Manuel] Ctr Hosp Porto, Neuropathol Unit, Hosp Santo Antonio, Oporto, Portugal.
   [Nogueira, Celia; Pereira, Cristina; Almeida, Ligia S.; Neiva, Raquel; Vilarinho, Laura] Dr Ricardo Jorge Natl Hlth Inst, Dept Human Genet, Newborn Screening Metab & Genet Unit, Oporto, Portugal.
   [Geraldes, Tiago] Hosp Garcia de Orta, Dept Neurol, Almada, Portugal.
C3 Hospital Professor Doutor Fernando Fonseca, EPE; Hospital Garcia de Orta
RP Cruz, S (corresponding author), Hosp Prof Doutor Fernando Fonseca, Dept Neurol, IC 19, P-2720276 Amadora, Portugal.
EM simao_cruz13@hotmail.com
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Choi BO, 2008, EXP MOL MED, V40, P354, DOI 10.3858/emm.2008.40.3.354
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   COLLOMBET JM, 1993, PEDIATRIE, V48, P287
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174
   Jaksch M, 2001, J MED GENET, V38, P665, DOI 10.1136/jmg.38.10.665
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Oldfors A, 2013, MUSCLE DIS PATHOLOGY, V0, P0
   Ronchi D, 2011, BIOCHEM BIOPH RES CO, V412, P245, DOI 10.1016/j.bbrc.2011.07.076
   RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Vilarinho L, 1998, EUR NEUROL, V39, P148, DOI 10.1159/000007925
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
NR 26
TC 6
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD NOV 15
PY 2017
VL 56
IS 5
BP 868
EP 872
DI 10.1002/mus.25593
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FJ8UC
UT WOS:000413043100013
PM 28128857
DA 2024-11-01
ER

PT J
AU Siira, SJ
   Shearwood, AMJ
   Bracken, CP
   Rackham, O
   Filipovska, A
AF Siira, Stefan J.
   Shearwood, Anne-Marie J.
   Bracken, Cameron P.
   Rackham, Oliver
   Filipovska, Aleksandra
TI Defects in RNA metabolism in mitochondrial disease
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE RNA metabolism; Mitochondrial disease; tRNA; PARE
ID trna(leu(uur)) gene; protein-synthesis; mutation; dna; melas; expression; polyadenylation; transcriptome; degradation; impairment
AB The expression of mitochondrially-encoded genes requires the efficient processing of long precursor RNAs at the 5' and 3' ends of tRNAs, a process which, when disrupted, results in disease. Two such mutations reside within mt-tRNA(Leu(UUR)); a m.3243A > G transition, which is the most common cause of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), and m.3302A > G which often causes mitochondria( myopathy (MM). We used parallel analysis of RNA ends (PARE) that captures the 5' terminal end of 5'-monophosphorylated mitochondrial RNAs to compare the effects of the m.3243A > G and m.3302A > G mutations on mitochondrial tRNA processing and downstream RNA metabolism. We confirmed previously identified RNA processing defects, identified common internal cleavage sites and new sites unique to the m.3243A > G mutants that do not correspond to transcript ends. These sites occur in regions of predicted RNA secondary structure, or are in close proximity to such regions, and may identify regions of importance to the processing of mtRNAs. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Siira, Stefan J.; Shearwood, Anne-Marie J.; Rackham, Oliver; Filipovska, Aleksandra] QEII Med Ctr, Harry Perkins Inst Med Res, Level 7 QQ Block,6 Verdun St, Nedlands, WA 6009, Australia.
   [Siira, Stefan J.; Shearwood, Anne-Marie J.; Rackham, Oliver; Filipovska, Aleksandra] QEII Med Ctr, Ctr Med Res, Level 7 QQ Block,6 Verdun St, Nedlands, WA 6009, Australia.
   [Bracken, Cameron P.] SA Pathol, Ctr Canc Biol, Div Human Immunol, Adelaide, SA 5000, Australia.
   [Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Sch Mol Sci, Nedlands, WA 6009, Australia.
C3 Queen Elizabeth II Medical Centre; Harry Perkins Institute of Medical Research; University of Western Australia; Queen Elizabeth II Medical Centre; University of Western Australia; Centre for Cancer Biology; SA Pathology; University of Western Australia
RP Filipovska, A (corresponding author), QEII Med Ctr, Harry Perkins Inst Med Res, Level 7 QQ Block,6 Verdun St, Nedlands, WA 6009, Australia.; Filipovska, A (corresponding author), QEII Med Ctr, Ctr Med Res, Level 7 QQ Block,6 Verdun St, Nedlands, WA 6009, Australia.
EM aleksandra.filipovska@uwa.edu.au
FU National Health and Medical Research Council [APP1058442, APP1045677, APP1041582, APP1023460, APP1005030, APP1043978]; Australian Research Council [DP170103000]; Cancer Council of Western Australia; University of Western Australia Australian Postgraduate Award
CR Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393
   German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kirino Yohei, 2005, RNA BIOL, V2, P41, DOI 10.4161/rna.2.2.1610
   Kuznetsova I, 2017, NUCL ACIDS RES, V0, P0
   Langmead B, 2009, GENOME BIOL, V10, P0, DOI 10.1186/gb-2009-10-3-r25
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Levy S, 2016, BIOCHEM SOC T, V44, P1475, DOI 10.1042/BST20160126
   Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727
   Martin M, 2011, EMBNET.JOURNAL, V17, P10, DOI 10.14806/ej.17.1.200
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rackham O, 2016, CELL REP, V16, P1874, DOI 10.1016/j.celrep.2016.07.031
   Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
NR 33
TC 5
Z9 6
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD APR 15
PY 2017
VL 85
IS 
BP 106
EP 113
DI 10.1016/j.biocel.2017.02.003
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ES6BE
UT WOS:000399630500013
PM 28189843
DA 2024-11-01
ER

PT J
AU Herst, PM
   Rowe, MR
   Carson, GM
   Berridge, MV
AF Herst, Patries M.
   Rowe, Matthew R.
   Carson, Georgia M.
   Berridge, Michael V.
TI Functional Mitochondria in Health and Disease
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE mitochondrial DNA; mitochondrial DNA mutations; mitochondriopathies; mito-nuclear cross talk; mitochondrial transfer; mitochondrial stress signals; mitopeptides
ID membrane electron-transport; surface oxygen-consumption; tunneling nanotubes; purkinje neurons; lactic-acidosis; stromal cells; transcription factor; clinical-features; skeletal-muscles; episodes melas
AB The ability to rapidly adapt cellular bioenergetic capabilities to meet rapidly changing environmental conditions is mandatory for normal cellular function and for cancer progression. Any loss of this adaptive response has the potential to compromise cellular function and render the cell more susceptible to external stressors such as oxidative stress, radiation, chemotherapeutic drugs, and hypoxia. Mitochondria play a vital role in bioenergetic and biosynthetic pathways and can rapidly adjust to meet the metabolic needs of the cell. Increased demand is met by mitochondrial biogenesis and fusion of individual mitochondria into dynamic networks, whereas a decrease in demand results in the removal of superfluous mitochondria through fission and mitophagy. Effective communication between nucleus and mitochondria (mito-nuclear cross talk), involving the generation of different mitochondrial stress signals as well as the nuclear stress response pathways to deal with these stressors, maintains bioenergetic homeostasis under most conditions. However, when mitochondrial DNA (mtDNA) mutations accumulate and mito-nuclear cross talk falters, mitochondria fail to deliver critical functional outputs. Mutations in mtDNA have been implicated in neuromuscular and neurodegenerative mitochondriopathies and complex diseases such as diabetes, cardiovascular diseases, gastrointestinal disorders, skin disorders, aging, and cancer. In some cases, drastic measures such as acquisition of new mitochondria from donor cells occurs to ensure cell survival. This review starts with a brief discussion of the evolutionary origin of mitochondria and summarizes how mutations in mtDNA lead to mitochondriopathies and other degenerative diseases. Mito-nuclear cross talk, including various stress signals generated by mitochondria and corresponding stress response pathways activated by the nucleus are summarized. We also introduce and discuss a small family of recently discovered hormone-like mitopeptides that modulate body metabolism. Under conditions of severe mitochondrial stress, mitochondria have been shown to traffic between cells, replacing mitochondria in cells with damaged and malfunctional mtDNA. Understanding the processes involved in cellular bioenergetics and metabolic adaptation has the potential to generate new knowledge that will lead to improved treatment of many of the metabolic, degenerative, and age-related inflammatory diseases that characterize modern societies.
C1 [Herst, Patries M.; Carson, Georgia M.; Berridge, Michael V.] Malaghan Inst Med Res, Canc Cell Biol, Wellington, New Zealand.
   [Herst, Patries M.] Univ Otago, Dept Radiat Therapy, Wellington, New Zealand.
   [Rowe, Matthew R.; Carson, Georgia M.] Victoria Univ, Sch Biol Sci, Wellington, New Zealand.
C3 Victoria University Wellington; Malaghan Institute; University of Otago; Victoria University Wellington
RP Herst, PM; Berridge, MV (corresponding author), Malaghan Inst Med Res, Canc Cell Biol, Wellington, New Zealand.; Herst, PM (corresponding author), Univ Otago, Dept Radiat Therapy, Wellington, New Zealand.
EM patries.herst@otago.ac.nz; mberridge@malaghan.org.nz
FU Health Council of New Zealand; New Zealand Cancer Society; Marsden Fund; Neurological Foundation; Malaghan Institute
CR Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Ahn CS, 2015, CANCER METAB, V3, P0, DOI 10.1186/s40170-015-0128-2
   Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069
   Alvero AB, 2006, CANCER-AM CANCER SOC, V106, P599, DOI 10.1002/cncr.21633
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Arnould T, 2015, INT J MOL SCI, V16, P18224, DOI 10.3390/ijms160818224
   Bae JS, 2005, HUM GENE THER, V16, P1006, DOI 10.1089/hum.2005.16.1006
   Berridge M, 2015, TUMOR CELL METABOLIS, V0, PP23, DOI 10.1007/978-3-7091-1824-5
   Berridge MV, 2010, MITOCHONDRION, V10, P584, DOI 10.1016/j.mito.2010.08.002
   Berridge MV, 2009, MOL NUTR FOOD RES, V53, P76, DOI 10.1002/mnfr.200700493
   Berridge MV, 2015, MOL CELL ONCOL, V3556, P1
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P2004
   Busch KB, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0442
   Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026
   Caicedo A, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09073
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Carelli V, 2015, INT J BIOCHEM CELL B, V63, P21, DOI 10.1016/j.biocel.2015.01.023
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen YX, 2016, CANCERS, V8, P0, DOI 10.3390/cancers8040040
   Cho YM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032778
   Choueiri TK, 2006, ANN ONCOL, V17, P860, DOI 10.1093/annonc/mdl010
   Cobb LJ, 2016, AGING-US, V8, P1
   Coppotelli G, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17050711
   Courtnay R, 2015, MOL BIOL REP, V42, P841, DOI 10.1007/s11033-015-3858-x
   Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111
   de Souza PL, 2006, CANCER CHEMOTH PHARM, V58, P427, DOI 10.1007/s00280-006-0189-6
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   DeBerardinis RJ, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600200
   Dieriks BV, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep42984
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Dong LF, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.22187
   Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x
   Feichtinger RG, 2014, EXP DERMATOL, V23, P607, DOI 10.1111/exd.12484
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Finsterer J, 2016, WORLD J CARDIOL, V8, P333, DOI 10.4330/wjc.v8.i5.333
   Gabaldón T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463
   Gabrielson M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0107109
   Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005
   Giordano-Santini R, 2016, SEMIN CELL DEV BIOL, V60, P146, DOI 10.1016/j.semcdb.2016.06.019
   Gopisetty G, 2016, GENE, V589, P27, DOI 10.1016/j.gene.2016.05.008
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gouliaeva NA, 2006, BIOFIZIKA+, V51, P692
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x
   Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006
   Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8
   Gumeni S, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/4587691
   Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0
   Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Herst PM, 2007, BIOCHEM PHARMACOL, V74, P1587, DOI 10.1016/j.bcp.2007.08.019
   Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018
   Herst PM, 2006, CURR MOL MED, V6, P895, DOI 10.2174/156652406779010777
   Herst PM, 2013, CURR PHARM BIOTECHNO, V14, P289
   Herst PM, 2009, HAEMATOL-HEMATOL J, V94, P928, DOI 10.3324/haematol.2008.003996
   Herst PM, 2004, BBA-BIOENERGETICS, V1656, P79, DOI 10.1016/j.bbabio.2004.01.008
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001
   Hofmann JN, 2014, CARCINOGENESIS, V35, P1028, DOI 10.1093/carcin/bgt495
   Hoitzing H, 2015, BIOESSAYS, V37, P687, DOI 10.1002/bies.201400188
   Holzerová E, 2015, INT J BIOCHEM CELL B, V63, P16, DOI 10.1016/j.biocel.2015.01.021
   Hroudová J, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/175062
   Iommarini L, 2014, HUM MOL GENET, V23, P1453, DOI 10.1093/hmg/ddt533
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P0, DOI 10.1038/nrm3458
   Kemp K, 2014, ACTA NEUROPATHOL, V128, P629, DOI 10.1007/s00401-014-1303-1
   Kim B, 2017, ONCOTARGET, V8, P60299, DOI 10.18632/oncotarget.19140
   Kim SJ, 2017, J PHYSIOL-LONDON, V595, P6613, DOI 10.1113/JP274472
   Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kohno K, 2015, INT J MOL SCI, V16, P19836, DOI 10.3390/ijms160819836
   Kukat C, 2013, TRENDS CELL BIOL, V23, P457, DOI 10.1016/j.tcb.2013.04.009
   Kumar A, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep40360
   Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039
   Lee C, 2016, FREE RADICAL BIO MED, V100, P182, DOI 10.1016/j.freeradbiomed.2016.05.015
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Liu KG, 2014, J NANOMATER, V2014, P0, DOI 10.1155/2014/910639
   Long YC, 2014, AM J PHYSIOL-ENDOC M, V306, PE581, DOI 10.1152/ajpendo.00665.2013
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lou E, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033093
   Lu CL, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0121046
   Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014
   MARGULIS L, 1970, P349, V0, P0
   Margulis L, 2006, P NATL ACAD SCI USA, V103, P13080, DOI 10.1073/pnas.0604985103
   Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Moschoi R, 2016, BLOOD, V128, P253, DOI 10.1182/blood-2015-07-655860
   Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603
   Nuebel E, 2016, BBA-MOL CELL RES, V1863, P2613, DOI 10.1016/j.bbamcr.2016.07.004
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678
   Önfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476
   Osswald M, 2016, NEURO-ONCOLOGY, V18, P479, DOI 10.1093/neuonc/now014
   Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071
   Palikaras K, 2016, MOL CELL ONCOL, V3, P0, DOI 10.1080/23723556.2015.1056332
   Pasquier J, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-94
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Phinney DG, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9472
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005
   Ro S, 2013, CELL RES, V23, P759, DOI 10.1038/cr.2013.37
   Rubio-Cosials A, 2013, CURR OPIN STRUC BIOL, V23, P116, DOI 10.1016/j.sbi.2012.12.004
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scarlett DJ, 2004, BIOFACTORS, V20, P199
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Sicheritz-Pontén T, 1998, BBA-BIOENERGETICS, V1365, P545, DOI 10.1016/S0005-2728(98)00099-1
   Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043
   Tran Q, 2016, TOXICOL RES-GER, V32, P177, DOI 10.5487/TR.2016.32.3.177
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001
   Vendramin R, 2017, EMBO J, V36, P1123, DOI 10.15252/embj.201695546
   Voigt A, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.12796
   Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053
   Wisnovsky SP, 2013, CHEM BIOL, V20, P1323, DOI 10.1016/j.chembiol.2013.08.010
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zhang Yan, 2011, COMMUN INTEGR BIOL, V4, P324, DOI 10.4161/cib.4.3.14855
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
NR 153
TC 194
Z9 213
U1 0
U2 51
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
EI 
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD NOV 3
PY 2017
VL 8
IS 
BP 
EP 
DI 10.3389/fendo.2017.00296
PG 16
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FL5TV
UT WOS:000414309500001
PM 29163365
DA 2024-11-01
ER

PT J
AU Kytövuori, L
   Gardberg, M
   Majamaa, K
   Martikainen, MH
AF Kytovuori, Laura
   Gardberg, Maria
   Majamaa, Kari
   Martikainen, Mika H.
TI The m.7510T&gt;C mutation: Hearing impairment and a complex neurologic phenotype
SO BRAIN AND BEHAVIOR
LA English
DT Article
DE hearing impairment; mitochondrial disorder; MT-TS1; neuromuscular disorder
ID mitochondrial trna(ser(ucn)) gene; ribosomal-rna gene; t7511c mutation; point mutation; dna mutations; disease; patient; family; prevalence; disorders
AB ObjectivesMutations in mitochondrial DNA cause a variety of clinical phenotypes ranging from a mild hearing impairment (HI) to severe encephalomyopathy. The MT-TS1 gene is a hotspot for mutations causing HI. The m.7510T>C mutation in MT-TS1 has been previously associated with non-syndromic HI in four families from different ethnic backgrounds. Materials and MethodsWe describe the clinical, genetic, and histopathological findings in a Finnish family with the heteroplasmic m.7510T>C mutation in mitochondrial DNA. ResultsThe family proband presented with a progressive mitochondrial disease phenotype including migraine, epilepsy, mild ataxia, and cognitive impairment in addition to HI. One young adult presented with HI only. Other family members had a mild phenotype comprising ataxia and tremor in addition to HI. Mutation heteroplasmy was 90% in the blood of maternal grandmother and 99% in the muscle and blood of the three other family members. Muscle histology was consistent with mitochondrial myopathy in three family members. The mitochondrial haplogroup of the family was a different branch of the haplogroup H than in the previous reports of this mutation. ConclusionOur results suggest that, in addition to sensorineural HI, the m.7510T>C mutation is associated with a spectrum of mitochondrial disease clinical features including migraine, epilepsy, cognitive impairment, ataxia, and tremor, and with evidence of mitochondrial myopathy.
C1 [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, Oulu, Finland.
   [Gardberg, Maria] Univ Turku, Dept Pathol, Turku, Finland.
   [Gardberg, Maria; Martikainen, Mika H.] Turku Univ Hosp, Turku, Finland.
   [Martikainen, Mika H.] Univ Turku, Div Clin Neurosci, Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Turku; University of Turku; University of Turku
RP Martikainen, MH (corresponding author), Turku Univ Hosp, Turku, Finland.; Martikainen, MH (corresponding author), Univ Turku, Div Clin Neurosci, Turku, Finland.
EM mikmar@utu.fi
FU Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perklens Minne; Sigrid Juseliuksen Saatio
CR Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   delsCastillo FJ, 2002, J MED GENET, V39, P0
   Dubowitz V, 2006, MUSCLE BIOPSY PRACTI, V0, P0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   Komlósi K, 2013, JIMD REP, V9, P105, DOI 10.1007/8904_2012_187
   Kouzaki H, 2007, J CLIN NEUROSCI, V14, P603, DOI 10.1016/j.jocn.2005.10.012
   Labay V, 2008, CLIN GENET, V73, P50, DOI 10.1111/j.1399-0004.2007.00925.x
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lehtonen MS, 2000, EUR J HUM GENET, V8, P315, DOI 10.1038/sj.ejhg.5200455
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Raheem O, 2010, ACTA NEUROPATHOL, V119, P495, DOI 10.1007/s00401-010-0643-8
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Yamasoba T, 2002, NEUROMUSCULAR DISORD, V12, P506, DOI 10.1016/S0960-8966(01)00329-7
   Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200
NR 30
TC 4
Z9 4
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2162-3279
EI 
J9 BRAIN BEHAV
JI Brain Behav.
PD DEC 15
PY 2017
VL 7
IS 12
BP 
EP 
DI 10.1002/brb3.859
PG 6
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA FR1UP
UT WOS:000418853300006
PM 29299381
DA 2024-11-01
ER

PT J
AU Sfyri, P
   Matsakas, A
AF Sfyri, Peggy
   Matsakas, Antonios
TI Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Review
DE Atherosclerosis; Apolipoprotein E; NADPH oxidases; Oxidative stress; Peripheral arterial disease; Skeletal muscle
ID magnetic-resonance-spectroscopy; mitochondrial-dna deletions; improves vasomotor function; endothelial growth-factor; ankle-brachial index; fatty liver-disease; hind-limb ischemia; oxidative stress; nadph oxidases; reactive oxygen
AB Atherosclerosis is a chronic inflammatory process that, in the presence of hyperlipidaemia, promotes the formation of atheromatous plaques in large vessels of the cardiovascular system. It also affects peripheral arteries with major implications for a number of other non-vascular tissues such as the skeletal muscle, the liver and the kidney. The aim of this review is to critically discuss and assimilate current knowledge on the impact of peripheral atherosclerosis and its implications on skeletal muscle homeostasis. Accumulating data suggests that manifestations of peripheral atherosclerosis in skeletal muscle originates in a combination of increased i)-oxidative stress, ii)inflammation, iii)-mitochondrial deficits, iv)-altered myofibre morphology and fibrosis, v)-chronic ischemia followed by impaired oxygen supply, vi)-reduced capillary density, vii)-proteolysis and viii)-apoptosis. These structural, biochemical and pathophysiological alterations impact on skeletal muscle metabolic and physiologic homeostasis and its capacity to generate force, which further affects the individual's quality of life. Particular emphasis is given on two major areas representing basic and applied science respectively: a)-the abundant evidence from a wellrecognised atherogenic model; the Apolipoprotein E deficient mouse and the role of a western-type diet and b)-on skeletal myopathy and oxidative stress-induced myofibre damage from human studies on peripheral arterial disease. A significant source of reactive oxygen species production and oxidative stress in cardiovascular disease is the family of NADPH oxidases that contribute to several pathologies. Finally, strategies targeting NADPH oxidases in skeletal muscle in an attempt to attenuate cellular oxidative stress are highlighted, providing a better understanding of the crossroads between peripheral atherosclerosis and skeletal muscle pathophysiology.
C1 [Sfyri, Peggy; Matsakas, Antonios] Univ Hull, Hull York Med Sch, Ctr Atherothrombot & Metab Dis, Mol Physiol Lab, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.
C3 University of York - UK; University of Hull
RP Matsakas, A (corresponding author), Univ Hull, Hull York Med Sch, Ctr Atherothrombot & Metab Dis, Mol Physiol Lab, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.
EM Antonios.Matsakas@hyms.ac.uk
FU European Union; Royal Society [FP7-PEOPLE-PCIG14-GA-2013-631440, RG140470]; Hull York Medical School through the University of Hull
CR AbdAlla Said, 2011, CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, V9, P190
   Abou-Khalil R, 2010, CELL CYCLE, V9, P892, DOI 10.4161/cc.9.5.10851
   Aggarwal Saurabh, 2012, THER ADV CARDIOVASC DIS, V6, P53, DOI 10.1177/1753944712437359
   Akahori H, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8792
   Akhmedov D, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00371
   Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43
   Allen JD, 2010, FREE RADICAL BIO MED, V49, P1138, DOI 10.1016/j.freeradbiomed.2010.06.033
   Altenhöfer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814
   Arai Y, 2007, CIRC J, V71, P412, DOI 10.1253/circj.71.412
   ARMSTRONG RB, 1991, SPORTS MED, V12, P184, DOI 10.2165/00007256-199112030-00004
   Arnold L, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9972
   Askew CD, 2005, J VASC SURG, V41, P802, DOI 10.1016/j.jvs.2005.01.037
   Askew CD, 2014, J SCI MED SPORT, V17, P623, DOI 10.1016/j.jsams.2013.10.251
   Azad GK, 2014, MOL BIOL REP, V41, P2717, DOI 10.1007/s11033-014-3181-y
   Bagher P, 2011, ACTA PHYSIOL, V202, P271, DOI 10.1111/j.1748-1716.2010.02244.x
   Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Balarini CM, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-3
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Baltgalvis KA, 2014, AM J PHYSIOL-HEART C, V306, PH1128, DOI 10.1152/ajpheart.00839.2013
   Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927
   Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6
   Batinic K, 2012, ATHEROSCLEROSIS, V222, P557, DOI 10.1016/j.atherosclerosis.2012.03.034
   Baum O, 2016, AM J PHYSIOL-REG I, V310, PR943, DOI 10.1152/ajpregu.00480.2015
   Behringer EJ, 2012, J PHYSIOL-LONDON, V590, P6277, DOI 10.1113/jphysiol.2012.239673
   Beleznai T, 2011, CARDIOVASC RES, V92, P199, DOI 10.1093/cvr/cvr181
   Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918
   Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2
   Botti C, 2012, J BIOL REG HOMEOS AG, V26, P67
   Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022
   Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046
   Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030
   Brass EP, 2001, AM J PHYSIOL-HEART C, V280, PH603, DOI 10.1152/ajpheart.2001.280.2.H603
   Brass EP, 2000, VASC MED, V5, P225, DOI 10.1177/1358836X0000500405
   Brevetti G, 2003, J VASC SURG, V38, P374, DOI 10.1016/S0741-5214(03)00124-1
   Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417
   Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001
   Buday A, 2010, AM J PHYSIOL-HEART C, V299, PH386, DOI 10.1152/ajpheart.01042.2009
   Caligiuri G, 1999, ATHEROSCLEROSIS, V145, P301, DOI 10.1016/S0021-9150(99)00081-7
   Catapano AL, 2017, BRIT J PHARMACOL, V174, P3973, DOI 10.1111/bph.13805
   Cauley JA, 2016, BMC GERIATR, V16, P0, DOI 10.1186/s12877-016-0389-9
   Chaillou T, 2014, PFLUG ARCH EUR J PHY, V466, P587, DOI 10.1007/s00424-013-1336-7
   Chan DC, 2006, QJM-INT J MED, V99, P277, DOI 10.1093/qjmed/hcl027
   Chen JH, 2012, INFLAMM RES, V61, P1299, DOI 10.1007/s00011-012-0529-4
   Chen XP, 2008, CURR HYPERTENS REV, V4, P245, DOI 10.2174/157340208786241336
   Chiba T, 2011, ATHEROSCLEROSIS, V219, P545, DOI 10.1016/j.atherosclerosis.2011.08.051
   Chow L, 2010, METABOLISM, V59, P70, DOI 10.1016/j.metabol.2009.07.009
   Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693
   Cifuentes-Pagano ME, 2015, CURR PHARM DESIGN, V21, P6023, DOI 10.2174/1381612821666151029112013
   Cilla M, 2016, ANN BIOMED ENG, V44, P2202, DOI 10.1007/s10439-015-1486-1
   Cluff K, 2013, AM J PHYSIOL-REG I, V305, PR291, DOI 10.1152/ajpregu.00525.2012
   Cole LK, 2011, CIRC RES, V108, P686, DOI 10.1161/CIRCRESAHA.110.238691
   Coleman R, 2006, ACTA HISTOCHEM, V108, P415, DOI 10.1016/j.acthis.2006.07.002
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Corbu A, 2010, NEUROL RES, V32, P63, DOI 10.1179/174313209X385725
   Crauwels HM, 2003, CARDIOVASC RES, V59, P189, DOI 10.1016/S0008-6363(03)00353-5
   Crawford RS, 2013, J SURG RES, V183, P952, DOI 10.1016/j.jss.2013.02.042
   Csányi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025
   dUscio LV, 2001, ARTERIOSCL THROM VAS, V21, P1017, DOI 10.1161/01.ATV.21.6.1017
   Dai SC, 2009, ARTERIOSCL THROM VAS, V29, P495, DOI 10.1161/ATVBAHA.108.180349
   Dashwood MR, 2011, J CELL COMMUN SIGNAL, V5, P45, DOI 10.1007/s12079-010-0109-8
   de Figueiredo ASP, 2015, J BIOL CHEM, V290, P13427, DOI 10.1074/jbc.M114.626077
   de Haan Judy B, 2011, FRONT BIOSCI (SCHOL ED), V3, P709
   Dedkov EI, 2003, J HISTOCHEM CYTOCHEM, V51, P853, DOI 10.1177/002215540305100701
   Desjarlais M, 2017, ARTERIOSCL THROM VAS, V37, P900, DOI 10.1161/ATVBAHA.117.309189
   Doran DE, 2007, ATHEROSCLEROSIS, V195, P39, DOI 10.1016/j.atherosclerosis.2006.11.030
   Dorighello GG, 2018, EXP GERONTOL, V109, P47, DOI 10.1016/j.exger.2017.02.010
   Douglas G, 2012, CARDIOVASC RES, V94, P20, DOI 10.1093/cvr/cvs026
   Dragneva G, 2013, DIS MODEL MECH, V6, P312, DOI 10.1242/dmm.010413
   Drummond GR, 2014, TRENDS ENDOCRIN MET, V25, P452, DOI 10.1016/j.tem.2014.06.012
   Duscha BD, 2011, ARTERIOSCL THROM VAS, V31, P2742, DOI 10.1161/ATVBAHA.111.230441
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   El-Lebedy D, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0329-1
   Elhage R, 1997, ARTERIOSCL THROM VAS, V17, P2679, DOI 10.1161/01.ATV.17.11.2679
   Ellulu MS, 2016, INFLAMMOPHARMACOLOGY, V24, P1, DOI 10.1007/s10787-015-0255-y
   Espinosa A, 2013, INT J MOL SCI, V14, P15740, DOI 10.3390/ijms140815740
   Ferreira LF, 2016, FREE RADICAL BIO MED, V98, P18, DOI 10.1016/j.freeradbiomed.2016.05.011
   Feussner G, 1996, AM J HUM GENET, V58, P281
   Foteinos G, 2008, CIRCULATION, V117, P1856, DOI 10.1161/CIRCULATIONAHA.107.746008
   Fransen P, 2008, PFLUG ARCH EUR J PHY, V455, P811, DOI 10.1007/s00424-007-0337-9
   Friedell ML, 2014, CURR PROB SURG, V51, P254, DOI 10.1067/j.cpsurg.2014.02.005
   Fronek A, 2007, ENDOTHELIUM-J ENDOTH, V14, P199, DOI 10.1080/10623320701547158
   Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y
   Fu SJ, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-369
   Fujimaki S, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/592915
   Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116
   García-Redondo AB, 2016, PHARMACOL RES, V114, P110, DOI 10.1016/j.phrs.2016.10.015
   Gardner AW, 2016, AGE, V38, P0, DOI 10.1007/s11357-016-9925-y
   Gardner AW, 2014, ANGIOLOGY, V65, P491, DOI 10.1177/0003319713489769
   Garg PK, 2009, CIRCULATION, V119, P251, DOI 10.1161/CIRCULATIONAHA.108.791491
   Gaudio E, 2012, INTERN EMERG MED, V7, PS297, DOI 10.1007/s11739-012-0826-5
   Getz GS, 2016, ARTERIOSCL THROM VAS, V36, P1734, DOI 10.1161/ATVBAHA.116.306874
   Getz GS, 2016, J LIPID RES, V57, P758, DOI 10.1194/jlr.R067249
   Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693
   Getz GS, 2009, J LIPID RES, V50, PS156, DOI 10.1194/jlr.R800058-JLR200
   Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17
   Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006
   Gradinaru D, 2015, MECH AGEING DEV, V151, P101, DOI 10.1016/j.mad.2015.03.003
   Gray SP, 2017, DIABETOLOGIA, V60, P927, DOI 10.1007/s00125-017-4215-5
   Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159
   Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3
   Greiner A, 2006, J VASC SURG, V43, P978, DOI 10.1016/j.jvs.2006.01.020
   Grochot-Przeczek A, 2013, GENE, V525, P220, DOI 10.1016/j.gene.2013.03.097
   Guns PJ, 2008, BRIT J PHARMACOL, V153, P508, DOI 10.1038/sj.bjp.0707585
   Ha DM, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0790-3
   Haas TL, 2012, COMPR PHYSIOL, V2, P2933, DOI 10.1002/cphy.c110065
   Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286
   Hart CA, 2013, EXP BIOL MED, V238, P1118, DOI 10.1177/1535370213503275
   Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, PH2326, DOI 10.1152/ajpheart.2000.279.5.H2326
   Hernández-Aguilera A, 2015, INT J MOL SCI, V16, P11323, DOI 10.3390/ijms160511323
   Hiatt WR, 2004, ANN NY ACAD SCI, V1033, P92, DOI 10.1196/annals.1320.008
   Ho TK, 2006, BRIT J SURG, V93, P1368, DOI 10.1002/bjs.5496
   Hoffmann C, 2017, CSH PERSPECT MED, V7, P0, DOI 10.1101/cshperspect.a029793
   Hofmann SM, 2008, DIABETES, V57, P5, DOI 10.2337/db07-0403
   Hoier B, 2013, J APPL PHYSIOL, V115, P1777, DOI 10.1152/japplphysiol.00979.2013
   Hsich E, 2000, CIRCULATION, V101, P1234, DOI 10.1161/01.CIR.101.11.1234
   Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, PE1110, DOI 10.1152/ajpendo.90964.2008
   Hussain Tarique, 2016, OXID MED CELL LONGEV, V2016, P7432797
   Imaizumi K, 2011, BIOSCI BIOTECH BIOCH, V75, P1023, DOI 10.1271/bbb.110059
   Irshad M, 2005, INDIAN J BIOCHEM BIO, V42, P73
   Isbell DC, 2006, J AM COLL CARDIOL, V47, P2289, DOI 10.1016/j.jacc.2005.12.069
   ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431
   Ishida T, 2004, J BIOL CHEM, V279, P45085, DOI 10.1074/jbc.M406360200
   Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI 10.1089/ars.2009.2585
   Jash S, 2015, STEM CELLS INT, V2015, P0, DOI 10.1155/2015/961307
   Jeon US, 2015, EXP MOL MED, V47, P0, DOI 10.1038/emm.2015.19
   Johansson ME, 2005, CLIN SCI, V108, P531, DOI 10.1042/CS20040322
   Jones WS, 2012, VASC MED, V17, P94, DOI 10.1177/1358863X11436334
   Joseph LC, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0145750
   Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, PH24, DOI 10.1152/ajpheart.00799.2009
   Kang J, 2008, J VASC SURG, V48, P701, DOI 10.1016/j.jvs.2008.04.006
   Karavia EA, 2011, FEBS J, V278, P3119, DOI 10.1111/j.1742-4658.2011.08238.x
   Kemp GJ, 2001, J VASC SURG, V34, P1103, DOI 10.1067/mva.2001.117152
   Kiani S, 2013, VASC MED, V18, P72, DOI 10.1177/1358863X13480551
   Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529
   Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607
   Koutakis P, 2015, J HISTOCHEM CYTOCHEM, V63, P256, DOI 10.1369/0022155415569348
   Koutakis P, 2014, REDOX BIOL, V2, P921, DOI 10.1016/j.redox.2014.07.002
   Kozakowska M, 2015, J MUSCLE RES CELL M, V36, P377, DOI 10.1007/s10974-015-9438-9
   Krishna SM, 2015, INT J MOL SCI, V16, P11294, DOI 10.3390/ijms160511294
   Kröller-Schön S, 2011, BASIC RES CARDIOL, V106, P1147, DOI 10.1007/s00395-011-0227-3
   Lassègue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972
   Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x
   Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200
   Lejay A, 2015, EUR J VASC ENDOVASC, V49, P205, DOI 10.1016/j.ejvs.2014.12.010
   Li MW, 2013, ARTERIOSCL THROM VAS, V33, P2306, DOI 10.1161/ATVBAHA.113.302028
   Li YH, 2014, LIPIDS HEALTH DIS, V13, P0, DOI 10.1186/1476-511X-13-136
   Lin JB, 2015, INT J MOL SCI, V16, P11131, DOI 10.3390/ijms160511131
   Liu MY, 2016, BIOCHEM BIOPH RES CO, V469, P456, DOI 10.1016/j.bbrc.2015.11.064
   Long J, 2004, J VASC SURG, V39, P723, DOI 10.1016/j.jvs.2003.12.006
   Lopez MF, 2014, EXPERT REV PROTEOMIC, V11, P371, DOI 10.1586/14789450.2014.901892
   Lozano FS, 2014, INT J CLIN PRACT, V68, P1478, DOI 10.1111/ijcp.12499
   Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020
   Lutgens E, 2005, CIRCULATION, V111, P3443, DOI 10.1161/CIRCULATIONAHA.104.510073
   Ma YG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040763
   Mahley RW, 2009, J LIPID RES, V50, PS183, DOI 10.1194/jlr.R800069-JLR200
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11
   Matsakas A, 2009, HISTOL HISTOPATHOL, V24, P611, DOI 10.14670/HH-24.611
   Mauer K, 2015, ANGIOLOGY, V66, P354, DOI 10.1177/0003319714532518
   Maxwell AJ, 2009, VASC MED, V14, P249, DOI 10.1177/1358863X08100040
   Mayr M, 2005, ARTERIOSCL THROM VAS, V25, P2135, DOI 10.1161/01.ATV.0000183928.25844.f6
   McClung JM, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00161
   McDermott MM, 2007, J VASC SURG, V46, P87, DOI 10.1016/j.jvs.2007.02.064
   Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4
   Menini S, 2012, BRIT J PHARMACOL, V166, P1344, DOI 10.1111/j.1476-5381.2012.01834.x
   Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-211
   Mian MOR, 2013, J PHARMACOL EXP THER, V347, P30, DOI 10.1124/jpet.113.206532
   Mimura J, 2015, FREE RADICAL BIO MED, V88, P221, DOI 10.1016/j.freeradbiomed.2015.06.019
   Minihane AM, 2007, P NUTR SOC, V66, P183, DOI 10.1017/S0029665107005435
   Mishra S, 2015, BIOCHEM BIOPH RES CO, V465, P159, DOI 10.1016/j.bbrc.2015.07.159
   Mitchell RG, 2007, VASC MED, V12, P285, DOI 10.1177/1358863X07084858
   Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com
   Moore SM, 2015, ANGIOGENESIS, V18, P265, DOI 10.1007/s10456-015-9465-6
   Morita S, 2016, BIOL PHARM BULL, V39, P1, DOI 10.1248/bpb.b15-00716
   Mortensen SP, 2014, EXP PHYSIOL, V99, P1552, DOI 10.1113/expphysiol.2014.081620
   Murrant CL, 2017, MICROCIRCULATION, V24, P0, DOI 10.1111/micc.12348
   NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133
   Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842
   Nakaya H, 2009, AM J PATHOL, V174, P2007, DOI 10.2353/ajpath.2009.080611
   Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003
   Nelson WD, 2007, CIRC RES, V101, P1319, DOI 10.1161/CIRCRESAHA.107.155564
   Neuhofer A, 2014, CARDIOVASC DIABETOL, V13, P0, DOI 10.1186/1475-2840-13-23
   Noguchi T, 2014, CIRC J, V78, P2317, DOI 10.1253/circj.CJ-14-0095
   Nogueira BV, 2007, ARCH MED RES, V38, P816, DOI 10.1016/j.arcmed.2007.06.005
   Nomura J, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep04554
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, PS5, DOI 10.1016/j.ejvs.2006.09.024
   Nossent AY, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.116.005281
   ONeill WC, 2015, ARTERIOSCL THROM VAS, V35, P439, DOI 10.1161/ATVBAHA.114.304764
   Pande RL, 2011, ARTERIOSCL THROM VAS, V31, P190, DOI 10.1161/ATVBAHA.110.217687
   Paoni NF, 2002, PHYSIOL GENOMICS, V11, P263, DOI 10.1152/physiolgenomics.00110.2002
   Paradis S, 2016, AM J PHYSIOL-CELL PH, V310, PC968, DOI 10.1152/ajpcell.00356.2015
   Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363
   Peck MA, 2010, ANN VASC SURG, V24, P532, DOI 10.1016/j.avsg.2009.12.003
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Pellegrin M, 2014, PHYSIOL REP, V2, P0, DOI 10.1002/phy2.234
   Pereira SS, 2012, ANIM SCI J, V83, P549, DOI 10.1111/j.1740-0929.2011.00982.x
   Pereira TMC, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-87
   Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314
   Pipinos II, 2000, J VASC SURG, V31, P944, DOI 10.1067/mva.2000.106421
   Pipinos IL, 2003, J VASC SURG, V38, P827, DOI 10.1016/S0741-5214(03)00602-5
   Pipinos Iraklis I, 2007, VASC ENDOVASCULAR SURG, V41, P481, DOI 10.1177/1538574407311106
   Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995
   Pipinos II, 2008, AM J PHYSIOL-REG I, V295, PR290, DOI 10.1152/ajpregu.90374.2008
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   Poledne R, 2015, PHYSIOL RES, V64, PS395, DOI 10.33549/physiolres.933152
   Potteaux S, 2007, DRUG DISCOVERY TODAY: DISEASE MODELS, V4, P165, DOI 10.1016/J.DDM0D.2007.11.005
   Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054
   Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109
   Quesada IM, 2015, ATHEROSCLEROSIS, V242, P469, DOI 10.1016/j.atherosclerosis.2015.08.011
   Raman KG, 2011, J VASC SURG, V53, P754, DOI 10.1016/j.jvs.2010.09.038
   Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48
   Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x
   Rhoads RP, 2009, AM J PHYSIOL-CELL PH, V296, PC1321, DOI 10.1152/ajpcell.00391.2008
   Risha Gohil TRAL, 2013, WORLD J CARDIOVASCUL, V3, P347, DOI 10.4236/wjcd.2013.34055
   Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7
   Rivera J, 2010, REDOX REP, V15, P50, DOI 10.1179/174329210X12650506623401
   Robbins JL, 2011, J APPL PHYSIOL, V111, P81, DOI 10.1152/japplphysiol.00141.2011
   Rodríguez-Sanabria F, 2010, MOL CELL BIOCHEM, V343, P59, DOI 10.1007/s11010-010-0498-2
   Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x
   Ryan TE, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00336
   Sacks FM, 2015, CURR OPIN LIPIDOL, V26, P56, DOI 10.1097/MOL.0000000000000146
   Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205
   Salvayre R, 2016, BIOCHIMIE, V125, P281, DOI 10.1016/j.biochi.2015.12.014
   Sarelius I, 2010, ACTA PHYSIOL, V199, P349, DOI 10.1111/j.1748-1716.2010.02129.x
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schiaffino S, 2017, FEBS J, V284, P517, DOI 10.1111/febs.13827
   Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253
   Schierwagen R, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep12931
   Schreyer SA, 2003, ATHEROSCLEROSIS, V171, P49, DOI 10.1016/j.atherosclerosis.2003.07.010
   Scicchitano BM, 2016, EUR J TRANSL MYOL, V26, P333, DOI 10.4081/ejtm.2016.6125
   Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122
   Sheehan AL, 2011, ATHEROSCLEROSIS, V216, P321, DOI 10.1016/j.atherosclerosis.2011.02.028
   Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003
   Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035
   Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657
   Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027
   Sinha I, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00029
   Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z
   Smith SME, 2012, CHEM BIOL, V19, P752, DOI 10.1016/j.chembiol.2012.04.015
   Sobey CG, 2015, FREE RADICAL RES, V49, P186, DOI 10.3109/10715762.2014.992893
   Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324
   Stachowicz A, 2014, J AM HEART ASSOC, V3, P0, DOI 10.1161/JAHA.114.001329
   Stapleton PA, 2007, AM J PHYSIOL-REG I, V293, PR1110, DOI 10.1152/ajpregu.00410.2007
   Stapleton PA, 2010, J INFLAMM-LOND, V7, P0, DOI 10.1186/1476-9255-7-54
   Stapleton PA, 2010, MICROCIRCULATION, V17, P47, DOI 10.1111/j.1549-8719.2009.00003.x
   Surra JC, 2010, J ATHEROSCLER THROMB, V17, P712
   Tabony AM, 2014, SKELET MUSCLE, V4, P0, DOI 10.1186/2044-5040-4-20
   Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012
   Tani M, 2014, ATHEROSCLEROSIS, V233, P39, DOI 10.1016/j.atherosclerosis.2013.11.080
   Teng BY, 2014, CARDIOVASC RES, V102, P157, DOI 10.1093/cvr/cvu033
   Teunissen PFA, 2015, CARDIOVASC RES, V107, P255, DOI 10.1093/cvr/cvv138
   Tian F, 2016, ARCH GERONTOL GERIAT, V63, P72, DOI 10.1016/j.archger.2015.11.004
   Tjaden K PE, 2015, AUSTIN J VASC MED, V2, P1011
   Togliatto G, 2013, J AM HEART ASSOC, V2, P0, DOI 10.1161/JAHA.113.000376
   Tsui JCS, 2008, BRIT J SURG, V95, P72, DOI 10.1002/bjs.5910
   Ulasova E, 2013, REDOX BIOL, V1, P381, DOI 10.1016/j.redox.2013.07.001
   Van Giau V, 2015, NEUROPSYCH DIS TREAT, V11, P1723, DOI 10.2147/NDT.S84266
   Vara D, 2014, CURR MOL MED, V14, P1103, DOI 10.2174/1566524014666140603114010
   Varu VN, 2010, J VASC SURG, V51, P230, DOI 10.1016/j.jvs.2009.08.073
   Vasquez EC, 2012, J BIOMED SCI, V19, P0, DOI 10.1186/1423-0127-19-22
   Veillard NR, 2004, ARTERIOSCL THROM VAS, V24, P2339, DOI 10.1161/01.ATV.0000146532.98235.e6
   Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629
   Violi F, 2017, ARTERIOSCL THROM VAS, V37, P218, DOI 10.1161/ATVBAHA.116.308351
   von Ballmoos MW, 2006, ARTERIOSCL THROM VAS, V26, P359, DOI 10.1161/01.ATV.0000198250.91406.6d
   Wagner T, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0145102
   Wang JL, 2012, ATHEROSCLEROSIS, V223, P342, DOI 10.1016/j.atherosclerosis.2012.06.003
   Wang YX, 2000, AM J PHYSIOL-HEART C, V278, PH428, DOI 10.1152/ajpheart.2000.278.2.H428
   Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF
   Wei YZ, 2008, AM J PHYSIOL-REG I, V294, PR673, DOI 10.1152/ajpregu.00561.2007
   Weiss D, 2001, AM J CARDIOL, V87, P0
   Weiss DJ, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-230
   Wenzel P, 2017, FREE RADICAL BIO MED, V109, P48, DOI 10.1016/j.freeradbiomed.2017.01.027
   White SH, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-1030-6
   Wu JH, 2002, ARTERIOSCL THROM VAS, V22, P469, DOI 10.1161/hq0302.105287
   Xu L, 2015, ARTERIOSCL THROM VAS, V35, P1787, DOI 10.1161/ATVBAHA.115.305609
   Yan H, 2005, BIOCHEM BIOPH RES CO, V336, P287, DOI 10.1016/j.bbrc.2005.08.066
   Yang RH, 1999, ARTERIOSCL THROM VAS, V19, P2762, DOI 10.1161/01.ATV.19.11.2762
   Yang YG, 2008, J VASC SURG, V48, P1546, DOI 10.1016/j.jvs.2008.07.063
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049
   Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200
   Zhou XP, 2015, MICROCIRCULATION, V22, P518, DOI 10.1111/micc.12222
   Zimmermann A, 2015, ADV MED SCI-POLAND, V60, P236, DOI 10.1016/j.advms.2015.03.003
   Zuo L, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.7015.00338
NR 288
TC 22
Z9 26
U1 1
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD JUL 8
PY 2017
VL 24
IS 
BP 
EP 
DI 10.1186/s12929-017-0346-8
PG 25
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA EZ8FV
UT WOS:000404961000001
PM 28688452
DA 2024-11-01
ER

PT J
AU Yoo, DH
   Choi, YC
   Nam, DE
   Choi, SS
   Kim, JW
   Choi, BO
   Chung, KW
AF Yoo, Da Hye
   Choi, Young-Chul
   Nam, Da Eun
   Choi, Sun Seong
   Kim, Ji Won
   Choi, Byung-Ok
   Chung, Ki Wha
TI Identification of <i>FASTKD2</i> compound heterozygous mutations as the underlying cause of autosomal recessive MELAS-like syndrome
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Mitochondrial encephalomyopathy; FASTKD2; Target sequencing; Korean
ID overlap syndrome; point mutation; gene; mtdna; neuropathy; family
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a condition that affects many parts of the body, particularly the brain and muscles. This study examined a Korean MELAS-like syndrome patient with seizure, stroke-like episode, and optic atrophy. Target sequencing of whole mtDNA and 73 nuclear genes identified compound heterozygous mutations p.R205X and p.L255P in the FASTKD2. Each of his unaffected parents has one of the two mutations, and both mutations were not found in 302 controls. FASTKD2 encodes a FAS-activated serine-threonine (FAST) kinase domain 2 which locates in the mitochondrial inner compartment. A FASTKD2 nonsense mutation was once reported as the cause of a recessive infantile mitochondrial encephalomyopathy. The present case showed relatively mild symptoms with a late onset age, compared to a previous patient with FASTKD2 mutation, implicating an inter-allelic clinical heterogeneity. Because this study is the second report of an autosomal recessive mitochondrial encephalomyopathy patient with a FASTKD2 mutation, it will extend the phenotypic spectrum of the FASTKD2 mutation.
C1 [Yoo, Da Hye; Nam, Da Eun; Choi, Sun Seong; Kim, Ji Won; Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, 56 Gonjudaehak Ro, Gongju, South Korea.
   [Choi, Young-Chul] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.
   [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.
   [Choi, Byung-Ok] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Tech, Dept Hlth Sci & Technol, Seoul, South Korea.
C3 Kongju National University; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)
RP Chung, KW (corresponding author), Kongju Natl Univ, Dept Biol Sci, 56 Gonjudaehak Ro, Gongju, South Korea.; Choi, BO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.
EM bochoi77@hanmail.net; kwchung@kongju.ac.kr
FU Kongju National University; Korean Health Technology R & D Project, Ministry of Health Welfare [H112C0135, HI14C3484]; National Research Foundation - MSIP, Republic of Korea [2017R1A2A2A05001356]
CR Antoniadi T, 2015, BMC MED GENET, V16, P0, DOI 10.1186/s12881-015-0224-8
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Das Sharmistha, 2014, BMC CANCER, V14, P852, DOI 10.1186/1471-2407-14-852
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nam SH, 2016, MOL CELLS, V39, P382, DOI 10.14348/molcells.2016.2288
   Popow J, 2015, RNA, V21, P1873, DOI 10.1261/rna.052365.115
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Simarro M, 2010, BIOCHEM BIOPH RES CO, V401, P440, DOI 10.1016/j.bbrc.2010.09.075
   Vellarikkal SK, 2015, HUM MUTAT, V36, P419, DOI 10.1002/humu.22767
   Vill K, 2015, NEUROPEDIATRICS, V46, P282, DOI 10.1055/s-0035-1554100
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
   Ylikallio E, 2014, EUR J HUM GENET, V22, P522, DOI 10.1038/ejhg.2013.190
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
NR 20
TC 31
Z9 36
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2017
VL 35
IS 
BP 54
EP 58
DI 10.1016/j.mito.2017.05.005
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EZ9QK
UT WOS:000405064700007
PM 28499982
DA 2024-11-01
ER

PT J
AU Eelczak, P
   Lewandowska, E
   Stepniak, I
   Oldak, M
   Pollak, A
   Lechowicz, U
   Pasennik, E
   Stepiew, T
   Wierzba-Bobrowicz, T
AF Eelczak, Paulina
   Lewandowska, Eliza
   Stepniak, Iwona
   Oldak, Monika
   Pollak, Agnieszka
   Lechowicz, Urszula
   Pasennik, Elzbieta
   Stepiew, Tomasz
   Wierzba-Bobrowicz, Teresa
TI PATHOLOGY OF MITOCHONDRIA IN MELAS SYNDROME: AN ULTRASTRUCTURAL STUDY
SO POLISH JOURNAL OF PATHOLOGY
LA English
DT Article
DE MELAS; A3243G mutation; abnormal mitochondria; ultrastructure
ID stroke-like-episodes; treatment options; skeletal-muscle; lactic-acidosis; dna mutation; disorders; myopathy; encephalopathy; diagnosis; disease
AB Ultrastructural changes in skeletal muscle biopsy in a 24-year-old female patient with clinically suspected mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS) syndrome are presented. We observed proliferation and/or pleomorphism of mitochondria in skeletal muscle and smooth muscle cells of arterioles, as well as in pericytes of capillaries. Paracrystalline inclusions were found only in damaged mitochondria of skeletal muscle. Genetic testing revealed a point mutation in A3243G tRNALeu(UUR) typical for MELAS syndrome. We conclude that differentiated pathological changes of mitochondria in the studied types of cells may be associated with the different energy requirements of these cells.
C1 [Eelczak, Paulina; Lewandowska, Eliza; Pasennik, Elzbieta; Stepiew, Tomasz; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, 9 Sobieskiego St, PL-02957 Warsaw, Poland.
   [Stepniak, Iwona] Inst Psychiat & Neurol, Dept Genet, Warsaw, Poland.
   [Stepniak, Iwona; Oldak, Monika; Pollak, Agnieszka; Lechowicz, Urszula] Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland.
C3 Institute of Psychiatry & Neurology; Institute of Psychiatry & Neurology; Institute of Physiology & Hearing Pathology
RP Lewandowska, E (corresponding author), Inst Psychiat & Neurol, Dept Neuropathol, 9 Sobieskiego St, PL-02957 Warsaw, Poland.
EM lewandow@ipin.edu.pl
FU Polish National Science Centre [2012/05/N/NZ5/02629]
CR Abu-Amero KK, 2009, J MED CASE REPORTS, V3, P1
   BONILLA E, 1980, ACTA NEUROPATHOL, V52, P35, DOI 10.1007/BF00687226
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Cheldi A, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-8
   Chinnery PF, 1999, LANCET, V354, P0
   Christy A, 2014, SCH J MED CASE REP, V2, P145
   DiFrancesco JC, 2008, EXP NEUROL, V212, P152, DOI 10.1016/j.expneurol.2008.03.015
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289
   Farrar GJ, 2013, TRENDS GENET, V10, P1
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2011, REV INVEST CLIN, V63, P100
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Koenigsberger MR, 1976, CNS 5 ANN M MONT CA, V0, P0
   Lang T, 2010, ULTRASTRUCT PATHOL, V34, P78, DOI 10.3109/01913121003624684
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Lee SJ, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/327167
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Misonou Y, 2014, BIOL OPEN, V3, P387, DOI 10.1242/bio.20147138
   OHAMA E, 1987, ACTA NEUROPATHOL, V75, P1, DOI 10.1007/BF00686785
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144
   Wang ZP, 2016, FOLIA NEUROPATHOL, V54, P66, DOI 10.5114/fn.2016.58917
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 42
TC 8
Z9 8
U1 0
U2 11
PU VESALIUS UNIV MEDICAL PUBL
PI CRACOW
PA WISLISKO 1, CRACOW, 00000, POLAND
SN 1233-9687
EI 
J9 POL J PATHOL
JI Pol. J. Pathol.
PD JUN 15
PY 2017
VL 68
IS 2
BP 173
EP 181
DI 10.5114/PJP.2017.65021
PG 9
WC Pathology
SC Pathology
GA FF8SX
UT WOS:000409289200012
PM 29025253
DA 2024-11-01
ER

PT J
AU DeBalsi, KL
   Longley, MJ
   Hoff, KE
   Copeland, WC
AF DeBalsi, Karen L.
   Longley, Matthew J.
   Hoff, Kirsten E.
   Copeland, William C.
TI Synergistic Effects of the <i>in cis</i> T251I and P587L Mitochondrial DNA Polymerase γ Disease Mutations
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID progressive external ophthalmoplegia; polg mutations; pathogenic mutations; exonuclease activity; biochemical-analysis; autosomal-dominant; accessory subunit; replication; disorders; toxicity
AB Human mitochondrial DNA (mtDNA) polymerase gamma (Pol gamma) is the only polymerase known to replicate the mitochondrial genome. The Pol gamma holoenzyme consists of the p140 catalytic subunit (POLG) and the p55 homodimeric accessory subunit (POLG2), which enhances binding of Pol gamma to DNA and promotes processivity of the holoenzyme. Mutations within POLG impede maintenance of mtDNA and cause mitochondrial diseases. Two common POLG mutations usually found in cis in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions. To determine whether T251I or P587L is the primary pathogenic allele or whether both substitutions are required to cause disease, we overproduced and purified WT, T251I, P587L, and T251I + P587L double variant forms of recombinant Pol gamma. Biochemical characterization of these variants revealed impaired DNA binding affinity, reduced thermostability, diminished exonuclease activity, defective catalytic activity, and compromisedDNAprocessivity, even in the presence of the p55 accessory subunit. However, physical association with p55 was unperturbed, suggesting intersubunit affinities similar to WT. Notably, although the single mutants were similarly impaired, a dramatic synergistic effect was found for the double mutant across all parameters. In conclusion, our analyses suggest that individually both T251I and P587L substitutions functionally impair Pol gamma, with greater pathogenicity predicted for the single P587L variant. Combining T251I and P587L induces extreme thermal lability and leads to synergistic nucleotide and DNA binding defects, which severely impair catalytic activity and correlate with presentation of disease in patients.
C1 [DeBalsi, Karen L.; Longley, Matthew J.; Hoff, Kirsten E.; Copeland, William C.] NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Intramural Research Program of the NIEHS, National Institutes of Health [ES 065078]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Al-Zubeidi D, 2014, PEDIATR NEUROL, V51, P448, DOI 10.1016/j.pediatrneurol.2014.04.006
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Caito SW, 2015, ANTIOXID REDOX SIGN, V23, P578, DOI 10.1089/ars.2015.6289
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36
   HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702
   Lucas P, 1997, CR ACAD SCI III-VIE, V320, P299, DOI 10.1016/S0764-4469(97)82771-0
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stumpf JD, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004748
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
NR 67
TC 14
Z9 14
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 15
PY 2017
VL 292
IS 10
BP 4198
EP 4209
DI 10.1074/jbc.M116.773341
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EN2JZ
UT WOS:000395837100018
PM 28154168
DA 2024-11-01
ER

PT J
AU Siibak, T
   Clemente, P
   Bratic, A
   Bruhn, H
   Kauppila, TES
   Macao, B
   Schober, FA
   Lesko, N
   Wibom, R
   Naess, K
   Nennesmo, I
   Wedell, A
   Peter, B
   Freyer, C
   Falkenberg, M
   Wredenberg, A
AF Siibak, Triinu
   Clemente, Paula
   Bratic, Ana
   Bruhn, Helene
   Kauppila, Timo E. S.
   Macao, Bertil
   Schober, Florian A.
   Lesko, Nicole
   Wibom, Rolf
   Naess, Karin
   Nennesmo, Inger
   Wedell, Anna
   Peter, Bradley
   Freyer, Christoph
   Falkenberg, Maria
   Wredenberg, Anna
TI A multi-systemic mitochondrial disorder due to a dominant p.Y955H disease variant in DNA polymerase gamma
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; kearns-sayre syndrome; saccharomyces-cerevisiae; mtdna deletions; mutations; replication; fidelity; defects; cells; polg
AB Mutations in the mitochondrial DNA polymerase, POLG, are associated with a variety of clinical presentations, ranging from early onset fatal brain disease in Alpers syndrome to chronic progressive external ophthalmoplegia. The majority of mutations are linked with disturbances of mitochondrial DNA (mtDNA) integrity and maintenance. On a molecular level, depending on their location within the enzyme, mutations either lead to mtDNA depletion or the accumulation of multiple mtDNA deletions, and in some cases these molecular changes can be correlated to the clinical presentation. We identified a patient with a dominant p.Y955H mutation in POLG, presenting with a severe, early-onset multi-systemic mitochondrial disease with bilateral sensorineural hearing loss, cataract, myopathy, and liver failure. Using a combination of disease models of Drosophila melanogaster and in vitro biochemistry analysis, we compare the molecular consequences of the p.Y955H mutation to the well-documented p.Y955C mutation. We demonstrate that both mutations affect mtDNA replication and display a dominant negative effect, with the p.Y955H allele resulting in a more severe polymerase dysfunction.
C1 [Siibak, Triinu; Macao, Bertil; Peter, Bradley; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, SE-40530 Gothenburg, Sweden.
   [Clemente, Paula; Schober, Florian A.; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Max Planck Inst Biol Ageing Karolinska Inst Lab, Div Metab Dis, Dept Lab Med, SE-17177 Stockholm, Sweden.
   [Clemente, Paula; Bruhn, Helene; Schober, Florian A.; Lesko, Nicole; Wibom, Rolf; Naess, Karin; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
   [Bratic, Ana; Kauppila, Timo E. S.] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.
   [Bruhn, Helene; Lesko, Nicole; Wibom, Rolf; Naess, Karin; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, SE-17176 Stockholm, Sweden.
   [Nennesmo, Inger] Karolinska Univ Hosp, Dept Pathol, SE-17177 Stockholm, Sweden.
   [Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden.
   [Siibak, Triinu] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.
C3 University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Max Planck Society; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Cologne
RP Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, SE-40530 Gothenburg, Sweden.; Wredenberg, A (corresponding author), Karolinska Inst, Max Planck Inst Biol Ageing Karolinska Inst Lab, Div Metab Dis, Dept Lab Med, SE-17177 Stockholm, Sweden.; Wredenberg, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.; Wredenberg, A (corresponding author), Karolinska Univ Hosp, Ctr Inherited Metab Dis, SE-17176 Stockholm, Sweden.
EM maria.falkenberg@medkem.gu.se; anna.wredenberg@ki.se
FU Swedish Research Council [VR521-2012-2571, VR521-2013-2341, VR521-2013-3621]; Stockholm County Council [K01762012, 20140053]; Swedish Foundation for Strategic Research [ICA 12-0017]; Knut & Alice Wallenberg Foundation [KAW 2013.0026, KAW 2011, KAW 2014]; Swedish Cancer Foundation [CAN 2016/816]; European Research Council; Swedish Brain Foundation [FO2015-0146]
CR Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986
   Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Merski M, 2013, J MED CHEM, V56, P2874, DOI 10.1021/jm301823g
   Merski M, 2012, P NATL ACAD SCI USA, V109, P16179, DOI 10.1073/pnas.1208076109
   Naess K, 2012, JIMD REP, V4, P67, DOI 10.1007/8904_2011_73
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stranneheim H, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-1090
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VanGoethem G, 1997, EUR J NEUROL, V4, P476
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 44
TC 9
Z9 9
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUL 1
PY 2017
VL 26
IS 13
BP 2515
EP 2525
DI 10.1093/hmg/ddx146
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EX7WS
UT WOS:000403460700013
PM 28430993
DA 2024-11-01
ER

PT J
AU Meyer, JN
   Leuthner, TC
   Luz, AL
AF Meyer, Joel N.
   Leuthner, Tess C.
   Luz, Anthony L.
TI Mitochondrial fusion, fission, and mitochondrial toxicity
SO TOXICOLOGY
LA English
DT Article
DE Mitochondrial fusion; Mitochondrial fission; Mitochondrial dynamics; Mitochondrial toxicity; Gene-environment interactions; Mitochondrial homeostasis; Mitochondrial DNA; Biomarker
ID innate immune-responses; quality-control; mitofusin 2; caenorhabditis-elegans; parkinsons-disease; arsenite exposure; oxidative stress; dna instability; skeletal-muscle; gene-expression
AB Mitochondrial dynamics are regulated by two sets of opposed processes: mitochondrial fusion and fission, and mitochondrial biogenesis and degradation (including mitophagy), as well as processes such as intracellular transport. These processes maintain mitochondrial homeostasis, regulate mitochondrial form, volume and function, and are increasingly understood to be critical components of the cellular stress response. Mitochondrial dynamics vary based on developmental stage and age, cell type, environmental factors, and genetic background. Indeed, many mitochondrial homeostasis genes are human disease genes. Emerging evidence indicates that deficiencies in these genes often sensitize to environmental exposures, yet can also be protective under certain circumstances. Inhibition of mitochondrial dynamics also affects elimination of irreparable mitochondrial DNA (mtDNA) damage and transmission of mtDNA mutations. We briefly review the basic biology of mitodynamic processes with a focus on mitochondrial fusion and fission, discuss what is known and unknown regarding how these processes respond to chemical and other stressors, and review the literature on interactions between mitochondrial toxicity and genetic variation in mitochondrial fusion and fission genes. Finally, we suggest areas for future research, including elucidating the full range of mitodynamic responses from low to high-level exposures, and from acute to chronic exposures; detailed examination of the physiological consequences of mitodynamic alterations in different cell types; mechanism-based testing of mitotoxicant interactions with inter individual variability in mitodynamics processes; and incorporating other environmental variables that affect mitochondria, such as diet and exercise.
C1 [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm & Integrated Toxicol, Durham, NC 27708 USA.
   Duke Univ, Environm Hlth Program, Durham, NC 27708 USA.
C3 Duke University; Duke University
RP Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm & Integrated Toxicol, Durham, NC 27708 USA.
EM joel.meyer@duke.edu; tess.leuthner@duke.edu; anthony.luz@duke.edu
FU NIH [R01ES017540, P42ES010356, F31ES026859, 1R21ES026743, T32ES021432]
CR Alaimo A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091848
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668
   Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008
   [Anonymous], 2012, PLOS ONE, V0, P0
   Aravamudan B, 2014, AM J PHYSIOL-LUNG C, V306, PL840, DOI 10.1152/ajplung.00155.2013
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242
   Babbar Mansi, 2013, MOL CELL PHARMACOL, V5, P109
   Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004
   Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Benard G, 2013, ANTIOXID REDOX SIGN, V19, P350, DOI 10.1089/ars.2011.4244
   Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y
   Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0
   Bess Amanda S, 2013, WORM, V2, Pe23763, DOI 10.4161/worm.23763
   Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532
   Bestman JE, 2015, DIFFERENTIATION, V89, P51, DOI 10.1016/j.diff.2015.01.001
   Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x
   Bobylev I, 2017, MOL NEUROBIOL, V0, P0
   Bohovych I, 2015, ANTIOXID REDOX SIGN, V22, P977, DOI 10.1089/ars.2014.6199
   Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82
   Branco AF, 2016, EUR J CLIN INVEST, V46, P285, DOI 10.1111/eci.12591
   Bukowiecki R, 2014, GERONTOLOGY, V60, P174, DOI 10.1159/000355050
   Busch KB, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0442
   Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191
   Chan SSL, 2017, TOXICOLOGY, V391, P75, DOI 10.1016/j.tox.2017.07.014
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Choi BO, 2015, CLIN GENET, V87, P594, DOI 10.1111/cge.12432
   Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017
   Costanzo M, 2015, EUR J HISTOCHEM, V59, P129, DOI 10.4081/ejh.2015.2515
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Dalmasso G, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0168198
   Das S, 2017, ENVIRON TOXICOL, V32, P630, DOI 10.1002/tox.22265
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   de Quadros T, 2016, ECOTOX ENVIRON SAFE, V132, P279, DOI 10.1016/j.ecoenv.2016.06.018
   Dhingra R, 2014, CIRC J, V78, P803, DOI 10.1253/circj.CJ-14-0240
   Ding H, 2010, BBA-GEN SUBJECTS, V1800, P250, DOI 10.1016/j.bbagen.2009.08.007
   Ditzel EJ, 2016, ENVIRON HEALTH PERSP, V124, P201, DOI 10.1289/ehp.1409501
   Divi RL, 2010, TOXICOL SCI, V118, P191, DOI 10.1093/toxsci/kfq235
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024
   Fonkem E, 2013, MUSCLE NERVE, V48, P140, DOI 10.1002/mus.23766
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009
   González-Hunt CP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114459
   Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Guillet V, 2010, MITOCHONDRION, V10, P115, DOI 10.1016/j.mito.2009.11.004
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Held NM, 2015, BIOESSAYS, V37, P867, DOI 10.1002/bies.201500013
   Heng JE, 1999, INVEST OPHTH VIS SCI, V40, P190
   Hepple RT, 2009, EXERC SPORT SCI REV, V37, P23, DOI 10.1097/JES.0b013e3181877dc5
   Hirata N, 2016, BIOCHEM BIOPH RES CO, V470, P300, DOI 10.1016/j.bbrc.2016.01.063
   Hoffmann RF, 2013, RESP RES, V14, P0, DOI 10.1186/1465-9921-14-97
   Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005
   Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110
   Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0
   Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001
   Barbosa DJ, 2014, TOXICOL SCI, V139, P0, DOI 10.1093/toxsci/kfu042
   Jugé R, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep35065
   Kanazawa T, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000022
   Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klein C, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a008888
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007
   Lee EJ, 2008, J NEURO-OPHTHALMOL, V28, P269, DOI 10.1097/WNO.0b013e31818e3c6b
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Lenaers G, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-46
   Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, P0, DOI 10.1186/2050-6511-14-9
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Liu SY, 2012, SCI WORLD J, V0, P0, DOI DOI 10.1100/2012/614263
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Lu HQ, 2013, AUTOPHAGY, V9, P1720, DOI 10.4161/auto.26550
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018
   Lv H, 2015, J NEUROL SCI, V358, P153, DOI 10.1016/j.jns.2015.08.1528
   Manella G, 2016, FRONT ENDOCRINOL, V7, P0, DOI 10.3389/fendo.2016.00162
   Melentijevic I, 2017, NATURE, V542, P367, DOI 10.1038/nature21362
   Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Meyer JN, 2012, AUTOPHAGY, V8, P1822, DOI 10.4161/auto.21741
   Millet AMC, 2016, ANN CLIN TRANSL NEUR, V3, P408, DOI 10.1002/acn3.305
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021
   Parameyong A, 2013, J PINEAL RES, V55, P313, DOI 10.1111/jpi.12078
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311
   Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017
   Pradhan M, 2010, SURV OPHTHALMOL, V55, P378, DOI 10.1016/j.survophthal.2009.10.005
   Quist EM, 2015, TOXICOL PATHOL, V43, P546, DOI 10.1177/0192623314551841
   Ravenscroft P, 2009, ARSENIC POLLUTION: A GLOBAL SYNTHESIS, V0, P0, DOI DOI 10.1002/9781444308785
   Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543
   Roberts RF, 2016, INT J BIOCHEM CELL B, V79, P427, DOI 10.1016/j.biocel.2016.07.020
   Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076
   Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007
   Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022
   Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374
   Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x
   Sitarz KS, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws049
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Tang S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004492
   Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00107
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   van der Bliek AM, 2009, EMBO J, V28, P1533, DOI 10.1038/emboj.2009.130
   Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800
   Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655
   Wang WL, 2012, MED ONCOL, V29, P70, DOI 10.1007/s12032-010-9779-6
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Weimer LH, 2006, J NEUROL SCI, V242, P47, DOI 10.1016/j.jns.2005.11.014
   West AP, 2017, TOXICOLOGY, V391, P54, DOI 10.1016/j.tox.2017.07.016
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   Wood CE, 2015, CARCINOGENESIS, V36, P782, DOI 10.1093/carcin/bgv057
   Xu S, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.7
   Yamada S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep40925
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
   Zubovych IO, 2010, MOL BIOL CELL, V21, P956, DOI 10.1091/mbc.E09-08-0673
NR 173
TC 342
Z9 380
U1 15
U2 207
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0300-483X
EI 1879-3185
J9 TOXICOLOGY
JI Toxicology
PD NOV 1
PY 2017
VL 391
IS 
BP 42
EP 53
DI 10.1016/j.tox.2017.07.019
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA FO5FZ
UT WOS:000416880200006
PM 28789970
DA 2024-11-01
ER

PT J
AU Ji, XB
   Zhao, LZ
   Ji, KQ
   Zhao, YY
   Li, W
   Zhang, R
   Hou, Y
   Lu, JQ
   Yan, CZ
AF Ji, Xinbo
   Zhao, Lizhen
   Ji, Kunqian
   Zhao, Yuying
   Li, Wei
   Zhang, Rui
   Hou, Ying
   Lu, Jianqiang
   Yan, Chuanzhu
TI Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Mitochondrial disease; Neuromuscular disorders; Histology; Growth differentiation factor 15; Biomarker
ID macrophage inhibitory cytokine-1; dna mutations; disorders; gdf15; progression; prevalence; cells; beta
AB The present study aimed to investigate whether serum growth differentiation factor 15 concentration is a valuable and reliable diagnostic biomarker of mitochondrial diseases. We examined consecutive patients with mitochondrial diseases, in comparison with patients with non-mitochondrial disease neuromuscular disorders and healthy controls. The serum concentrations of growth differentiation factor 15 were measured by ELISA, and compared with those of FGF21, lactate, and creatine kinase. We also evaluated the correlations between growth differentiation factor 15 concentrations and the Newcastle Mitochondrial Disease Adult Scale, numbers of ragged-red fibers, and COX-negative fibers in the biopsied muscles. The median serum growth differentiation factor 15 concentration was significantly elevated in 42 patients with mitochondrial diseases, compared with 20 patients with non-mitochondrial disease neuromuscular disorders and 50 healthy controls. The area under the curve of growth differentiation factor 15 for the diagnosis of muscle-manifesting mitochondrial diseases was 0.999, in comparison with those area under the curves of the other biomarkers including fibroblast growth factor 21 (0.935, p < 0.01), lactate (0.845 for p < 0.001), and creatine kinase (0.575, p < 0.001). Growth differentiation factor 15 was significantly correlated with mitochondrial disease severity and the proportion of ragged-red fibers identified in the biopsied muscles. Circulating growth differentiation factor 15 measurement is a superior biomarker with high sensitivity and specificity, which can be used as a non-invasive test to screen for primary mitochondrial diseases and dysmetabolic myopathy with associated mitochondrial dysfunction in susceptible individuals.
C1 [Ji, Xinbo; Zhao, Lizhen; Ji, Kunqian; Zhao, Yuying; Li, Wei; Zhang, Rui; Hou, Ying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Shandong, Peoples R China.
   [Ji, Xinbo; Zhao, Lizhen; Ji, Kunqian; Zhao, Yuying; Li, Wei; Zhang, Rui; Hou, Ying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China.
   [Zhao, Lizhen] Yidu Cent Hosp Weifang City, Dept Neurol, Qingzhou Shi, Peoples R China.
   [Lu, Jianqiang] Univ Alberta, WCM Hlth Sci Ctr, Neuropathol Sect, Edmonton, AB, Canada.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Minist Educ, Dept Neurol,Qilu Hosp,Key Lab Expt Teratol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; University of Alberta; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Minist Educ, Dept Neurol,Qilu Hosp,Key Lab Expt Teratol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM jixinbo@yeah.net; zhaolizhendoc@163.com; kunqianji@163.com; zyy72@126.com; weili722@163.com; ruizhang1991@yahoo.com; purewligirl@163.com; jqlu@live.ca; czyan1964@gmail.com
FU National Natural Science Foundation of China [81171182, 81671235]
CR Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Fujita Y, 2016, GERIATR GERONTOL INT, V16, P17, DOI 10.1111/ggi.12724
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Izumiya Y, 2014, CAN J CARDIOL, V30, P338, DOI 10.1016/j.cjca.2013.12.010
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kempf T, 2013, CRIT CARE, V17, P0, DOI 10.1186/cc12765
   Koene S, 2015, JIMD REP, V24, P69, DOI 10.1007/8904_2015_436
   Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199
   Liu FC, 2016, INT J NEUROSCI, V126, P499, DOI 10.3109/00207454.2015.1034801
   Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196
   Montoro-García S, 2012, EUR J INTERN MED, V23, P169, DOI 10.1016/j.ejim.2011.08.022
   Osada M, 2007, BIOCHEM BIOPH RES CO, V354, P913, DOI 10.1016/j.bbrc.2007.01.089
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Tiwari KK, 2015, TOXICOL IN VITRO, V29, P1369, DOI 10.1016/j.tiv.2015.05.008
   Trovik J, 2014, INT J GYNECOL CANCER, V24, P252, DOI 10.1097/IGC.0000000000000037
   Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003
   Yang CZ, 2014, ANN ONCOL, V25, P1215, DOI 10.1093/annonc/mdu120
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 28
TC 38
Z9 41
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD DEC 15
PY 2017
VL 54
IS 10
BP 8110
EP 8116
DI 10.1007/s12035-016-0283-7
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA FM8MF
UT WOS:000415341900044
PM 27889897
DA 2024-11-01
ER

PT J
AU Barness, LA
   Wong, K
AF Barness, Lewis A.
   Wong, Kondi
TI Mitochondrial Myopathies and Disorders
SO METABOLIC DISEASES: FOUNDATIONS OF CLINICAL MANAGEMENT, GENETICS, AND PATHOLOGY, 2ND EDITION
LA English
DT Article; Book Chapter
DE lactic acidosis; ragged red fibers; Leigh syndrome; Leber hereditary optic neuropathy; Kearns-Sayre syndrome; biotinidase deficiency
ID progressive external ophthalmoplegia; hereditary optic neuropathy; kearns-sayre-syndrome; subacute necrotizing encephalomyelopathy; pyruvate-dehydrogenase complex; linked cardioskeletal myopathy; ragged-red fibers; neurogastrointestinal encephalomyopathy mngie; neutropenia barth-syndrome; transfer rnaleu(uur) gene
AB Genetic disorders of mitochondria cause disease when they reduce subcellular energy production through a variety of impairments in the electron transport chain, thus decreasing oxidative phosphorylation. Such abnormalities typically lead to neuropathies and/or myopathies including cardiomyopathies. Hepatic and renal pathology may also occur. The age of onset and severity are variable, but signs and symptoms are often present during infancy. The metabolic hallmarks include lactic acidosis, an increased ratio of blood lactate to pyruvate, and ketonemia. Muscle biopsies show characteristic ragged red fibers, which are obvious with trichrome staining. Some disorders which are inherited through the mother, source of all mitochondrial DNA, lead to early blindness due to progressive optic neuropathy, i.e., Leber's Hereditary Optic Neuropathy. Exciting recent research with gene replacement therapy and stem cell technology has provided new insights and hope for patients with genetic blindness. Other disorders affecting mitochondrial DNA mutations may also eventually be treated with molecular (gene replacement) or advanced cellular (stem cell) therapeutic strategies. In addition, early diagnosis through newborn screening is now routinely achieved for some disorders such as biotinidase deficiency, allowing curative therapy through nutritional supplements.
C1 [Barness, Lewis A.] Univ S Florida, Pediat, Morsani Coll Med, Tampa, FL 33620 USA.
   [Barness, Lewis A.] Univ Wisconsin, Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.
   [Wong, Kondi] Tampa Gen Hosp, 1 Tampa Gen Circle, Tampa, FL 33606 USA.
C3 State University System of Florida; University of South Florida; University of Wisconsin System; University of Wisconsin Madison; Tampa General Hospital
RP Barness, LA (corresponding author), Univ S Florida, Pediat, Morsani Coll Med, Tampa, FL 33620 USA.; Barness, LA (corresponding author), Univ Wisconsin, Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.
CR Abe K, 1997, NEUROLOGY, V49, P837, DOI 10.1212/WNL.49.3.837
   Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480
   Aeby A, 2007, J INHERIT METAB DIS, V30, P827, DOI 10.1007/s10545-007-0612-0
   Ambonville C, 2008, DIABETES METAB, V34, P389, DOI 10.1016/j.diabet.2008.05.002
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   ATKIN BM, 1979, PEDIATR RES, V13, P109, DOI 10.1203/00006450-197902000-00005
   ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009
   Avis HJ, 2011, J PEDIATR-US, V158, P458, DOI 10.1016/j.jpeds.2010.08.015
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Barness LA, 1997, POTTERS PATHOLOGY FE, V0, P571
   Barness LA, 1997, METABOLIC DIS, V0, P0
   Barritt GJ, 1985, P141, V0, P0
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   BARTON DE, 1987, CYTOGENET CELL GENET, V46, P577
   BEHBEHANI AW, 1984, EUR J PEDIATR, V143, P67, DOI 10.1007/BF00442753
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BERTORINI T, 1978, ARCH NEUROL-CHICAGO, V35, P643, DOI 10.1001/archneur.1978.00500340019004
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   BIRD LM, 1994, AM J MED GENET, V53, P141, DOI 10.1002/ajmg.1320530205
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   BLASS JP, 1972, J CLIN INVEST, V51, P1845, DOI 10.1172/JCI106986
   BODNAR AG, 1993, AM J HUM GENET, V53, P663
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   BOLHUIS PA, 1991, AM J HUM GENET, V48, P481
   BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BOUSTANY RN, 1983, ANN NEUROL, V14, P462, DOI 10.1002/ana.410140411
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   BRUTON D, 1977, PATHOLOGY, V9, P115, DOI 10.3109/00313027709085249
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Cathelineau CL, 1989, ACTA PAEDIATR SCAND, V65, P717
   CEDERBAUM SD, 1976, PEDIATR RES, V10, P713, DOI 10.1203/00006450-197610080-00002
   Challa S, 2004, NEUROL INDIA, V52, P353
   Chalmers RM, 1996, BRAIN, V119, P1481, DOI 10.1093/brain/119.5.1481
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHUN K, 1990, EUR J BIOCHEM, V194, P587, DOI 10.1111/j.1432-1033.1990.tb15656.x
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   COOPER JR, 1969, SCIENCE, V164, P74, DOI 10.1126/science.164.3875.74
   COOPER JR, 1970, NEW ENGL J MED, V283, P793, DOI 10.1056/NEJM197010082831506
   CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9
   Cornelio F, 1987, PERSP INHER METAB DI, V7, P45
   Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   DAVIDSON M, 1983, BIOCHEM J, V214, P703, DOI 10.1042/bj2140703
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DEVIVO DC, 1977, J CLIN ENDOCR METAB, V45, P1281, DOI 10.1210/jcem-45-6-1281
   DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1990, NEUROL CLIN, V8, P483, DOI 10.1016/S0733-8619(18)30332-3
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   DiMauro S, 1997, MITOCHONDRIAL ENCEPH, V0, P201
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   DiMauro S, 1997, PROMISING AVENUES IN, V0, P0
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   DUBOIS LG, 1992, J CLIN NEURO-OPHTHAL, V12, P15
   Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635
   EGGER J, 1987, CLIN PEDIATR, V26, P167, DOI 10.1177/000992288702600401
   Emmanuele V, 2012, ARCH NEUROLOGY, V0, P0
   ENDO H, 1991, J INHERIT METAB DIS, V14, P793, DOI 10.1007/BF01799952
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   ESTOURNET B, 1991, REV NEUROL-FRANCE, V147, P491
   EVANS OB, 1984, J PEDIATR-US, V105, P961, DOI 10.1016/S0022-3476(84)80090-6
   FALK RE, 1976, PEDIATRICS, V58, P713
   FARMER TW, 1973, NEUROLOGY, V23, P429
   FARRELL DF, 1975, SCIENCE, V187, P1082, DOI 10.1126/science.803713
   FAYON M, 1992, GASTROENTEROLOGY, V103, P1332, DOI 10.1016/0016-5085(92)91525-9
   FEIGENBAUM AS, 1993, GENOMICS, V17, P376, DOI 10.1006/geno.1993.1335
   FERRANS VJ, 1976, CIRCULATION, V53, P708, DOI 10.1161/01.CIR.53.4.708
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finegold D, 1997, DIAGNOSIS PROMISE DN, V0, P0
   FRANCIOSI RA, 1988, HUM PATHOL, V19, P1361, DOI 10.1016/S0046-8177(88)80296-X
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Freckmann ML, 1997, J PEDIATR-US, V130, P431, DOI 10.1016/S0022-3476(97)70206-3
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517
   Frerman FE, 1995, NUCL ENCODED DEFECTS, V0, P0
   FREYTAG SO, 1984, J BIOL CHEM, V259, P2831
   FULHAM M, 1988, MED J AUSTRALIA, V149, P320, DOI 10.5694/j.1326-5377.1988.tb120635.x
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   GILBERT EF, 1983, ARCH PATHOL LAB MED, V107, P162
   Goodman SI, 1991, INT PEDIAT, V6, P59
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GREENBERG DA, 1984, J NEUROCHEM, V42, P1062, DOI 10.1111/j.1471-4159.1984.tb12711.x
   HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6
   HAMMANS SR, 1994, MITOCHONDRIAL DISORD, V0, P49
   Hanke SP, 2012, PEDIAT CARDIOLOGY, V0, P0
   HANSEN TL, 1983, CLIN CHIM ACTA, V131, P39, DOI 10.1016/0009-8981(83)90350-9
   HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589
   HARDING AE, 1983, Q J MED, V52, P489
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HARDING BN, 1986, BRAIN, V109, P181, DOI 10.1093/brain/109.1.181
   Hassani A, 2010, CURR OPIN NEUROL, V23, P459, DOI 10.1097/WCO.0b013e32833d1096
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   He QA, 2010, AM J PHYSIOL-HEART C, V299, PH210, DOI 10.1152/ajpheart.00098.2010
   Hinttala R, 2006, J MED GENET, V43, P881, DOI 10.1136/jmg.2006.042168
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 1996, HANDBOOK OF MUSCLE DISEASE, V0, P479
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   HO L, 1986, J CLIN INVEST, V78, P844, DOI 10.1172/JCI112651
   Hofmann S, 1999, SURF 1 MUTATIONS ARE, V0, P0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOMMES FA, 1973, PEDIATR RES, V7, P616, DOI 10.1203/00006450-197307000-00003
   Hommes FA, 1979, INHERITED DISORDERS, V0, P239
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463
   Hwang J M, 1996, KOREAN J OPHTHALMOL, V10, P122
   INO T, 1988, J PEDIATR-US, V113, P511, DOI 10.1016/S0022-3476(88)80642-5
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86
   JAMES TN, 1975, CIRCULATION, V52, P333, DOI 10.1161/01.CIR.52.2.333
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNEY DL, 1987, CIRCULATION, V75, P705, DOI 10.1161/01.CIR.75.4.705
   KEARNS THOMAS P, 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KELLER BB, 1987, AM HEART J, V114, P782, DOI 10.1016/0002-8703(87)90789-7
   KELLEY R I, 1989, AMERICAN JOURNAL OF HUMAN GENETICS, V45, P0
   KIMURA S, 1991, PEDIATR NEUROL, V7, P56, DOI 10.1016/0887-8994(91)90108-W
   KITANO A, 1990, NEUROLOGY, V40, P1312, DOI 10.1212/WNL.40.8.1312
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   KODAMA S, 1983, BRAIN DEV-JPN, V5, P381, DOI 10.1016/S0387-7604(83)80043-6
   KOIKE K, 1990, P NATL ACAD SCI USA, V87, P5594, DOI 10.1073/pnas.87.15.5594
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Komulainen T, 2010, BMC NEUROL, V10, P0, DOI 10.1186/1471-2377-10-29
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   KURE K, 1990, ACTA NEUROPATHOL, V80, P393, DOI 10.1007/BF00307693
   Laberge AM, 2005, AM J HUM GENET, V77, P313, DOI 10.1086/432491
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   LEW EO, 1989, ACTA NEUROPATHOL, V77, P599, DOI 10.1007/BF00687887
   LEWIN R, 1987, SCIENCE, V238, P24, DOI 10.1126/science.3116666
   LI K, 1989, J BIOL CHEM, V264, P13998
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   LOMBES A, 1991, NEUROLOGY, V41, P491, DOI 10.1212/WNL.41.4.491
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   MACAYA A, 1993, NEUROPEDIATRICS, V24, P60, DOI 10.1055/s-2008-1071515
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Makaryan V, 2012, EUR J HAEMATOL, V88, P195, DOI 10.1111/j.1600-0609.2011.01725.x
   MALHOTRA V, 1994, AM HEART J, V128, P1009, DOI 10.1016/0002-8703(94)90601-7
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARAGOS C, 1989, J BIOL CHEM, V264, P12294
   Marchiafava E, 1903, RIV PATOL NERV MENT, V8, P544
   MARSAC C, 1982, CLIN CHIM ACTA, V119, P121, DOI 10.1016/0009-8981(82)90412-0
   Martelli A, 2012, DIS MODEL MECH, V5, P165, DOI 10.1242/dmm.008706
   Matsuoka T, 1991, NEUROMUSCUL DISORD, V1, P443, DOI 10.1016/0960-8966(91)90007-F
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2025, DOI 10.1212/WNL.43.10.2025
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MCCORMICK K, 1985, AM J MED GENET, V22, P291, DOI 10.1002/ajmg.1320220211
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCGREGOR CGA, 1984, AM J CARDIOL, V53, P982, DOI 10.1016/0002-9149(84)90553-8
   MCKAY N, 1986, EUR J PEDIATR, V144, P445, DOI 10.1007/BF00441736
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MEDINA L, 1990, AM J NEURORADIOL, V11, P379
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Miles MV, 2011, MITOCHONDRION, V11, P127, DOI 10.1016/j.mito.2010.08.010
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   Momoi N, 2012, EUR J PEDIATR, V171, P515, DOI 10.1007/s00431-011-1597-0
   MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1
   MOOY PD, 1984, EUR J PEDIATR, V143, P92, DOI 10.1007/BF00445792
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Mühlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   MURPHY JV, 1981, PEDIATRICS, V68, P401
   MURPHY JV, 1973, PEDIATRICS, V51, P710
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   NAGAI T, 1992, PEDIATR NEUROL, V8, P328, DOI 10.1016/0887-8994(92)90084-C
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   NARKEWICZ MR, 1991, J PEDIATR-US, V119, P260, DOI 10.1016/S0022-3476(05)80736-X
   Naviaux RK, 1997, SPECTRUM MITOCHONDRI, V0, P0
   Naylor EW, 1997, ELECTROSPRAY TANDEM, V0, P0
   NEUSTEIN HB, 1979, PEDIATRICS, V64, P24
   Newman NJ, 1993, OPHTHALMOL CLIN N AM, V4, P431
   Nielsen Mette Lundgren, 2011, UGESKR LAEGER, V173, P2943
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ohkuma A, 2009, MUSCLE NERVE, V39, P333, DOI 10.1002/mus.21167
   OLD SE, 1989, ANN NEUROL, V26, P746, DOI 10.1002/ana.410260610
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Olson S, 1990, AM J HUM GENET, V46, P340
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Ontko J, 1976, ENZYMES MITOCHONDRIA, V0, P0
   OTULAKOWSKI G, 1988, SOMAT CELL MOLEC GEN, V14, P411, DOI 10.1007/BF01534650
   PAMPHLETT R, 1985, MED J AUSTRALIA, V143, P306, DOI 10.5694/j.1326-5377.1985.tb123019.x
   Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3
   PAPADIMITRIOU A, 1984, PEDIATR RES, V18, P1023, DOI 10.1203/00006450-198418100-00023
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   PARROTROULAUD F, 1991, J INHERIT METAB DIS, V14, P289, DOI 10.1007/BF01811684
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PEIFFER J, 1988, PATHOL RES PRACT, V183, P706, DOI 10.1016/S0344-0338(88)80056-6
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Phadke M, 2012, INDIAN J PEDIAT, V0, P0
   PINCUS JH, 1973, PEDIATRICS, V51, P716
   PINCUS JH, 1969, NEUROLOGY, V19, P841, DOI 10.1212/WNL.19.9.841
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pineda M, 2010, MOVEMENT DISORD, V25, P1262, DOI 10.1002/mds.23129
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   POULTON J, 1989, LANCET, V1, P236
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   PRICK MJJ, 1982, NEUROPEDIATRICS, V13, P108, DOI 10.1055/s-2008-1059608
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   REICHMANN H, 1993, ACTA NEUROPATHOL, V85, P679, DOI 10.1007/BF00334681
   REID JD, 1968, J PEDIATR-US, V73, P335, DOI 10.1016/S0022-3476(68)80109-X
   RHEAD W, 1993, PEDIATR RES, V33, P129, DOI 10.1203/00006450-199302000-00008
   Robinson B H, 1989, ADV HUM GENET, V18, P151
   ROBINSON BH, 1984, J INHERIT METAB DIS, V7, P69, DOI 10.1007/BF03047378
   ROBINSON BH, 1989, ANN NY ACAD SCI, V573, P337, DOI 10.1111/j.1749-6632.1989.tb15009.x
   ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013
   ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9
   ROBINSON BH, 1985, PRENATAL DIAG, V5, P67, DOI 10.1002/pd.1970050112
   Robinson BH, 1995, LACTIC ACIDEMIA DISO, V0, P0
   ROBINSON BH, 1989, ANN NY ACAD SCI, V573, P337
   Robinson BH, 1997, J PEDIAT, V111, P525
   Ronchi D, 2011, J NEUROL SCI, V308, P173, DOI 10.1016/j.jns.2011.05.042
   ROSSI L, 1985, CHEST, V87, P340, DOI 10.1378/chest.87.3.340
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROYAL V, 1991, NUCLEIC ACIDS RES, V19, P4021, DOI 10.1093/nar/19.14.4021
   RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Saitoh S, 1998, NEUROLOGY, V50, P531, DOI 10.1212/WNL.50.2.531
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sanchez MIGL, 2016, PHARMACOL THERAPEUT, V165, P132, DOI 10.1016/j.pharmthera.2016.06.004
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115
   Schmucker S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016199
   Schuepbach WMM, 2007, J NEUROL, V254, P146, DOI 10.1007/s00415-006-0255-3
   SENGERS RCA, 1984, EUR J PEDIATR, V141, P192, DOI 10.1007/BF00572761
   SENGERS RCA, 1983, EUR J PEDIATR, V140, P332, DOI 10.1007/BF00442676
   Servidei S, 1994, ADV PEDIATR, V41, P1
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shehata BM, 1998, PEDIATR DEVEL PATHOL, V1, P56, DOI 10.1007/s100249900007
   Sherer SW, 1989, J BIOL CHEM, V264, P12294
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, ADV HUM GENET, V19, P267
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoffner JM, 1995, METABOLIC MOL BASES, V7th, P1535
   SILVER MM, 1980, HUM PATHOL, V11, P598, DOI 10.1016/S0046-8177(80)80071-2
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Silvestri G, 1900, V1993, V0, P1200
   SINGLETON R, 1990, NEUROLOGY, V40, P363, DOI 10.1212/WNL.40.2.363
   SMITH D, 1990, OPHTHALMOLOGY, V97, P1156
   SMITH JL, 1973, ARCH OPHTHALMOL-CHIC, V90, P349
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z
   SPERL W, 1988, EUR J PEDIATR, V147, P418, DOI 10.1007/BF00496424
   STACPOOLE PW, 1983, NEW ENGL J MED, V309, P390, DOI 10.1056/NEJM198308183090702
   STANSBIE D, 1986, J INHERIT METAB DIS, V9, P105, DOI 10.1007/BF01799447
   SUSSMAN W, 1950, AM HEART J, V40, P312, DOI 10.1016/0002-8703(50)90175-X
   SUZUKI K, 1969, ARCH NEUROL-CHICAGO, V20, P62, DOI 10.1001/archneur.1969.00480070072008
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Takeuchi Jun, 2008, NIHON RONEN IGAKKAI ZASSHI, V45, P95, DOI 10.3143/geriatrics.45.95
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   tHart LM, 1996, HUM MUTAT, V7, P193
   TRIJBELS JMF, 1988, EUR J PEDIATR, V148, P92, DOI 10.1007/BF00445910
   Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   TULINIUS MH, 1991, J PEDIATR-US, V119, P251, DOI 10.1016/S0022-3476(05)80735-8
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Ulicná O, 2012, PHYSIOL RES, V61, P185, DOI 10.33549/physiolres.932236
   Vallejo-Torres L, 2015, PEDIATRICS, V136, PE424, DOI 10.1542/peds.2014-3399
   van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Raam BJ, 2009, CURR OPIN HEMATOL, V16, P14, DOI 10.1097/MOH.0b013e32831c83f3
   VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
   VILASECA MA, 1991, J INHERIT METAB DIS, V14, P285, DOI 10.1007/BF01811683
   VONGLUTZ G, 1976, FEBS LETT, V72, P299, DOI 10.1016/0014-5793(76)80991-X
   WALKER B E, 1992, GASTROENTEROLOGY, V102, P0
   Wallace D C, 1987, BIRTH DEFECTS ORIG ARTIC SER, V23, P137
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALTER GF, 1986, NEUROPATH APPL NEURO, V12, P95, DOI 10.1111/j.1365-2990.1986.tb00683.x
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang QJ, 2016, ADV EXP MED BIOL, V854, P543, DOI 10.1007/978-3-319-17121-0_72
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   WICKING CA, 1986, BIOCHEM J, V239, P89, DOI 10.1042/bj2390089
   WILSON DC, 1993, EUR J PEDIATR, V152, P260, DOI 10.1007/BF01956158
   WITZLEBEN CL, 1978, ARCH PATHOL LAB MED, V102, P306
   WONG LTK, 1986, PEDIATR RES, V20, P274, DOI 10.1203/00006450-198603000-00016
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Young JM, 2011, ATHEROSCLEROSIS, V218, P188, DOI 10.1016/j.atherosclerosis.2011.04.034
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133
   ZIMMERMANN A, 1982, VIRCHOWS ARCH A, V396, P187, DOI 10.1007/BF00431240
NR 344
TC 0
Z9 0
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 
EI 
J9 
PD JUN 15
PY 2017
VL 0
IS 
BP 191
EP 269
DI 10.3233/978-1-61499-718-4-191
PG 79
WC Genetics & Heredity; Pediatrics
SC Genetics & Heredity; Pediatrics
GA BH3OQ
UT WOS:000399881700009
DA 2024-11-01
ER

PT J
AU Huang, XP
   Bedoyan, JK
   Demirbas, D
   Harris, DJ
   Miron, A
   Edelheit, S
   Grahame, G
   DeBrosse, SD
   Wong, LJ
   Hoppel, CL
   Kerr, DS
   Anselm, I
   Berry, GT
AF Huang, Xiaoping
   Bedoyan, Jirair K.
   Demirbas, Didem
   Harris, David J.
   Miron, Alexander
   Edelheit, Simone
   Grahame, George
   DeBrosse, Suzanne D.
   Wong, Lee Jun
   Hoppel, Charles L.
   Kerr, Douglas S.
   Anselm, Irina
   Berry, Gerard T.
TI Succinyl-CoA synthetase (<i>SUCLA2</i>) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Succinyl-CoA synthetase deficiency; Pyruvate dehydrogenase complex deficiency; Electron transport chain complexes; Propionyl-CoA; Liquid chromatography tandem mass spectrometry; SUCLA2
ID mild methylmalonic aciduria; ligase deficiency; dehydrogenase complex; pyruvate-carboxylase; beta-subunit; encephalomyopathy; mutation; fibroblasts; carnitine; synthase
AB Mutations in SUCLA2 result in succinyl-CoA ligase (ATP-forming) or succinyl-CoA synthetase (ADP-forming) (A-SCS) deficiency, a mitochondrial tricarboxylic acid cycle disorder. The phenotype associated with this gene defect is largely encephalomyopathy. We describe two siblings compound heterozygous for SUCLA2 mutations, c.985A>G (p.M329V) and c.920C>T (p.A307V), with parents confirmed as carriers of each mutation. We developed a new LC-MS/MS based enzyme assay to demonstrate the decreased SCS activity in the siblings with this unique genotype. Both siblings shared bilateral progressive hearing loss, encephalopathy, global developmental delay, generalized myopathy, and dystonia with choreoathetosis. Prior to diagnosis and because of lactic acidosis and low activity of muscle pyruvate dehydrogenase complex (PDC), sibling 1 (S1) was placed on dichloroacetate, while sibling 2 (S2) was on a ketogenic diet. S1 developed severe cyclic vomiting refractory to therapy, while S2 developed Leigh syndrome, severe GI dysmotility, intermittent anemia, hypogammaglobulinemia and eventually succumbed to his disorder. The mitochondrial DNA contents in skeletal muscle (SM) were normal in both siblings. Pyruvate dehydrogenase complex, ketoglutarate dehydrogenase complex, and several mitochondrial electron transport chain (ETC) activities were low or at the low end of the reference range in frozen SM from S1 and/or S2. In contrast, activities of PDC, other mitochondrial enzymes of pyruvate metabolism, ETC and, integrated oxidative phosphorylation, in skin fibroblasts were not significantly impaired. Although we show that propionyl-CoA inhibits PDC, it does not appear to account for decreased PDC activity in SM. A better understanding of the mechanisms of phenotypic variability and the etiology for tissue-specific secondary deficiencies of mitochondrial enzymes of oxidative metabolism, and independently mitochondrial DNA depletion (common in other cases of A-SCS deficiency), is needed given the implications for control of lactic acidosis and possible clinical management. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Huang, Xiaoping; Demirbas, Didem; Harris, David J.; Berry, Gerard T.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA USA.
   [Bedoyan, Jirair K.; DeBrosse, Suzanne D.] Univ Hosp Cleveland, Med Ctr, Ctr Human Genet, Cleveland, OH 44106 USA.
   [Bedoyan, Jirair K.; Miron, Alexander; Edelheit, Simone; DeBrosse, Suzanne D.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.
   [Bedoyan, Jirair K.; Grahame, George; Hoppel, Charles L.; Kerr, Douglas S.] Univ Hosp Cleveland, Med Ctr, CIDEM, Cleveland, OH 44106 USA.
   [Harris, David J.; Berry, Gerard T.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [Wong, Lee Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Hoppel, Charles L.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.
   [Anselm, Irina] Boston Childrens Hosp, Dept Neurol, Boston, MA USA.
   [Bedoyan, Jirair K.; DeBrosse, Suzanne D.; Kerr, Douglas S.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.
C3 Harvard University; Boston Children's Hospital; University System of Ohio; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University System of Ohio; Case Western Reserve University; University Hospitals of Cleveland; University System of Ohio; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; Harvard University; Boston Children's Hospital; University System of Ohio; Case Western Reserve University
RP Berry, GT (corresponding author), Boston Childrens Hosp, Ctr Life Sci, Suite 14070,3 Blackfan Circle, Boston, MA 02115 USA.
EM Gerard.Berry@childrens.harvard.edu
FU Manton Center for Orphan Disease Research Gene Discovery Core, Boston Children's Hospital; Genomics Core Facility of the Case Western Reserve University (CWRU) School of Medicine's Genetics and Genome Sciences Department; Clinical and Translational Science Collaborative (CTSC) CWRU Core Utilization Pilot Grant [05496]; NIH [RDCRN 5U54NS078059-05]; project NAMDC [7413]
CR ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009
   BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   CHUANG DT, 1983, BIOCHEM J, V214, P177, DOI 10.1042/bj2140177
   Coonrod EM, 2013, EXPERT REV MOL DIAGN, V13, P529, DOI 10.1586/14737159.2013.811907
   Donti TR, 2014, DIS MODEL MECH, V7, P271, DOI 10.1242/dmm.013466
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   FRIOLET R, 1994, J CLIN INVEST, V94, P1490, DOI 10.1172/JCI117488
   HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066
   Jaberi E, 2013, J HUM GENET, V58, P526, DOI 10.1038/jhg.2013.45
   Kacso G, 2016, BIOCHEM J, V473, P3463, DOI 10.1042/BCJ20160594
   Kerr D, 2012, METHODS MOL BIOL, V837, P93, DOI 10.1007/978-1-61779-504-6_7
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   Lamperti C, 2012, MOL GENET METAB, V107, P403, DOI 10.1016/j.ymgme.2012.08.020
   Matilainen S, 2015, EUR J HUM GENET, V23, P325, DOI 10.1038/ejhg.2014.128
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Minkler PE, 2015, MOL GENET METAB, V116, P231, DOI 10.1016/j.ymgme.2015.10.002
   Minkler PE, 2015, ANAL CHEM, V87, P8994, DOI 10.1021/acs.analchem.5b02198
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nogueira C, 2015, J CHILD NEUROL, V30, P228, DOI 10.1177/0883073814527158
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Stacpoole PW, 2012, MITOCHONDRION, V12, P623, DOI 10.1016/j.mito.2012.09.005
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   Venegas Victor, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1907s68
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
NR 29
TC 14
Z9 15
U1 1
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD MAR 15
PY 2017
VL 120
IS 3
BP 213
EP 222
DI 10.1016/j.ymgme.2016.11.005
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA EP0ME
UT WOS:000397080600007
PM 27913098
DA 2024-11-01
ER

PT J
AU Mazurova, S
   Magner, M
   Kucerova-Vidrova, V
   Vondrackova, A
   Stranecky, V
   Pristoupilova, A
   Zamecnik, J
   Hansikova, H
   Zeman, J
   Tesarova, M
   Honzik, T
AF Mazurova, Stella
   Magner, Martin
   Kucerova-Vidrova, Vendula
   Vondrackova, Alzbeta
   Stranecky, Viktor
   Pristoupilova, Anna
   Zamecnik, Josef
   Hansikova, Hana
   Zeman, Jiri
   Tesarova, Marketa
   Honzik, Tomas
TI Thymidine kinase 2 and alanyl-tRNA synthetase 2 deficiencies cause lethal mitochondrial cardiomyopathy: case reports and review of the literature
SO CARDIOLOGY IN THE YOUNG
LA English
DT Article
DE Alanyl-tRNA synthetase 2; thymidine kinase 2; mitochondrial cardiomyopathy; ragged red fibres; leucoencephalopathy
ID respiratory-chain deficiency; dna depletion syndrm; tk2 gene; cardiac manifestations; clinical spectrum; myopathic form; human-disease; mutations; defects; onset
AB Cardiomyopathy is a common manifestation in neonates and infants with mitochondrial disorders. In this study, we report two cases manifesting with fatal mitochondrial hypertrophic cardiomyopathy, which include the third known patient with thymidine kinase 2 deficiency and the ninth patient with alanyl-tRNA synthetase 2 deficiency. The girl with thymidine kinase 2 deficiency had hypertrophic cardiomyopathy together with regression of gross motor development at the age of 13 months. Neurological symptoms and cardiac involvement progressed into severe myopathy, psychomotor arrest, and cardiorespiratory failure at the age of 22 months. The imaging methods and autoptic studies proved that she suffered from unique findings of leucoencephalopathy, severe, mainly cerebellar neuronal degeneration, and hepatic steatosis. The girl with alanyl-tRNA synthetase 2 deficiency presented with cardiac failure and underlying hypertrophic cardiomyopathy within 12 hours of life and subsequently died at 9 weeks of age. Muscle biopsy analyses demonstrated respiratory chain complex I and IV deficiencies, and histological evaluation revealed massive mitochondrial accumulation and cytochrome c oxidase-negative fibres in both cases. Exome sequencing in the first case revealed compound heterozygozity for one novel c.209T>C and one previously published c.416C>T mutation in the TK2 gene, whereas in the second case homozygozity for the previously described mutation c.1774C>T in the AARS2 gene was determined. The thymidine kinase 2 mutations resulted in severe mitochondrial DNA depletion (to 12% of controls) in the muscle. We present, for the first time, severe leucoencephalopathy and hepatic steatosis in a patient with thymidine kinase 2 deficiency and the finding of a ragged red fibre-like image in the muscle biopsy in a patient with alanyl-tRNA synthetase 2 deficiency.
C1 [Mazurova, Stella; Magner, Martin; Kucerova-Vidrova, Vendula; Vondrackova, Alzbeta; Hansikova, Hana; Zeman, Jiri; Tesarova, Marketa; Honzik, Tomas] Charles Univ Prague, Med Fac 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Stranecky, Viktor; Pristoupilova, Anna] Charles Univ Prague, Med Fac 1, Inst Inherited Metab Disorders, Prague, Czech Republic.
   Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Dept Pathol & Mol Med, Med Fac 2, Prague, Czech Republic.
   [Zamecnik, Josef] Univ Hosp Motol Prague, Prague, Czech Republic.
C3 Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; Motol University Hospital
RP Honzik, T (corresponding author), Charles Univ Prague, Med Fac 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Honzik, T (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM tomas.honzik@vfn.cz
FU Charles University; General University Hospital in Prague [PRVOUK-P24/LF1/3, RVO-VFN 64165, SVV 260256/2016, UNCE 204011]; Grant Agency of the Czech Republic [GAUK 1402213, 14-36804G]; Ministry of Education of the Czech Republic [LQ1604 NPU II, LM2015091]; Ministry of Health of the Czech Republic [15-28208A]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alston C, 2015, HUM GENET, V134, P869, DOI 10.1007/s00439-015-1568-z
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chung WK, 2015, J MED GENET, V52, P627, DOI 10.1136/jmedgenet-2015-103140
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Darley-Usmar VM, 1987, MITOCHONDRIA PRACTIC, Vxvi, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Euro L, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00021
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Haack TB, 2015, ANN CLIN TRANSL NEUR, V2, P492, DOI 10.1002/acn3.189
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Knierim E, 2015, MITOCHONDRION, V20, P1, DOI 10.1016/j.mito.2014.10.007
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lax NZ, 2015, J NEUROPATH EXP NEUR, V74, P688, DOI 10.1097/NEN.0000000000000209
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Magner M, 2011, EUR J PAEDIATR NEURO, V15, P101, DOI 10.1016/j.ejpn.2010.10.001
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Mazurova S, 2013, PRAGUE MED REP, V114, P139
   McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pejznochová M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246
   Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sheehan DC, 1987, THEORY PRACTICE HIST, Vxiii, P0
   Shehata BM, 2015, AM J MED GENET A, V167, P2114, DOI 10.1002/ajmg.a.37138
   Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   SRERE PA, 1969, ARCH BIOCHEM BIOPHYS, V129, P708, DOI 10.1016/0003-9861(69)90231-8
   Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Zhao Z, 2012, NEUROLOGY, V78, P1644, DOI 10.1212/WNL.0b013e3182574f8f
NR 53
TC 25
Z9 27
U1 0
U2 10
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1047-9511
EI 1467-1107
J9 CARDIOL YOUNG
JI Cardiol. Young
PD JUL 15
PY 2017
VL 27
IS 5
BP 936
EP 944
DI 10.1017/S1047951116001876
PG 9
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA EW3OH
UT WOS:000402408300016
PM 27839525
DA 2024-11-01
ER

PT J
AU Garone, C
   D'Souza, AR
   Dallabona, C
   Lodi, T
   Rebelo-Guiomar, P
   Rorbach, J
   Donati, MA
   Procopio, E
   Montomoli, M
   Guerrini, R
   Zeviani, M
   Calvo, SE
   Mootha, VK
   DiMauro, S
   Ferrero, I
   Minczuk, M
AF Garone, Caterina
   D'Souza, Aaron R.
   Dallabona, Cristina
   Lodi, Tiziana
   Rebelo-Guiomar, Pedro
   Rorbach, Joanna
   Donati, Maria Alice
   Procopio, Elena
   Montomoli, Martino
   Guerrini, Renzo
   Zeviani, Massimo
   Calvo, Sarah E.
   Mootha, Vamsi K.
   DiMauro, Salvatore
   Ferrero, Ileana
   Minczuk, Michal
TI Defective mitochondrial rRNA methyltransferase MRM2 causes <i>MELAS</i>-like clinical syndrome
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID sideroblastic anemia; hypertrophic cardiomyopathy; phenotypic spectrum; lactic-acidosis; mutations cause; large subunit; brain-stem; leukoencephalopathy; rhabdomyolysis; translation
AB Defects in nuclear-encoded proteins of themitochondrial translation machinery cause early-onset and tissue-specific deficiency of one ormore OXPHOS complexes. Here, we report a 7-year-old Italian boy with childhood-onset rapidly progressive encephalomyopathy and stroke-like episodes. Multiple OXPHOS defects and decreased mtDNA copy number (40%) were detected in muscle homogenate. Clinical features combined with low level of plasma citrulline were highly suggestive of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, however, the common m. 3243A>G mutation was excluded. Targeted exome sequencing of genes encoding themitochondrial proteome identified a damaging mutation, c.567G>A, affecting a highly conserved amino acid residue (p.Gly189Arg) of the MRM2 protein. MRM2 has never before been linked to a human disease and encodes an enzyme responsible for 2'-O-methyl modification at position U1369 in the human mitochondrial 16S rRNA. We generated a knockout yeast model for the orthologous gene that showed a defect in respiration and the reduction of the 2'-O-methyl modification at the equivalent position (U2791) in the yeastmitochondrial 21S rRNA. Complementation with the mrm2 allele carrying the equivalent yeast mutation failed to rescue the respiratory phenotype, which was instead completely rescued by expressing the wild-type allele. Our findings establish that defective MRM2 causes a MELAS-like phenotype, and suggests the genetic screening of the MRM2 gene in patients with am. 3243A>G negative MELAS-like presentation.
C1 [Garone, Caterina; D'Souza, Aaron R.; Rebelo-Guiomar, Pedro; Rorbach, Joanna; Zeviani, Massimo; Minczuk, Michal] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Garone, Caterina; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Dallabona, Cristina; Lodi, Tiziana; Ferrero, Ileana] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43121 Parma, Italy.
   [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, P-4099002 Oporto, Portugal.
   [Donati, Maria Alice; Procopio, Elena] A Meyer Childrens Hosp, Metabol Unit, I-50139 Florence, Italy.
   [Montomoli, Martino; Guerrini, Renzo] Univ Florence, A Meyer Childrens Hosp, Pediatr Neurol Unit & Labs, I-50139 Florence, Italy.
   [Calvo, Sarah E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
C3 University of Cambridge; Columbia University; University of Parma; Universidade do Porto; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School
RP Garone, C; Minczuk, M (corresponding author), Univ Cambridge, MRC, Mitochondrial Biol Unit, Wellcome Trust, MRC Bldg,Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.
EM cg562@mrc-mbu.cam.ac.uk; mam@mrc-mbu.cam.ac.uk
FU European Commission under 'Marie Sklodowska-Curie Actions', Individual Fellowship - Reintegration Panel [Mitobiopath-705560]; MRC core funding [MC_U105697135]; Fundacao para a Ciencia e a Tecnologia, Portugal [PD/BD/105750/2014]; Fondazione Telethon (Italy) [GGP15041]; European Union Seventh Framework Programme FP7 under the project 'DESIRE' [602531]; NRJ-Institut de France grant; ERC advanced grant [FP7-322424]; National Institutes of Health [NIH R01 GM0077465, R35GM122455]; Medical Research Council, UK; Fundação para a Ciência e a Tecnologia [PD/BD/105750/2014] Funding Source: FCT; MRC [MC_U105697135, MC_UP_1002/1, MC_UU_00015/4, MC_UU_00015/5] Funding Source: UKRI
CR Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391
   AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2, P0
   Bar-Yaacov D, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002557
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, PD158, DOI 10.1093/nar/gkw1099
   Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976
   Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Finsterer J, 2016, EUR J PAEDIATR NEURO, V20, P824, DOI 10.1016/j.ejpn.2016.08.002
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kwon JH, 2003, EUR NEUROL, V50, P123, DOI 10.1159/000072517
   Lee KW, 2014, J BIOL CHEM, V289, P24936, DOI 10.1074/jbc.C114.581868
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0
   Metodiev MD, 2016, AM J HUM GENET, V98, P993, DOI 10.1016/j.ajhg.2016.03.010
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Metodiev MD, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004110
   Nakagaki Hideaki, 2005, RINSHO SHINKEIGAKU, V45, P502
   Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005
   Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003
   Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139
   Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011
   Powell CA, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00079
   Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064
   Steen C, 1999, EUR J PEDIATR, V158, P730, DOI 10.1007/s004310051189
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Van Haute L, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12039
   Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z
   Wedatilake Y, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0477-0
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yarham JW, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004424
   Yokoyama Jun, 2016, RINSHO SHINKEIGAKU, V56, P204, DOI 10.5692/clinicalneurol.cn-000834
   Zaganelli S, 2017, J BIOL CHEM, V292, P4519, DOI 10.1074/jbc.M116.771105
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 61
TC 50
Z9 58
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD NOV 1
PY 2017
VL 26
IS 21
BP 4257
EP 4266
DI 10.1093/hmg/ddx314
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FK4HU
UT WOS:000413453900014
PM 28973171
DA 2024-11-01
ER

PT J
AU Nazli, A
   Safdar, A
   Saleem, A
   Akhtar, M
   Brady, LI
   Schwartzentruber, J
   Tarnopolsky, MA
AF Nazli, Aisha
   Safdar, Adeel
   Saleem, Ayesha
   Akhtar, Mahmood
   Brady, Lauren I.
   Schwartzentruber, Jeremy
   Tarnopolsky, Mark A.
TI A mutation in the <i>TMEM65</i> gene results in mitochondrial myopathy with severe neurological manifestations
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID complex-i deficiency; dna disease; adults; protein
AB Recent research has suggested that transmembrane protein 65 (TMEM65) is localized within the inner mitochondrial membrane. Little else is known about its function. In this study we investigated the location and function of TMEM65. Further, we report the functional consequences of a novel homozygous splice variant (c.472+1G>A) in the TMEM65 gene in a patient with mitochondrial encephalomyopathy. Here we investigated the location of TMEM65 by immunofluorescence staining of the protein and by immunoblotting of the isolated mitochondrial fractions in healthy fibroblasts and those from the patient. To study the function of TMEM65 we knocked down mRNA using TMEM65-specific siRNA, and measured mitochondrial function by enzymology, protein abundance and oxygen consumption rate in fibroblasts. Subcellular fractionation confirmed that the TMEM65 protein was present in the inner mitochondrial membrane. Knocking down TMEM65 expression in dermal fibroblasts severely affected mitochondrial content and respiration rate. Further evidence for the essential role of TMEM65 in mitochondrial function came from the demonstration of severe cellular and clinical consequences resulting from the novel TMEM65 gene mutation. In conclusion, these findings suggest that TMEM65, an inner mitochondrial membrane protein, plays a significant role in mitochondrial respiratory chain function. We also provide the first evidence that a mutation in the TMEM65 gene results in mitochondrial dysfunction and a severe mitochondrial encephalomyopathy phenotype.
C1 [Nazli, Aisha; Safdar, Adeel; Saleem, Ayesha; Brady, Lauren I.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Nazli, Aisha; Akhtar, Mahmood; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ, Canada.
   [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ, Canada.
C3 McMaster University; McMaster University; McGill University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat & Med, HSC 2H26,1200 Main St West, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU CIHR grant; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation
CR Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Foulds Charles E, 2010, MOL ENDOCRINOL, V24, P1090, DOI 10.1210/me.2009-0427
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Lines MA, 2014, NEUROLOGY, V82, P963, DOI 10.1212/WNL.0000000000000219
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, PE580, DOI 10.1152/ajpendo.2000.278.4.E580
   Nishimura N, 2014, PEERJ, V2, P0, DOI 10.7717/peerj.349
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010778
   Sambuughin N, 2013, J HUM GENET, V58, P226, DOI 10.1038/jhg.2012.156
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 22
TC 15
Z9 16
U1 0
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUN 15
PY 2017
VL 25
IS 6
BP 744
EP 751
DI 10.1038/ejhg.2017.20
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EW8DO
UT WOS:000402748700012
PM 28295037
DA 2024-11-01
ER

PT J
AU Lax, NZ
   Gorman, GS
   Turnbull, DM
AF Lax, N. Z.
   Gorman, G. S.
   Turnbull, D. M.
TI Review: Central nervous system involvement in mitochondrial disease
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Review
DE mitochondrial disease; mitochondrial DNA; neurodegeneration; respiratory chain defects
ID stroke-like episodes; complex i deficiency; progressive external ophthalmoplegia; recessive ataxia syndrome; lactic-acidosis; l-arginine; dna mutations; 3243a-greater-than-g mutation; cognitive impairment; epileptic phenotypes
AB Mitochondrial respiratory chain defects are an important cause of inherited disorders affecting approximately 1 in 5000 people in the UK population. Collectively these disorders are termed 'mitochondrial diseases' and they result from either mitochondrial DNA mutations or defects in nuclear DNA. Although they are frequently multisystem disorders, neurological deficits are particularly common, wide-ranging and disabling for patients. This review details the manifold neurological impairments associated with mitochondrial disease, and describes the efforts to understand how they arise and progressively worsen in patients with mitochondrial disease. We describe advances in our understanding of disease pathogenesis through detailed neuropathological studies and how this has spurred the development of cellular and animal models of disease. We underscore the importance of continued clinical, molecular genetic, neuropathological and animal model studies to fully characterize mitochondrial diseases and understand mechanisms of neurodegeneration. These studies are instrumental for the next phase of mitochondrial research that has a particular emphasis on finding novel ways to treat mitochondrial disease to improve patient care and quality of life.
C1 [Lax, N. Z.; Gorman, G. S.; Turnbull, D. M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Wellcome Trust [074454/Z/04/Z]; Newcastle University Centre for Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Medical Research Council [M501700]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; Lily Foundation; UK NHS Specialist Commissioners; Wellcome Trust Centre [096919/Z/11/Z]; MRC [G0900652, MR/K000608/1, MR/L016354/1, G0800674, G0502157, G0400074, G1100540, MC_G0802536, G0700718] Funding Source: UKRI
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   BEAUSANGLINDER M, 1981, ACTA PHYSIOL SCAND, V111, P193, DOI 10.1111/j.1748-1716.1981.tb06724.x
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Chung K, 2013, NAT METHODS, V10, P508, DOI 10.1038/NMETH.2481
   de Haas R, 2016, BEHAV BRAIN RES, V296, P191, DOI 10.1016/j.bbr.2015.09.006
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Ebrahimi-Fakhari D, 2015, PEDIATR NEUROL, V53, P549, DOI 10.1016/j.pediatrneurol.2015.08.018
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Emmanuele V, 2012, J NEUROL SCI, V317, P29, DOI 10.1016/j.jns.2012.03.005
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Gierthmühlen J, 2010, J NEUROL, V257, P1798, DOI 10.1007/s00415-010-5613-5
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graham BR, 2014, BMC NEPHROL, V15, P0, DOI 10.1186/1471-2369-15-10
   GROPEN TI, 1994, STROKE, V25, P1873, DOI 10.1161/01.STR.25.9.1873
   Grünewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Joseph JT, 2014, J NEUROPATH EXP NEUR, V73, P1009, DOI 10.1097/NEN.0000000000000123
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kunz WS, 2000, ANN NEUROL, V48, P766, DOI 10.1002/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Mignarri A, 2015, J NEUROL SCI, V349, P254, DOI 10.1016/j.jns.2014.12.040
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Minobe S, 2015, J CLIN NEUROSCI, V22, P407, DOI 10.1016/j.jocn.2014.05.021
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Neargarder SA, 2007, COGN BEHAV NEUROL, V20, P83, DOI 10.1097/WNN.0b013e3180335faf
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Peng NJ, 2000, NEURORADIOLOGY, V42, P26, DOI 10.1007/s002340050005
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   Peralta S, 2014, HUM MOL GENET, V23, P1399, DOI 10.1093/hmg/ddt526
   Phillips J, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26013
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Rodan LH, 2015, MITOCHONDRION, V22, P66, DOI 10.1016/j.mito.2015.03.002
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Simeone KA, 2014, EXP NEUROL, V251, P84, DOI 10.1016/j.expneurol.2013.11.005
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Vos Melissa, 2010, FRONT SYNAPTIC NEUROSCI, V2, P139, DOI 10.3389/fnsyn.2010.00139
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 115
TC 40
Z9 41
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD FEB 15
PY 2017
VL 43
IS 2
BP 102
EP 118
DI 10.1111/nan.12333
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EO8JB
UT WOS:000396934200002
PM 27287935
DA 2024-11-01
ER

PT J
AU Benazzo, A
   Trucchi, E
   Cahill, JA
   Delser, PM
   Mona, S
   Fumagalli, M
   Bunnefeld, L
   Cornetti, L
   Ghirotto, S
   Girardi, M
   Ometto, L
   Panziera, A
   Rota-Stabelli, O
   Zanetti, E
   Karamanlidis, A
   Groff, C
   Paule, L
   Gentile, L
   Vilà, C
   Vicario, S
   Boitani, L
   Orlando, L
   Fuselli, S
   Vernesi, C
   Shapiro, B
   Ciucci, P
   Bertorelle, G
AF Benazzo, Andrea
   Trucchi, Emiliano
   Cahill, James A.
   Delser, Pierpaolo Maisano
   Mona, Stefano
   Fumagalli, Matteo
   Bunnefeld, Lynsey
   Cornetti, Luca
   Ghirotto, Silvia
   Girardi, Matteo
   Ometto, Lino
   Panziera, Alex
   Rota-Stabelli, Omar
   Zanetti, Enrico
   Karamanlidis, Alexandros
   Groff, Claudio
   Paule, Ladislav
   Gentile, Leonardo
   Vila, Carles
   Vicario, Saverio
   Boitani, Luigi
   Orlando, Ludovic
   Fuselli, Silvia
   Vernesi, Cristiano
   Shapiro, Beth
   Ciucci, Paolo
   Bertorelle, Giorgio
TI Survival and divergence in a small group: The extraordinary genomic history of the endangered Apennine brown bear stragglers
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE balancing selection; genetic drift; genetic load; Ursus arctos; Neolithic impact
ID population-size; ursus-arctos; biased dispersal; spatial-patterns; natal dispersal; genetic rescue; evolution; selection; reveal; conservation
AB About 100 km east of Rome, in the central Apennine Mountains, a critically endangered population of similar to 50 brown bears live in complete isolation. Mating outside this population is prevented by several 100 km of bear-free territories. We exploited this natural experiment to better understand the gene and genomic consequences of surviving at extremely small population size. We found that brown bear populations in Europe lost connectivity since Neolithic times, when farming communities expanded and forest burning was used for land clearance. In central Italy, this resulted in a 40-fold population decline. The overall genomic impact of this decline included the complete loss of variation in the mitochondrial genome and along long stretches of the nuclear genome. Several private and deleterious amino acid changes were fixed by random drift; predicted effects include energy deficit, muscle weakness, anomalies in cranial and skeletal development, and reduced aggressiveness. Despite this extreme loss of diversity, Apennine bear genomes show nonrandom peaks of high variation, possibly maintained by balancing selection, at genomic regions significantly enriched for genes associated with immune and olfactory systems. Challenging the paradigm of increased extinction risk in small populations, we suggest that random fixation of deleterious alleles (i) can be an important driver of divergence in isolation, (ii) can be tolerated when balancing selection prevents random loss of variation at important genes, and (iii) is followed by or results directly in favorable behavioral changes.
C1 [Benazzo, Andrea; Trucchi, Emiliano; Ghirotto, Silvia; Panziera, Alex; Zanetti, Enrico; Fuselli, Silvia; Bertorelle, Giorgio] Univ Ferrara, Dept Life Sci & Biotechnol, I-44121 Ferrara, Italy.
   [Trucchi, Emiliano] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-1066 Oslo, Norway.
   [Cahill, James A.; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.
   [Delser, Pierpaolo Maisano; Mona, Stefano] Univ Paris 06, EPHE, Museum Natl Hist Nat, Inst Systemat Evolut Biodiversite,UMR 7205,CNRS, CP39, F-75005 Paris, France.
   [Delser, Pierpaolo Maisano; Mona, Stefano] Paris Sci & Lettres Res Univ, EPHE, F-75005 Paris, France.
   [Delser, Pierpaolo Maisano] Univ Dublin, Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.
   [Fumagalli, Matteo] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England.
   [Bunnefeld, Lynsey] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Bunnefeld, Lynsey] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland.
   [Cornetti, Luca] Univ Basel, Zool Inst, CH-4051 Basel, Switzerland.
   [Girardi, Matteo; Vernesi, Cristiano] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, Italy.
   [Ometto, Lino; Rota-Stabelli, Omar] Fdn Edmund Mach, Dept Sustainable Agroecosyst & Bioresources, I-38010 San Michele All Adige, Italy.
   [Karamanlidis, Alexandros] ARCTUROS, Protect & Management Wildlife & Nat Environm, Aetos 53075, Florina, Greece.
   [Groff, Claudio] Provincia Autonoma Trento, Forest & Wildlife Serv, I-38100 Trento, Italy.
   [Paule, Ladislav] Tech Univ, Fac Forestry, Dept Phytol, Zvolen 96053, Slovakia.
   [Gentile, Leonardo] Natl Pk Abruzzo Lazio & Molise, Vet Serv, I-67032 Pescasseroli, Italy.
   [Vila, Carles] Consejo Super Invest Cientif, Donana Biol Stn, Dept Integrat Ecol, Seville 4102, Spain.
   [Vicario, Saverio] CNR, Inst Atmospher Pollut Res & Technol, I-70126 Bari, Italy.
   [Boitani, Luigi; Ciucci, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy.
   [Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark.
C3 University of Ferrara; University of Oslo; University of California System; University of California Santa Cruz; Universite PSL; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite PSL; Ecole Pratique des Hautes Etudes (EPHE); Trinity College Dublin; Imperial College London; University of Edinburgh; University of Stirling; University of Basel; Fondazione Edmund Mach; Fondazione Edmund Mach; Technical University Zvolen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; University of Copenhagen
RP Bertorelle, G (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44121 Ferrara, Italy.
EM ggb@unife.it
FU Vodafone Greece; Vodafone Group Foundation; Fondo Ateneo Ricerca (FAR) grants from University of Ferrara; Agence Nationale de la Recherche Demochips Grant [ANR-12-BSV7-0012]; Agence Nationale de la Recherche (ANR) [ANR-12-BSV7-0012] Funding Source: Agence Nationale de la Recherche (ANR)
CR Abascal F, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-1090-1
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257
   Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101
   Alonso S, 2008, MOL BIOL EVOL, V25, P997, DOI 10.1093/molbev/msn049
   Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x
   Bidon T, 2014, MOL BIOL EVOL, V31, P1353, DOI 10.1093/molbev/msu109
   Blomqvist D, 2010, BMC EVOL BIOL, V10, P0, DOI 10.1186/1471-2148-10-33
   Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x
   Brauer A, 2007, P NATL ACAD SCI USA, V104, P450, DOI 10.1073/pnas.0603321104
   Bunnefeld L, 2015, GENETICS, V201, P1157, DOI 10.1534/genetics.115.179861
   BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x
   Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002
   Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664
   Ciucci P, 2015, J MAMMAL, V96, P206, DOI 10.1093/jmammal/gyu029
   Ciucci P, 2014, J MAMMAL, V95, P572, DOI 10.1644/13-MAMM-A-218
   Ciucci P, 2008, URSUS, V19, P130, DOI 10.2192/07PER012.1
   Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483
   Colangelo P, 2012, BIOL J LINN SOC, V107, P15, DOI 10.1111/j.1095-8312.2012.01926.x
   Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x
   Curry-Lindahl K, 1972, INTERNATIONAL ASSOCIATION FOR BEAR RESEARCH AND MANAGEMENT, V2, P74
   Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023
   Delser PM, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33753
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, PD481, DOI 10.1093/nar/gkv1351
   Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x
   Falush D, 2003, GENETICS, V164, P1567
   FEBBO D, 1990, AQUILO SER ZOOLOGICA, V27, P85
   Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703
   Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002
   Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139
   Fyfe RM, 2015, GLOBAL CHANGE BIOL, V21, P1197, DOI 10.1111/gcb.12776
   Gilpin ME, 1986, P19, V0, P0
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5
   Henry RC, 2016, AM NAT, V188, P423, DOI 10.1086/688170
   Jerina K, 2008, J MAMMAL, V89, P1491, DOI 10.1644/07-MAMM-A-357.1
   Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983
   Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, P0, DOI 10.1186/s12859-014-0356-4
   Kronenberger JA, 2017, ANIM CONSERV, V20, P3, DOI 10.1111/acv.12286
   LANDE R, 1994, EVOLUTION, V48, P1460, DOI 10.2307/2410240
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054
   Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254
   Marlon JR, 2013, QUATERNARY SCI REV, V65, P5, DOI 10.1016/j.quascirev.2012.11.029
   MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0
   Meyer Matthias, 2010, COLD SPRING HARB PROTOC, V2010, P0, DOI 10.1101/pdb.prot5448
   Miller W, 2012, P NATL ACAD SCI USA, V109, PE2382, DOI 10.1073/pnas.1210506109
   Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221
   Nadachowska-Brzyska K, 2016, MOL ECOL, V25, P1058, DOI 10.1111/mec.13540
   Norén K, 2016, MOL ECOL, V25, P3309, DOI 10.1111/mec.13674
   OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P3251, DOI 10.1073/pnas.79.10.3251
   Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001
   Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x
   Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123
   Preatoni D, 2005, ACTA OECOL, V28, P189, DOI 10.1016/j.actao.2005.04.002
   Prüfer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886
   Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026
   RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146
   Robinson JA, 2016, CURR BIOL, V26, P1183, DOI 10.1016/j.cub.2016.02.062
   Rogers RL, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006601
   Sarkissian CD, 2015, CURR BIOL, V25, P2577, DOI 10.1016/j.cub.2015.08.032
   Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015
   Schubert M, 2014, P NATL ACAD SCI USA, V111, PE5661, DOI 10.1073/pnas.1416991111
   Steyaert SMJG, 2016, WILDLIFE BIOL, V22, P144, DOI 10.2981/wlb.00165
   Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5
   Stow AJ, 2001, MOL ECOL, V10, P867, DOI 10.1046/j.1365-294X.2001.01253.x
   Swenson JE, 2011, MAMMAL REV, V41, P87, DOI 10.1111/j.1365-2907.2010.00179.x
   TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028
   Tallmon DA, 2017, ANIM CONSERV, V20, P16, DOI 10.1111/acv.12335
   Terhorst J, 2017, NAT GENET, V49, P303, DOI 10.1038/ng.3748
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105
   Wang L, 2016, MOL ECOL, V25, P3605, DOI 10.1111/mec.13714
   Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009
   Wood JLA, 2016, EVOL APPL, V9, P640, DOI 10.1111/eva.12375
   Wright S, 1931, GENETICS, V16, P0097
   Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952
   Young JM, 2008, AM J HUM GENET, V83, P228, DOI 10.1016/j.ajhg.2008.07.005
   Zennaro P, 2015, GEOPHYS RES LETT, V42, P5023, DOI 10.1002/2015GL064259
NR 79
TC 93
Z9 96
U1 3
U2 69
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 7
PY 2017
VL 114
IS 45
BP E9589
EP E9597
DI 10.1073/pnas.1707279114
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM0DT
UT WOS:000414631200021
PM 29078308
DA 2024-11-01
ER

PT J
AU Llewellyn, KJ
   Nalbandian, A
   Weiss, LN
   Chang, I
   Yu, H
   Khatib, B
   Tan, BC
   Scarfone, V
   Kimonis, VE
AF Llewellyn, Katrina J.
   Nalbandian, Angele
   Weiss, Lan N.
   Chang, Isabela
   Yu, Howard
   Khatib, Bibo
   Tan, Baichang
   Scarfone, Vanessa
   Kimonis, Virginia E.
TI Myogenic differentiation of VCP disease induced pluripotent stem cells: A novel platform for drug discovery
SO PLOS ONE
LA English
DT Article
ID inclusion-body myopathy; mitochondrial quality-control; containing protein vcp; skeletal-muscle cells; paget-disease; frontotemporal dementia; in-vitro; alzheimers-disease; ips cells; bone
AB Valosin Containing Protein (VCP) disease is an autosomal dominant multisystem proteinopathy caused by mutations in the VCP gene, and is primarily associated with progressive muscle weakness, including atrophy of the pelvic and shoulder girdle muscles. Currently, no treatments are available and cardiac and respiratory failures can lead to mortality at an early age. VCP is an AAA ATPase multifunction complex protein and mutations in the VCP gene resulting in disrupted autophagic clearance. Due to the rarity of the disease, the myopathic nature of the disorder, ethical and practical considerations, VCP disease muscle biopsies are difficult to obtain. Thus, disease-specific human induced pluripotent stem cells (hiPSCs) now provide a valuable resource for the research owing to their renewable and pluripotent nature. In the present study, we report the differentiation and characterization of a VCP disease-specific hiPSCs into precursors expressing myogenic markers including desmin, myogenic factor 5 (MYF5), myosin and heavy chain 2 (MYH2). VCP disease phenotype is characterized by high expression of TAR DNA Binding Protein-43 (TDP-43), ubiquitin (Ub), Light Chain 3-1/II protein (LC3-1/II), and p62/SOSTM1 (p62) protein indicating disruption of the autophagy cascade. Treatment of hiPSC precursors with autophagy stimulators Rapamycin, Perifosine, or AT101 showed reduction in VCP pathology markers TDP-43, LC3-1/II and p62/SOSTM1. Conversely, autophagy inhibitors chloroquine had no beneficial effect, and Spautin-1 or MHY1485 had modest effects. Our results illustrate that hiPSC technology provide a useful platform for a rapid drug discovery and hence constitutes a bridge between clinical and bench research in VCP and related diseases.
C1 [Llewellyn, Katrina J.; Nalbandian, Angele; Weiss, Lan N.; Chang, Isabela; Yu, Howard; Khatib, Bibo; Tan, Baichang; Kimonis, Virginia E.] Univ Calif Irvine, Sch Med, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92717 USA.
   [Llewellyn, Katrina J.; Nalbandian, Angele; Weiss, Lan N.; Khatib, Bibo; Scarfone, Vanessa; Kimonis, Virginia E.] Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92717 USA.
C3 University of California System; University of California Irvine; University of California System; University of California Irvine
RP Kimonis, VE (corresponding author), Univ Calif Irvine, Sch Med, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92717 USA.; Kimonis, VE (corresponding author), Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92717 USA.
EM vkimonis@uci.edu
FU California Stem Cell Clinical Fellowship [TG2-01152]; NIAMS, National Institute of Health [R01, R56, AR050236]; UC Irvine Institute of Clinical Translational Science (ICTS)
CR ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567
   Abujarour R, 2015, FRONT CELL DEV BIOL, V3, P0, DOI 10.3389/fcell.2015.00029
   Amantini Consuelo, 2015, ONCOSCIENCE, V2, P395
   Angelos MG, 2015, CURR OPIN ORGAN TRAN, V20, P663, DOI 10.1097/MOT.0000000000000244
   Awaya T, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051638
   Badadani M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013183
   Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009
   BISCHOFF R, 1969, J CELL BIOL, V41, P188, DOI 10.1083/jcb.41.1.188
   Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007
   Bové J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068
   Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015
   Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200
   Cai Zhiyou, 2013, J BIOCHEM PHARMACOL RES, V1, P84
   Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297
   Choi YJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043418
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903
   de Boer AS, 2015, CELL CYCLE, V0, P0
   Dec E FD, 2014, J STEM CELL RES THER, V4, P0
   Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225
   Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005
   Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002
   Grimm FA, 2015, ASSAY DRUG DEV TECHN, V0, P0
   Haston KM, 2015, ANN REV PHARM TOXICO, V0, P0
   Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92
   Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Ju JS, 1900, V19, V0, PR38
   KAUFMAN SJ, 1991, DEV BIOL, V146, P228, DOI 10.1016/0012-1606(91)90462-C
   Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376
   Kim MN, 2015, CANCER CHEMOTH PHARM, V76, P257, DOI 10.1007/s00280-015-2787-7
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kimonis V, 2007, GENEREVIEWS, V0, P1993
   Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, PS44, DOI 10.1097/01.wad.0000183081.76820.5a
   Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200
   Knappe S, 2015, FRONT AGING NEUROSCI, V7, P0, DOI 10.3389/fnagi.2015.00161
   Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002
   LAL H, 1983, NEUROPHARMACOLOGY, V22, P1423, DOI 10.1016/0028-3908(83)90111-9
   Liang X, 2014, CELL BIOSCI, V4, P0, DOI 10.1186/2045-3701-4-10
   Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037
   Maehr R, 2011, CLIN PHARMACOL THER, V89, P750, DOI 10.1038/clpt.2011.1
   Majounie E, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2011.07.011
   Mehta SG, 2013, CLIN GENET, V83, P422, DOI 10.1111/cge.12000
   Mei H, 2014, NEOPLASMA, V61, P186, DOI 10.4149/neo_2014_024
   MEOLA G, 1991, EUR J BASIC APPL HIS, V35, P219
   Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407
   Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676
   MIRRA JM, 1995, SKELETAL RADIOL, V24, P163
   Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174
   Moharil J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0141365
   Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11
   Nacmias B, 2014, CURR MOL MED, V14, P993, DOI 10.2174/1566524014666141010152143
   Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522
   Nalbandian A, 2012, CTS-CLIN TRANSL SCI, V5, P226, DOI 10.1111/j.1752-8062.2012.00407.x
   Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y
   Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9
   Nieweg K, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.72
   Okano H, 2014, MOL BRAIN, V7, P0, DOI 10.1186/1756-6606-7-22
   Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187
   QUINN LS, 1985, NATURE, V313, P692, DOI 10.1038/313692a0
   Raikwar SP, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0116582
   Ralston SH, 2008, BONE, V43, P819, DOI 10.1016/j.bone.2008.06.015
   Ralston SH, 2008, LANCET, V372, P155, DOI 10.1016/S0140-6736(08)61035-1
   Richardson PG, 2012, EXPERT OPIN DRUG MET, V8, P623, DOI 10.1517/17425255.2012.681376
   Roca I, 2015, J CLIN MED, V4, P243, DOI 10.3390/jcm4020243
   Rosso SM, 2001, BRAIN, V124, P1948, DOI 10.1093/brain/124.10.1948
   Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x
   Schröder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407
   SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4
   Shamirian S, 2015, ALZ DIS ASSOC DIS, V29, P90, DOI 10.1097/WAD.0b013e318298e54f
   Shelton M, 2015, METHODS, V0, P0
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Siddiqui A, 2015, J NEUROSCI, V35, P12833, DOI 10.1523/JNEUROSCI.0109-15.2015
   Singh R, 2015, MOL THER, V0, P0
   Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469
   STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1
   Stoccoa G, 2015, CURR DRUG METAB, V0, P0
   Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012
   Takahashi Jun, 2013, RINSHO SHINKEIGAKU, V53, P1009
   Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014
   Tzatzalos E, 2015, ADV DRUG DELIV REV, V0, P0
   Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471
   Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200
   Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003
   Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1
   Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009
   Young-Pearse TL, 2016, CURR OPIN NEUROBIOL, V36, P66, DOI 10.1016/j.conb.2015.10.006
   Zhang JL, 2015, TUMOR BIOL, V36, P5699, DOI 10.1007/s13277-015-3244-2
   Zhou Yi Ping, 2009, FEN ZI XI BAO SHENG WU XUE BAO, V42, P193
   Zirin J, 2013, PLOS BIOL, V11, P0, DOI 10.1371/journal.pbio.1001708
NR 98
TC 10
Z9 12
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2017
VL 12
IS 6
BP 
EP 
DI 10.1371/journal.pone.0176919
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6MJ
UT WOS:000402624300009
PM 28575052
DA 2024-11-01
ER

PT J
AU Yahata, N
   Matsumoto, Y
   Omi, M
   Yamamoto, N
   Hata, R
AF Yahata, Naoki
   Matsumoto, Yuji
   Omi, Minoru
   Yamamoto, Naoki
   Hata, Ryuji
TI TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID pluripotent stem-cells; stroke-like episodes; lactic-acidosis; genm; construction; elimination; patient; gene
AB Induced pluripotent stem cells (iPSCs) are suitable for studying mitochondrial diseases caused by mitochondrial DNA (mtDNA) mutations. Here, we generated iPSCs from a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with the m.13513G>A mutation. The patient's dermal fibroblasts were reprogrammed, and we established two iPSC clones with and without mutant mtDNA. Furthermore, we tried to decrease mutant mtDNA level in iPSCs using transcription activator-like effector nucleases (TALENs). We originally engineered platinum TALENs, which were transported into mitochondria, recognized the mtDNA sequence including the m.13513 position, and preferentially cleaved G13513A mutant mtDNA (G13513A-mpTALEN). The m.13513G>A heteroplasmy level in MELAS-iPSCs was decreased in the short term by transduction of G13513A-mpTALEN. Our data demonstrate that this mtDNA-targeted nuclease would be a powerful tool for changing the heteroplasmy level in heteroplasmic iPSCs, which could contribute to elucidation of the pathological mechanisms of mitochondrial diseases caused by mtDNA mutations.
C1 [Yahata, Naoki; Omi, Minoru; Hata, Ryuji] Fujita Hlth Univ, Sch Med, Dept Anat 1, Toyoake, Aichi, Japan.
   [Matsumoto, Yuji] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi, Japan.
   [Yamamoto, Naoki] Fujita Hlth Univ, Ctr Res Promot & Support, Div Molecularbiol, Joint Res Support Promot Facil, Toyoake, Aichi, Japan.
   [Hata, Ryuji] Ehime Univ, Grad Sch Med, Dept Anat, To On, Ehime, Japan.
C3 Fujita Health University; Fujita Health University; Fujita Health University; Ehime University
RP Hata, R (corresponding author), Fujita Hlth Univ, Sch Med, Dept Anat 1, Toyoake, Aichi, Japan.; Hata, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat, To On, Ehime, Japan.
EM hata@fujita-hu.ac.jp
FU Hori Sciences and Arts Foundation; Fujita Health University; JPSP KAKENHI [JP16K19675, JP26860831]
CR Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Moraes CT, 2014, EMBO MOL MED, V6, P434, DOI 10.1002/emmm.201303769
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nakagawa M, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03594
   NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
   Ochiai H, 2010, GENES CELLS, V15, P875, DOI 10.1111/j.1365-2443.2010.01425.x
   Okita K, 2011, NAT METHODS, V8, P409, DOI 10.1038/NMETH.1591
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Sakuma T, 2017, METHODS MOL BIOL, V1630, P25, DOI 10.1007/978-1-4939-7128-2_2
   Sakuma T, 2013, SCI REP-UK, V3, P0, DOI 10.1038/srep03379
   Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shigemi R, 2011, BRAIN DEV-JPN, V33, P518, DOI 10.1016/j.braindev.2010.07.013
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008067
   Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22
   Wahlestedt M, 2014, STEM CELLS, V32, P1173, DOI 10.1002/stem.1630
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Yokota M, 2015, HUM MOL GENET, V24, P4698, DOI 10.1093/hmg/ddv201
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Zheng XD, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13378
NR 35
TC 52
Z9 54
U1 0
U2 8
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD NOV 14
PY 2017
VL 7
IS 
BP 
EP 
DI 10.1038/s41598-017-15871-y
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM6MF
UT WOS:000415166000053
PM 29138463
DA 2024-11-01
ER

PT J
AU Oláhová, M
   Thompson, K
   Hardy, SA
   Barbosa, IA
   Besse, A
   Anagnostou, ME
   White, K
   Davey, T
   Simpson, MA
   Champion, M
   Enns, G
   Schelley, S
   Lightowlers, RN
   Chrzanowska-Lightowlers, ZMA
   McFarland, R
   Deshpande, C
   Bonnen, PE
   Taylor, RW
AF Olahova, Monika
   Thompson, Kyle
   Hardy, Steven A.
   Barbosa, Ines A.
   Besse, Arnaud
   Anagnostou, Maria-Eleni
   White, Kathryn
   Davey, Tracey
   Simpson, Michael A.
   Champion, Michael
   Enns, Greg
   Schelley, Susan
   Lightowlers, Robert N.
   Chrzanowska-Lightowlers, Zofia M. A.
   McFarland, Robert
   Deshpande, Charu
   Bonnen, Penelope E.
   Taylor, Robert W.
TI Pathogenic variants in <i>HTRA2</i> cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID serine-protease; parkinson disease; essential tremor; dna maintenance; barth-syndrome; cell-death; mutations; gene; neutropenia; deficiency
AB Mitochondrial diseases collectively represent one of the most heterogeneous group of metabolic disorders. Symptoms can manifest at any age, presenting with isolated or multiple-organ involvement. Advances in next-generation sequencing strategies have greatly enhanced the diagnosis of patients with mitochondrial disease, particularly where a mitochondrial aetiology is strongly suspected yet OXPHOS activities in biopsied tissue samples appear normal. We used whole exome sequencing (WES) to identify the molecular basis of an early-onset mitochondrial syndrome-pathogenic biallelic variants in the HTRA2 gene, encoding a mitochondria-localised serine protease-in five subjects from two unrelated families characterised by seizures, neutropenia, hypotonia and cardio-respiratory problems. A unifying feature in all affected children was 3-methylglutaconic aciduria (3-MGA-uria), a common biochemical marker observed in some patients with mitochondrial dysfunction. Although functional studies of HTRA2 subjects' fibroblasts and skeletal muscle homogenates showed severely decreased levels of mutant HTRA2 protein, the structural subunits and complexes of the mitochondrial respiratory chain appeared normal. We did detect a profound defect in OPA1 processing in HTRA2-deficient fibroblasts, suggesting a role for HTRA2 in the regulation of mitochondrial dynamics and OPA1 proteolysis. In addition, investigated subject fibroblasts were more susceptible to apoptotic insults. Our data support recent studies that described important functions for HTRA2 in programmed cell death and confirm that patients with genetically-unresolved 3-MGA-uria should be screened by WES with pathogenic variants in the HTRA2 gene prioritised for further analysis.
C1 [Olahova, Monika; Thompson, Kyle; Hardy, Steven A.; Anagnostou, Maria-Eleni; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M. A.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Barbosa, Ines A.; Simpson, Michael A.] Kings Coll London, Sch Med, Div Genet & Mol Med, London, England.
   [Besse, Arnaud] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [White, Kathryn; Davey, Tracey] Newcastle Univ, Elect Microscopy Res Serv, Newcastle Upon Tyne, Tyne & Wear, England.
   [Champion, Michael] Evelina London Childrens Hosp, Guys & St Thomas NHS Fdn Trusts, Dept Inherited Metab Dis, London, England.
   [Enns, Greg; Schelley, Susan] Lucile Packard Childrens Hosp Stanford, Palo Alto, CA USA.
   [Enns, Greg; Schelley, Susan] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA.
   [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Clin Genet Unit, London, England.
C3 Newcastle University - UK; University of London; King's College London; Baylor College of Medicine; Newcastle University - UK; Lucile Packard Children's Hospital (LPCH); Stanford University; Guy's & St Thomas' NHS Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; Biotechnology and Biological Sciences Research Council [BB/M012093/1]; Department of Health via the NIHR comprehensive Biomedical Research Centre; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS08372]; King's College London; Wellcome Trust [096919/Z/11/Z] Funding Source: Wellcome Trust; BBSRC [BB/M012093/1] Funding Source: UKRI; MRC [G0601943] Funding Source: UKRI
CR Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Deerinck TJ, 2010, MICROSCOPY, V1, P6
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111
   Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008
   Kanabus M, 2015, J INHERIT METAB DIS, V38, P211, DOI 10.1007/s10545-015-9813-0
   Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117
   KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6
   Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005
   Krüger R, 2011, NEUROBIOL AGING, V32, P0, DOI 10.1016/j.neurobiolaging.2009.11.021
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   Magner M, 2015, J INHERIT METAB DIS, V38, P583, DOI 10.1007/s10545-015-9833-9
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Mandel H, 2016, J MED GENET, V53, P690, DOI 10.1136/jmedgenet-2016-103922
   Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Oláhová M, 2015, EUR J HUM GENET, V23, P935, DOI 10.1038/ejhg.2014.214
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0
   Tzoulis C, 2015, P NATL ACAD SCI USA, V112, PE2268, DOI 10.1073/pnas.1503105112
   Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291
   Wortmann SB, 2015, AM J HUM GENET, V96, P245, DOI 10.1016/j.ajhg.2014.12.013
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
NR 40
TC 20
Z9 26
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JAN 15
PY 2017
VL 40
IS 1
BP 121
EP 130
DI 10.1007/s10545-016-9977-2
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA EG6CW
UT WOS:000391132500009
PM 27696117
DA 2024-11-01
ER

PT J
AU Mezuki, S
   Fukuda, K
   Matsushita, T
   Fukushima, Y
   Matsuo, R
   Goto, Y
   Yasukawa, T
   Uchiumi, T
   Kang, DC
   Kitazono, T
   Ago, T
AF Mezuki, Satomi
   Fukuda, Kenji
   Matsushita, Tomonaga
   Fukushima, Yoshihisa
   Matsuo, Ryu
   Goto, Yu-ichi
   Yasukawa, Takehiro
   Uchiumi, Takeshi
   Kang, Dongchon
   Kitazono, Takanari
   Ago, Tetsuro
TI Isolated and repeated stroke-like episodes in a middle-aged man with a mitochondrial ND3 T10158C mutation: a case report
SO BMC NEUROLOGY
LA English
DT Article
DE Cognitive impairment; MELAS; Mitochondrial ND3 gene; T10158C; Sporadic
ID complex-i deficiency; missense mutation; leigh-syndrome; gene; encephalopathy; disease
AB Background: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, is the most common phenotype of mitochondrial disease. It often develops in childhood or adolescence, usually before the age of 40, in a maternally-inherited manner. Mutations in mitochondrial DNA (mtDNA) are frequently responsible for MELAS. Case presentation: A 55-year-old man, who had no family or past history of mitochondrial disorders, suddenly developed bilateral visual field constriction and repeated stroke-like episodes. He ultimately presented with cortical blindness, recurrent epilepsy and severe cognitive impairment approximately 6 months after the first episode. Genetic analysis of biopsied biceps brachii muscle, but not of peripheral white blood cells, revealed a T10158C mutation in the mtDNA-encoded gene of NADH dehydrogenase subunit 3 (ND3), which has previously been thought to be associated with severe or fatal mitochondrial disorders that develop during the neonatal period or in infancy. Conclusion: A T10158C mutation in the ND3 gene can cause atypical adult-onset stroke-like episodes in a sporadic manner.
C1 [Mezuki, Satomi; Fukuda, Kenji; Matsushita, Tomonaga; Fukushima, Yoshihisa] St Marys Hosp, Stroke Ctr, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan.
   [Mezuki, Satomi; Matsuo, Ryu; Kitazono, Takanari; Ago, Tetsuro] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
   [Goto, Yu-ichi] Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, NCNP, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878551, Japan.
   [Yasukawa, Takehiro; Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Dept Pathol Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
C3 Kyushu University; National Center for Neurology & Psychiatry - Japan; Kyushu University
RP Mezuki, S (corresponding author), St Marys Hosp, Stroke Ctr, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan.; Ago, T (corresponding author), Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM smezuki@intmed2.med.kyushu-u.ac.jp; agou@intmed2.med.kyushu-u.ac.jp
FU Grants-in-Aid for Scientific Research [17H01550] Funding Source: KAKEN
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kreutz M, 2015, METHODS MOL BIOL, V1315, P17, DOI 10.1007/978-1-4939-2715-9_2
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mukai M, 2015, NEUROL CLIN NEUROSCI, V3, P153, DOI 10.1111/ncn3.173
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
NR 16
TC 12
Z9 12
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
EI 
J9 BMC NEUROL
JI BMC Neurol.
PD DEC 13
PY 2017
VL 17
IS 
BP 
EP 
DI 10.1186/s12883-017-1001-4
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA FQ2EW
UT WOS:000418170700001
PM 29237403
DA 2024-11-01
ER

PT J
AU Zanolini, A
   Potic, A
   Carrara, F
   Lamantea, E
   Diodato, D
   Blasevich, F
   Marchet, S
   Marina, M
   Pallotti, F
   Morandi, L
   Zeviani, M
   Lamperti, C
AF Zanolini, Alice
   Potic, Ana
   Carrara, Franco
   Lamantea, Eleonora
   Diodato, Daria
   Blasevich, Flavia
   Marchet, Silvia
   Marina, Mora
   Pallotti, Francesco
   Morandi, Lucia
   Zeviani, Massimo
   Lamperti, Costanza
TI Pure myopathy with enlarged mitochondria associated to a new mutation in <i>MTND2</i> gene
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE ND2; Exercise intolerance; Complex I deficiency
ID cytochrome-b gene; exercise intolerance; complex-i; nonsense mutation; dna; deficiency
AB To date, only few mutations in the mitochondrial DNA (mtDNA)-encoded ND2 subunit of Complex I have been reported, usually presenting a severe phenotype characterized by early onset encephalomyopathy and early death. In this report, we describe a new mutation in the MTND2 gene in a 21-year-old man with a mild myopathic phenotype characterized by exercise intolerance and increased plasma lactate at rest. Electromyography and brain NMR were normal, and no cardiac involvement was present. Muscle biopsy showed a massive presence of ragged red - COX-positive fibres, with enlarged mitochondria containing osmiophilic inclusions. Biochemical assays revealed a severe isolated complex I deficiency. We identified a novel, heteroplasmic mutation m.4831G>A in the MTND2 gene, causing the p.Gly121Asp substitution in the ND2 protein. The mutation was present in the 95% of mitochondrial genomes from patient's muscle tissue, at a lower level in cells from the urinary tract and at a lowest level in lymphocytes from patient's blood; the base substitution was absent in fibroblasts and in the tissues from proband's healthy mother and brother. The specific skeletal muscle tissue involvement can explain the childhood-onset and the relatively benign, exclusively myopathic course of the disease. (C) 2017 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Zanolini, Alice; Carrara, Franco; Lamantea, Eleonora; Diodato, Daria; Marchet, Silvia; Zeviani, Massimo; Lamperti, Costanza] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Potic, Ana] Univ Belgrade, Fac Med, Dept Neurol, Clin Child Neurol & Psychiat, Belgrade 11000, Serbia.
   [Blasevich, Flavia; Marina, Mora; Morandi, Lucia] Fdn IRCCS Ist Neurol Carlo Besta, Div Neurol 4, I-20126 Milan, Italy.
   [Diodato, Daria] Osped Pediat Bambin Gesu, Div Neuromuscular & Neurodegenerat Disorders, Rome, Italy.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Pallotti, Francesco] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Belgrade; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Bambino Gesu; University of Insubria
RP Lamperti, C (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
EM costanza.lamperti@istituto-besta.it
FU Fondazione Pierfranco e Luisa Mariani [CM23]; Italian Association of Mitochondrial Disease Patients and Families (Mitocon ONLUS); Cell line and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases of Telethon Network of Genetics Biobanks [GTB12001J]; MRC [MC_UP_1002/1] Funding Source: UKRI
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BROWN MD, 1992, GENETICS, V130, P163
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Zeviani M, 2006, SCI MED, V10, P154
NR 13
TC 8
Z9 8
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-4269
EI 
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR 15
PY 2017
VL 10
IS 
BP 24
EP 27
DI 10.1016/j.ymgmr.2016.11.009
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA FC4ZB
UT WOS:000406849200008
PM 28070494
DA 2024-11-01
ER

PT J
AU Martín-Hernández, E
   García-Silva, MT
   Quijada-Fraile, P
   Rodríguez-García, ME
   Rivera, H
   Hernández-Laín, A
   Coca-Robinot, D
   Fernández-Toral, J
   Arenas, J
   Martín, MA
   Martínez-Azorín, F
AF Martin-Hernandez, Elena
   Teresa Garcia-Silva, Maria
   Quijada-Fraile, Pilar
   Elena Rodriguez-Garcia, Maria
   Rivera, Henry
   Hernandez-Lain, Aurelio
   Coca-Robinot, David
   Fernandez-Toral, Joaquin
   Arenas, Joaquin
   Martin, Miguel A.
   Martinez-Azorin, Francisco
TI Myopathic mtDNA Depletion Syndrome Due to Mutation in <i>TK2</i> Gene
SO PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
LA English
DT Article
DE mitochondria; mitochondrial DNA; whole-exome sequencing; TK2; mtDNA depletion syndromes; myopathy
ID mitochondrial-dna depletion
AB Whole-exome sequencing was used to identify the disease gene(s) in a Spanish girl with failure to thrive, muscle weakness, mild facial weakness, elevated creatine kinase, deficiency of mitochondrial complex III and depletion of mtDNA. With wholeexome sequencing data, it was possible to get the whole mtDNA sequencing and discard any pathogenic variant in this genome. The analysis of whole exome uncovered a homozygous pathogenic mutation in thymidine kinase 2 gene (TK2; NM_004614.4:c.323C>T, p.T108M). TK2 mutations have been identified mainly in patients with the myopathic form of mtDNA depletion syndromes. This patient presents an atypical TK2-related myopathic form of mtDNA depletion syndromes, because despite having a very low content of mtDNA (<20%), she presents a slower and less severe evolution of the disease. In conclusion, our data confirm the role of TK2 gene in mtDNA depletion syndromes and expanded the phenotypic spectrum.
C1 [Martin-Hernandez, Elena; Teresa Garcia-Silva, Maria; Quijada-Fraile, Pilar] Hosp Univ 12 Octubre, Unidad Pediat Enfermedades Raras Metab Hereditari, Dept Pediat, Madrid, Spain.
   [Teresa Garcia-Silva, Maria; Rivera, Henry; Arenas, Joaquin; Martin, Miguel A.; Martinez-Azorin, Francisco] CIBERER, Madrid, Spain.
   [Elena Rodriguez-Garcia, Maria; Rivera, Henry; Arenas, Joaquin; Martin, Miguel A.; Martinez-Azorin, Francisco] Hosp Univ 12 Octubre I 12, Lab Enfermedades Mitocondriales, Inst Invest, Madrid, Spain.
   [Hernandez-Lain, Aurelio] Hosp Univ 12 Octubre, Serv Anat Patol Neuropatol, Madrid, Spain.
   [Coca-Robinot, David] Hosp Univ 12 Octubre, Serv Radiol Pediat, Madrid, Spain.
   [Fernandez-Toral, Joaquin] HUCA, Unidad Genet, Oviedo, Asturias, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Central University Hospital Asturias
RP Martínez-Azorín, F (corresponding author), Hosp 12 Octubre I 12, Lab Enfermedades Mitocondriales, CAA, 6a Planta,Bloque E,Avda Cordoba S-N, E-28041 Madrid, Spain.
EM fmartinez@h12o.es
FU Spanish Instituto de Salud Carlos III (ISCIII); European Regional Development Fund (ERDF) [PI10/00063, PI14/00790]
CR Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Delmiro A, 2013, HUM MUTAT, V34, P1623, DOI 10.1002/humu.22445
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
NR 8
TC 5
Z9 6
U1 0
U2 7
PU ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS
PI LAWRENCE
PA 810 EAST 10TH STREET, LAWRENCE, KS 66044 USA
SN 1093-5266
EI 1615-5742
J9 PEDIATR DEVEL PATHOL
JI Pediatr. Dev. Pathol.
PD SEP-OCT 15
PY 2017
VL 20
IS 5
BP 416
EP 420
DI 10.1177/1093526616686439
PG 5
WC Pathology; Pediatrics
SC Pathology; Pediatrics
GA FI9CK
UT WOS:000412301100007
PM 28812460
DA 2024-11-01
ER

PT J
AU Mendell, JR
   Sahenk, Z
   Al-Zaidy, S
   Rodino-Klapac, LR
   Lowes, LP
   Alfano, LN
   Berry, K
   Miller, N
   Yalvac, M
   Dvorchik, I
   Moore-Clingenpeel, M
   Flanigan, KM
   Church, K
   Shontz, K
   Curry, C
   Lewis, S
   McColly, M
   Hogan, MJ
   Kaspar, BK
AF Mendell, Jerry R.
   Sahenk, Zarife
   Al-Zaidy, Samiah
   Rodino-Klapac, Louise R.
   Lowes, Linda P.
   Alfano, Lindsay N.
   Berry, Katherine
   Miller, Natalie
   Yalvac, Mehmet
   Dvorchik, Igor
   Moore-Clingenpeel, Melissa
   Flanigan, Kevin M.
   Church, Kathleen
   Shontz, Kim
   Curry, Choumpree
   Lewis, Sarah
   McColly, Markus
   Hogan, Mark J.
   Kaspar, Brian K.
TI Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes
SO MOLECULAR THERAPY
LA English
DT Article
ID mitochondrial-dna deletions; tgf-beta superfamily; muscular-dystrophy; pilot trial; muscle mass; expression; immunolocalization; polymyositis; protein; mice
AB Sporadic inclusion body myositis, a variant of inflammatory myopathy, has features distinct from polymyositis/dermato-myositis. The disease affects men more than women, most commonly after age 50. Clinical features include weakness of the quadriceps, finger flexors, ankle dorsiflexors, and dysphagia. The distribution of weakness is similar to Becker muscular dystrophy, where we previously reported improvement following intramuscular injection of an isoform of follistatin (FS344) by AAV1. For this clinical trial, rAAV1.CMV. huFS344, 6 x 10(11) vg/kg, was delivered to the quadriceps muscles of both legs of six sporadic inclusion body myositis subjects. The primary outcome for this trial was distance traveled for the 6-min walk test. The protocol included an exercise regimen for each participant. Performance, annualized to a median 1-year change, improved +56.0 m/year for treated subjects compared to a decline of -25.8 m/year (p = 0.01) in untreated subjects (n = 8), matched for age, gender, and baseline measures. Four of the six treated subjects showed increases ranging from 58-153 m, whereas two were minimally improved (5-23 m). Treatment effects included decreased fibrosis and improved regeneration. These findings show promise for follistatin gene therapy for mild to moderately affected, ambulatory sporadic inclusion body myositis patients. More advanced disease with discernible muscle loss poses challenges.
C1 [Mendell, Jerry R.; Sahenk, Zarife; Al-Zaidy, Samiah; Rodino-Klapac, Louise R.; Lowes, Linda P.; Alfano, Lindsay N.; Berry, Katherine; Miller, Natalie; Yalvac, Mehmet; Flanigan, Kevin M.; Church, Kathleen; Shontz, Kim; Curry, Choumpree; Lewis, Sarah; McColly, Markus; Kaspar, Brian K.] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA.
   [Mendell, Jerry R.; Sahenk, Zarife; Al-Zaidy, Samiah; Rodino-Klapac, Louise R.; Flanigan, Kevin M.; Kaspar, Brian K.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA.
   [Mendell, Jerry R.; Sahenk, Zarife; Lowes, Linda P.; Alfano, Lindsay N.; Berry, Katherine; Miller, Natalie; Flanigan, Kevin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.
   [Lowes, Linda P.; Alfano, Lindsay N.; Berry, Katherine; Miller, Natalie] Nationwide Childrens Hosp, Clin Therapies, Columbus, OH 43205 USA.
   [Dvorchik, Igor; Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Biostat Res Core, Columbus, OH 43205 USA.
   [Hogan, Mark J.] Nationwide Childrens Hosp, Dept Radiol, Vasc & Intervent Radiol, Columbus, OH 43205 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital
RP Mendell, JR (corresponding author), Nationwide Childrens Hosp, Gene Therapy Ctr, 700 Childrens Dr, Columbus, OH 43205 USA.
EM jerry.mendell@nationwidechildrens.org
FU Parent Project Muscular Dystrophy
CR Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407
   Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070
   Badrising UA, 2002, ANN NEUROL, V51, P369, DOI 10.1002/ana.10121
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   Barohn RJ, 2006, NEUROLOGY, V66, PS123, DOI 10.1212/01.wnl.0000192258.32408.54
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   Dalakas MC, 2010, CURR OPIN PHARMACOL, V10, P346, DOI 10.1016/j.coph.2010.03.001
   Dalakas MC, 2009, BRAIN, V132, P1536, DOI 10.1093/brain/awp104
   Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006
   Dalakas MC, 2001, NEUROLOGY, V56, P323, DOI 10.1212/WNL.56.3.323
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   Dimachkie MM, 2012, SEMIN NEUROL, V32, P237, DOI 10.1055/s-0032-1329197
   Dong YJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0058554
   EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hansen J, 2011, ENDOCRINOLOGY, V152, P164, DOI 10.1210/en.2010-0868
   HAWLEY RJ, 1984, ARCH NEUROL-CHICAGO, V41, P383, DOI 10.1001/archneur.1984.04050160045014
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI 10.1016/j.nmd.2010.07.087
   Johnson Liam G, 2009, J CLIN NEUROMUSCUL DIS, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Jorgensen AN, 2016, CLIN PHYSIOL FUNCT I, V36, P504, DOI 10.1111/cpf.12259
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f
   Lee SJ, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000789
   Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200
   Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133
   Lindberg C, 2003, NEUROLOGY, V61, P260, DOI 10.1212/01.WNL.0000071852.27182.C7
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200
   Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251
   Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009
   Muth IE, 2009, J NEUROL NEUROSUR PS, V80, P1344, DOI 10.1136/jnnp.2009.174276
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Phillips DJ, 2009, CYTOKINE GROWTH F R, V20, P153, DOI 10.1016/j.cytogfr.2009.02.007
   Sancricca C, 2011, NEUROL SCI, V32, P841, DOI 10.1007/s10072-011-0657-6
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SUGINO K, 1993, J BIOL CHEM, V268, P15579
   Tawil R, 2004, NEUROLOGY, V63, P718
   Tawil R, 2001, NEUROLOGY, V57, P1566
   TAWIL R, 1994, NEUROLOGY, V44, P442, DOI 10.1212/WNL.44.3_Part_1.442
   Viollet L, 2009, MUSCLE NERVE, V40, P438, DOI 10.1002/mus.21420
   Wilson FC, 2008, J RHEUMATOL, V35, P445
   Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091
   YUNIS EJ, 1971, LAB INVEST, V25, P240
   Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008
NR 54
TC 79
Z9 101
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD APR 5
PY 2017
VL 25
IS 4
BP 870
EP 879
DI 10.1016/j.ymthe.2017.02.015
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine
GA ER5YC
UT WOS:000398879500007
PM 28279643
DA 2024-11-01
ER

PT J
AU Khan, NA
   Nikkanen, J
   Yatsuga, S
   Jackson, C
   Wang, LY
   Pradhan, S
   Kivelä, R
   Pessia, A
   Velagapudi, V
   Suomalainen, A
AF Khan, Nahid A.
   Nikkanen, Joni
   Yatsuga, Shuichi
   Jackson, Christopher
   Wang, Liya
   Pradhan, Swagat
   Kivela, Riikka
   Pessia, Alberto
   Velagapudi, Vidya
   Suomalainen, Anu
TI mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression
SO CELL METABOLISM
LA English
DT Article
ID unfolded-protein response; one-carbon metabolism; nicotinamide riboside; dna deletions; mouse model; disease; activation; disorders; biomarker; mice
AB Mitochondrial dysfunction elicits various stress responses in different model systems, but how these responses relate to each other and contribute to mitochondrial disease has remained unclear. Mitochondrial myopathy (MM) is the most common manifestation of adult-onset mitochondrial disease and shows a multifaceted tissue-specific stress response: (1) transcriptional response, including metabolic cytokines FGF21 and GDF15; (2) remodeling of one-carbon metabolism; and (3) mitochondrial unfolded protein response. We show that these processes are part of one integrated mitochondrial stress response (ISRmt), which is controlled by mTORC1 in muscle. mTORC1 inhibition by rapamycin downregulated all components of ISRmt, improved all MM hallmarks, and reversed the progression of even late-stage MM, without inducing mitochondrial biogenesis. Our evidence suggests that (1) chronic upregulation of anabolic pathways contributes to MM progression, (2) long-term induction of ISRmt is not protective for muscle, and (3) rapamycin treatment trials should be considered for adult-type MM with raised FGF21.
C1 [Khan, Nahid A.; Nikkanen, Joni; Yatsuga, Shuichi; Jackson, Christopher; Pradhan, Swagat; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.
   [Yatsuga, Shuichi] Kurume Univ, Dept Pediat & Child Hlth, Sch Med, Fukuoka, Japan.
   [Wang, Liya] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden.
   [Kivela, Riikka] Univ Helsinki, Res Programs Unit, Translat Canc Biol, FIN-00290 Helsinki, Finland.
   [Pessia, Alberto; Velagapudi, Vidya] Univ Helsinki, Inst Mol Med Finland, Metabol Unit, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki 00790, Finland.
C3 University of Helsinki; Kurume University; Swedish University of Agricultural Sciences; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki 00790, Finland.
EM anu.wartiovaara@helsinki.fi
FU United Mitochondrial Disease Foundation; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Academy of Finland; University of Helsinki; European Research Council [ERC-AdG10-268955]; Helsinki Biomedical Graduate School; Swiss National Foundation; Novartis Foundation for medical biological research
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489
   Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405
   Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Heliö TM, 2013, CARDIOGENETICS, V3, P31, DOI 10.4081/cardiogenetics.2013.e6
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Kundu M, 2011, ANTIOXID REDOX SIGN, V14, P1953, DOI 10.1089/ars.2010.3809
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nilsson R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4128
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   Saxton RA, 2017, CELL, V168, P960, DOI 10.1016/j.cell.2017.02.004
   Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757
   Shoubridge E A, 1996, METHODS ENZYMOL, V264, P465, DOI 10.1016/S0076-6879(96)64042-7
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, PW652, DOI 10.1093/nar/gkp356
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Zheng X, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13374
NR 45
TC 258
Z9 284
U1 3
U2 30
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD AUG 1
PY 2017
VL 26
IS 2
BP 419
EP +
DI 10.1016/j.cmet.2017.07.007
PG 15
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA FC2PR
UT WOS:000406681000017
PM 28768179
DA 2024-11-01
ER

PT J
AU Namaghi, IB
   Vaziri, H
AF Namaghi, I. Bahrehmand
   Vaziri, H.
TI Sperm mitochondrial DNA deletion in Iranian infertiles with asthenozoospermia
SO ANDROLOGIA
LA English
DT Article
DE asthenozoospermia; gap; PCR; motility; mtDNA; sperm
ID oxidative stress; mutations; motility; fertility; diseases; polymorphisms; decline; muscle; common; damage
AB Asthenozoospermia is an important cause of male infertility. The mutations in sperm mitochondrial DNA (mtDNA) result in either functionless or malfunctioning some proteins, subsequently affecting sperm motility leading to asthenozoospermia. The purpose of this study was to investigate sperm mtDNA 4,977-bp deletion in infertile men with low sperm motility/immotile spermatozoa compared to healthy subjects with high sperm motility. Semen samples of 256 asthenozoospermic infertiles and 200 controls from northern Iran were collected. After extraction of spermatozoa total DNA, Gap-polymerase chain reaction (Gap-PCR) was performed. The deletion was observed in 85.93% of patients with asthenozoospermia compared with 14% in controls [OR=37.5397, 95% confidence interval=12.937-108.9276, p<.0001]. It is concluded that there is a strong association between sperm mtDNA 4,977-bp deletion and asthenozoospermia-induced infertility in the population examined. Large-scale mtDNA deletions in spermatozoa may induce bioenergetic disorders. Nevertheless, to validate our results broader research may be needed.
C1 [Namaghi, I. Bahrehmand; Vaziri, H.] Univ Guilan, Dept Biol, Fac Sci, Rasht, Iran.
C3 University of Guilan
RP Vaziri, H (corresponding author), Univ Guilan, Dept Biol, Fac Sci, Rasht, Iran.
EM vaziri@guilan.ac.ir
FU University of Guilan
CR Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x
   Aitken R John, 2003, REPROD BIOMED ONLINE, V7, P65
   Apostolova N, 2011, MITOCHONDRIAL DNA RE, V0, P0, DOI DOI 10.5772/19162
   Baklouti-Gargouri S, 2013, MOL BIOL REP, V40, P4705, DOI 10.1007/s11033-013-2566-7
   Chen SS, 2002, HUM REPROD, V17, P718, DOI 10.1093/humrep/17.3.718
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/revreprod/3.3.172
   Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656
   Fraczek M, 2007, J ANDROL, V28, P325, DOI 10.2164/jandrol.106.001149
   Gashti NG, 2014, ANDROLOGIA, V46, P258, DOI 10.1111/and.12073
   Gendron SP, 2012, MECH AGEING DEV, V133, P68, DOI 10.1016/j.mad.2012.01.002
   Ieremiadou F, 2009, BMC RES NOTES, V2, P1
   Iwai K, 2006, MUTAT RES-FUND MOL M, V595, P191, DOI 10.1016/j.mrfmmm.2005.10.001
   Kamalidehghan B, 2006, ARCH MED RES, V37, P730, DOI 10.1016/j.arcmed.2006.02.005
   Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616
   Kumar D Prabhu, 2009, INDIAN J HUM GENET, V15, P93, DOI 10.4103/0971-6866.60183
   Lestienne P, 1997, MOL HUM REPROD, V3, P811, DOI 10.1093/molehr/3.9.811
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Paoli D, 2011, FERTIL STERIL, V95, P2315, DOI 10.1016/j.fertnstert.2011.03.059
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5
   Shen SL, 2013, WORLD J UROL, V31, P1395, DOI 10.1007/s00345-013-1023-5
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719
   St John JC, 2000, J ANDROL, V21, P189
   St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wei YH, 2000, ZOOL STUD, V39, P1
   Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984
   Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yu M, 2012, ADV CLIN CHEM, V57, P99, DOI 10.1016/B978-0-12-394384-2.00004-8
NR 40
TC 20
Z9 20
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD APR 15
PY 2017
VL 49
IS 3
BP 
EP 
DI 10.1111/and.12627
PG 6
WC Andrology
SC Endocrinology & Metabolism
GA EP6NE
UT WOS:000397495400010
PM 27362525
DA 2024-11-01
ER

PT J
AU Hebbar, M
   Girisha, KM
   Srivastava, A
   Bielas, S
   Shukla, A
AF Hebbar, Malavika
   Girisha, Katta M.
   Srivastava, Anshika
   Bielas, Stephanie
   Shukla, Anju
TI Homozygous c.359del variant in <i>MGME1</i> is associated with early onset cerebellar ataxia
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE MGME1; Mitochondrial DNA depletion syndrome; Exome sequencing; Ataxia
ID sequencing data
AB We ascertained a child with early onset cerebellar ataxia and identified a novel frameshift deletion, c.359del [p. (Pro120Leufs*2), NM_052865.2] in exon 2 of MGME1 (mitochondrial genome maintenance exonuclease 1) by exome sequencing. Variations in MGME1 have been reported to cause mitochondrial DNA (mtDNA) depletion syndrome 11 (MIM # 615084) in an earlier work. The phenotype included progressive external ophthalmoplegia, emaciation, respiratory failure and late onset progressive ataxia. However, the child presented here has early onset progressive ataxia, speech delay, microcephaly, cerebellar atrophy and fundus albipunctatus. This is the second report of a mutation in MGME1 and describes a more severe phenotype. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Hebbar, Malavika; Girisha, Katta M.; Shukla, Anju] Manipal Univ, Dept Med Genet, Kasturba Med Coll, Manipal 576104, Karnataka, India.
   [Srivastava, Anshika; Bielas, Stephanie] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.
C3 Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; University of Michigan System; University of Michigan
RP Shukla, A (corresponding author), Manipal Univ, Dept Med Genet, Kasturba Med Coll, Manipal 576104, Karnataka, India.
EM anju.shukla@manipal.edu
FU National Institutes of Health [1R21NS094047-01]
CR Girisha KM, 2016, CLIN GENET, V90, P536, DOI 10.1111/cge.12762
   Guo YF, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep14283
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
NR 4
TC 6
Z9 6
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT 15
PY 2017
VL 60
IS 10
BP 533
EP 535
DI 10.1016/j.ejmg.2017.07.010
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA FH1OB
UT WOS:000410908200007
PM 28711739
DA 2024-11-01
ER

PT J
AU Buck, E
   Zügel, M
   Schumann, U
   Merz, T
   Gumpp, AM
   Witting, A
   Steinacker, JM
   Landwehrmeyer, GB
   Weydt, P
   Calzia, E
   Lindenberg, KS
AF Buck, Eva
   Zuegel, Martina
   Schumann, Uwe
   Merz, Tamara
   Gumpp, Anja M.
   Witting, Anke
   Steinacker, Juergen M.
   Landwehrmeyer, G. Bernhard
   Weydt, Patrick
   Calzia, Enrico
   Lindenberg, Katrin S.
TI High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function
SO PLOS ONE
LA English
DT Article
ID skeletal-muscle; gene-expression; weight-loss; model; dysfunction; brain; onset; age; abnormality; pathogenesis
AB Alterations in mitochondrial respiration are an important hallmark of Huntington's disease (HD), one of the most common monogenetic causes of neurodegeneration. The ubiquitous expression of the disease causing mutant huntingtin gene raises the prospect that mitochondrial respiratory deficits can be detected in skeletal muscle. While this tissue is readily accessible in humans, transgenic animal models offer the opportunity to cross-validate findings and allow for comparisons across organs, including the brain. The integrated respiratory chain function of the human vastus lateralis muscle was measured by high-resolution respirometry (HRR) in freshly taken fine-needle biopsies from seven pre-manifest HD expansion mutation carriers and nine controls. The respiratory parameters were unaffected. For comparison skeletal muscle isolated from HD knock-in mice (Hdh(Q111)) as well as a broader spectrum of tissues including cortex, liver and heart muscle were examined by HRR. Significant changes of mitochondrial respiration in the HdhQ knock-in mouse model were restricted to the liver and the cortex. Mitochondrial mass as quantified by mitochondrial DNA copy number and citrate synthase activity was stable in murine HD-model tissue compared to control. mRNA levels of key enzymes were determined to characterize mitochondrial metabolic pathways in HdhQ mice. We demonstrated the feasibility to perform high-resolution respirometry measurements from small human HD muscle biopsies. Furthermore, we conclude that alterations in respiratory parameters of pre-manifest human muscle biopsies are rather limited and mirrored by a similar absence of marked alterations in HdhQ skeletal muscle. In contrast, the Hdh Q111 murine cortex and liver did show respiratory alterations highlighting the tissue specific nature of mutant huntingtin effects on respiration.
C1 [Buck, Eva; Merz, Tamara; Gumpp, Anja M.; Witting, Anke; Landwehrmeyer, G. Bernhard; Weydt, Patrick; Lindenberg, Katrin S.] Univ Ulm, Dept Neurol, Ulm, Germany.
   [Zuegel, Martina; Schumann, Uwe; Steinacker, Juergen M.] Univ Ulm, Div Sports & Rehabil Med, Med Ctr, Ulm, Germany.
   [Weydt, Patrick] Univ Bonn, Dept Neurodegenerat Dis, Bonn, Germany.
   [Calzia, Enrico] Univ Ulm, Inst Anesthesiol Pathophysiol & Proc Dev, Ulm, Germany.
C3 Ulm University; Ulm University; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ulm University
RP Lindenberg, KS (corresponding author), Univ Ulm, Dept Neurol, Ulm, Germany.
EM katrin.lindenberg@uni-ulm.de
FU Virtual Helmholtz Institute "RNA dysmetabolism in Amyotrophic lateral sclerosis and frontotemporal dementia"; seed fund grant of the EINSTEIN study from the European Huntington's disease network [584/14]; Deutsche Forschungsgemeinschaft [GRK1789]
CR Aidt FH, 2013, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0071904
   Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767
   Arning L, 2007, HUM GENET, V122, P175, DOI 10.1007/s00439-007-0393-4
   AVERBACK P, 1980, J PATHOL, V132, P55, DOI 10.1002/path.1711320106
   Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e
   Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007
   Carroll JB, 2015, LANCET NEUROL, V14, P1135, DOI 10.1016/S1474-4422(15)00177-5
   Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162
   Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65
   Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028
   Djoussé L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF
   Duan WZ, 2014, MOVEMENT DISORD, V29, P1366, DOI 10.1002/mds.25992
   Eigentler A, 2020, MITOCHONDRIAL PHYSIOL NETW, V17, P1
   FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313
   Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626
   Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d
   Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277
   Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013
   Herbst EAF, 2015, NEUROSCIENCE, V303, P515, DOI 10.1016/j.neuroscience.2015.07.025
   Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004
   Hölter SM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0080923
   Hoffmann R, 2014, MOVEMENT DISORD, V29, P831, DOI 10.1002/mds.25862
   Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335
   Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Kehoe P, 1999, J MED GENET, V36, P108
   Larsen S, 2014, ANAL BIOCHEM, V446, P64, DOI 10.1016/j.ab.2013.10.023
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Liot G, 2016, BIOCH BIOPHYS RES CO, V0, P0
   Lodi R, 2000, ANN NEUROL, V48, P72
   Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Marder K, 2009, NEUROLOGY, V73, P385, DOI 10.1212/WNL.0b013e3181b04aa2
   Mielcarek M, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004550
   Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016
   Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x
   Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884
   Pasquarelli N, 2015, NEUROPHARMACOLOGY, V91, P148, DOI 10.1016/j.neuropharm.2014.12.001
   Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Picard Martin, 2010, AGING CELL, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x
   Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373
   Sánchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Silva AC, 2013, MITOCHONDRION, V13, P801, DOI 10.1016/j.mito.2013.05.006
   Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192
   Stüwe SH, 2013, NEUROLOGY, V80, P743, DOI 10.1212/WNL.0b013e318282514e
   Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540
   van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4
   Weydt P, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-1
   Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115
   Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633
   Zielonka D, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00380
NR 55
TC 13
Z9 15
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD APR 13
PY 2017
VL 12
IS 4
BP 
EP 
DI 10.1371/journal.pone.0175248
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET0MB
UT WOS:000399955400036
PM 28406926
DA 2024-11-01
ER

PT J
AU Kato, T
AF Kato, Tadafumi
TI Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond
SO SCHIZOPHRENIA RESEARCH
LA English
DT Review
DE Bipolar disorder; Mitochondrial DNA; Calcium; Paraventricular thalamic nucleus; Animal model
ID magnetic-resonance-spectroscopy; brain energy-metabolism; progressive external ophthalmoplegia; intracellular ph; phosphorus-metabolism; p-31-mr spectroscopy; multiple deletions; gender-differences; dna polymorphisms; mtdna deletions
AB Bipolar disorder is one of two major psychotic disorders together with schizophrenia and causes severe psychosocial disturbance. Lack of adequate animal models hampers development of new mood stabilizers. We proposed a mitochondrial dysfunction hypothesis and have been studying the neurobiology of bipolar disorder based on this hypothesis. We showed that deletions of mitochondrial DNA (Delta mtDNA) play a pathophysiological role at least in some patients with bipolar disorder possibly by affecting intracellular calcium regulation. Mutant polymerase gamma transgenic mice that accumulate Delta mtDNA in the brain showed recurrent spontaneous depression-like episodes which were prevented by a serotonin-selective reuptake inhibitor and worsened by lithium withdrawal. The animal model would be useful to develop new mood stabilizers. (C) 2016 The Author. Published by Elsevier B.V.
C1 [Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
C3 RIKEN
RP Kato, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24116005, 24249063]; Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [24116005] Funding Source: KAKEN
CR Ament SA, 2015, P NATL ACAD SCI USA, V112, P3576, DOI 10.1073/pnas.1424958112
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V0, P0
   Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Cataldo AM, 2010, AM J PATHOL, V177, P575, DOI 10.2353/ajpath.2010.081068
   Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a
   Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x
   Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450
   De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216
   Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601
   Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030
   Dudley J, 2016, J AFFECT DISORDERS, V191, P248, DOI 10.1016/j.jad.2015.11.045
   Dudley JA, 2015, J AFFECT DISORDERS, V175, P251, DOI 10.1016/j.jad.2015.01.026
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Hamakawa H, 2004, PSYCHIAT CLIN NEUROS, V58, P82, DOI 10.1111/j.1440-1819.2004.01197.x
   Hou L, 2016, HUM MOL GENET, V0, P0
   Hsu DT, 2014, FRONT BEHAV NEUROSCI, V8, P0, DOI 10.3389/fnbeh.2014.00073
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, P0, DOI 10.1186/1744-9081-8-9
   Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022
   Jamison KayRedfield, 2007, MANIC-DEPRESSIVE ILLNESS: BIPOLAR DISORDERS AND RECURRENT DEPRESSION, V2nd, P0
   Jensen JE, 2008, EXP CLIN PSYCHOPHARM, V16, P199, DOI 10.1037/1064-1297.16.3.199
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Kasahara T, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001877
   Kataoka M, 2016, MOL PSYCHIATR, V21, P885, DOI 10.1038/mp.2016.69
   Kato T, 1998, J NEUROL SCI, V155, P182, DOI 10.1016/S0022-510X(97)00308-0
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R
   Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054
   Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kato T, 2008, NEUROSCI RES, V61, P143, DOI 10.1016/j.neures.2008.02.002
   Kato T, 2015, PSYCHIAT CLIN NEUROS, V69, P65, DOI 10.1111/pcn.12247
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006
   Kubota M, 2010, INT J NEUROPSYCHOPH, V13, P1355, DOI 10.1017/S1461145710000362
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Mamdani F, 2014, SCHIZOPHR RES, V159, P370, DOI 10.1016/j.schres.2014.08.026
   Mancuso M, 2008, J AFFECT DISORDERS, V106, P173, DOI 10.1016/j.jad.2007.05.016
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526
   Murashita J, 2000, PSYCHOL MED, V30, P107, DOI 10.1017/S0033291799001439
   Nakamura T, 2016, PSYCHIAT CLIN NEUROS, V70, P342, DOI 10.1111/pcn.12395
   Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3
   Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391
   RAINBOW TC, 1982, J NEUROSCI, V2, P1439
   Sequeira Adolfo, 2012, FRONTIERS IN GENETICS, V3, P103, DOI 10.3389/fgene.2012.00103
   Shi XF, 2015, BIPOLAR DISORD, V17, P743, DOI 10.1111/bdi.12339
   Shi XF, 2012, BIPOLAR DISORD, V14, P607, DOI 10.1111/j.1399-5618.2012.01040.x
   Sikoglu EM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054536
   Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711
   Sun XJ, 2006, J PSYCHIATR NEUROSCI, V31, P189
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TSUJIMOTO T, 1990, J AFFECT DISORDERS, V18, P199, DOI 10.1016/0165-0327(90)90037-9
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Warsh JJ, 2004, CLIN NEUROSCI RES, V4, P201, DOI 10.1016/j.cnr.2004.09.012
   Washizuka S, 2004, BIOL PSYCHIAT, V56, P483, DOI 10.1016/j.biopsych.2004.07.004
   Weber WA, 2013, J AFFECT DISORDERS, V150, P1109, DOI 10.1016/j.jad.2013.04.047
   Yoshimi N, 2016, MOL PSYCHIATR, V21, P1504, DOI 10.1038/mp.2015.217
   Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954
NR 69
TC 71
Z9 72
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0920-9964
EI 1573-2509
J9 SCHIZOPHR RES
JI Schizophr. Res.
PD SEP 15
PY 2017
VL 187
IS 
BP 62
EP 66
DI 10.1016/j.schres.2016.10.037
PG 5
WC Psychiatry
SC Psychiatry
GA FG7TT
UT WOS:000410628300010
PM 27839913
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Cardaioli, E
   Rubegni, A
   Gallus, GN
   Malandrini, A
   Rufa, A
   Battisti, C
   Carluccio, MA
   Rocchi, R
   Giannini, F
   Bianchi, A
   Mancuso, M
   Siciliano, G
   Dotti, MT
   Federico, A
AF Da Pozzo, Paola
   Cardaioli, Elena
   Rubegni, Anna
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Rufa, Alessandra
   Battisti, Carla
   Carluccio, Maria Alessandra
   Rocchi, Raffaele
   Giannini, Fabio
   Bianchi, Amedeo
   Mancuso, Michelangelo
   Siciliano, Gabriele
   Dotti, Maria Teresa
   Federico, Antonio
TI Novel <i>POLG</i> mutations and variable clinical phenotypes in 13 Italian patients
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial diseases; DNA polymerase gamma; Genetics; Clinical phenotypes
ID dna-polymerase-gamma; mitochondrial; family; ophthalmoplegia; neuropathy; disease; ataxia; gene
AB POLG gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA (mtDNA) replication and repair. Mutations in POLG have been linked to a spectrum of clinical phenotypes, resulting in autosomal recessive or dominant mitochondrial diseases. These mutations have been associated with heterogeneous phenotypes, presenting with varying severity and at different ages of onset, ranging from the neonatal period to late adult life. We screened 13 patients for POLG mutations. All patients underwent a complete neurological examination, and in most of cases, muscle biopsy was performed. We detected 15 different variations in 13 unrelated Italian patients. Two mutations were novel and mapped in the pol domain (p.Thr989dup and p.Ala847Thr) of the enzyme. We also report new cases carrying controversial variations previously described as incompletely penetrant or a variant of unknown significance. Our study increases the range of clinical presentations associated with mutations in POLG gene, underlining some peculiar clinical features, such as PEO associated with corneal edema, and epilepsy, severe neuropathy with achalasia. The addition of two new substitutions, including the second report of an in-frame duplication, to the growing list of defects increases the value of POLG genetic diagnosis in a range of neurological presentations.
C1 [Da Pozzo, Paola; Cardaioli, Elena; Gallus, Gian Nicola; Malandrini, Alessandro; Rufa, Alessandra; Battisti, Carla; Carluccio, Maria Alessandra; Rocchi, Raffaele; Giannini, Fabio; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Med Surg & Neurol Sci, Viale Bracci 2, I-53100 Siena, Italy.
   [Rubegni, Anna] IRCCS Fdn Stella Maris, Pisa, Italy.
   [Bianchi, Amedeo] Hosp Arezzo, Dept Neurosci, Arezzo, Italy.
   [Mancuso, Michelangelo; Siciliano, Gabriele] Univ Pisa, Dept Neurosci, Neurol Clin, Pisa, Italy.
C3 University of Siena; IRCCS Fondazione Stella Maris; University of Pisa
RP Federico, A (corresponding author), Univ Siena, Dept Med Surg & Neurol Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
FU Regione Toscana; Ministry of Public Health
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bortot B, 2009, DIGEST LIVER DIS, V41, P494, DOI 10.1016/j.dld.2008.11.013
   Burusnukul P, 2009, J CHILD NEUROL, V24, P482, DOI 10.1177/0883073808324539
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
NR 25
TC 16
Z9 16
U1 0
U2 3
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD APR 15
PY 2017
VL 38
IS 4
BP 563
EP 570
DI 10.1007/s10072-016-2734-3
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ER6UF
UT WOS:000398943100004
PM 28130605
DA 2024-11-01
ER

PT J
AU Hedermann, G
   Lokken, N
   Dahlqvist, JR
   Vissing, J
AF Hedermann, Gitte
   Lokken, Nicoline
   Dahlqvist, Julia R.
   Vissing, John
TI Dysphagia is prevalent in patients with CPEO and single, large-scale deletions in mtDNA
SO MITOCHONDRION
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; Dysphagia; Mitochondrial myopathy; Single large-scale deletion; CPEO
ID progressive external ophthalmoplegia; disease; common
AB Background: The aim of this study was to assess the frequency of subjective and objective dysphagia in patients with chronic progressive external ophthalmoplegia (CPEO) due to single, large-scale deletions (LSDs) of mitochondrial DNA (mtDNA). Methods: Sixteen patients with CPEO and single LSDs of mtDNA were included in the study and compared to a control group of 12 patients with the m.3243A > G mtDNA mutation. Patients had to drink 80 ml of water at 4 degrees C as fast as they could (cold-water test) and fill out a standardized questionnaire about dysphagia. Results: Eight patients (50%) with CPEO and single LSDs of mtDNA had a prolonged cold-water test, including one with a PEG-tube, who was unable to perform the test, and nine patients reported subjective swallowing problems (56.3%). All mitochondrial myopathy patients in the control group had a normal duration of the cold-water test. Conclusions: The study shows that dysphagia is a common problem in patients with CPEO and LSDs of mtDNA. Dysphagia seems to be progressive with age as abnormal swallowing occurred preferentially in persons >= 45 years. The study shows that increased awareness of this symptom should be given to address appropriate treatment interventions and avoid complications such as social isolation, malnutrition and aspiration pneumonia. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Hedermann, Gitte; Lokken, Nicoline; Dahlqvist, Julia R.; Vissing, John] Univ Copenhagen, Dept Neurol, Copenhagen Neuromuscular Ctr, Rigshosp, Sect 3342,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet
RP Hedermann, G (corresponding author), Univ Copenhagen, Dept Neurol, Copenhagen Neuromuscular Ctr, Rigshosp, Sect 3342,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM hedermann@gmail.com; nicoline.loekken@regionh.dk; julia.rebecka.dahlqvist@regionh.dk; vissing@rh.dk
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Cox FM, 2009, J NEUROL, V256, P2009, DOI 10.1007/s00415-009-5229-9
   Knuijt S, 2014, DISABIL REHABIL, V36, P1285, DOI 10.3109/09638288.2013.845255
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Read JL, 2012, INT J LANG COMM DIS, V47, P106, DOI 10.1111/j.1460-6984.2011.00072.x
   WINTZEN AR, 1994, CAN J NEUROL SCI, V21, P53, DOI 10.1017/S0317167100048770
   Witting N, 2014, ACTA NEUROL SCAND, V130, P125, DOI 10.1111/ane.12244
NR 11
TC 8
Z9 10
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2017
VL 32
IS 
BP 27
EP 30
DI 10.1016/j.mito.2016.11.007
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EI0LG
UT WOS:000392165400005
PM 27856367
DA 2024-11-01
ER

PT J
AU Nam, HS
   Iunnchenkoi, E
   Dasgupta, S
   Hoque, MO
AF Nam, Hae-Seong
   Iunnchenkoi, Evgeny
   Dasgupta, Santanu
   Hoque, Mohammad O.
TI Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now?
SO BIOMARKERS IN MEDICINE
LA English
DT Review
DE chronic obstructive pulmonary disease; mitochondria; mitochondrial d-ysfunction; non-small-cell lung cancer
ID oxidative stress; dna mutations; displacement loop; skeletal-muscle; free-radicals; copd; apoptosis; fusion; dynamics; fission
AB Recent advances in mitochondrial biogenesis have provided the emerging recognition that mitochondria do much more than 'simply providing energy for cellular function'. Currently, a constantly improving understanding of the mitochondrial structure and function has been providing valuable insights into the contribution of defects in mitochondrial metabolism to various human diseases, including chronic obstructive pulmonary disease and lung cancer. The growing interest in mitochondria research led to development of new biomedical fields in the two main smoking-related lung diseases. However, there is considerable paucity in our understanding of mechanisms by which mitochondrial dynamics regulate lung diseases. In this review, we will discuss our current knowledge on the role of mitochondrial dysfunction in the pathogenesis of chronic obstructive pulmonary disease and non-small-cell lung cancer.
C1 [Nam, Hae-Seong; Iunnchenkoi, Evgeny; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Baltimore, MD 21231 USA.
   [Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.
   [Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.
   [Nam, Hae-Seong] Inha Univ, Sch Med, Inha Univ Hosp, Div Pulmonol,Dept Internal Med, Incheon 22332, South Korea.
   [Dasgupta, Santanu] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Inha University; Inha University Hospital; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)
RP Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Baltimore, MD 21231 USA.; Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.; Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.
EM mhoque1@jhmi.edu
FU FAMRI (Miami, FL, USA) [103015_CIA]; National Cancer Institute [R01CA208709, 1R01CA208709-01]
CR Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601
   Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415
   Agustí AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013
   Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276
   Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   AMBROSIO G, 1993, J BIOL CHEM, V268, P18532
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005
   Aravamudan B, 2013, EXPERT REV RESP MED, V7, P631, DOI 10.1586/17476348.2013.834252
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0
   Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703
   Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57
   BIESELE J J, 1956, J BIOPHYS BIOCHEM CYTOL, V2, P319
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   Boelens MC, 2011, LUNG CANCER, V72, P177, DOI 10.1016/j.lungcan.2010.08.014
   Bozinovski S, 2016, BRIT J PHARMACOL, V173, P635, DOI 10.1111/bph.13198
   Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004
   Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841
   Caramori G, 2011, INT J BIOCHEM CELL B, V43, P1030, DOI 10.1016/j.biocel.2010.08.022
   Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chiang YY, 2009, MODERN PATHOL, V22, P1139, DOI 10.1038/modpathol.2009.83
   Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021
   Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475
   Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385
   Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752
   CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526
   Dasgupta S, 2012, J CELL PHYSIOL, V227, P2451, DOI 10.1002/jcp.22980
   Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001
   Demedts IK, 2006, RESP RES, V7, P0, DOI 10.1186/1465-9921-7-53
   Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004
   Denholm R, 2014, AM J RESP CRIT CARE, V190, P549, DOI 10.1164/rccm.201402-0338OC
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ding CM, 2012, EXP THER MED, V3, P861, DOI 10.3892/etm.2012.490
   Durham AL, 2015, LUNG CANCER, V90, P121, DOI 10.1016/j.lungcan.2015.08.017
   Fang HY, 2012, HUM PATHOL, V43, P105, DOI 10.1016/j.humpath.2011.04.012
   Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Guo YT, 2013, AM J RESP CRIT CARE, V188, P1313, DOI 10.1164/rccm.201304-0732OC
   György H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a
   Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714
   Hoffmann RF, 2013, RESP RES, V14, P0, DOI 10.1186/1465-9921-14-97
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045
   Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477
   HusgafvelPursiainen K, 1997, ENVIRON MOL MUTAGEN, V30, P224, DOI 10.1002/(SICI)1098-2280(1997)30:2<224::AID-EM15>3.0.CO;2-F
   Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998
   Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3
   Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64
   Kamp DW, 2011, ONCOLOGY-NY, V25, P400
   Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005
   Kawada I, 2013, CANCER BIOL THER, V14, P679, DOI 10.4161/cbt.25091
   Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664
   Lawless MW, 2009, J CELL MOL MED, V13, P2800, DOI 10.1111/j.1582-4934.2009.00845.x
   Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167
   Lennon FE, 2014, EXPERT OPIN INV DRUG, V23, P675, DOI 10.1517/13543784.2014.899350
   Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330
   Li XY, 2013, J HEMATOL ONCOL, V6, P0, DOI 10.1186/1756-8722-6-19
   Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017
   Lloreta J, 1996, ULTRASTRUCT PATHOL, V20, P67, DOI 10.3109/01913129609023240
   Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85
   Loukides S, 2013, CURR DRUG TARGETS, V14, P235, DOI 10.2174/1389450111314020008
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   LYONS MJ, 1958, NATURE, V181, P1003, DOI 10.1038/1811003a0
   Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866
   Miró O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Moghaddas S, 2003, ARCH BIOCHEM BIOPHYS, V414, P59, DOI 10.1016/S0003-9861(03)00166-8
   Mukaro VRS, 2011, CURR DRUG TARGETS, V12, P460
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Papi A, 2004, THORAX, V59, P679, DOI 10.1136/thx.2003.018291
   Peng H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082739
   Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895
   Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Plataki Maria, 2006, INT J CHRON OBSTRUCT PULMON DIS, V1, P161, DOI 10.2147/copd.2006.1.2.161
   Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023
   Purdue MP, 2007, THORAX, V62, P51, DOI 10.1136/thx.2006.064196
   Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008
   Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543
   Remels AH, 2008, EUR RESPIR J, V31, P502, DOI 10.1183/09031936.00068207
   Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106
   Roberts ER, 2013, COMPUT STRUCT BIOTEC, V6, P0, DOI 10.5936/csbj.201303019
   Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020
   Ryter SW, 2015, REDOX BIOL, V4, P215, DOI 10.1016/j.redox.2014.12.010
   Scatena R, 2012, ADV EXP MED BIOL, V942, P287, DOI 10.1007/978-94-007-2869-1_13
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699
   Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296
   Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121
   SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Soulitzis N, 2012, RESP MED, V106, P954, DOI 10.1016/j.rmed.2012.03.019
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Sureshbabu A, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00384
   Suzuki M, 2003, CLIN CANCER RES, V9, P5636
   Taivassalo T, 2015, CHEST, V149, P1302
   Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Ueda K, 2006, CLIN CANCER RES, V12, P6730, DOI 10.1158/1078-0432.CCR-06-1196
   Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XD, 2001, GENE DEV, V15, P2922
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198
   Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002
NR 135
TC 38
Z9 42
U1 2
U2 17
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND
SN 1752-0363
EI 1752-0371
J9 BIOMARK MED
JI Biomark. Med.
PD MAY 15
PY 2017
VL 11
IS 6
BP 475
EP 489
DI 10.2217/bmm-2016-0373
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EZ2PX
UT WOS:000404552900008
PM 28598223
DA 2024-11-01
ER

PT J
AU Tumiene, B
   Voisin, N
   Preiksaitiene, E
   Petroska, D
   Grikiniene, J
   Samaitiene, R
   Utkus, A
   Reymond, A
   Kucinskas, V
AF Tumiene, Birute
   Voisin, Norine
   Preiksaitiene, Egle
   Petroska, Donatas
   Grikiniene, Jurgita
   Samaitiene, Ruta
   Utkus, Algirdas
   Reymond, Alexandre
   Kucinskas, Vaidutis
TI Inflammatory myopathy in a patient with Aicardi-Goutieres syndrome
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Inflammatory myopathy; Aicardi-Goutieres syndrome; Type I interferonopathy; Autoimmune myositis; Exome sequencing
ID p.asp18asn mutation; lupus-erythematosus; autoimmune-disease; i interferons; trex1; dna; activation; biomarkers; rnaseh2a; samhd1
AB Aicardi-Goutieres syndrome (AGS) is an inflammatory disorder belonging to the recently characterized group of type I interferonopathies. The most consistently affected tissues in AGS are the central nervous system and skin, but various organ systems and tissues have been reported to be affected, pointing to the systemic nature of the disease. Here we describe a patient with AGS due to a homozygous p.Arg114His mutation in the TREX1 gene. The histologically proven inflammatory myopathy in our patient expands the range of clinical features of AGS. Histological signs of muscle biopsies in the proband, and in two other AGS patients described earlier, are similar to those seen in various autoimmune myositises and could be ascribed to inapproapriate IFN I activation. In view of signs of possible mitochondrial damage in AGS, we propose that mitochondrial DNA could be a trigger of autoimmune responses in AGS. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Tumiene, Birute; Preiksaitiene, Egle; Utkus, Algirdas; Kucinskas, Vaidutis] Vilnius Univ, Ctr Med Genet, Dept Human & Med Genet, Vilnius, Lithuania.
   [Voisin, Norine; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.
   [Petroska, Donatas] Vilnius Univ, Fac Med, Dept Pathol Forens Med & Pharmacol, Vilnius, Lithuania.
   [Petroska, Donatas] Vilnius Univ, Hosp Santariskiu Klin, Natl Ctr Pathol, Vilnius, Lithuania.
   [Grikiniene, Jurgita; Samaitiene, Ruta] Vilnius Univ, Fac Med, Clin Childrens Dis, Vilnius, Lithuania.
C3 Vilnius University; University of Lausanne; Vilnius University; Vilnius University; Vilnius University Hospital Santariskiu Klinikos; Vilnius University
RP Tumiene, B (corresponding author), Vilnius Univ, Fac Med, Dept Human & Med Genet, Santariskiu 2, LT-08661 Vilnius, Lithuania.
EM tumbir@gmail.com
FU Lithuanian-Swiss cooperation program to reduce economic and social disparities within the enlarged European Union [CH-3-SMM-0104]; Swiss National Science Foundation [31003A_160203]; Swiss National Science Foundation (SNF) [31003A_160203] Funding Source: Swiss National Science Foundation (SNF)
CR Abe J, 2013, RHEUMATOLOGY, V52, P406, DOI 10.1093/rheumatology/kes181
   Alfaiz AA, 2016, EUR J HUM GENET, V24, P1001, DOI 10.1038/ejhg.2015.227
   Alfaiz AA, 2014, HUM MUTAT, V35, P447, DOI 10.1002/humu.22529
   Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162
   Beck-Engeser GB, 2011, RETROVIROLOGY, V8, P0, DOI 10.1186/1742-4690-8-91
   Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845
   Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005
   Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
   Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x
   Ellyard JI, 2014, ARTHRITIS RHEUMATOL, V66, P3382, DOI 10.1002/art.38824
   Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61
   Greenberg Steven A, 2010, CURR RHEUMATOL REP, V12, P198, DOI 10.1007/s11926-010-0101-6
   Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620
   Hayashi K, 2015, INT IMMUNOL, V27, P435, DOI 10.1093/intimm/dxv021
   Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jakati S, 2015, INT J RHEUM DIS, V18, P886, DOI 10.1111/1756-185X.12592
   Kalliolias GD, 2012, BIOMARK MED, V6, P137, DOI 10.2217/BMM.12.8
   Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213
   Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367
   Rice GI, 2015, J CLIN IMMUNOL, V35, P235, DOI 10.1007/s10875-015-0147-3
   Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8
   Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032
   Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017
NR 26
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD MAR 15
PY 2017
VL 60
IS 3
BP 154
EP 158
DI 10.1016/j.ejmg.2016.12.004
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA EQ4SL
UT WOS:000398068600002
PM 28089741
DA 2024-11-01
ER

PT J
AU Bugiardini, E
   Poole, OV
   Manole, A
   Pittman, AM
   Horga, A
   Hargreaves, I
   Woodward, CE
   Sweeney, MG
   Holton, JL
   Taanman, JW
   Plant, GT
   Poulton, J
   Zeviani, M
   Ghezzi, D
   Taylor, J
   Smith, C
   Fratter, C
   Kanikannan, MA
   Paramasivam, A
   Thangaraj, K
   Spinazzola, A
   Holt, IJ
   Houlden, H
   Hanna, MG
   Pitceathly, RDS
AF Bugiardini, Enrico
   Poole, Olivia V.
   Manole, Andreea
   Pittman, Alan M.
   Horga, Alejandro
   Hargreaves, Iain
   Woodward, Cathy E.
   Sweeney, Mary G.
   Holton, Janice L.
   Taanman, Jan-Willem
   Plant, Gordon T.
   Poulton, Joanna
   Zeviani, Massimo
   Ghezzi, Daniele
   Taylor, John
   Smith, Conrad
   Fratter, Carl
   Kanikannan, Meena A.
   Paramasivam, Arumugam
   Thangaraj, Kumarasamy
   Spinazzola, Antonella
   Holt, Ian J.
   Houlden, Henry
   Hanna, Michael G.
   Pitceathly, Robert D. S.
TI Clinicopathologic and molecular spectrum of <i>RNASEH1</i>-related mitochondrial disease
SO NEUROLOGY-GENETICS
LA English
DT Article
ID h1
AB Objective: Pathologic ribonuclease H1 (RNase H1) causes aberrant mitochondrial DNA (mtDNA) segregation and is associated with multiple mtDNA deletions. We aimed to determine the prevalence of RNase H1 gene (RNASEH1) mutations among patients with mitochondrial disease and establish clinically meaningful genotype-phenotype correlations. Methods: RNASEH1 was analyzed in patients with (1) multiple deletions/depletion of muscle mtDNA and (2) mendelian progressive external ophthalmoplegia (PEO) with neuropathologic evidence of mitochondrial dysfunction, but no detectable multiple deletions/depletion of muscle mtDNA. Clinicopathologic and molecular evaluation of the newly identified and previously reported patients harboring RNASEH1 mutations was subsequently undertaken. Results: Pathogenic c.424G>A p.Val142Ile RNASEH1 mutations were detected in 3 pedigrees among the 74 probands screened. Given that all 3 families had Indian ancestry, RNASEH1 genetic analysis was undertaken in 50 additional Indian probands with variable clinical presentations associated with multiple mtDNA deletions, but no further RNASEH1 mutations were confirmed. RNASEH1-related mitochondrial disease was characterized by PEO (100%), cerebellar ataxia (57%), and dysphagia (50%). The ataxia neuropathy spectrum phenotype was observed in 1 patient. Although the c.424G>A p.Val142Ile mutation underpins all reported RNASEH1-related mitochondrial disease, haplotype analysis suggested an independent origin, rather than a founder event, for the variant in our families. Conclusions: In our cohort, RNASEH1 mutations represent the fourth most common cause of adult mendelian PEO associated with multiple mtDNA deletions, following mutations in POLG, RRM2B, and TWNK. RNASEH1 genetic analysis should also be considered in all patients with POLG-negative ataxia neuropathy spectrum. The pathophysiologic mechanisms by which the c.424G>A p.Val142Ile mutation impairs human RNase H1 warrant further investigation.
C1 [Bugiardini, Enrico; Poole, Olivia V.; Manole, Andreea; Horga, Alejandro; Holton, Janice L.; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   Natl Hosp Neurol & Neurosurg, London, England.
   [Manole, Andreea; Pittman, Alan M.; Holton, Janice L.; Houlden, Henry; Hanna, Michael G.] UCL Inst Neurol, Dept Mol Neurosci, London, England.
   [Holton, Janice L.] UCL Inst Neurol, Div Neuropathol, London, England.
   [Taanman, Jan-Willem; Spinazzola, Antonella; Holt, Ian J.] UCL Inst Neurol, Dept Clin Neurosci, London, England.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, England.
   [Woodward, Cathy E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London, England.
   [Plant, Gordon T.] Natl Hosp Neurol & Neurosurg, Dept Neuroophthalmol, London, England.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge, England.
   [Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, Milan, Italy.
   [Taylor, John; Smith, Conrad; Fratter, Carl] Churchill Hosp, Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, Oxford, England.
   [Kanikannan, Meena A.] Nizams Inst Med Sci, Dept Neurol, Hyderabad, Telangana, India.
   [Paramasivam, Arumugam; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana, India.
   [Holt, Ian J.] MRC Mill Hill Lab, London, England.
   [Holt, Ian J.] Biodonostia Res Inst, San Sebastian, Spain.
   [Pitceathly, Robert D. S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Oxford; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Nizam's Institute of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of London; King's College London
RP Pitceathly, RDS (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.; Pitceathly, RDS (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England.
EM r.pitceathly@ucl.ac.uk
FU European Community's Seventh Framework Programme (FP7) [2012-305121]; Medical Research Council Centre [G0601943]; Wellcome Trust; Department of Health's National Institute for Health Research Biomedical Research Centres; National Institute for Health Research; Lily Foundation; NewLife [SG/14-15/11]; Medical Research Council [MR/J010448/1]; Wellcome Trust [0948685/Z/10/Z]; Department of Biotechnology; Council of Scientific and Industrial Research, Government of India [BioAge: BSC0118]; Science and Engineering Research Board, Government of India [PDF/2016/000881]; Medical Research Council Senior Non-Clinical Fellowship [MC_PC_13029]; MRC [MC_UU_00015/5, MR/K000608/1, G0800674, G0802760, MC_U105663140, MR/J004758/1, G1001253, MR/J010448/1, G108/638, MC_UP_1002/1, MC_PC_13029/2, MC_UP_1202/14] Funding Source: UKRI
CR Akman G, 2016, P NATL ACAD SCI USA, V113, PE4276, DOI 10.1073/pnas.1600537113
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   KELLER W, 1972, P NATL ACAD SCI USA, V69, P3360, DOI 10.1073/pnas.69.11.3360
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
NR 10
TC 16
Z9 17
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD JUN 15
PY 2017
VL 3
IS 3
BP 
EP 
DI 10.1212/NXG.0000000000000149
PG 7
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA FW1BM
UT WOS:000425030300003
PM 28508084
DA 2024-11-01
ER

PT J
AU Dimmock, DP
   Lawlor, MW
AF Dimmock, David P.
   Lawlor, Michael W.
TI Presentation and Diagnostic Evaluation of Mitochondrial Disease
SO PEDIATRIC CLINICS OF NORTH AMERICA
LA English
DT Article
DE Mitochondrial; Myopathy; Metabolic; Electron transport chain; mtDNA; Diagnosis
ID disorders; dysfunction; nuclear; genes
AB Mitochondrial disease (MD) occurs when alteration of mitochondria] respiratory chain complex function caused by genetic mutation produces a detectable disease state. These mutations may be found in either the nuclear or mitochondrial genomes, and may only be present in a subset of cells or body tissues. Thus, the phenotype of MD is extremely variable and the definitive diagnosis of MD is complex. This article provides a brief description of a strategy used in the diagnosis of MD, by integrating data. from clinical, imaging, pathologic, molecular, and enzymatic assessments. Additional information on characteristic findings seen in classic MD syndromes is also provided.
C1 [Dimmock, David P.] Rady Childrens Inst Genom Med, 3020 Childrens Way,MC 5129, San Diego, CA 92123 USA.
   [Dimmock, David P.] Med Coll Wisconsin, Dept Pediat, Div Genet, Human Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Lawlor, Michael W.] Med Coll Wisconsin, Dept Pathol & Lab Med, Div Pediat Pathol, Neurosci Res Ctr, 8701 Watertown Plank Rd,TBRC Bldg,Room C4490, Milwaukee, WI 53226 USA.
C3 Medical College of Wisconsin; Medical College of Wisconsin
RP Lawlor, MW (corresponding author), 8701 Watertown Plank Rd,TBRC Bldg,Room C4490, Milwaukee, WI 53226 USA.
EM mlawlor@mcw.edu
FU Children's Hospital of Wisconsin Research Institute; Clinical and Translational Science Institute of Southeastern Wisconsin (NCATS) [8UL1 TR000055]
CR Bennett B, 2016, FREE RADICAL BIO MED, V92, P141, DOI 10.1016/j.freeradbiomed.2016.01.001
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Chinnery PF, 1993, GENEREVIEWS, V0, P0
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Gloerich J, 2007, J PROTEOME RES, V6, P506, DOI 10.1021/pr060487w
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Parikh S, 2014, MITOCHONDRION, V14, P26, DOI 10.1016/j.mito.2013.07.116
   Spinazzi M, 2011, MITOCHONDRION, V11, P893, DOI 10.1016/j.mito.2011.07.006
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
NR 14
TC 14
Z9 18
U1 0
U2 21
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0031-3955
EI 1557-8240
J9 PEDIATR CLIN N AM
JI Pediatr. Clin. N. Am.
PD FEB 15
PY 2017
VL 64
IS 1
BP 161
EP +
DI 10.1016/j.pcl.2016.08.011
PG 12
WC Pediatrics
SC Pediatrics
GA EG3YR
UT WOS:000390981100012
PM 27894442
DA 2024-11-01
ER

PT J
AU Zheng, HX
   Li, L
   Jiang, XY
   Yan, S
   Qin, ZD
   Wang, XF
   Jin, L
AF Zheng, Hong-Xiang
   Li, Lei
   Jiang, Xiao-Yan
   Yan, Shi
   Qin, Zhendong
   Wang, Xiaofeng
   Jin, Li
TI MtDNA genomes reveal a relaxation of selective constraints in low-BMI individuals in a Uyghur population
SO HUMAN GENETICS
LA English
DT Article
ID human mitochondrial-dna; adaptive evolution; insulin-resistance; skeletal-muscle; dysfunction; mutations; variants; diseases; obesity; load
AB Considerable attention has been focused on the effect of deleterious mutations caused by the recent relaxation of selective constraints on human health, including the prevalence of obesity, which might represent an adaptive response of energy-conserving metabolism under the conditions of modern society. Mitochondrial DNA (mtDNA) encoding 13 core subunits of oxidative phosphorylation plays an important role in metabolism. Therefore, we hypothesized that a relaxation of selection constraints on mtDNA and an increase in the proportion of deleterious mutations have played a role in obesity prevalence. In this study, we collected and sequenced the mtDNA genomes of 722 Uyghurs, a typical population with a high prevalence of obesity. We identified the variants that occurred in the Uyghur population for each sample and found that the number of nonsynonymous mutations carried by Uyghur individuals declined with elevation of their BMI (P = 0.015). We further calculated the nonsynonymous and synonymous ratio (N/S) of the high-BMI and low-BMI haplogroups, and the results showed that a significantly higher N/S occurred in the whole mtDNA genomes of the low-BMI haplogroups (0.64) than in that of the high-BMI haplogroups (0.35, P = 0.030) and ancestor haplotypes (0.41, P = 0.032); these findings indicated that low-BMI individuals showed a recent relaxation of selective constraints. In addition, we investigated six clinical characteristics and found that fasting plasma glucose might be correlated with the N/S and selective pressures. We hypothesized that a higher proportion of deleterious mutations led to mild mitochondrial dysfunction, which helps to drive glucose consumption and thereby prevents obesity. Our results provide new insights into the relationship between obesity predisposition and mitochondrial genome evolution.
C1 [Zheng, Hong-Xiang; Li, Lei; Yan, Shi; Qin, Zhendong; Wang, Xiaofeng; Jin, Li] Fudan Univ, Key Lab Contemp Anthropol, Minist Educ, Shanghai, Peoples R China.
   [Zheng, Hong-Xiang; Li, Lei; Yan, Shi; Qin, Zhendong; Wang, Xiaofeng; Jin, Li] Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Shanghai, Peoples R China.
   [Zheng, Hong-Xiang; Li, Lei; Yan, Shi; Qin, Zhendong; Wang, Xiaofeng; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.
   [Jiang, Xiao-Yan] Tongji Univ, Sch Med, Minist Educ China, Key Lab Arrhythmias, Shanghai, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Tongji University
RP Wang, XF; Jin, L (corresponding author), Fudan Univ, Key Lab Contemp Anthropol, Minist Educ, Shanghai, Peoples R China.; Wang, XF; Jin, L (corresponding author), Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Shanghai, Peoples R China.; Wang, XF; Jin, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.
EM zhenghongxiang@gmail.com; lei.li1005@gmail.com; xiaoyanjiang001@163.com; biopolyhedron@gmail.com; zhendong.qin@gmail.com; xiaofengwang71@163.com; lijin@fudan.edu.cn
FU National Natural Science Foundation of China [31401062, 31271338, 81100551]
CR Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002
   Bellisari A, 2008, OBES REV, V9, P165, DOI 10.1111/j.1467-789X.2007.00392.x
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Chen XX, 2009, J XINJIANG MED U, V32, P15
   Cong L, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0090262
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505
   Fu WQ, 2014, AM J HUM GENET, V95, P421, DOI 10.1016/j.ajhg.2014.09.006
   Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690
   Haviland WA, 2010, EVOLUTION PREHISTORY: THE HUMAN CHALLENGE, V0, P0
   He J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106723
   Henn BM, 2016, P NATL ACAD SCI USA, V113, PE440, DOI 10.1073/pnas.1510805112
   Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931
   Hwang AB, 2011, AGING-US, V3, P304, DOI 10.18632/aging.100292
   Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Jiang XY, 2010, ENDOCRINE, V37, P383, DOI 10.1007/s12020-010-9318-4
   Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012
   Kang LL, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31083
   Kang LL, 2013, MOL BIOL EVOL, V30, P2579, DOI 10.1093/molbev/mst147
   Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Knoll N, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094882
   Li L, 2015, AGE, V37, P0, DOI 10.1007/s11357-015-9750-8
   Li ST, 2014, EUR J HUM GENET, V22, P0, DOI 10.1038/ejhg.2013.282
   Liu J, 2012, MOL BIOL EVOL, V29, P1255, DOI 10.1093/molbev/msr290
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lu M, 2009, CLIN EXP HYPERTENS, V31, P179, DOI 10.1080/10641960802621325
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Porter C, 2012, J PHYSIOL-LONDON, V590, P5935, DOI 10.1113/jphysiol.2012.241083
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang ZF, 2011, MOL BIOL EVOL, V28, P1553, DOI 10.1093/molbev/msq336
   Xu L, 2009, OBESITY, V17, P121, DOI 10.1038/oby.2008.504
   Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017
   YAMADA T, 1975, J LAB CLIN MED, V86, P38
   Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83
NR 46
TC 10
Z9 10
U1 0
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD OCT 15
PY 2017
VL 136
IS 10
BP 1353
EP 1362
DI 10.1007/s00439-017-1829-0
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA FH5ZI
UT WOS:000411250800004
PM 28799012
DA 2024-11-01
ER

PT J
AU Wortmann, SB
   Timal, S
   Venselaar, H
   Wintjes, LT
   Kopajtich, R
   Feichtinger, RG
   Onnekink, C
   Mühlmeister, M
   Brandt, U
   Smeitink, JA
   Veltman, JA
   Sperl, W
   Lefeber, D
   Pruijn, G
   Stojanovic, V
   Freisinger, P
   von Spronsen, F
   Derks, TGJ
   Veenstra-Knol, HE
   Mayr, JA
   Rötig, A
   Tarnopolsky, M
   Prokisch, H
   Rodenburg, RJ
AF Wortmann, Saskia B.
   Timal, Sharita
   Venselaar, Hanka
   Wintjes, Liesbeth T.
   Kopajtich, Robert
   Feichtinger, Rene G.
   Onnekink, Carla
   Muhlmeister, Mareike
   Brandt, Ulrich
   Smeitink, Jan A.
   Veltman, Joris A.
   Sperl, Wolfgang
   Lefeber, Dirk
   Pruijn, Ger
   Stojanovic, Vesna
   Freisinger, Peter
   von Spronsen, Francjan
   Derks, Terry G. J.
   Veenstra-Knol, Hermine E.
   Mayr, Johannes A.
   Rotig, Agnes
   Tarnopolsky, Mark
   Prokisch, Holger
   Rodenburg, Richard J.
TI Biallelic variants in <i>WARS2</i> encoding mitochondrial tryptophanyl-tRNA synthase in six individuals with mitochondrial encephalopathy
SO HUMAN MUTATION
LA English
DT Article
DE COX deficiency; lactic acidosis; liver; mitochondrial disorder
ID synthetase; mutations; deficiency; diagnosis
AB Mitochondrial protein synthesis involves an intricate interplay between mitochondrial DNA encoded RNAs and nuclear DNA encoded proteins, such as ribosomal proteins and aminoacyl-tRNA synthases. Eukaryotic cells contain 17 mitochondria-specific aminoacyl-tRNA synthases. WARS2 encodes mitochondrial tryptophanyl-tRNA synthase (mtTrpRS), a homodimeric class Ic enzyme (mitochondrial tryptophan-tRNA ligase; EC 6.1.1.2). Here, we report six individuals from five families presenting with either severe neonatal onset lactic acidosis, encephalomyopathy and early death or a later onset, more attenuated course of disease with predominating intellectual disability. Respiratory chain enzymes were usually normal in muscle and fibroblasts, while a severe combined respiratory chain deficiency was found in the liver of a severely affected individual. Exome sequencing revealed rare biallelic variants in WARS2 in all affected individuals. An increase of uncharged mitochondrial tRNA(Trp) and a decrease of mtTrpRS protein content were found in fibroblasts of affected individuals. We hereby define the clinical, neuroradiological, and metabolic phenotype of WARS2 defects. This confidently implicates that mutations in WARS2 cause mitochondrial disease with a broad spectrum of clinical presentation.
C1 [Wortmann, Saskia B.; Feichtinger, Rene G.; Sperl, Wolfgang; Mayr, Johannes A.] Salzburger Landeskliniken SALK, Dept Pediat, Salzburg, Austria.
   [Wortmann, Saskia B.; Feichtinger, Rene G.; Sperl, Wolfgang; Mayr, Johannes A.] PMU, Salzburg, Austria.
   [Wortmann, Saskia B.; Kopajtich, Robert; Prokisch, Holger] Helmholtz Zentrum Munich, Inst Human Genet, Neuherberg, Germany.
   [Wortmann, Saskia B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Timal, Sharita; Wintjes, Liesbeth T.; Muhlmeister, Mareike; Brandt, Ulrich; Smeitink, Jan A.; Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Pediat, Nijmegen, Netherlands.
   [Timal, Sharita; Lefeber, Dirk] Radboud Univ Nijmegen, Med Ctr, Cognit & Behav Translat Metab Lab, Dept Neurol,Donders Ctr Brain, Nijmegen, Netherlands.
   [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands.
   [Onnekink, Carla; Pruijn, Ger] Radboud Inst Molecular Life Sci, Dept Biomol Chem, Nijmegen, Netherlands.
   [Onnekink, Carla; Pruijn, Ger] Radboud Univ Nijmegen, Med Ctr, Inst Mol & Mat, Dept Biomol Chem, Nijmegen, Netherlands.
   [Veltman, Joris A.] Radboud Inst Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands.
   [Veltman, Joris A.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   [Stojanovic, Vesna] Univ Novi Sad, Sch Med, Novi Sad, Serbia.
   [Stojanovic, Vesna] Ins Child & Youth Hlth Care Vojvodina, Intens Care Unit, Novi Sad, Serbia.
   [Freisinger, Peter] Klinikum Steinenberg, Childrens Hosp, Reutlingen, Germany.
   [von Spronsen, Francjan; Derks, Terry G. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Metabol Dis, Groningen, Netherlands.
   [Veenstra-Knol, Hermine E.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.
   [Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, INSERM,U1163, Paris, France.
   [Tarnopolsky, Mark] McMaster Univ, Med Ctr, Div Neuromuscular & Neurometab Dis, Dept Pediat, Hamilton, ON, Canada.
C3 Paracelsus Private Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Newcastle University - UK; University of Novi Sad; University of Groningen; University of Groningen; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); McMaster University
RP Wortmann, SB (corresponding author), Salzburger Landeskliniken SALK, Dept Pediat, Salzburg, Austria.; Wortmann, SB (corresponding author), PMU, Salzburg, Austria.; Rodenburg, RJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Pediat, Nijmegen, Netherlands.
EM s.wortmann-hagemann@salk.at; Richard.Rodenburg@radboudumc.nl
FU E-Rare Project GENOMIT [01GM1603, 01GM1207]; Austrian Science Funds [FWF] [I2741-B26]; ECFP7-PEOPLE-ITN Projects [317433]; Verein zur Forderung und Forschung der Padiatrie Salzburg; Radboudumc; Austrian Science Fund (FWF) [I2741] Funding Source: Austrian Science Fund (FWF)
CR Almalki A, 2014, BBA-MOL BASIS DIS, V1842, P56, DOI 10.1016/j.bbadis.2013.10.008
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621
   FEICHTINGER RG, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/1320241
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Jia J, 2002, BIOCHEM J, V365, P749, DOI 10.1042/BJ20020141
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kremer LS, 2016, AM J HUM GENET, V98, P358, DOI 10.1016/j.ajhg.2015.12.009
   Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Musante L, 2017, HUM MUTAT, V38, P621, DOI 10.1002/humu.23205
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Nishri D, 2016, EUR J PAEDIATR NEURO, V20, P412, DOI 10.1016/j.ejpn.2016.02.012
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schägger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Simon M, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005097
   Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339
   Vanlander AV, 2015, HUM MUTAT, V36, P222, DOI 10.1002/humu.22728
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 26
TC 22
Z9 23
U1 0
U2 4
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD DEC 15
PY 2017
VL 38
IS 12
BP 1786
EP 1795
DI 10.1002/humu.23340
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA FL4ZW
UT WOS:000414241200015
PM 28905505
DA 2024-11-01
ER

PT J
AU Morrow, RM
   Picard, M
   Derbeneva, O
   Leipzig, J
   McManus, MJ
   Gouspillou, G
   Barbat-Artigas, S
   Dos Santos, C
   Hepple, RT
   Murdock, DG
   Wallace, DC
AF Morrow, Ryan M.
   Picard, Martin
   Derbeneva, Olga
   Leipzig, Jeremy
   McManus, Meagan J.
   Gouspillou, Gilles
   Barbat-Artigas, Sebastien
   Dos Santos, Carlos
   Hepple, Russell T.
   Murdock, Deborah G.
   Wallace, Douglas C.
TI Mitochondrial energy deficiency leads to hyperproliferation of skeletal muscle mitochondria and enhanced insulin sensitivity
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mitochondria; skeletal muscle; ANT1; insulin sensitivity
ID differentiation factor 15; uncoupling protein-1; oxidative-metabolism; lipid-metabolism; expression; dna; resistance; biomarker; myopathy; mutation
AB Diabetes is associated with impaired glucose metabolism in the presence of excess insulin. Glucose and fatty acids provide reducing equivalents to mitochondria to generate energy, and studies have reported mitochondrial dysfunction in type II diabetes patients. If mitochondrial dysfunction can cause diabetes, then we hypothesized that increased mitochondrial metabolism should render animals resistant to diabetes. This was confirmed in mice in which the heart-muscle-brain adenine nucleotide translocator isoform 1 (ANT1) was inactivated. ANT1-deficient animals are insulin-hypersensitive, glucose-tolerant, and resistant to high fat diet (HFD)-induced toxicity. In ANT1-deficient skeletal muscle, mitochondrial gene expression is induced in association with the hyperproliferation of mitochondria. The ANT1-deficient muscle mitochondria produce excess reactive oxygen species (ROS) and are partially uncoupled. Hence, the muscle respiration under nonphosphorylating conditions is increased. Muscle transcriptome analysis revealed the induction of mitochondrial biogenesis, down-regulation of diabetes-related genes, and increased expression of the genes encoding the myokines FGF21 and GDF15. However, FGF21 was not elevated in serum, and FGF21 and UCP1 mRNAs were not induced in liver or brown adipose tissue (BAT). Hence, increased oxidation of dietary-reducing equivalents by elevated muscle mitochondrial respiration appears to be the mechanism by which ANT1-deficient mice prevent diabetes, demonstrating that the rate of mitochondrial oxidation of calories is important in the etiology of metabolic disease.
C1 [Morrow, Ryan M.; Picard, Martin; Derbeneva, Olga; McManus, Meagan J.; Dos Santos, Carlos; Murdock, Deborah G.; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Morrow, Ryan M.; Picard, Martin; Derbeneva, Olga; McManus, Meagan J.; Dos Santos, Carlos; Murdock, Deborah G.; Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Leipzig, Jeremy] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.
   [Gouspillou, Gilles] Univ Qubec Montreal, Fac Sci, Dept Sci & Act Phys, Montreal, PQ H2L 2C4, Canada.
   [Barbat-Artigas, Sebastien] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ H3T 1J4, Canada.
   [Hepple, Russell T.] McGill Univ, McGill Univ Hlth Ctr, Dept Kinesiol, Montreal, PQ H3A 0G4, Canada.
   [Picard, Martin] Columbia Univ, Coll Phys & Surg, Med Ctr,Div Behav Med, Columbia Translat Neurosci Initiat,Dept Neurol,De, Columbia, NY 10032 USA.
   [Derbeneva, Olga] DxTer Diagnost, Res & Operat, Rancho Dominguez, CA 90220 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Universite de Montreal; McGill University; Columbia University
RP Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM wallaced1@email.chop.edu
FU NIH Grants [NS021328, CA182384, OD01944, DK73691]; University of Pennsylvania Diabetes Research Center Mouse Phenotyping, Physiology, and Metabolism Core Grant [P30DK19525]
CR Anders S, 2010, GENOME BIOL, V11, P0, DOI 10.1186/gb-2010-11-10-r106
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Gouspillou G, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103044
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Keipert S, 2011, AGING CELL, V10, P122, DOI 10.1111/j.1474-9726.2010.00648.x
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288
   Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007
   Nies VJM, 2016, FRONT ENDOCRINOL, V6, P0, DOI 10.3389/fendo.2015.00193
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMOA031314
   Picard M, 2008, AM J PHYSIOL-REG I, V295, PR659, DOI 10.1152/ajpregu.90357.2008
   Picard M, 2015, PSYCHONEUROENDOCRINO, V61, P74, DOI 10.1016/j.psyneuen.2015.07.595
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com
   Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006
   Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004
   Shin MY, 2016, J KOREAN MED SCI, V31, P1413, DOI 10.3346/jkms.2016.31.9.1413
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 39
TC 65
Z9 68
U1 0
U2 25
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 7
PY 2017
VL 114
IS 10
BP 2705
EP 2710
DI 10.1073/pnas.1700997114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM7SA
UT WOS:000395511400086
PM 28223503
DA 2024-11-01
ER

PT J
AU DeBalsi, KL
   Hoff, KE
   Copeland, WC
AF DeBalsi, Karen L.
   Hoff, Kirsten E.
   Copeland, William C.
TI Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE Mitochondrial DNA mutations; MtDNA replication; DNA polymerase gamma; POLG; Aging; Age-related diseases
ID progressive external ophthalmoplegia; transcription-factor-a; structure-function defects; somatic mtdna mutations; human skeletal-muscle; hydrogen-peroxide release; polymerase-gamma; autosomal-dominant; caloric restriction; point mutations
AB As regulators of bioenergetics in the cell and the primary source of endogenous reactive oxygen species (ROS), dysfunctional mitochondria have been implicated for decades in the process of aging and age related diseases. Mitochondria( DNA (mtDNA) is replicated and repaired by nuclear-encoded mtDNA polymerase gamma (Pol gamma) and several other associated proteins, which compose the mtDNA replication machinery. Here, we review evidence that errors caused by this replication machinery and failure to repair these mtDNA errors results in mtDNA mutations. Clonal expansion of mtDNA mutations results in mitochondrial dysfunction, such as decreased electron transport chain (ETC) enzyme activity and impaired cellular respiration. We address the literature that mitochondrial dysfunction, in conjunction with altered mitochondrial dynamics, is a major driving force behind aging and age-related diseases. Additionally, interventions to improve mitochondrial function and attenuate the symptoms of aging are examined. Published by Elsevier B.V.
C1 [DeBalsi, Karen L.; Hoff, Kirsten E.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES 065078]
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/917085
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, PE672, DOI 10.1152/ajpendo.90839.2008
   Bereiter-Hahn J, 2014, PROG MOL BIOL TRANSL, V127, P93, DOI 10.1016/B978-0-12-394625-6.00004-0
   Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934
   Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chauhan A, 2014, BIOGERONTOLOGY, V15, P1, DOI 10.1007/s10522-013-9474-z
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Colman RJ, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4557
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337
   DUVOISIN RC, 1992, ANN NY ACAD SCI, V648, P187, DOI 10.1111/j.1749-6632.1992.tb24537.x
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Filippov V, 2001, MOL GENET GENOMICS, V265, P771, DOI 10.1007/s004380100483
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002
   Gaziev AI, 2014, BIOGERONTOLOGY, V15, P417, DOI 10.1007/s10522-014-9515-2
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Halsne R, 2012, DNA REPAIR, V11, P278, DOI 10.1016/j.dnarep.2011.12.001
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Ikeda M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0119687
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Ingram DK, 2015, AGEING RES REV, V20, P46, DOI 10.1016/j.arr.2014.11.005
   Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Iyer S, 2009, MITOCHONDRION, V9, P196, DOI 10.1016/j.mito.2009.01.012
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kim YA, 2013, J PHYSIOL BIOCHEM, V69, P697, DOI 10.1007/s13105-013-0246-7
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x
   Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004
   Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Luo L, 2013, EXP GERONTOL, V48, P427, DOI 10.1016/j.exger.2013.02.009
   Luo Y, 2015, INT J MOL SCI, V16, P20704, DOI 10.3390/ijms160920704
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866
   Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143
   Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z
   Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002
   Pagano AF, 2014, MED SCI SPORT EXER, V46, P1314, DOI 10.1249/MSS.0000000000000237
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Reijns MAM, 2012, CELL, V149, P0, DOI 10.1016/j.cell.2012.04.011
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008
   Safdar A, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0075-9
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Saleem A, 2014, AM J PHYSIOL-CELL PH, V306, PC241, DOI 10.1152/ajpcell.00270.2013
   Sanchez-Martinez A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043954
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Schriner SE, 2006, AGE, V28, P209, DOI 10.1007/s11357-006-9010-z
   Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, PE92, DOI 10.1152/ajpendo.00366.2003
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393
   Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, PC1561, DOI 10.1152/ajpcell.00076.2008
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061540
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Testa G, 2014, CURR PHARM DESIGN, V20, P2950, DOI 10.2174/13816128113196660699
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wenz Tina, 2011, J AGING RES, V2011, P810619, DOI 10.4061/2011/810619
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu HJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071006
   Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834
   Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, PH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 271
TC 122
Z9 141
U1 2
U2 61
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD JAN 15
PY 2017
VL 33
IS 
BP 89
EP 104
DI 10.1016/j.arr.2016.04.006
PG 16
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA EJ9DX
UT WOS:000393527900009
PM 27143693
DA 2024-11-01
ER

PT J
AU Langdahl, JH
   Frederiksen, AL
   Hansen, SJ
   Andersen, PH
   Yderstræde, KB
   Duno, M
   Vissing, J
   Frost, M
AF Langdahl, Jakob Hogild
   Frederiksen, Anja Lisbeth
   Hansen, Stinus Jorn
   Andersen, Per Heden
   Yderstraede, Knud Bonnet
   Duno, Morten
   Vissing, John
   Frost, Morten
TI Mitochondrial Point Mutation m.3243A&gt;G Associates With Lower Bone Mineral Density, Thinner Cortices, and Reduced Bone Strength: A Case-Control Study
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE M.3243A > G; MITOCHONDRIAL; BONE TURNOVER MARKERS; DIABETES; HRPQCT
ID oxidative stress; diabetes-mellitus; a3243g mutation; body-weight; dna; women; microarchitecture; men; dysfunction; prevalence
AB Mitochondrial dysfunction is associated with several clinical manifestations including diabetes mellitus (DM), neurological disorders, renal and hepatic diseases, and myopathy. Although mitochondrial dysfunction is associated with increased bone resorption and decreased bone formation in mouse models, effects of alterations in mitochondrial function on bone remodeling and mass have not been investigated in humans. We recruited 45 carriers (29 females, 16 males) with the m.3243A>G mutation and healthy controls matched for gender, age, height, and menopausal status. DXA and HRpQCT scans were performed, and bone turnover markers (BTMs) P1NP and CTX were measured. Cases and controls were well matched except for body weight, which was lower in cases (63.6 +/- 18.1kg versus 74.6 +/- 14.8kg, p<0.01), and manifest DM was present in 25 of 45 cases (none in controls). Bone scans showed lower BMD at the lumbar spine, total hip, and femoral neck in cases. Mean lumbar spine, total hip, and femoral neck T-scores were -1.5, -1.3, and -1.6 in cases, respectively, and -0.8, -0.3, and -0.7 in controls (all p<0.05). The m.3243A>G mutation was associated with lower BMD, cortical but not trabecular density, cortical thickness, and estimated bone strength. Furthermore, BTMs were lower in the m.3243A>G group before but not after adjustment for DM. The mitochondrial point mutation m.3243A>G was associated with decreased bone mass and strength. Although the coexistence of DM may have influenced bone turnover, the bone phenotype observed in m.3243A>G cases appeared to mirror age-related deterioration in bone, suggesting that mitochondrial dysfunction may cause a premature aging of bone. (C) 2017 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
C1 [Langdahl, Jakob Hogild; Frederiksen, Anja Lisbeth] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark.
   [Langdahl, Jakob Hogild; Frederiksen, Anja Lisbeth; Hansen, Stinus Jorn] Univ Southern Denmark, Inst Clin Res, Odense, Denmark.
   [Langdahl, Jakob Hogild; Andersen, Per Heden] Hosp Southwest Jutland, Dept Endocrinol, Esbjerg, Denmark.
   [Hansen, Stinus Jorn; Yderstraede, Knud Bonnet; Frost, Morten] Odense Univ Hosp, Dept Endocrinol, Sdr Blvd 29, DK-5000 Odense C, Denmark.
   [Duno, Morten] Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
   [Vissing, John] Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
C3 University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Rigshospitalet; Rigshospitalet; University of Copenhagen
RP Frost, M (corresponding author), Odense Univ Hosp, Dept Endocrinol, Sdr Blvd 29, DK-5000 Odense C, Denmark.
EM frostnielsen@yahoo.com
FU Region of Southern Denmark; A.P. Moeller and Chastine Mc-Kinney Moeller Foundation; Karola Joergensen Research Foundation; Danish Council for Independent Research
CR Abate EG, 2017, FRONT ENDOCRINOL, V7, P0, DOI 10.3389/fendo.2016.00172
   Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0
   Apabhai S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022294
   Bartell SM, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4773
   Bhattacharyya A, 1998, QJM-MON J ASSOC PHYS, V91, P375
   Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4
   Cervellati C, 2013, CLIN CHEM LAB MED, V51, P333, DOI 10.1515/cclm-2012-0095
   DAWSONHUGHES B, 1987, CALCIFIED TISSUE INT, V40, P310, DOI 10.1007/BF02556691
   Evans AL, 2015, J BONE MINER RES, V30, P920, DOI 10.1002/jbmr.2407
   FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hansen S, 2014, CALCIFIED TISSUE INT, V94, P269, DOI 10.1007/s00223-013-9808-5
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hoxha Rexhep, 2014, MATER SOCIOMED, V26, P306, DOI 10.5455/msm.2014.26.306-308
   Kobayashi K, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09148
   Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024
   McKay H, 2011, ACTA PAEDIATR, V100, P97, DOI 10.1111/j.1651-2227.2010.01995.x
   Miyazaki T, 2012, J BIOL CHEM, V287, P0, DOI 10.1074/jbc.M112.385369
   Napoli N, 2017, NAT REV ENDOCRINOL, V13, P208, DOI 10.1038/nrendo.2016.153
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Rumney RMH, 2012, J BIOMECH, V45, P549, DOI 10.1016/j.jbiomech.2011.11.036
   Rumney Robin M H, 2012, FRONT ENDOCRINOL (LAUSANNE), V3, P116, DOI 10.3389/fendo.2012.00116
   Saraví FD, 2013, J OSTEOPOROS, V2013, P0, DOI 10.1155/2013/953271
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Shanbhogue VV, 2016, J BONE MINER RES, V31, P1541, DOI 10.1002/jbmr.2817
   Shanbhogue VV, 2016, LANCET DIABETES ENDO, V4, P159, DOI 10.1016/S2213-8587(15)00283-1
   Shanbhogue VV, 2015, J BONE MINER RES, V30, P2188, DOI 10.1002/jbmr.2573
   Shigemoto M, 1998, INTERNAL MED, V37, P265, DOI 10.2169/internalmedicine.37.265
   Sornay-Rendu E, 2013, J BONE MINER RES, V28, P1679, DOI 10.1002/jbmr.1880
   Tanaka K, 2000, INTERNAL MED, V39, P249, DOI 10.2169/internalmedicine.39.249
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van den Berg LEM, 2010, BONE, V47, P643, DOI 10.1016/j.bone.2010.06.021
   Varanasi SS, 1999, OSTEOPOROSIS INT, V10, P143, DOI 10.1007/s001980050209
   Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4
NR 41
TC 12
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD OCT 15
PY 2017
VL 32
IS 10
BP 2041
EP 2048
DI 10.1002/jbmr.3193
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FJ7HH
UT WOS:000412927400009
PM 28603900
DA 2024-11-01
ER

PT J
AU Lopez-Gomez, C
   Levy, RJ
   Sanchez-Quintero, MJ
   Juanola-Falgarona, M
   Barca, E
   Garcia-Diaz, B
   Tadesse, S
   Garone, C
   Hirano, M
AF Lopez-Gomez, Carlos
   Levy, Rebecca J.
   Sanchez-Quintero, Maria J.
   Juanola-Falgarona, Marti
   Barca, Emanuele
   Garcia-Diaz, Beatriz
   Tadesse, Saba
   Garone, Caterina
   Hirano, Michio
TI Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID mitochondrial-dna depletion; deoxynucleotide pools; myopathy; mutations; therapy; disease; mice
AB Objective: Thymidine kinase 2 (TK2), a critical enzyme in the mitochondrial pyrimidine salvage pathway, is essential for mitochondrial DNA (mtDNA) maintenance. Mutations in the nuclear gene, TK2, cause TK2 deficiency, which manifests predominantly in children as myopathy with mtDNA depletion. Molecular bypass therapy with the TK2 products, deoxycytidine monophosphate (dCMP) and deoxythymidine monophosphate (dTMP), prolongs the life span of Tk2-deficient (Tk2(-/-)) mice by 2- to 3-fold. Because we observed rapid catabolism of the deoxynucleoside monophosphates to deoxythymidine (dT) and deoxycytidine (dC), we hypothesized that: (1) deoxynucleosides might be the major active agents and (2) inhibition of deoxycytidine deamination might enhance dTMP+dCMP therapy. Methods: To test these hypotheses, we assessed two therapies in Tk2(-/-) mice: (1) dT+dC and (2) coadministration of the deaminase inhibitor, tetrahydrouridine (THU), with dTMP+dCMP. Results: We observed that dC+dT delayed disease onset, prolonged life span of Tk2-deficient mice and restored mtDNA copy number as well as respiratory chain enzyme activities and levels. In contrast, dCMP+dTMP+THU therapy decreased life span of Tk2(-/-) animals compared to dCMP+dTMP. Interpretation: Our studies demonstrate that deoxynucleoside substrate enhancement is a novel therapy, which may ameliorate TK2 deficiency in patients.
C1 [Lopez-Gomez, Carlos; Levy, Rebecca J.; Sanchez-Quintero, Maria J.; Juanola-Falgarona, Marti; Barca, Emanuele; Garcia-Diaz, Beatriz; Tadesse, Saba; Garone, Caterina; Hirano, Michio] Columbia Univ, Med Ctr, H Houston Merritt Neuromuscular Res Ctr, Dept Neurol, New York, NY USA.
   [Barca, Emanuele] Univ Messina, Dept Clin & Expt Med, Messina, Italy.
   [Garcia-Diaz, Beatriz] Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Neurociencias, Malaga, Spain.
   [Garone, Caterina] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 Columbia University; University of Messina; Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); University of Cambridge
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NIH [P01 HD32062]; Muscular Dystrophy Association; Associazione Malattie Metaboliche Congenite ereditarie (AMMeC); Arturo Estopinan TK2 Research Fund; Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF) from the J. Willard and Alice S. Marriott Foundation; NIH (from NICHD) [R01 HD057543, R01 HD056103]; Office of Dietary Supplements; NINDS [U54 NS078059]; NICHD
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   COWAN MJ, 1985, CLIN IMMUNOL IMMUNOP, V37, P30, DOI 10.1016/0090-1229(85)90132-1
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1141
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Holleran JL, 2015, CANCER CHEMOTH PHARM, V76, P803, DOI 10.1007/s00280-015-2857-x
   Kamath VG, 2015, J BIOL CHEM, V290, P2034, DOI 10.1074/jbc.M114.624213
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   Martí R, 2012, METHODS MOL BIOL, V837, P121, DOI 10.1007/978-1-61779-504-6_8
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sun R, 2014, BIOCHEMISTRY-US, V53, P6142, DOI 10.1021/bi5006877
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P370, DOI 10.1080/15257771003729732
   Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007
   Zeviani M, 2016, MEDLINK NEUROLOGY, V0, P0
NR 26
TC 71
Z9 76
U1 2
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD MAY 15
PY 2017
VL 81
IS 5
BP 641
EP 652
DI 10.1002/ana.24922
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EV6PM
UT WOS:000401891300006
PM 28318037
DA 2024-11-01
ER

PT J
AU Phowthongkum, P
   Sun, A
AF Phowthongkum, P.
   Sun, A.
TI Novel truncating variant in <i>DNA2</i>-related congenital onset myopathy and ptosis suggests genotype phenotype correlation
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE DNA2; Myopathy; Mitochondrial disease; Genotype-phenotype correlation
ID mitochondrial-dna instability; disease; genes
AB DNA2 encodes a protein with nuclease, ATPase, and helicase domains, and serves to maintain mitochondrial DNA integrity. Mutations in DNA2 cause autosomal dominant progressive ophthalmoplegia with mitochondrial DNA deletions. This disorder was first reported in four patients with heterozygous, missense mutations in DNA2. Clinical symptoms include limb-girdle and lower extremity weakness, myalgia, and ophthalmbplegia. All had a slowly progressive disease course and did not present for clinical evaluation until the fifth or sixth decade. We report a case of congenital-onset myopathy and ptosis in a child who was found to have a novel DNA2 variant resulting in a premature termination codon (p.Asn568Ilefs*4). Only one other case of a truncating mutation in DNA2 has been reported, and that patient also had early-onset, severe disease. We hypothesize that haploinsufficiency for the DNA2 protein due to truncating mutations results in mitochondrial genome instability and clinical symptoms of early-onset myopathy. Missense mutations that allow for residual protein function lead to a milder clinical phenotype. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Phowthongkum, P.; Sun, A.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98105 USA.
   [Phowthongkum, P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle
RP Sun, A (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98105 USA.
EM Angela.Sun@seattlechildrens.org
FU King Anandamahidol Foundation; American College of Medical Genetics Foundation/Horizon Pharma fellowship
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 7
TC 9
Z9 9
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL 15
PY 2017
VL 27
IS 7
BP 616
EP 618
DI 10.1016/j.nmd.2017.03.013
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EZ1SL
UT WOS:000404491000002
PM 28554558
DA 2024-11-01
ER

PT J
AU Kasahara, T
   Ishiwata, M
   Kakiuchi, C
   Fuke, S
   Iwata, N
   Ozaki, N
   Kunugi, H
   Minabe, Y
   Nakamura, K
   Iwata, Y
   Fujii, K
   Kanba, S
   Ujike, H
   Kusumi, I
   Kataoka, M
   Matoba, N
   Takata, A
   Iwamoto, K
   Yoshikawa, T
   Kato, T
AF Kasahara, Takaoki
   Ishiwata, Mizuho
   Kakiuchi, Chihiro
   Fuke, Satoshi
   Iwata, Nakao
   Ozaki, Norio
   Kunugi, Hiroshi
   Minabe, Yoshio
   Nakamura, Kazuhiko
   Iwata, Yasuhide
   Fujii, Kumiko
   Kanba, Shigenobu
   Ujike, Hiroshi
   Kusumi, Ichiro
   Kataoka, Muneko
   Matoba, Nana
   Takata, Atsushi
   Iwamoto, Kazuya
   Yoshikawa, Takeo
   Kato, Tadafumi
TI Enrichment of deleterious variants of mitochondrial DNA polymerase gene (<i>POLG1</i>) in bipolar disorder
SO PSYCHIATRY AND CLINICAL NEUROSCIENCES
LA English
DT Article
DE bipolar disorder; mitochondrial dysfunction; POLG; POLG1; rare variants
ID progressive external ophthalmoplegia; mutations; gamma; consequences; dysfunction; efficiency; nucleus; impact
AB Aim: Rare missense variants, which likely account for a substantial portion of the genetic 'dark matter' for a common complex disease, are challenging because the impacts of variants on disease development are difficult to substantiate. This study aimed to examine the impacts of amino acid substitution variants in the POLG1 found in bipolar disorder, as an example and proof of concept, in three different modalities of assessment: in silico predictions, in vitro biochemical assays, and clinical evaluation. We then tested whether deleterious variants in POLG1 contributed to the genetics of bipolar disorder. Methods: We searched for variants in the POLG1 gene in 796 Japanese patients with bipolar disorder and 767 controls and comprehensively investigated all 23 identified variants in the three modalities of assessment. POLG1 encodes mitochondrial DNA polymerase and is one of the causative genes for a Mendelian-inheritance mitochondrial disease, which is occasionally accompanied by mood disorders. The healthy control data from the Tohoku Medical Megabank Organization were also employed. Results: Although the frequency of carriers of deleterious variants varied from one method to another, every assessment achieved the same conclusion that deleterious POLG1 variants were significantly enriched in the variants identified in patients with bipolar disorder compared to those in controls. Conclusion: Together with mitochondrial dysfunction in bipolar disorder, the present results suggested deleterious POLG1 variants as a credible risk for the multifactorial disease.
C1 [Kasahara, Takaoki; Ishiwata, Mizuho; Kakiuchi, Chihiro; Fuke, Satoshi; Fujii, Kumiko; Kataoka, Muneko; Matoba, Nana; Takata, Atsushi; Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
   [Iwata, Nakao] Fujita Hlth Univ, Dept Psychiat, Fac Med, Toyoake, Aichi, Japan.
   [Ozaki, Norio] Nagoya Univ, Dept Psychiat, Fac Med, Nagoya, Aichi, Japan.
   [Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo, Japan.
   [Minabe, Yoshio; Nakamura, Kazuhiko; Iwata, Yasuhide] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka, Japan.
   [Fujii, Kumiko] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan.
   [Kanba, Shigenobu] Kyushu Univ, Sch Med, Dept Psychiat, Fukuoka, Japan.
   [Ujike, Hiroshi] Okayama Univ, Sch Med, Dept Psychiat, Okayama, Japan.
   [Kusumi, Ichiro] Hokkaido Univ, Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.
   [Iwamoto, Kazuya] Kumamoto Univ, Grad Sch Med, Dept Mol Brain Sci, Kumamoto, Japan.
   [Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan.
   [Kakiuchi, Chihiro] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.
   [Fuke, Satoshi] Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga, Japan.
   [Minabe, Yoshio] Kanazawa Univ, Fac Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan.
   [Nakamura, Kazuhiko] Hirosaki Univ, Sch Med, Dept Psychiat, Hirosaki, Aomori, Japan.
   [Ujike, Hiroshi] Ujike Nishiguchi Clin, Okayama, Japan.
   [Kataoka, Muneko] Med Ctr Narita Hosp, Narita, Japan.
   [Matoba, Nana] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan.
   [Takata, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Genet, Yokohama, Kanagawa, Japan.
C3 RIKEN; Fujita Health University; Nagoya University; National Center for Neurology & Psychiatry - Japan; Hamamatsu University School of Medicine; Dokkyo Medical University; Kyushu University; Okayama University; Hokkaido University; Kumamoto University; RIKEN; University of Tokyo; Shiga University of Medical Science; Kanazawa University; Hirosaki University; RIKEN; Yokohama City University
RP Kato, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
FU Japan Agency for Medical Research and Development; Japanese Ministry of Education, Culture, Sports, Science and Technology; Independent Investigator Award from NARSAD; Grants-in-Aid for Scientific Research [15K21081, 24116005, 24116009, 15H04891, 17K09754] Funding Source: KAKEN
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Ament SA, 2015, P NATL ACAD SCI USA, V112, P3576, DOI 10.1073/pnas.1424958112
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bubser M, 1999, SYNAPSE, V32, P13, DOI 10.1002/(SICI)1098-2396(199904)32:1<13::AID-SYN2>3.0.CO;2-R
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157
   Choi YH, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0039927
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   González-Pérez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hou LP, 2016, HUM MOL GENET, V25, P3383, DOI 10.1093/hmg/ddw181
   Hsu DT, 2009, J COMP NEUROL, V512, P825, DOI 10.1002/cne.21934
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Kataoka M, 2016, MOL PSYCHIATR, V21, P885, DOI 10.1038/mp.2016.69
   Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001
   Kato T, 2015, PSYCHIAT CLIN NEUROS, V69, P65, DOI 10.1111/pcn.12247
   Kawakami N, 2014, LARGE SCALE EPIDEMIOLOGY STUDY OF THE PREVALENCE OF MENTAL DISORDERS: WORLD MENTAL HEALTH JAPAN SURVEY SECOND. A REPORT OF THE HEALTH LABOUR SCIENCES RESEARCH GRANT FROM THE MINISTRY OF HEALTH LABOUR AND WELFARE (H25-SEISHIN-IPPAN-006), V0, P0
   Kerner B, 2015, FRONT PSYCHIATRY, V6, P0, DOI 10.3389/fpsyt.2015.00105
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kurihara T, 2006, INTERNAL MED, V45, P415, DOI 10.2169/internalmedicine.45.0148
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2009, LAB INVEST, V87, P326
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12
   Mi HY, 2016, NUCLEIC ACIDS RES, V44, PD336, DOI 10.1093/nar/gkv1194
   Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x
   Nagasaki M, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9018
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978
   Peterson TA, 2013, J MOL BIOL, V425, P4047, DOI 10.1016/j.jmb.2013.08.008
   Reva B, 2011, NUCLEIC ACIDS RES, V39, PE118, DOI 10.1093/nar/gkr407
   Salazar-Juárez A, 2002, AM J PHYSIOL-REG I, V283, PR897, DOI 10.1152/ajpregu.00259.2002
   Scaini G, 2016, NEUROSCI BIOBEHAV R, V68, P694, DOI 10.1016/j.neubiorev.2016.06.040
   Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 44
TC 22
Z9 22
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1323-1316
EI 1440-1819
J9 PSYCHIAT CLIN NEUROS
JI Psychiatry Clin. Neurosci.
PD AUG 15
PY 2017
VL 71
IS 8
BP 518
EP 529
DI 10.1111/pcn.12496
PG 12
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FD0ZT
UT WOS:000407267900003
PM 27987238
DA 2024-11-01
ER

PT J
AU Gueguen, A
   Jardel, C
   Polivka, M
   Tan, SV
   Gray, F
   Vignal, C
   Lombè, A
   Gout, O
   Bostock, H
AF Gueguen, Antoine
   Jardel, Claude
   Polivka, Marc
   Tan, S. Veronica
   Gray, Francoise
   Vignal, Catherine
   Lombes, Anne
   Gout, Olivier
   Bostock, Hugh
TI Nerve excitability changes related to muscle weakness in chronic progressive external ophthalmoplegia
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Article
DE CPEO; Mitochondrial disease; Nerve excitability; Myelin sheath; Barrett-Barrett conductance
ID kearns-sayre-syndrome; mitochondrial-dna deletions; channel dysfunction; myelinated axons; motor axons; neuropathy; mutations; disorder; myopathy; mtdna
AB Objective: To explore potential spreading to peripheral nerves of the mitochondrial dysfunction in chronic progressive external ophthalmoplegia (CPEO) by assessing axonal excitability. Methods: CPEO patients (n = 13) with large size deletion of mitochondrial DNA and matching healthy controls (n = 22) were included in a case-control study. Muscle strength was quantified using MRC sum-score and used to define two groups of patients: CPEO-weak and CPEO-normal (normal strength). Nerve excitability properties of median motor axons were assessed with the TROND protocol and changes interpreted with the aid of a model. Results: Alterations of nerve excitability strongly correlated with scores of muscle strength. CPEO-weak displayed abnormal nerve excitability compared to CPEO-normal and healthy controls, with increased superexcitability and responses to hyperpolarizing current. Modeling indicated that the CPEO-weak recordings were best explained by an increase in the 'Barrett-Barrett' conductance across the myelin sheath. Conclusion: CPEO patients with skeletal weakness presented sub-clinical nerve excitability changes, which were not consistent with axonal membrane depolarization, but suggested Schwann cell involvement. Significance: This study provides new insights into the spreading of large size deletion of mitochondrial DNA to Schwann cells in CPEO patients. (C) 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Gueguen, Antoine; Gout, Olivier] Fdn Ophtalmol A de Rothschild, Dept Neurol, Paris, France.
   [Jardel, Claude; Lombes, Anne] Hop La Pitie Salpetriere, AP HP, Dept Metab Biochem, F-75651 Paris, France.
   [Polivka, Marc; Gray, Francoise] Hop Lariboisiere, AP HP, Dept Anat Pathol, Paris, France.
   [Tan, S. Veronica; Bostock, Hugh] UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.
   [Vignal, Catherine] Fdn Ophtalmol A de Rothschild, Dept Neuroophthalmol, Paris, France.
   [Jardel, Claude; Lombes, Anne] Inst Cochin, INSERM, U1016, F-75014 Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; University of London; University College London; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Bostock, H (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM h.bostock@ucl.ac.uk
CR BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Farrar MA, 2010, PEDIATRICS, V126, PE734, DOI 10.1542/peds.2009-2930
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573
   Jen J, 2001, NEUROLOGY, V57, P1843, DOI 10.1212/WNL.57.10.1843
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542
   Kiernan MC, 2012, AMINOFFS ELECTRODIAG, V0, P0
   KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111
   LIN CSY, 2006, HDB CLIN NEUROPHYSIO, V7, P381
   Merkies ISJ, 2003, MUSCLE NERVE, V28, P93, DOI 10.1002/mus.10410
   Ng K, 2010, J NEUROL NEUROSUR PS, V81, P844, DOI 10.1136/jnnp.2009.178921
   PEYRONNARD JM, 1980, ANN NEUROL, V7, P262, DOI 10.1002/ana.410070310
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   SHY GM, 1967, AM J MED, V42, P163, DOI 10.1016/0002-9343(67)90015-0
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tomlinson SE, 2016, BRAIN, V139, P380, DOI 10.1093/brain/awv380
   Tomlinson SE, 2010, BRAIN, V133, P3530, DOI 10.1093/brain/awq318
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   YIANNIKAS C, 1986, ANN NEUROL, V20, P249, DOI 10.1002/ana.410200211
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 32
TC 3
Z9 3
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1388-2457
EI 1872-8952
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD JUL 15
PY 2017
VL 128
IS 7
BP 1258
EP 1263
DI 10.1016/j.clinph.2017.04.013
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FB2WL
UT WOS:000406003800017
PM 28535487
DA 2024-11-01
ER

PT J
AU Rodríguez-Aguilera, JC
   Cortés, AB
   Fernández-Ayala, DJM
   Navas, P
AF Carlos Rodriguez-Aguilera, Juan
   Cortes, Ana Belen
   Fernandez-Ayala, Daniel J. M.
   Navas, Placido
TI Biochemical Assessment of Coenzyme Q<sub>10</sub> Deficiency
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE coenzyme Q(10); CoQ(10) deficiency syndrome; CoQ(10) biosynthesis; mitochondria diseases
ID diphosphate synthase subunit-2; q biosynthesis; cerebellar-ataxia; coq(10) deficiency; ubiquinone deficiency; mitochondrial encephalomyopathy; phenotypic variability; respiratory-chain; mutations cause; adck3
AB Coenzyme Q(10) (CoQ(10)) deficiency syndrome includes clinically heterogeneous mitochondrial diseases that show a variety of severe and debilitating symptoms. A multiprotein complex encoded by nuclear genes carries out CoQ(10) biosynthesis. Mutations in any of these genes are responsible for the primary CoQ(10) deficiency, but there are also different conditions that induce secondary CoQ(10) deficiency including mitochondrial DNA (mtDNA) depletion and mutations in genes involved in the fatty acid beta-oxidation pathway. The diagnosis of CoQ(10) deficiencies is determined by the decrease of its content in skeletal muscle and/or dermal skin fibroblasts. Dietary CoQ(10) supplementation is the only available treatment for these deficiencies that require a rapid and distinct diagnosis. Here we review methods for determining CoQ(10) content by HPLC separation and identification using alternative approaches including electrochemical detection and mass spectrometry. Also, we review procedures to determine the CoQ(10) biosynthesis rate using labeled precursors.
C1 [Carlos Rodriguez-Aguilera, Juan; Cortes, Ana Belen] Lab Fisiopatol Celular & Bioenerget, Seville 41013, Spain.
   [Carlos Rodriguez-Aguilera, Juan; Cortes, Ana Belen; Fernandez-Ayala, Daniel J. M.; Navas, Placido] Univ Pablo de Olavide CISC, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain.
   [Fernandez-Ayala, Daniel J. M.; Navas, Placido] Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)
RP Navas, P (corresponding author), Univ Pablo de Olavide CISC, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain.; Navas, P (corresponding author), Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
EM jcrodagu@upo.es; abcorrod@upo.es; dmorfer@upo.es; pnavas@upo.es
FU Instituto de Salud Carlos III [FIS PI14-01962]; Junta de Andalucia [BIO177]
CR Alcázar-Fabra M, 2016, BBA-BIOENERGETICS, V1857, P1073, DOI 10.1016/j.bbabio.2016.03.010
   Arias A, 2012, J CHROMATOGR B, V908, P23, DOI 10.1016/j.jchromb.2012.09.027
   Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000
   Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147
   Bentinger M, 2008, BIOFACTORS, V32, P99, DOI 10.1002/biof.5520320112
   Blumkin L, 2014, JIMD REP, V12, P103, DOI 10.1007/8904_2013_251
   Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023
   Brea-Calvo G, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005301
   Buján N, 2014, J INHERIT METAB DIS, V37, P53, DOI 10.1007/s10545-013-9620-4
   Cascajo MV, 2016, RNA BIOL, V13, P622, DOI 10.1080/15476286.2015.1119366
   Chung WK, 2015, J MED GENET, V52, P627, DOI 10.1136/jmedgenet-2015-103140
   Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9
   Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Fernández-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009
   Fragaki K, 2011, MITOCHONDRION, V11, P533, DOI 10.1016/j.mito.2011.02.002
   Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   González-Mariscal I, 2014, MOL SYNDROMOL, V5, P107, DOI 10.1159/000362897
   González-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haas D, 2009, J INHERIT METAB DIS, V32, P570, DOI 10.1007/s10545-009-1150-8
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hikmat O, 2016, EUR J NEUROL, V23, P1188, DOI 10.1111/ene.13003
   Horvath R, 2012, J NEUROL NEUROSUR PS, V83, P174, DOI 10.1136/jnnp-2011-301258
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lanning NJ, 2014, CELL REP, V7, P907, DOI 10.1016/j.celrep.2014.03.065
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Liu YT, 2014, J NEUROL NEUROSUR PS, V85, P493, DOI 10.1136/jnnp-2013-306483
   Lohman DC, 2014, P NATL ACAD SCI USA, V111, PE4697, DOI 10.1073/pnas.1413128111
   López LC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011897
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   López-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9
   López-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003
   Maes M, 2009, NEUROENDOCRINOL LETT, V30, P470
   Martín-Montalvo A, 2013, J BIOL CHEM, V288, P28126, DOI 10.1074/jbc.M113.474494
   Martín-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422
   Mignot C, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-173
   Miles MV, 2011, MITOCHONDRION, V11, P127, DOI 10.1016/j.mito.2010.08.010
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7
   Parrado-Fernández C, 2011, FREE RADICAL BIO MED, V50, P1728, DOI 10.1016/j.freeradbiomed.2011.03.024
   Pineda M, 2010, MOVEMENT DISORD, V25, P1262, DOI 10.1002/mds.23129
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Saiki R, 2008, AM J PHYSIOL-RENAL, V295, PF1535, DOI 10.1152/ajprenal.90445.2008
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Stefely JA, 2016, MOL CELL, V63, P608, DOI 10.1016/j.molcel.2016.06.030
   Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002
   Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528
   Turunen M, 2000, J MOL BIOL, V297, P607, DOI 10.1006/jmbi.2000.3596
   Yubero D, 2016, MITOCHONDRION, V30, P51, DOI 10.1016/j.mito.2016.06.007
   Yubero D, 2015, BIOFACTORS, V41, P424, DOI 10.1002/biof.1242
   Yubero D, 2015, EXPERT REV MOL DIAGN, V15, P1049, DOI 10.1586/14737159.2015.1062727
   Yubero D, 2014, MOL SYNDROMOL, V5, P147, DOI 10.1159/000362390
NR 62
TC 38
Z9 38
U1 1
U2 13
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
EI 
J9 J CLIN MED
JI J. Clin. Med.
PD MAR 15
PY 2017
VL 6
IS 3
BP 
EP 
DI 10.3390/jcm6030027
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA EP3NI
UT WOS:000397288600005
PM 28273876
DA 2024-11-01
ER

PT J
AU Xu, XL
   Wang, B
   Ren, CH
   Hu, JN
   Greenberg, DA
   Chen, TX
   Xie, LP
   Jin, KL
AF Xu, Xianglai
   Wang, Brian
   Ren, Changhong
   Hu, Jiangnan
   Greenberg, David A.
   Chen, Tianxiang
   Xie, Liping
   Jin, Kunlin
TI Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases
SO AGING AND DISEASE
LA English
DT Review
DE vascular aging; stroke; dementia; arterial stiffness; endothelial dysfunction
ID small vessel disease; cerebral-blood-flow; monocyte chemoattractant protein-1; smooth-muscle-cells; pulse-wave velocity; mitochondrial-dna deletions; testosterone replacement therapy; mild cognitive impairment; renin-angiotensin system; transgenic mouse model
AB As with many age-related diseases including vascular dysfunction, age is considered an independent and crucial risk factor. Complicated alterations of structure and function in the vasculature are linked with aging hence, understanding the underlying mechanisms of age-induced vascular pathophysiological changes holds possibilities for developing clinical diagnostic methods and new therapeutic strategies. Here, we discuss the underlying molecular mediators that could be involved in vascular aging, e.g., the renin-angiotensin system and pro-inflammatory factors, metalloproteinases, calpain-1, monocyte chemoattractant protein-1 (MCP-1) and TGF beta-1 as well as the potential roles of testosterone and estrogen. We then relate all of these to clinical manifestations such as vascular dementia and stroke in addition to reviewing the existing clinical measurements and potential interventions for age-related vascular dysfunction.
C1 [Xu, Xianglai] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China.
   [Xu, Xianglai; Wang, Brian; Ren, Changhong; Hu, Jiangnan; Jin, Kunlin] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.
   [Xie, Liping] Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Hangzhou, Zhejiang, Peoples R China.
   [Ren, Changhong] Capital Med Univ, Xuanwu Hosp, Inst Hypoxia Med, Beijing, Peoples R China.
   [Greenberg, David A.] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Chen, Tianxiang] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China.
C3 Fudan University; University of North Texas System; University of North Texas Denton; Zhejiang University; Capital Medical University; Buck Institute for Research on Aging; Shanghai Jiao Tong University
RP Xu, XL (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China.; Xie, LP (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.; Jin, KL (corresponding author), Univ North Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA.
EM xuxianglai@163.com; xielp@zjuem.zju.edu.cn; Kunlin.Jin@unthsc.edu
FU China Scholarship Council [201406320118]; American Heart Association Predoctoral Fellowship [15PRE25700416]; Sigma Xi [G201503151162287]; National Natural Science Foundation of China [81301996]; Ph. D. Programs Foundation of Ministry of Education of China [20130101120017]; National Institutes of Health grant [NS084148-01A1]; National Science Foundation of Beijing [7161014]; American Heart Association (AHA) [15PRE25700416] Funding Source: American Heart Association (AHA)
CR Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080
   Akinyemi RO, 2013, CURR ALZHEIMER RES, V10, P642
   Akishita M, 2007, HYPERTENS RES, V30, P1029, DOI 10.1291/hypres.30.1029
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aziz M, 2015, INT J MOL MED, V36, P18, DOI 10.3892/ijmm.2015.2196
   Banoei MM, 2007, CELL MOL NEUROBIOL, V27, P867, DOI 10.1007/s10571-007-9206-5
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Basso N, 2007, AM J PHYSIOL-HEART C, V293, PH1351, DOI 10.1152/ajpheart.00393.2007
   Beckman JS, 2001, CIRC RES, V89, P295, DOI 10.1161/res.89.4.295
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhasin S, 2001, J ANDROL, V22, P718
   Blum Arnon, 2012, J VASC INTERV NEUROL, V5, P33
   Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, PH620, DOI 10.1152/ajpheart.00624.2012
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Brisset M, 2013, NEUROLOGY, V80, P662, DOI 10.1212/WNL.0b013e318281ccc2
   Brissette MJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036368
   Bullitt E, 2009, AM J NEURORADIOL, V30, P1857, DOI 10.3174/ajnr.A1695
   Çalik AN, 2014, CLIN INTERV AGING, V9, P0, DOI 10.2147/CIA.S63337
   Calvet D, 2014, INT J STROKE, V9, P291, DOI 10.1111/ijs.12015
   Chang-Quan H, 2011, INT J CLIN PRACT, V65, P1295, DOI 10.1111/j.1742-1241.2011.02810.x
   Chen PL, 2006, NEUROLOGY, V67, P1056, DOI 10.1212/01.wnl.0000237526.32692.67
   Chen XL, 1998, CIRC RES, V83, P952
   Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Deplanque D, 2013, INT J STROKE, V8, P413, DOI 10.1111/j.1747-4949.2011.00755.x
   Ding J, 2015, ARTERIOSCL THROM VAS, V35, P1889, DOI 10.1161/ATVBAHA.115.305451
   Dockery F, 2003, J AM GERIATR SOC, V51, P1627, DOI 10.1046/j.1532-5415.2003.51515.x
   Dupuis F, 2005, BRIT J PHARMACOL, V144, P349, DOI 10.1038/sj.bjp.0706001
   English KM, 2000, CLIN SCI, V99, P77, DOI 10.1042/CS19990345
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   Estato V, 2013, MICROVASC RES, V87, P41, DOI 10.1016/j.mvr.2013.02.007
   Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14
   Fleegal-DeMotta MA, 2009, J CEREBR BLOOD F MET, V29, P640, DOI 10.1038/jcbfm.2008.158
   Fleenor BS, 2010, J PHYSIOL-LONDON, V588, P3971, DOI 10.1113/jphysiol.2010.194753
   Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005
   Fortuño A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098
   Fournier A, 2009, EXPERT REV NEUROTHER, V9, P1413, DOI 10.1586/ern.09.89
   Franklin SS, 1997, CIRCULATION, V96, P308
   Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936
   Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088
   Fuh JL, 2006, MATURITAS, V53, P447, DOI 10.1016/j.maturitas.2005.07.009
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251
   Gasecki D, 2012, STROKE, V43, P543, DOI 10.1161/STROKEAHA.111.633487
   Gleason CE, 2015, PLOS MED, V12, P0, DOI 10.1371/journal.pmed.1001833
   Goglia L, 2010, MOL HUM REPROD, V16, P761, DOI 10.1093/molehr/gaq049
   Greendale GA, 2009, NEUROLOGY, V72, P1850, DOI 10.1212/WNL.0b013e3181a71193
   Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08
   Hajjar I, 2013, CURR OPIN CARDIOL, V28, P417, DOI 10.1097/HCO.0b013e3283620745
   Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c
   Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342
   Hashimoto J, 2008, AM J HYPERTENS, V21, P1304, DOI 10.1038/ajh.2008.291
   Hassan A, 2004, STROKE, V35, P654, DOI 10.1161/01.STR.0000117238.75736.53
   Hassan A, 2003, BRAIN, V126, P424, DOI 10.1093/brain/awg040
   Hatanaka R, 2011, CEREBROVASC DIS, V31, P329, DOI 10.1159/000322599
   Henderson VW, 2007, MENOPAUSE, V14, P572, DOI 10.1097/gme.0b013e31803df49c
   Henderson VW, 2003, NEUROLOGY, V60, P1369, DOI 10.1212/01.WNL.0000059413.75888.BE
   Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200
   Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241
   Huang G, 2016, LANCET DIABETES ENDO, V4, P657, DOI 10.1016/S2213-8587(16)30102-4
   Hughes TM, 2014, JAMA NEUROL, V71, P562, DOI 10.1001/jamaneurol.2014.186
   Hughes TM, 2013, NEUROLOGY, V81, P1711, DOI 10.1212/01.wnl.0000435301.64776.37
   Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008
   Ito T, 2002, STROKE, V33, P2297, DOI 10.1161/01.STR.0000027274.03779.F3
   Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9
   Jamadar RJ, 2012, ASIAN J ANDROL, V14, P232, DOI 10.1038/aja.2011.107
   JAMES MA, 1995, HYPERTENSION, V26, P301, DOI 10.1161/01.HYP.26.2.301
   Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, P0, DOI 10.3389/fnagi.2013.00017
   Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840
   Jochemsen HM, 2015, NEUROLOGY, V84, P448, DOI 10.1212/WNL.0000000000001201
   Jones RD, 2003, BRIT J PHARMACOL, V138, P733, DOI 10.1038/sj.bjp.0705141
   Kalaria RN, 2002, CEREBROVASC DIS, V13, P48, DOI 10.1159/000049150
   Kang SM, 2002, AM J CARDIOL, V89, P862, DOI 10.1016/S0002-9149(02)02202-6
   Kelly DM, 2013, J ENDOCRINOL, V217, PR47, DOI 10.1530/JOE-12-0582
   Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549
   Kim AS, 2013, STROKE, V44, PS123, DOI 10.1161/STROKEAHA.111.000067
   Kim Y, 2013, PHYS CHEM CHEM PHYS, V15, P18353, DOI 10.1039/c3cp52614c
   Knottnerus ILH, 2009, CEREBROVASC DIS, V27, P519, DOI 10.1159/000212672
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Kuo HK, 2010, INT J CARDIOL, V143, P184, DOI 10.1016/j.ijcard.2009.02.005
   Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2
   Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129
   Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   Lee J, 2015, EXP MOL MED, V47, P0, DOI 10.1038/emm.2015.42
   Li BY, 2011, APOPTOSIS, V16, P732, DOI 10.1007/s10495-011-0602-4
   Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116
   Liu H, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2011.05.027
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Luckhaus C, 2008, NEUROIMAGE, V40, P495, DOI 10.1016/j.neuroimage.2007.11.053
   Lv WS, 2016, MOL NEUROBIOL, V53, P2679, DOI 10.1007/s12035-015-9315-y
   Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400
   Mahmud A, 2004, J RENIN-ANGIO-ALDO S, V5, P102, DOI 10.3317/jraas.2004.025
   Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm
   Marijic J, 2001, CIRC RES, V88, P210
   Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684
   Marshall RS, 2012, J ALZHEIMERS DIS, V32, P633, DOI 10.3233/JAD-2012-120949
   Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530/EJE-09-0092
   Matsumoto M, 2007, HYPERTENS RES, V30, P767, DOI 10.1291/hypres.30.767
   Matsuo T, 2005, HEART VESSELS, V20, P8, DOI 10.1007/s00380-004-0793-5
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   McCarrey AC, 2015, HORM BEHAV, V74, P167, DOI 10.1016/j.yhbeh.2015.04.018
   McNulty M, 2005, AM J HYPERTENS, V18, P504, DOI 10.1016/j.amjhyper.2004.11.011
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Mendelsohn ME, 2002, AM J CARDIOL, V89, P0
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004
   Mitchell ES, 2011, CLIMACTERIC, V14, P252, DOI 10.3109/13697137.2010.516848
   Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253
   Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, PH1914, DOI 10.1152/ajpheart.00300.2009
   Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1
   Nakajima T, 1995, EUR J PHARMACOL, V294, P625, DOI 10.1016/0014-2999(95)00602-8
   Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369
   Nation DA, 2015, JAMA NEUROL, V72, P546, DOI 10.1001/jamaneurol.2014.4477
   Nation DA, 2013, NEUROLOGY, V81, P2024, DOI 10.1212/01.wnl.0000436935.47657.78
   Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008
   Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165
   Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299
   Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478
   Niwa K, 2001, AM J PHYSIOL-HEART C, V281, PH2417, DOI 10.1152/ajpheart.2001.281.6.H2417
   Novella S, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00165
   Ochi N, 2010, AM J HYPERTENS, V23, P889, DOI 10.1038/ajh.2010.60
   Ochi N, 2009, HYPERTENS RES, V32, P255, DOI 10.1038/hr.2009.13
   Okamoto Y, 2012, ACTA NEUROPATHOL, V123, P381, DOI 10.1007/s00401-011-0925-9
   Osawa A, 2004, DISABIL REHABIL, V26, P739, DOI 10.1080/09638280410001704331
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940
   Pase MP, 2014, PHYSIOL BEHAV, V130, P23, DOI 10.1016/j.physbeh.2014.03.015
   Perret-Guillaume C, 2009, J HYPERTENS, V27, PS3, DOI 10.1097/01.hjh.0000354511.14086.f1
   Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264
   Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004
   Popp O, 2003, BIOL CHEM, V384, P951, DOI 10.1515/BC.2003.107
   Price JM, 2001, NEUROL RES, V23, P506, DOI 10.1179/016164101101198758
   Qiu CX, 2003, STROKE, V34, P594, DOI 10.1161/01.STR.0000060127.96986.F4
   Rabkin SW, 2011, BLOOD PRESSURE, V20, P274, DOI 10.3109/08037051.2011.566246
   Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623
   Rajagopalan S, 2002, AM J CARDIOL, V89, P562, DOI 10.1016/S0002-9149(01)02297-4
   Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076
   Rajagopalan Sanjay, 2006, J CLIN HYPERTENS (GREENWICH), V8, P783, DOI 10.1111/j.1524-6175.2006.05797.x
   Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076
   Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x
   Robb AO, 2009, HYPERTENSION, V53, P952, DOI 10.1161/HYPERTENSIONAHA.109.130898
   Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7
   Román GC, 2003, J AM GERIATR SOC, V51, PS296, DOI 10.1046/j.1532-5415.5155.x
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Roy AK, 1999, VITAM HORM, V55, P309
   Ryan J, 2014, BJOG-INT J OBSTET GY, V121, P1729, DOI 10.1111/1471-0528.12828
   Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40
   Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015
   Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233
   Scragg JL, 2004, BIOCHEM BIOPH RES CO, V318, P503, DOI 10.1016/j.bbrc.2004.04.054
   Scuteri A, 2005, J HYPERTENS, V23, P1211, DOI 10.1097/01.hjh.0000170384.38708.b7
   Scuteri A, 2007, J HYPERTENS, V25, P1035, DOI 10.1097/HJH.0b013e3280895b55
   Seo WK, 2008, CEREBROVASC DIS, V26, P618, DOI 10.1159/000166837
   Shah K, 2009, AM J GERIATR PHARMAC, V7, P250, DOI 10.1016/j.amjopharm.2009.11.001
   Smulyan H, 2001, J AM COLL CARDIOL, V37, P1374, DOI 10.1016/S0735-1097(01)01166-4
   Sohn IS, 2014, CURR HYPERTENS REV, V10, P37, DOI 10.2174/157340211001141111160311
   Soucy KG, 2006, J APPL PHYSIOL, V101, P1751, DOI 10.1152/japplphysiol.00138.2006
   Stegbauer J, 2011, CURR OPIN NEPHROL HY, V20, P84, DOI 10.1097/MNH.0b013e3283414d40
   Takahashi K, 2005, GYNECOL OBSTET INVES, V60, P162, DOI 10.1159/000086570
   Tang YH, 2016, AGING DIS, V7, P326, DOI 10.14336/AD.2015.1125
   Tarumi T, 2014, J CEREBR BLOOD F MET, V34, P971, DOI 10.1038/jcbfm.2014.44
   Topouchian J, 2007, VASC HEALTH RISK MAN, V3, P381
   Tota S, 2013, PSYCHOPHARMACOLOGY, V226, P357, DOI 10.1007/s00213-012-2913-8
   Touyz Rhian M, 2003, EXPERT REV CARDIOVASC THER, V1, P91, DOI 10.1586/14779072.1.1.91
   Tsao CW, 2013, NEUROLOGY, V81, P984, DOI 10.1212/WNL.0b013e3182a43e1c
   Tsuchiya K, 2006, AM J PHYSIOL-ENDOC M, V291, PE771, DOI 10.1152/ajpendo.00560.2005
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   van Elderen SGC, 2010, EUR RADIOL, V20, P1132, DOI 10.1007/s00330-009-1655-4
   van Sloten TT, 2015, J AM COLL CARDIOL, V66, P2116, DOI 10.1016/j.jacc.2015.08.888
   Vendemiale G, 2013, AGING CLIN EXP RES, V25, P247, DOI 10.1007/s40520-013-0043-8
   Véron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001
   Viboolvorakul S, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/230791
   Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409
   Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2
   Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002
   Wang MY, 2012, AGING CELL, V11, P500, DOI 10.1111/j.1474-9726.2012.00813.x
   Wang MY, 2005, AM J PATHOL, V167, P1429, DOI 10.1016/S0002-9440(10)61229-1
   Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45
   Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8
   Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837
   Webb CM, 1999, CIRCULATION, V100, P1690, DOI 10.1161/01.CIR.100.16.1690
   Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4
   Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04
   Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182
   Werner C, 2008, CLIN RES CARDIOL, V97, P418, DOI 10.1007/s00392-008-0668-3
   Williams MRI, 2001, J CLIN ENDOCR METAB, V86, P5389, DOI 10.1210/jc.86.11.5389
   Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789
   Wolf G, 2002, KIDNEY INT, V61, P1986, DOI 10.1046/j.1523-1755.2002.00365.x
   Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025
   Wu Z, 2003, ENDOCRINOLOGY, V144, P3251, DOI 10.1210/en.2003-0015
   Xiao QZ, 2014, ARTERIOSCL THROM VAS, V34, P90, DOI 10.1161/ATVBAHA.113.301418
   Xie XD, 2006, LIFE SCI, V78, P2166, DOI 10.1016/j.lfs.2005.09.038
   Yalcin A, 2016, AGING DIS, V7, P0, DOI 10.14336/AD.2015.0819
   Yaron M, 2009, EUR J ENDOCRINOL, V160, P839, DOI 10.1530/EJE-09-0052
   Yeap BB, 2009, J CLIN ENDOCR METAB, V94, P2353, DOI 10.1210/jc.2008-2416
   Yildiz O, 2005, J CARDIOVASC PHARM, V45, P580, DOI 10.1097/01.fjc.0000161400.06704.1e
   Ying WZ, 2013, HYPERTENSION, V62, P951, DOI 10.1161/HYPERTENSIONAHA.113.01835
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu J, 2010, ENDOCRINOLOGY, V151, P1822, DOI 10.1210/en.2009-1048
   Yu Q, 2000, GENE DEV, V14, P163
   Yu WC, 2008, J HUM HYPERTENS, V22, P24, DOI 10.1038/sj.jhh.1002259
   Zaydun G, 2006, ATHEROSCLEROSIS, V184, P137, DOI 10.1016/j.atherosclerosis.2005.03.043
   Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029
   Zhao HP, 2016, AGING DIS, V7, P295, DOI 10.14336/AD.2015.1009
   Zhou P, 2008, EUR J PHARMACOL, V593, P87, DOI 10.1016/j.ejphar.2008.07.014
NR 212
TC 48
Z9 58
U1 2
U2 34
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
EI 
J9 AGING DIS
JI Aging Dis.
PD JUL 15
PY 2017
VL 8
IS 4
BP 486
EP 505
DI 10.14336/AD.2017.0507
PG 20
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA FB6EM
UT WOS:000406234100011
PM 28840062
DA 2024-11-01
ER

PT J
AU El-Hattab, AW
   Craigen, WJ
   Scaglia, F
AF El-Hattab, Ayman W.
   Craigen, William J.
   Scaglia, Fernando
TI Mitochondrial DNA maintenance defects
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE mitochondrial diseases; mitochondrial DNA (mtDNA); mtDNA depletion syndromes; multiple mtDNA deletions; mitochondrial fusion; mtDNA replication
ID progressive external ophthalmoplegia; encephalomyopathy (mngie)-like phenotype; deoxyguanosine kinase-deficiency; adenine-nucleotide translocator; onset spinocerebellar ataxia; impair mtdna replication; coa ligase deficiency; loss-of-function; autosomal-dominant; polymerase-gamma
AB The maintenance of mitochondrial DNA (mtDNA) depends on a number of nuclear gene-encoded proteins including a battery of enzymes forming the replisome needed to synthesize mtDNA. These enzymes need to be in balanced quantities to function properly that is in part achieved by exchanging intramitochondrial contents through mitochondrial fusion. In addition, mtDNA synthesis requires a balanced supply of nucleotides that is achieved by nucleotide recycling inside the mitochondria and import from the cytosol. Mitochondrial DNA maintenance defects (MDMDs) are a group of diseases caused by pathogenic variants in the nuclear genes involved in mtDNA maintenance resulting in impaired mtDNA synthesis leading to quantitative (mtDNA depletion) and qualitative (multiple mtDNA deletions) defects in mtDNA. Defective mtDNA leads to organ dysfunction due to insufficient mtDNA-encoded protein synthesis, resulting in an inadequate energy production to meet the needs of affected organs. MDMDs are inherited as autosomal recessive or dominant traits, and are associated with a broad phenotypic spectrum ranging from mild adult-onset ophthalmoplegia to severe infantile fatal hepatic failure. To date, pathogenic variants in 20 nuclear genes known to be crucial for mtDNA maintenance have been linked to MDMDs, including genes encoding enzymes of mtDNA replication machinery (POLG, POLG2, TWNK, TEAM, RNASEH1, MGME1, and DNA2), genes encoding proteins that function in maintaining a balanced mitochondrial nucleotide pool (TIC2, DGUOK, SUCLGI, SUCLA2, ABAT, RRM2B, TYMP, SLC25A4, AGK, and MPV17), and genes encoding proteins involved in mitochondrial fusion (OPA1, MFN2, and FBXL4). (C) 2017 Published by Elsevier B.V.
C1 [El-Hattab, Ayman W.] Tawam Hosp, Dept Pediat, Div Clin Genet & Metab Disorders, Al Ain, U Arab Emirates.
   [Craigen, William J.; Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Craigen, WJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
EM wcraigen@bcm.edu
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Akman G, 2016, P NATL ACAD SCI USA, V113, PE4276, DOI 10.1073/pnas.1600537113
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antoun G, 2016, JIMD REP, V27, P1, DOI 10.1007/8904_2015_491
   Baroy T, 2016, EUR J MED GENET, V59, P342, DOI 10.1016/j.ejmg.2016.05.005
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonneau D, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu184
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carelli V, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awu234
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   Delettre-Cribaillet C, 1993, GENEREVIEWS, V0, P0
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4
   Ebrahimi-Fakhari D, 2015, PEDIATR NEUROL, V53, P549, DOI 10.1016/j.pediatrneurol.2015.08.018
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2016, CELL CALCIUM, V0, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Epand RM, 2009, BIOCHEMISTRY-US, V48, P12358, DOI 10.1021/bi901769r
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Gorman GS, 2014, GENEREVIEWS, V0, P0
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hanchard NA, 2011, MOL GENET METAB, V103, P262, DOI 10.1016/j.ymgme.2011.03.006
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Landsverk ML, 2014, MOLEC GENET METAB RE, V1, P451, DOI 10.1016/j.ymgmr.2014.09.007
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Barreto LCLS, 2016, NEUROEPIDEMIOLOGY, V46, P157, DOI 10.1159/000443706
   Löllgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Louro P, 2016, J INHERIT METAB DIS, V39, P743, DOI 10.1007/s10545-016-9951-z
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   Munnich A, 2012, INBORN METABOLIC DIS, V0, P223
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Paradas C, 2013, JAMA NEUROL, V70, P1425, DOI 10.1001/jamaneurol.2013.3185
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Prasad C, 2013, MOL GENET METAB, V108, P190, DOI 10.1016/j.ymgme.2012.12.007
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Randolph LM, 2011, MOL GENET METAB, V102, P149, DOI 10.1016/j.ymgme.2010.10.014
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Tsuji M, 2010, J INHERIT METAB DIS, V33, P85, DOI 10.1007/s10545-009-9022-9
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
   Zuchner S, 2014, GENEREVIEWS, V0, P0
NR 137
TC 194
Z9 213
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 15
PY 2017
VL 1863
IS 6
BP 1539
EP 1555
DI 10.1016/j.bbadis.2017.02.017
PG 17
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EZ4TE
UT WOS:000404704600037
PM 28215579
DA 2024-11-01
ER

PT J
AU Soldath, P
   Madsen, KL
   Buch, AE
   Duno, M
   Wibrand, F
   Vissing, J
AF Soldath, Patrick
   Madsen, Karen Lindhardt
   Buch, Astrid Emilie
   Duno, Morten
   Wibrand, Flemming
   Vissing, John
TI Pure exercise intolerance and ophthalmoplegia associated with the m. 12,294G > A mutation in the <i>MT</i>-<i>TL2</i> gene: a case report
SO BMC MUSCULOSKELETAL DISORDERS
LA English
DT Article
DE Case report; Mitochondrial DNA; MT-TL2 mutation; Mitochondrial myopathy; Exercise intolerance; Exercise physiological study; Maximal oxidative capacity
ID transfer-rna mutations; mitochondrial; dna; muscle; myoglobinuria; pathogenicity; capacity
AB Background: Pure exercise intolerance associated with exclusive affection of skeletal muscle is a very rare phenotype of patients with mitochondrial myopathy. Moreover, the exercise intolerance in these rare patients is yet not well explored, as most of known cases have not been assessed by objective testing, but only by interview. We report a patient with a mitochondrial DNA (mtDNA) mutation that gives rise to an exclusive myopathy associated with exercise intolerance and ophthalmoplegia. We quantified the patient's exercise intolerance through detailed exercise testing. Case presentation: A 39-year-old man presented with exercise intolerance and chronic progressive external ophthalmoplegia. Sequencing of the entire mtDNA identified a m. 12,294G > A mutation in the MT-TL2 gene. The mutation was heteroplasmic in skeletal muscle (75%) while undetectable in blood, urinary sediment, and buccal mucosa as well as in tissues from the patient's mother. The mutation affected a highly conserved site in the anticodon stem of the mitochondrial transfer RNA Leucine (CUN) molecule and lead to a severe combined respiratory chain defect. Exercise physiological studies in the patient demonstrated a significantly reduced maximal oxygen uptake of 20.4 ml O-2 x min(-1) x kg(-1) (about half of normal) as well as threefold elevated lactate/pyruvate ratios. Conclusion: The findings of our study support that the m. 12,294G > A mutation is pathogenic. Likely, the mutation arose sporadically in early embryogenesis after differentiation of the mesoderm into muscle progenitor cells, leading to a pure myopathic phenotype.
C1 [Soldath, Patrick; Madsen, Karen Lindhardt; Buch, Astrid Emilie; Vissing, John] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.
   [Soldath, Patrick; Madsen, Karen Lindhardt; Buch, Astrid Emilie; Vissing, John] Rigshosp, Copenhagen Neuromuscular Ctr, Dept Neurol, Copenhagen, Denmark.
   [Duno, Morten; Wibrand, Flemming] Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
C3 University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet
RP Soldath, P (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.; Soldath, P (corresponding author), Rigshosp, Copenhagen Neuromuscular Ctr, Dept Neurol, Copenhagen, Denmark.
EM Patricksoldath@gmail.com
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/s40478-014-0137-3
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Parson W, 2013, FORENSIC SCI INT-GEN, V7, P543, DOI 10.1016/j.fsigen.2013.06.003
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Rafiq J, 2016, JIMD REP, V25, P65, DOI 10.1007/8904_2015_459
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   WASSERMAN K, 1985, J APPL PHYSIOL, V59, P935, DOI 10.1152/jappl.1985.59.3.935
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 24
TC 7
Z9 7
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2474
EI 
J9 BMC MUSCULOSKEL DIS
JI BMC Musculoskelet. Disord.
PD OCT 19
PY 2017
VL 18
IS 
BP 
EP 
DI 10.1186/s12891-017-1781-0
PG 6
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA FK4JT
UT WOS:000413460400001
PM 29052516
DA 2024-11-01
ER

PT J
AU Jackson, CB
   Hahn, D
   Schröter, B
   Richter, U
   Battersby, BJ
   Schmitt-Mechelke, T
   Marttinen, P
   Nuoffer, JM
   Schaller, A
AF Jackson, Christopher B.
   Hahn, Dagmar
   Schroter, Barbara
   Richter, Uwe
   Battersby, Brendan J.
   Schmitt-Mechelke, Thomas
   Marttinen, Paula
   Nuoffer, Jean-Marc
   Schaller, Andre
TI A novel mitochondrial <i>ATP6</i> frameshift mutation causing isolated complex V deficiency, ataxia and encephalomyopathy
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE MT-ATP6; ATP synthase; Mitochondrial disease; Mitochondrial DNA (mtDNA); Complex V deficiency
ID biochemical-characterization; hypertrophic cardiomyopathy; point mutation; leigh-syndrome; gene mutation; synthase; dna; organization; disorders; diseases
AB We describe a novel frameshift mutation in the mitochondrial ATP6 gene in a 4-year-old girl associated with ataxia, microcephaly, developmental delay and intellectual disability. A heteroplasmic frameshift mutation in the MT-ATP6 gene was confirmed in the patient's skeletal muscle and blood. The mutation was not detectable in the mother's DNA extracted from blood or buccal cells. Enzymatic and oxymetric analysis of the mitochondrial respiratory system in the patients' skeletal muscle and skin fibroblasts demonstrated an isolated complex V deficiency. Native PAGE with subsequent immunoblotting for complex V revealed impaired complex V assembly and accumulation of ATPase subcomplexes. Whilst northern blotting confirmed equal presence of ATP8/6 mRNA, metabolic S-35-labelling of mitochondrial translation products showed a severe depletion of the ATP6 protein together with aberrant translation product accumulation. In conclusion, this novel isolated complex V defect expands the clinical and genetic spectrum of mitochondrial defects of complex V deficiency. Furthermore, this work confirms the benefit of native PAGE as an additional diagnostic method for the identification of OXPHOS defects, as the presence of complex V subcomplexes is associated with pathogenic mutations of mtDNA. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Jackson, Christopher B.; Hahn, Dagmar; Nuoffer, Jean-Marc] Univ Hosp Bern, Inst Clin Chem, Bern, Switzerland.
   [Jackson, Christopher B.] Univ Helsinki, Res Programs Mol Neurol, Biomedicum Helsinki, Haartmaninkatu 8, Helsinki, Finland.
   [Schroter, Barbara; Schmitt-Mechelke, Thomas] Cantonal Hosp Lucerne, Childrens Hosp, Dept Neuropaediat, Luzern, Switzerland.
   [Richter, Uwe; Battersby, Brendan J.; Marttinen, Paula] Univ Helsinki, Inst Biotechnol, Helsinki, Finland.
   [Schaller, Andre] Univ Hosp Bern, Div Human Genet, Bern, Switzerland.
C3 University of Bern; University Hospital of Bern; University of Helsinki; Lucerne Cantonal Hospital; University of Helsinki; University of Bern; University Hospital of Bern
RP Jackson, CB (corresponding author), Univ Helsinki, Res Programs Mol Neurol, Biomedicum Helsinki, Haartmaninkatu 8, Helsinki, Finland.
EM christopher.jackson@helsinki.fi; Schroeter.Barbara@bluewin.ch; Uwe.Richter@helsinki.fi; Brendan.Battersby@helsinki.fi; Thomas.Schmitt@luks.ch; Paula.Marttinen@helsinki.fi; Jean-Marc.Nuoffer@insel.ch; Andre.Schaller@insel.ch
FU Swiss National Science Foundation [P2BEP3_162065]; Novartis Foundation for medical biological research; Academy of Finland; University of Helsinki; Swiss National Science Foundation (SNF) [P2BEP3_162065] Funding Source: Swiss National Science Foundation (SNF)
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   deCoo IFM, 1996, AM J HUM GENET, V58, P636
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5
   Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Jackson CB, 2014, MITOCHONDRION, V17, P67, DOI 10.1016/j.mito.2014.05.011
   Jackson CB, 2014, BRIT J OPHTHALMOL, V98, P1453, DOI 10.1136/bjophthalmol-2014-305300
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Schaller A, 2011, MITOCHONDRION, V11, P488, DOI 10.1016/j.mito.2011.01.005
   Schaller A, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-4
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, PS10, DOI 10.1016/j.bbabio.2008.05.044
NR 35
TC 23
Z9 25
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD JUN 15
PY 2017
VL 60
IS 6
BP 345
EP 351
DI 10.1016/j.ejmg.2017.04.006
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA EW4OT
UT WOS:000402481500012
PM 28412374
DA 2024-11-01
ER

PT J
AU Jacobi, D
   Atger, F
   Lee, CH
AF Jacobi, David
   Atger, Florian
   Lee, Chih-Hao
TI Circadian Control of Mitochondrial Dynamics and Its Implication in Aging
SO CIRCADIAN RHYTHMS AND THEIR IMPACT ON AGING
LA English
DT Article; Book Chapter
DE Mitochondrial dynamics; Mitophagy; Metabolic diseases; Oxidative stress; Electron transport chain; Circadian rhythm
ID dominant optic atrophy; dna mutations; life-span; degenerative diseases; nutrient utilization; energy-expenditure; oxidative stress; gene-expression; mutator mice; cell death
AB The circadian clock promotes metabolic efficiency by pre-programmed regulation of metabolic pathways in anticipation of the upcoming feeding/fasting cycle. Recent studies have suggested that the master circadian regulators Bmal1/Clock play an important role in controlling mitochondrial function, including oxidative metabolism and mitochondrial dynamics. The latter includes mitochondrial fusion, fission, and selective autophagy (mitophagy) that follows fission. These processes not only allow mitochondria to undergo architectural/organizational changes in response to different nutrient conditions but also ensure quality control by removing damaged components through mitophagy. Results from mouse genetic models indicate that Bmal1-dependent regulation of fission and mitophagy genes reduces oxidative stress and maintains metabolic flexibility in the liver. In addition, aha-1, a C. elegans Bmal1 homologue, is required for orderly organizations of muscle mitochondria. Interestingly, Baml1 whole body knockout mice develop premature aging phenotypes, while AHA-1 over-expression increases lifespan in worms. Given that mitochondrial dysfunction appears to be a common feature associated with aging, obesity, and related metabolic diseases, these findings implicate an evolutionarily conserved regulatory mechanism that links mitochondrial fidelity to lifespan and/or healthspan.
C1 [Jacobi, David; Lee, Chih-Hao] Harvard TH Chan Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.
   [Jacobi, David; Atger, Florian] Univ Nantes, Inst Thorax, INSERM, CNRS, Nantes, France.
   [Jacobi, David] CHU Nantes, Inst Thorax, Nantes, France.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes
RP Lee, CH (corresponding author), Harvard TH Chan Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.
EM clee@hsph.harvard.edu
CR Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050
   Atger F, 2015, P NATL ACAD SCI USA, V112, PE6579, DOI 10.1073/pnas.1515308112
   Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027
   Bernhardt D, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep07885
   Braun RJ, 2011, BIOCHEM SOC T, V39, P1520, DOI 10.1042/BST0391520
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099
   Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gong CX, 2015, CHRONOBIOL INT, V32, P1254, DOI 10.3109/07420528.2015.1085388
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006
   Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI 10.1042/bse0470053
   Jouffe C, 2013, PLOS BIOL, V11, P0, DOI 10.1371/journal.pbio.1001455
   Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009
   Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   Marcheva Biliana, 2013, HANDB EXP PHARMACOL, V0, PP127, DOI 10.1007/978-3-642-25950-0_6
   McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, PE1673, DOI 10.1073/pnas.1519650113
   NOBES CD, 1990, J BIOL CHEM, V265, P12903
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417
   Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rojo M, 2002, J CELL SCI, V115, P1663
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Santel A, 2001, J CELL SCI, V114, P867
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007
   Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003
   Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014
   Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
NR 76
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2199-9007
EI 2199-9015
J9 HEALTHY AGEING LONG
PD JUN 15
PY 2017
VL 7
IS 
BP 147
EP 161
DI 10.1007/978-3-319-64543-8_7
PG 15
WC Geriatrics & Gerontology; Medicine, Research & Experimental
SC Geriatrics & Gerontology; Research & Experimental Medicine
GA BK4ZA
UT WOS:000437924300008
DA 2024-11-01
ER

PT J
AU Viscomi, C
   Zeviani, M
AF Viscomi, Carlo
   Zeviani, Massimo
TI MtDNA-maintenance defects: syndromes and genes
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article; Proceedings Paper
ID mitochondrial neurogastrointestinal encephalomyopathy; progressive external ophthalmoplegia; adenine-nucleotide translocator; onset spinocerebellar ataxia; dominant optic atrophy; loss-of-function; autosomal-dominant; dna-polymerase; polg mutations; multiple deletions
AB A large group of mitochondrial disorders, ranging from early-onset pediatric encephalopathic syndromes to late-onset myopathy with chronic progressive external ophthalmoplegia (CPEOs), are inherited as Mendelian disorders characterized by disturbed mitochondrial DNA (mtDNA) maintenance. These errors of nuclear-mitochondrial intergenomic signaling may lead to mtDNA depletion, accumulation of mtDNA multiple deletions, or both, in critical tissues. The genes involved encode proteins belonging to at least three pathways: mtDNA replication and maintenance, nucleotide supply and balance, and mitochondrial dynamics and quality control. In most cases, allelic mutations in these genes may lead to profoundly different phenotypes associated with either mtDNA depletion or multiple deletions.
C1 [Viscomi, Carlo; Zeviani, Massimo] MRC MBU, MRC Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.
RP Zeviani, M (corresponding author), MRC MBU, MRC Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.
EM mdz21@mrc-mbu.cam.ac.uk
FU ERC grant [FP7-322424]; CoEN grant [3038]; MRC core grant; MRC [MC_UU_00015/5, MC_UP_1002/1] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonnen PE, 2013, AM J HUM GENET, V93, P773, DOI 10.1016/j.ajhg.2013.09.003
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2012, NEUROLOGY, V78, P0
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 106
TC 127
Z9 131
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JUL 15
PY 2017
VL 40
IS 4
BP 587
EP 599
DI 10.1007/s10545-017-0027-5
PG 13
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA EZ9AC
UT WOS:000405020500012
PM 28324239
DA 2024-11-01
ER

PT J
AU Hatakeyama, H
   Goto, Y
AF Hatakeyama, Hideyuki
   Goto, Yu-ichi
TI Respiratory Chain Complex Disorganization Impairs Mitochondrial and Cellular Integrity <i>Phenotypic Variation in Cytochrome</i> c <i>Oxidase Deficiency</i>
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID pluripotent stem-cells; human mtdna; mutation; disease; subunit; patient; codon; encephalomyopathy; supercomplexes; microdeletion
AB The relationships between the molecular abnormalities in mitochondrial respiratory chain complexes and their negative contributions to mitochondrial and cellular functions have been proved to be essential for better understandings in mitochondrial medicine. Herein, we established the method to identify disease phenotypic differences among patients with muscle histopathological cytochrome c oxidase (COX) deficiency, as one of the representative clinical features in mitochondrial diseases, by using patients' myoblasts that are derived from biopsied skeletal muscle tissues. We identified two obviously different severities in molecular diagnostic criteria of COX deficiency among patients: structurally stable, but functionally mild/moderate defect and severe functional defect with the disrupted COX holoenzyme structure. COX holoenzyme disorganization actually triggered several mitochondrial dysfunctions, including the decreased ATP level, the increased oxidative stress Level, and the damaged membrane potential Level, all of which Lead to the deteriorated cellular growth, the accelerated cellular senescence, and the induced apoptotic cell death. Our cell-based in vitro diagnostic approaches would be widely applicable to understanding patient-specific pathomechanism in various types of mitochondrial diseases, including other respiratory chain complex deficiencies and other mitochondrial metabolic enzyme deficiencies.
C1 [Hatakeyama, Hideyuki; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
   [Hatakeyama, Hideyuki; Goto, Yu-ichi] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Hatakeyama, H; Goto, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.
EM hideyuki@ncnp.go.jp; goto@ncnp.go.jp
FU Japan Society for the Promotion of Science [20790760]; Ministry of Health, Labour, and Welfare, Japan; Japan Agency for Medical Research and Development AMED-CREST; Grants-in-Aid for Scientific Research [20790760] Funding Source: KAKEN
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293
   Okita K, 2011, NAT METHODS, V8, P409, DOI 10.1038/NMETH.1591
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Schäfer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200
   Schägger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
NR 30
TC 8
Z9 11
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JAN 15
PY 2017
VL 187
IS 1
BP 110
EP 121
DI 10.1016/j.ajpath.2016.09.003
PG 12
WC Pathology
SC Pathology
GA EG1YC
UT WOS:000390829300012
PM 27855277
DA 2024-11-01
ER

PT J
AU Bindu, S
   Pillai, VB
   Kanwal, A
   Samant, S
   Mutlu, GM
   Verdin, E
   Dulin, N
   Gupta, MP
AF Bindu, Samik
   Pillai, Vinodkumar B.
   Kanwal, Abhinav
   Samant, Sadhana
   Mutlu, Gokhan M.
   Verdin, Eric
   Dulin, Nickolai
   Gupta, Mahesh P.
TI SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article
DE DNA damage; fibroblasts; pulmonary fibrosis; SIRT3
ID growth-factor-beta; fatty-acid oxidation; cell-death; gene-expression; ros production; lung fibrosis; tgf-beta; stress; mice; bleomycin
AB Myofibroblast differentiation is a key process in the pathogenesis of fibrotic diseases. Transforming growth factor-beta(1) (TGF-beta(1)) is a powerful inducer of myofibroblast differentiation and is implicated in pathogenesis of tissue fibrosis. This study was undertaken to determine the role of mitochondrial deacetylase SIRT3 in TGF-beta(1)-induced myofibroblast differentiation in vitro and lung fibrosis in vivo. Treatment of human lung fibroblasts with TGF-beta(1) resulted in increased expression of fibrosis markers, smooth muscle alpha-actin (alpha-SMA), collagen-1, and fibronectin. TGF-beta(1) treatment also caused depletion of endogenous SIRT3, which paralleled with increased production of reactive oxygen species (ROS), DNA damage, and subsequent reduction in levels of 8-oxoguanine DNA glycosylase (OGG1), an enzyme that hydrolyzes oxidized guanine (8-oxo-dG) and thus protects DNA from oxidative damage. Overexpression of SIRT3 by adenovirus-mediated transduction reversed the effects of TGF-beta(1) on ROS production and mitochondrial DNA damage and inhibited TGF-beta(1)-induced myofibroblast differentiation. To determine the antifibrotic role of SIRT3 in vivo, we used the bleomycin-induced mouse model of pulmonary fibrosis. Compared with wild-type controls, Sirt3-knockout mice showed exacerbated fibrosis after intratracheal instillation of bleomycin. Increased lung fibrosis was associated with decreased levels of OGG1 and concomitant accumulation of 8-oxo-dG and increased mitochondrial DNA damage. In contrast, the transgenic mice with whole body Sirt3 overexpression were protected from bleomycin-induced mtDNA damage and development of lung fibrosis. These data demonstrate a critical role of SIRT3 in the control of myofibroblast differentiation and lung fibrosis.
C1 [Bindu, Samik; Pillai, Vinodkumar B.; Kanwal, Abhinav; Samant, Sadhana; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Mutlu, Gokhan M.; Dulin, Nickolai] Univ Chicago, Dept Med, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Verdin, Eric] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.
C3 University of Chicago; University of Chicago; University of California System; University of California San Francisco; The J David Gladstone Institutes
RP Gupta, MP (corresponding author), Univ Chicago, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Gupta, MP (corresponding author), Univ Chicago, Pritzker Sch Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM mgupta@surgery.bsd.uchicago.edu
FU National Heart, Lung, and Blood Institute [HL-117041, HL-111455, 1R56HL127395]
CR Abrigo J, 2015, PHYTOMEDICINE, V22, P885, DOI 10.1016/j.phymed.2015.06.011
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Akamata K, 1900, DOI 10.18632/ONCOTARGET.12504, V0, P0
   Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007
   Brar SS, 2012, AM J PHYSIOL-LUNG C, V303, PL413, DOI 10.1152/ajplung.00343.2011
   BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Cheng Y, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.254
   Cheresh P, 2015, AM J RESP CELL MOL, V52, P25, DOI 10.1165/rcmb.2014-0038OC
   Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Desmoulière A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014
   Gazdhar A, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep05336
   Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030
   GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Griese M, 2013, AM J RESP CRIT CARE, V188, P83, DOI 10.1164/rccm.201303-0427OC
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com
   Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Jablonski RP, 2015, AM J RESP CRIT CARE, V191, P0
   Kach J, 2014, J BIOL CHEM, V289, P7505, DOI 10.1074/jbc.M113.546812
   Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778
   Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200
   Kincaid B, 2013, FRONT AGING NEUROSCI, V5, P0, DOI 10.3389/fnagi.2013.00048
   Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946
   PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649
   Pillai VB, 2016, AM J PHYSIOL-HEART C, V310, PH962, DOI 10.1152/ajpheart.00832.2015
   Pillai VB, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7656
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354
   Rahman M, 2014, J CELL BIOL, V206, P289, DOI 10.1083/jcb.201404118
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1082
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730
   SANTANA A, 1995, AM J RESP CELL MOL, V13, P34, DOI 10.1165/ajrcmb.13.1.7541221
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590
   Singh SK, 2011, NUCLEIC ACIDS RES, V39, P6789, DOI 10.1093/nar/gkr275
   Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08
   Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810
   Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com
   Tian F, 2009, REJUV RES, V12, P209, DOI 10.1089/rej.2009.0849
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang QJ, 1999, THORAX, V54, P805, DOI 10.1136/thx.54.9.805
   White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446
   Wu JF, 2014, BMC DEV BIOL, V14, P0, DOI 10.1186/1471-213X-14-21
   Wu YT, 2014, FREE RADICAL RES, V48, P1070, DOI 10.3109/10715762.2014.920956
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yeung M, 2015, APOPTOSIS, V20, P811, DOI 10.1007/s10495-015-1119-z
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
NR 62
TC 74
Z9 80
U1 0
U2 28
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD JAN 15
PY 2017
VL 312
IS 1
BP L68
EP L78
DI 10.1152/ajplung.00188.2016
PG 11
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA EK2XT
UT WOS:000393791100007
PM 27815257
DA 2024-11-01
ER

PT J
AU Nasca, A
   Scotton, C
   Zaharieva, I
   Neri, M
   Selvatici, R
   Magnusson, OT
   Gal, A
   Weaver, D
   Rossi, R
   Armaroli, A
   Pane, M
   Phadke, R
   Sarkozy, A
   Muntoni, F
   Hughes, I
   Cecconi, A
   Hajnóczky, G
   Donati, A
   Mercuri, E
   Zeviani, M
   Ferlini, A
   Ghezzi, D
AF Nasca, Alessia
   Scotton, Chiara
   Zaharieva, Irina
   Neri, Marcella
   Selvatici, Rita
   Magnusson, Olafur Thor
   Gal, Aniko
   Weaver, David
   Rossi, Rachele
   Armaroli, Annarita
   Pane, Marika
   Phadke, Rahul
   Sarkozy, Anna
   Muntoni, Francesco
   Hughes, Imelda
   Cecconi, Antonella
   Hajnoczky, Gyoergy
   Donati, Alice
   Mercuri, Eugenio
   Zeviani, Massimo
   Ferlini, Alessandra
   Ghezzi, Daniele
TI Recessive mutations in <i>MSTO1</i> cause mitochondrial dynamics impairment, leading to myopathy and ataxia
SO HUMAN MUTATION
LA English
DT Article
DE ataxia; mitochondrial dynamics; MSTO1; myopathy; skeletal abnormalities
ID dominant optic atrophy; dna-sequencing data; protein; division; fusion; cells; gene; saccharomyces; morphology; drosophila
AB We report here the first families carrying recessive variants in the MSTO1 gene: compound heterozygous mutations were identified in two sisters and in an unrelated singleton case, who presented a multisystem complex phenotype mainly characterized by myopathy and cerebellar ataxia. Human MSTO1 is a poorly studied protein, suggested to have mitochondrial localization and to regulate morphology and distribution of mitochondria. As for other mutations affecting genes involved in mitochondrial dynamics, no biochemical defects typical of mitochondrial disorders were reported. Studies in patients' fibroblasts revealed that MSTO1 protein levels were strongly reduced, the mitochondrial network was fragmented, and the fusion events among mitochondria were decreased, confirming the deleterious effect of the identified variants and the role of MSTO1 in modulating mitochondrial dynamics. We also found that MSTO1 is mainly a cytosolic protein. These findings indicate recessive mutations in MSTO1 as a new cause for inherited neuromuscular disorders with multisystem features.
C1 [Nasca, Alessia; Ghezzi, Daniele] Fdn IRCCS Neurol Inst Besta, Mol Neurogenet Unit, Via Temolo 4, I-20126 Milan, Italy.
   [Scotton, Chiara; Neri, Marcella; Selvatici, Rita; Rossi, Rachele; Armaroli, Annarita; Ferlini, Alessandra] Univ Ferrara, Med Genet Unit, Dept Med Sci, Ferrara, Italy.
   [Zaharieva, Irina; Phadke, Rahul; Sarkozy, Anna; Muntoni, Francesco; Ferlini, Alessandra] UCL Great Ormond St Hosp, Dubowitz Neuromuscular Ctr, London, England.
   [Magnusson, Olafur Thor] deCODE Genet, Reykjavik, Iceland.
   [Gal, Aniko; Weaver, David; Hajnoczky, Gyoergy] Thomas Jefferson Univ, MitoCare Ctr Mitochondrial Imaging Res & Diagnost, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
   [Gal, Aniko] Semmelweis Univ, Inst Genom Med & Rare Disorders, Budapest, Hungary.
   [Pane, Marika; Mercuri, Eugenio] Catholic Univ, Neuropsichiat Unit, Policlin Gemelli, Rome, Italy.
   [Hughes, Imelda] Royal Manchester Childrens Hosp, Manchester, Lancs, England.
   [Cecconi, Antonella] Hosp S Maria Annunziata Bagno Ripoli, Pediat Med Genet, Florence, Italy.
   [Donati, Alice] Meyer Children Hosp, Unit Metab & Muscular Dis, Florence, Italy.
   [Zeviani, Massimo] Mitochondrial Biol Unit MRC, Cambridge, England.
C3 University of Ferrara; University of London; University College London; Jefferson University; Semmelweis University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Royal Manchester Children's Hospital; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER
RP Ghezzi, D (corresponding author), Fdn IRCCS Neurol Inst Besta, Mol Neurogenet Unit, Via Temolo 4, I-20126 Milan, Italy.; Ferlini, A (corresponding author), Univ Ferrara, Unit Med Genet, Via Fossato Mortara 74, I-44121 Ferrara, Italy.; Zeviani, M (corresponding author), Wellcome Trust Res Labs, MRC Mitochondrial Biol Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.
EM mdz21@mrc-mbu.cam.ac.uk; fla@unife.it; daniele.ghezzi@istituto-besta.it
FU EU NeurOmics [2012-305121-2]; European Community's Seventh Framework Programme; Regione Emilia Romagna; Telethon [GGP15041]; Pierfranco and Luisa Mariani Foundation; MRC-QQR [2015-20120]; ERC [FP7-322424]; NRJ-Institut de France grant; Telethon Network of Genetic Biobanks [GTB12001J]; MRC Neuromuscular Centre; Muscular Dystrophy UK; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; MRC [MC_UU_00015/5, MC_UP_1002/1] Funding Source: UKRI
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gal A, 2016, EUROPEAN J HUMAN S1, V24, P199
   Ghezzi D, 2009, HUM MOL GENET, V18, P1058, DOI 10.1093/hmg/ddn441
   Gurvitz A, 2002, FEMS YEAST RES, V2, P123, DOI 10.1111/j.1567-1364.2002.tb00077.x
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mayorov Vladimir I, 2008, BMC BIOCHEMISTRY, V9, P9, DOI 10.1186/1471-2091-9-22
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Miklos GLG, 1997, P NATL ACAD SCI USA, V94, P5189, DOI 10.1073/pnas.94.10.5189
   Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103
   Nasca A, 2016, HUM MUTAT, V37, P898, DOI 10.1002/humu.23033
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Weaver D, 2014, MOL CELL, V54, P870, DOI 10.1016/j.molcel.2014.03.048
   Weber TA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063683
NR 27
TC 39
Z9 45
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG 15
PY 2017
VL 38
IS 8
BP 970
EP 977
DI 10.1002/humu.23262
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA FA3EA
UT WOS:000405323500010
PM 28544275
DA 2024-11-01
ER

PT J
AU Wortmann, SB
   Mayr, JA
   Nuoffer, JM
   Prokisch, H
   Sperl, W
AF Wortmann, Saskia B.
   Mayr, Johannes A.
   Nuoffer, Jean Marc
   Prokisch, Holger
   Sperl, Wolfgang
TI A Guideline for the Diagnosis of Pediatric Mitochondrial Disease: The Value of Muscle and Skin Biopsies in the Genetics Era
SO NEUROPEDIATRICS
LA English
DT Article
DE exome sequencing; genome sequencing; next-generation sequencing; mitochondrial disease; mitochondrial DNA
ID 3-methylglutaconic aciduria; leigh-syndrome; mutations; disorders; spectrum; epidemiology; genes
AB Mitochondrial diseases are highly heterogeneous on the clinical, biochemical, and genetic level. In the traditional diagnostic approach ("biopsy first") the evaluation of the affected individual and his body fluids, combined with the analysis of the respiratory chain enzymes in muscle based the subsequent Sanger sequencing of single candidate genes ("from function to gene"). Within the past few years, next-generation sequencing techniques of leucocyte-derived DNA (e.g., exome sequencing), with a diagnostic yield of more than 40%, have become the first line routine technology. This implicates that the invasive muscle biopsy is performed less often, especially in children. Furthermore, in this "genetics-first" approach the detection of new candidate genes precedes functional evaluations ("from gene to function") leading to reverse phenotyping of affected individuals. Here, we line out the value of muscle and other tissue biopsies in this "genetics-first" era. We describe when and why it is still needed. We create awareness of pitfalls in the genetic diagnostics of mitochondrial diseases still necessitating tissue biopsies. Finally, we discuss why tissue biopsies are required for confirmatory diagnostics, or for getting a biochemical diagnosis in patients with hidden variants not detectable by standard genetics.
C1 [Wortmann, Saskia B.; Mayr, Johannes A.; Sperl, Wolfgang] Salzburger Landeskliniken SALK, Dept Pediat, Salzburg, Austria.
   [Wortmann, Saskia B.; Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Salzburg, Austria.
   [Wortmann, Saskia B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Wortmann, Saskia B.; Prokisch, Holger] Helmholtz Zentrum Munich, Inst Human Genet, Neuherberg, Germany.
   [Nuoffer, Jean Marc] Bern Univ Hosp, Univ Inst Clin Chem, Bern, Switzerland.
C3 Paracelsus Private Medical University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bern; University Hospital of Bern
RP Wortmann, SB (corresponding author), Paracelsus Med Univ, Salzburger Landeskliniken, Dept Pediat, Mullner Hauptstr 48, A-5020 Salzburg, Austria.
EM s.wortmann-hagemann@salk.at
FU E-Rare project GENOMIT [01GM1207]; E-Rare project GENOMIT (Austrian Science Fonds [FWF]) [I 2741-B26]; Vereinigung zur Forderung padiatrischer Forschung und Fortbildung Salzburg; Austrian Science Fund (FWF) [I2741] Funding Source: Austrian Science Fund (FWF)
CR Aulbert W, 2014, NEUROPEDIATRICS, V45, P346, DOI 10.1055/s-0034-1383823
   Baertling F, 2016, CHILD NERV SYST, V32, P2077, DOI 10.1007/s00381-016-3190-3
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Distelmaier F, 2017, BRAIN, V140, P0, DOI 10.1093/brain/aww303
   Ferri L, 2016, CLIN GENET, V90, P461, DOI 10.1111/cge.12756
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kremer LS, 2016, BIORXIV, V2016, P0, DOI 10.1101/066738
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sperl W, 2015, J INHERIT METAB DIS, V38, P391, DOI 10.1007/s10545-014-9787-3
   Thiels C, 2016, JIMD REP, V29, P89, DOI 10.1007/8904_2015_525
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wortmann SB, 2015, AM J HUM GENET, V96, P245, DOI 10.1016/j.ajhg.2014.12.013
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 28
TC 48
Z9 50
U1 1
U2 7
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0174-304X
EI 1439-1899
J9 NEUROPEDIATRICS
JI Neuropediatrics
PD AUG 15
PY 2017
VL 48
IS 4
BP 309
EP 314
DI 10.1055/s-0037-1603776
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA FC0FA
UT WOS:000406512800012
PM 28599323
DA 2024-11-01
ER

PT J
AU Darin, N
   Hedberg-Oldfors, C
   Kroksmark, AK
   Moslemi, AR
   Kollberg, G
   Oldfors, A
AF Darin, N.
   Hedberg-Oldfors, C.
   Kroksmark, A. -K.
   Moslemi, A. -R.
   Kollberg, G.
   Oldfors, A.
TI Benign mitochondrial myopathy with exercise intolerance in a large multigeneration family due to a homoplasmic m.3250T&gt;C mutation in <i>MTTL1</i>
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE benign; disease; exercise intolerance; m.3250T > C; mitochondrial; mitochondrial DNA; MTTL1; myopathy
ID transfer rnaleu(uur) gene; complex i deficiency; clinical-features; trna(trp) gene; point mutation; dna; encephalomyopathy
AB Background and purpose: Most mitochondrial disorders with onset in early childhood are progressive and involve multiple organs. The m.3250T>C mutation in MTTL1 has previously been described in a few individuals with a possibly riboflavin-responsive myopathy and an association with sudden infant death syndrome was suspected. We describe a large family with this mutation and evaluate the effect of riboflavin treatment. Methods: Medical data were collected with the help of a standardized data collection form. Sanger sequencing was used to screen for variants in mitochondrial DNA and the proportion of the mutation was analyzed in different tissues. Biochemical and muscle morphological investigations of muscle tissue were performed in two individuals. The effect of riboflavin treatment was evaluated in two individuals. Results: Thirteen family members experienced exercise intolerance with fatigue and weakness. Inheritance was maternal with 100% penetrance. The course was either static or showed improvement over time. There was no evidence of other organ involvement except for a possible mild transient cardiac enlargement in one child. Muscle investigations showed isolated complex I deficiency and mitochondrial proliferation. The level of m.3250T>C was apparently 100%, i.e. homoplasmic, in all examined tissues. Riboflavin treatment showed no effect in any treated family member and there have been no cases of sudden infant death in this family. Conclusions: This study illustrates the importance of considering mitochondrial disorders in the work-up of individuals with exercise intolerance and provides a better understanding of the phenotype associated with the m.3250T>C.
C1 [Darin, N.; Kroksmark, A. -K.] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Pediat, Gothenburg, Sweden.
   [Hedberg-Oldfors, C.; Moslemi, A. -R.; Oldfors, A.] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Pathol & Genet, Gothenburg, Sweden.
   [Kollberg, G.] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg
RP Darin, N (corresponding author), Sahlgrens Univ Hosp, Sahlgrenska Acad, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden.
EM niklas.darin@vgregion.se
FU ALF grants; Ahlqvist's Foundation; Region Vastra Gotaland
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/s40478-014-0137-3
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Melberg A, 1998, NEUROLOGY, V50, P299, DOI 10.1212/WNL.50.1.299
   MORGANHUGHES JA, 1979, J NEUROL SCI, V43, P27, DOI 10.1016/0022-510X(79)90071-6
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Peverelli L, 2014, MUSCLE NERVE, V50, P292, DOI 10.1002/mus.24262
   Shinde A, 2000, RINSHO SHINKEIGAKU, V40, P561
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
NR 27
TC 10
Z9 10
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD APR 15
PY 2017
VL 24
IS 4
BP 587
EP 593
DI 10.1111/ene.13249
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EQ3PK
UT WOS:000397984800012
PM 28181352
DA 2024-11-01
ER

PT J
AU Crouch, ML
   Knowels, G
   Stuppard, R
   Ericson, NG
   Bielas, JH
   Marcinek, DJ
   Syrjala, KL
AF Crouch, Marie-Laure
   Knowels, Gary
   Stuppard, Rudolph
   Ericson, Nolan G.
   Bielas, Jason H.
   Marcinek, David J.
   Syrjala, Karen L.
TI Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects
SO PLOS ONE
LA English
DT Article
ID stem-cell transplantation; breast-cancer survivors; childhood-cancer; adult survivors; induced hepatotoxicity; glutathione depletion; doxorubicin acts; body-composition; dna deletions; vitamin-e
AB Fatigue is the symptom most commonly reported by long-term cancer survivors and is increasingly recognized as related to skeletal muscle dysfunction. Traditional chemotherapeutic agents can cause acute toxicities including cardiac and skeletal myopathies. To investigate the mechanism by which chemotherapy may lead to persistent skeletal muscle dysfunction, mature adult mice were injected with a single cyclophosphamide dose and evaluated for 6 weeks. We found that exposed mice developed a persistent decrease in treadmill running time compared to baseline (25.7 +/- 10.6 vs. 49.0 +/- 16.8 min, P = 0.0012). Further, 6 weeks after drug exposure, in vivo parameters of mitochondrial function remained below baseline including maximum ATP production (482.1 +/- 48.6 vs. 696.2 +/- 76.6, P = 0.029) and phosphocreatine to ATP ratio (3.243 +/- 0.1 vs. 3.878 +/- 0.1, P = 0.004). Immunoblotting of homogenized muscles from treated animals demonstrated a transient increase in HNE adducts 1 week after exposure that resolved by 6 weeks. However, there was no evidence of an oxidative stress response as measured by quantitation of SOD1, SOD2, and catalase protein levels. Examination of mtDNA demonstrated that the mutation frequency remained comparable between control and treated groups. Interestingly, there was evidence of a transient increase in NF-B p65 protein 1 day after drug exposure as compared to saline controls (0.091 +/- 0.017 vs. 0.053 +/- 0.022, P = 0.033). These data suggest that continued impairment in muscle and mitochondria function in cyclophosphamide-treated animals is not linked to persistent oxidative stress and that alternative mechanisms need to be considered.
C1 [Crouch, Marie-Laure; Syrjala, Karen L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.
   [Knowels, Gary; Stuppard, Rudolph; Marcinek, David J.] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA.
   [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Translat Res Program, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.
   [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Bielas, Jason H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Syrjala, Karen L.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
C3 Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle
RP Syrjala, KL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Syrjala, KL (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
EM ksyrjala@fredhutch.org
FU National Institutes of Health/National Cancer Institute [P30 CA015704, R01 CA112631, R01 CA160684, R01 CA215134]; National Cancer Institute and National Institute on Aging [P20 CA103728]
CR Abraham P, 2011, HUM EXP TOXICOL, V30, P1924, DOI 10.1177/0960327111402240
   Ahlberg K, 2003, LANCET, V362, P640, DOI 10.1016/S0140-6736(03)14186-4
   al-Majid S, 2001, BIOL RES NURS, V2, P186, DOI 10.1177/109980040100200304
   Anton E, 2002, INT J EXP PATHOL, V83, P47, DOI 10.1046/j.1365-2613.2002.00208.x
   Arakaki LSL, 2007, APPL SPECTROSC, V61, P978, DOI 10.1366/000370207781745928
   Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107
   Banthia R, 2006, J BEHAV MED, V29, P269, DOI 10.1007/s10865-006-9053-8
   Bennett Jill A, 2013, ONCOL NURS FORUM, V40, PE126, DOI 10.1188/13.ONF.E126-E134
   Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067
   Bertram LAC, 2011, CANCER CAUSE CONTROL, V22, P427, DOI 10.1007/s10552-010-9714-3
   Bjelogrlic SK, 2005, BASIC CLIN PHARMACOL, V97, P311, DOI 10.1111/j.1742-7843.2005.pto_166.x
   Bjelogrlic SK, 2013, BASIC CLIN PHARMACOL, V113, P228, DOI 10.1111/bcpt.12086
   BLEI ML, 1993, P NATL ACAD SCI USA, V90, P7396, DOI 10.1073/pnas.90.15.7396
   BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673
   Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743
   Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1468, DOI 10.1093/jnci/djq344
   Braun TP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106489
   Bylow K, 2011, UROLOGY, V77, P934, DOI 10.1016/j.urology.2010.11.024
   Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247
   Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023
   Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513
   CROOK TR, 1986, CANCER RES, V46, P5035
   CROOK TR, 1986, CANCER RES, V46, P5029
   Cuce G, 2015, CHEM-BIOL INTERACT, V232, P7, DOI 10.1016/j.cbi.2015.02.016
   DORR RT, 1994, CHEM-BIOL INTERACT, V93, P117, DOI 10.1016/0009-2797(94)90091-4
   Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x
   Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196
   Gilliam LAA, 2013, FREE RADICAL BIO MED, V65, P988, DOI 10.1016/j.freeradbiomed.2013.08.191
   Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, PC195, DOI 10.1152/ajpcell.00217.2011
   Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965
   Gilliam LAA, 2011, AM J PHYSIOL-LUNG C, V300, PL225, DOI 10.1152/ajplung.00264.2010
   Gilliam LAA, 2011, MUSCLE NERVE, V43, P94, DOI 10.1002/mus.21809
   Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009
   Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861
   GOLDING EM, 1995, J EXP BIOL, V198, P1775
   Gouspillou G, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep08717
   Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752
   HEINEMAN FW, 1990, MAGN RESON MED, V13, P490, DOI 10.1002/mrm.1910130316
   Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82
   Hochman DJ, 2014, ENVIRON TOXICOL, V29, P908, DOI 10.1002/tox.21818
   Hoffman MC, 2013, J CLIN ONCOL, V31, P2799, DOI 10.1200/JCO.2012.47.8081
   Hoffmeister PA, 2013, BIOL BLOOD MARROW TR, V19, P1081, DOI 10.1016/j.bbmt.2013.04.017
   Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014
   Kim Sung-Hwan, 2013, LAB ANIM RES, V29, P204, DOI 10.5625/lar.2013.29.4.204
   Kumari KK, 2012, J BIOENERG BIOMEMBR, V44, P179, DOI 10.1007/s10863-012-9423-6
   Kushmerick MJ, 1997, AM J PHYSIOL-CELL PH, V272, PC1739, DOI 10.1152/ajpcell.1997.272.5.C1739
   Kwolek-Mirek M, 2015, CELL BIOCHEM BIOPHYS, V71, P1525, DOI 10.1007/s12013-014-0376-8
   Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863
   Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF
   Gomes PRL, 2014, REV BRAS GINECOL OBS, V36, P244
   Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001
   Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002
   Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045
   Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, PC457, DOI 10.1152/ajpcell.00237.2003
   McDonald C, 2011, CANCER FORUM, V35, P102
   Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233
   Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006
   Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211
   Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268
   Ness KK, 2012, CANCER-AM CANCER SOC, V118, P828, DOI 10.1002/cncr.26337
   Nishikawa T, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0131394
   Patterson RE, 2011, BREAST CANCER RES TR, V127, P541, DOI 10.1007/s10549-010-1236-x
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Petrick JL, 2014, J GERIATR ONCOL, V5, P359, DOI 10.1016/j.jgo.2014.06.002
   Petrick JL, 2014, CANCER CAUSE CONTROL, V25, P1179, DOI 10.1007/s10552-014-0421-3
   Rom O, 2013, FREE RADICAL BIO MED, V65, P190, DOI 10.1016/j.freeradbiomed.2013.06.024
   Saquib N, 2011, PSYCHO-ONCOLOGY, V20, P252, DOI 10.1002/pon.1742
   Sayed-Ahmed MM, 2014, INHI BITION OF GENE, V0, P0
   Sehl M, 2013, J CANCER SURVIV, V7, P20, DOI 10.1007/s11764-012-0239-5
   Sekeroglu V, 2011, ASIAN PAC J CANCER P, V12, P2925
   Sheean PM, 2012, BREAST CANCER RES TR, V135, P663, DOI 10.1007/s10549-012-2200-8
   Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102
   Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002
   Siegel MP, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026963
   Slater ME, 2015, BIOL BLOOD MARROW TR, V21, P1278, DOI 10.1016/j.bbmt.2015.04.007
   Smith LB, 2014, THE ROLE OF IL 1BETA, V0, P0
   Sun Y, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/170309
   Syrjala KL, 2010, J CANCER SURVIV, V4, P225, DOI 10.1007/s11764-010-0126-x
   Taylor D J, 1983, MOL BIOL MED, V1, P77
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006
   Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Wardell TM, 2003, MUTAT RES-FUND MOL M, V525, P19, DOI 10.1016/S0027-5107(02)00313-5
   Wei C, 2015, PEDIATR BLOOD CANCER, V62, P1992, DOI 10.1002/pbc.25601
   Winters-Stone KM, 2011, BREAST CANCER RES TR, V127, P447, DOI 10.1007/s10549-011-1444-z
   Zhu H, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17536
NR 87
TC 28
Z9 31
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2017
VL 12
IS 7
BP 
EP 
DI 10.1371/journal.pone.0181086
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA6HV
UT WOS:000405544800119
PM 28700655
DA 2024-11-01
ER

PT J
AU Melvin, RG
   Ballard, JWO
AF Melvin, Richard G.
   Ballard, John William O.
TI Cellular and population level processes influence the rate, accumulation and observed frequency of inherited and somatic mtDNA mutations
SO MUTAGENESIS
LA English
DT Review
ID mitochondrial-dna mutations; cytochrome-c-oxidase; purifying selection; transcriptional profiles; replication machinery; comparative genomics; germline mutation; polymerase-gamma; skeletal-muscle; control region
AB Mitochondria are found in all animals and have the unique feature of containing multiple copies of their own small, circular DNA genome (mtDNA). The rate and pattern of mutation accumulation in the mtDNA are influenced by molecular, cellular and population level processes. We distinguish between inherited and somatic mtDNA mutations and review evidence for the often-made assumption that mutations accumulate at a higher rate in mtDNA than in nuclear DNA (nDNA). We conclude that the whole genome mutation accumulation rate is higher for mtDNA than for nDNA but include the caveat that rates overlap considerably between the individual mtDNA- and nDNA-encoded genes. Next, we discuss the postulated causal mechanisms for the high rate of mtDNA mutation accumulation in both inheritance and in somatic cells. Perhaps unexpectedly, mtDNA is resilient to many mutagens of nDNA but is prone to errors of replication. We then consider the influence of maternal inheritance, recombination and selection on the observed accumulation pattern of inherited mtDNA mutations. Finally, we discuss environmental influences of temperature and diet on the observed frequency of inherited and somatic mtDNA mutations. We conclude that it is necessary to understand the cellular processes to fully interpret the pattern of mutations and how they influence our interpretations of evolution and disease.
C1 [Melvin, Richard G.; Ballard, John William O.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
C3 University of New South Wales Sydney
RP Melvin, RG (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
EM r.melvin@unsw.edu.au
FU Australian Research Council [DP160102575]
CR Akhmedov AT, 2015, MOL CELL BIOCHEM, V409, P283, DOI 10.1007/s11010-015-2532-x
   Alfadda AA, 2012, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2012/936486
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Angelova PR, 2016, FREE RADICAL BIO MED, V100, P81, DOI 10.1016/j.freeradbiomed.2016.06.005
   Arganda S, 2017, P ROY SOC B-BIOL SCI, V284, P0, DOI 10.1098/rspb.2016.2052
   ASAKAWA S, 1991, J MOL EVOL, V32, P511, DOI 10.1007/BF02102653
   Attene-Ramos MS, 2015, ENVIRON HEALTH PERSP, V123, P49, DOI 10.1289/ehp.1408642
   Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019
   Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x
   Ballard JWO, 2015, BIOSCIENCE REP, V35, P0, DOI 10.1042/BSR20150232
   Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x
   Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066
   Baris TZ, 2016, AM J PHYSIOL-REG I, V311, PR157, DOI 10.1152/ajpregu.00008.2016
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033
   Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6
   Blanchard JL, 1996, MOL BIOL EVOL, V13, P537, DOI 10.1093/oxfordjournals.molbev.a025614
   Branco AF, 2016, EUR J CLIN INVEST, V46, P285, DOI 10.1111/eci.12591
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Cagnone G, 2016, GENETICS, V202, P931, DOI 10.1534/genetics.115.181321
   Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040
   Charlesworth B, 2012, GENETICS, V190, P5, DOI 10.1534/genetics.111.134288
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Delgado AM, 2009, BMC EVOL BIOL, V9, P0, DOI 10.1186/1471-2148-9-49
   Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342
   Dixon GB, 2015, SCIENCE, V348, P1460, DOI 10.1126/science.1261224
   DOBZHANSKY T, 1955, COLD SPRING HARB SYM, V20, P1
   Drake JW, 1998, GENETICS, V148, P1667
   Dubay SG, 2014, MOL ECOL, V23, P3551, DOI 10.1111/mec.12836
   Duret L, 2009, PLOS BIOL, V7, P217, DOI 10.1371/journal.pbio.1000028
   Ellison CK, 2008, P NATL ACAD SCI USA, V105, P15831, DOI 10.1073/pnas.0804253105
   Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571
   Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662
   Fan WW, 2012, GENE DEV, V26, P384, DOI 10.1101/gad.175802.111
   Fealy CE, 2014, J APPL PHYSIOL, V117, P239, DOI 10.1152/japplphysiol.01064.2013
   Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007
   Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0
   Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x
   Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017
   GARESSE R, 1988, GENETICS, V118, P649
   Garvin MR, 2015, GENOME BIOL EVOL, V7, P1404, DOI 10.1093/gbe/evv078
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Gillespie JH, 2000, GENETICS, V155, P909
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2
   Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204
   Hagström E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865
   HESS ST, 1994, J MOL BIOL, V236, P1022, DOI 10.1016/0022-2836(94)90009-4
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Hoolahan AH, 2011, GENETICA, V139, P1509, DOI 10.1007/s10709-012-9650-0
   Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   James JE, 2016, MOL ECOL, V25, P67, DOI 10.1111/mec.13475
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Joers P, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053249
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Khrapko K, 2014, PROG MOL BIOL TRANSL, V127, P29, DOI 10.1016/B978-0-12-394625-6.00002-7
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Le Couteur DG, 2016, CELL MOL LIFE SCI, V73, P1237, DOI 10.1007/s00018-015-2120-y
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   Lee WTY, 2016, CELL DEATH DISCOV, V2, P0, DOI 10.1038/cddiscovery.2016.16
   Levin L, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00448
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li Q, 2016, J HUM GENET, V61, P1021, DOI 10.1038/jhg.2016.95
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lobon I, 2016, GENOME BIOL EVOL, V8, P2020, DOI 10.1093/gbe/evw124
   Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0
   Lynch M, 1998, GENETICA, V102-3, P29, DOI 10.1023/A:1017022522486
   Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834
   Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884
   Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050
   Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Mao M, 2014, MOL BIOL EVOL, V31, P636, DOI 10.1093/molbev/mst255
   Millar CD, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000209
   Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230
   Montooth KL, 2009, J MOL EVOL, V69, P94, DOI 10.1007/s00239-009-9255-0
   Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119
   Moriyama EN, 1997, J MOL EVOL, V45, P378, DOI 10.1007/PL00006243
   Mossman JA, 2016, GENETICS, V204, P613, DOI 10.1534/genetics.116.192328
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248
   Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006
   Patel MR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.16923
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Quintela M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0101821
   Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852
   Rand DM, 2001, GENETICS, V159, P173
   Rawson PD, 2002, P NATL ACAD SCI USA, V99, P12955, DOI 10.1073/pnas.202335899
   Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802
   Rollins LA, 2016, MOL BIOL EVOL, V33, P995, DOI 10.1093/molbev/msv343
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sackton TB, 2003, EVOLUTION, V57, P2315
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296
   Silva G, 2014, P ROY SOC B-BIOL SCI, V281, P0, DOI 10.1098/rspb.2014.1093
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Strakova A, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.14552
   Sung W, 2015, MOL BIOL EVOL, V32, P1672, DOI 10.1093/molbev/msv055
   Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175
   TURELLI M, 1992, GENETICS, V132, P713
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Uchimura A, 2015, GENOME RES, V25, P1125, DOI 10.1101/gr.186148.114
   Valente WJ, 2016, NUCLEIC ACIDS RES, V44, P8513, DOI 10.1093/nar/gkw716
   Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375
   Venn O, 2014, SCIENCE, V344, P1272, DOI 10.1126/science.344.6189.1272
   Wahl D, 2016, AGEING RES REV, V31, P80, DOI 10.1016/j.arr.2016.06.006
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Werren John H, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202
   Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yao Z, 2013, ONCOGENE, V32, P2592, DOI 10.1038/onc.2012.259
   Yee WKW, 2013, CURR BIOL, V23, PR55, DOI 10.1016/j.cub.2012.12.002
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
NR 150
TC 13
Z9 15
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD MAY 15
PY 2017
VL 32
IS 3
BP 323
EP 334
DI 10.1093/mutage/gex004
PG 12
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA EU2PX
UT WOS:000400872500001
PM 28521046
DA 2024-11-01
ER

PT J
AU Ahmed, ST
   Alston, CL
   Hopton, S
   He, LP
   Hargreaves, IP
   Falkous, G
   Oláhová, M
   McFarland, R
   Turnbull, DM
   Rocha, MC
   Taylor, RW
AF Ahmed, Syeda T.
   Alston, Charlotte L.
   Hopton, Sila
   He, Langping
   Hargreaves, Iain P.
   Falkous, Gavin
   Olahova, Monika
   McFarland, Robert
   Turnbull, Doug M.
   Rocha, Mariana C.
   Taylor, Robert W.
TI Using a quantitative quadruple immunofluorescent assay to diagnose isolated mitochondrial Complex I deficiency
SO SCIENTIFIC REPORTS
LA English
DT Article
ID assembly factor; leigh-syndrome; dna mutation; g13513a mutation; nd5 gene; melas; identification; subunits; tmem126b; children
AB Isolated Complex I (CI) deficiency is the most commonly observed mitochondrial respiratory chain biochemical defect, affecting the largest OXPHOS component. CI is genetically heterogeneous; pathogenic variants affect one of 38 nuclear-encoded subunits, 7 mitochondrial DNA (mtDNA)-encoded subunits or 14 known CI assembly factors. The laboratory diagnosis relies on the spectrophotometric assay of enzyme activity in mitochondrially-enriched tissue homogenates, requiring at least 50 mg skeletal muscle, as there is no reliable histochemical method for assessing CI activity directly in tissue cryosections. We have assessed a validated quadruple immunofluorescent OXPHOS (IHC) assay to detect CI deficiency in the diagnostic setting, using 10 mu m transverse muscle sections from 25 patients with genetically-proven pathogenic CI variants. We observed loss of NDUFB8 immunoreactivity in all patients with mutations affecting nuclear-encoding structural subunits and assembly factors, whilst only 3 of the 10 patients with mutations affecting mtDNA-encoded structural subunits showed loss of NDUFB8, confirmed by BN-PAGE analysis of CI assembly and IHC using an alternative, commercially-available CI (NDUFS3) antibody. The IHC assay has clear diagnostic potential to identify patients with a CI defect of Mendelian origins, whilst highlighting the necessity of complete mitochondrial genome sequencing in the diagnostic work-up of patients with suspected mitochondrial disease.
C1 [Ahmed, Syeda T.; Alston, Charlotte L.; Hopton, Sila; He, Langping; Falkous, Gavin; Olahova, Monika; McFarland, Robert; Turnbull, Doug M.; Rocha, Mariana C.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alston, Charlotte L.; Hopton, Sila; He, Langping; Falkous, Gavin; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hargreaves, Iain P.] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England.
   [Hargreaves, Iain P.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.
   [Rocha, Mariana C.] Univ London, Kings Coll London, BHF Ctr Res Excellence, James Black Ctr, 125 Coldharbour Lane, London SE5 9NU, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Liverpool John Moores University; University of London; King's College London
RP Taylor, RW (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.; Taylor, RW (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; National Institute for Health Research (NIHR) [NIHR-HCS-D12-03-04]; MRC [MR/L016354/1, G0800674, MC_G0802536, MR/K000608/1, G0700718] Funding Source: UKRI
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2016, J MED GENET, V53, P634, DOI 10.1136/jmedgenet-2015-103576
   Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509
   Gorman GS, 1979, CLIN SCI LONDON ENGL, V128, P895
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leman G, 2015, INT J BIOCHEM CELL B, V65, P91, DOI 10.1016/j.biocel.2015.05.017
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Perales-Clemente E, 2010, MOL CELL BIOL, V30, P3038, DOI 10.1128/MCB.00025-10
   Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Sánchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 47
TC 14
Z9 14
U1 0
U2 3
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD NOV 15
PY 2017
VL 7
IS 
BP 
EP 
DI 10.1038/s41598-017-14623-2
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM7NQ
UT WOS:000415266100025
PM 29142257
DA 2024-11-01
ER

PT J
AU Saneto, RP
AF Saneto, Russell P.
TI Genetics of Mitochondrial Disease
SO ADVANCES IN GENETICS, VOL 98
LA English
DT Review; Book Chapter
ID progressive external ophthalmoplegia; hereditary optic neuropathy; impair mtdna replication; kearns-sayre syndrome; loss-of-function; clinical-features; mutations cause; intramitochondrial fibers; severe hypermetabolism; dna characteristics
AB Mitochondria are intracellular organelles responsible for adenosine triphosphate production. The strict control of intracellular energy needs require proper mitochondrial functioning. The mitochondria are under dual controls of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA). Mitochondrial dysfunction can arise from changes in either mtDNA or nDNA genes regulating function. There are an estimated similar to 1500 proteins in the mitoproteome, whereas the mtDNA genome has 37 proteins. There are, to date, similar to 275 genes shown to give rise to disease. The unique physiology of mitochondrial functioning contributes to diverse gene expression. The onset and range of phenotypic expression of disease is diverse, with onset from neonatal to seventh decade of life. The range of dysfunction is heterogeneous, ranging from single organ to multisystem involvement. The complexity of disease expression has severely limited gene discovery. Combining phenotypes with improvements in gene sequencing strategies are improving the diagnosis process. This chapter focuses on the interplay of the unique physiology and gene discovery in the current knowledge of genetically derived mitochondrial disease.
C1 [Saneto, Russell P.] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; Seattle Children's Hospital
RP Saneto, RP (corresponding author), Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA.
EM russ.saneto@seattlechildrens.org
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bratic A, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006028
   Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026
   Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cao LQ, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000756
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430
   Christian B, 2009, MOL CELL, V35, P400, DOI 10.1016/j.molcel.2009.08.003
   CLARK DS, 1975, CHEST, V68, P727, DOI 10.1378/chest.68.5.727
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DiMauro SHM, 2015, GENEREVIEWS, V0, P0
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Ding Y, 2013, BIOCHEM GENET, V51, P588, DOI 10.1007/s10528-013-9589-6
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Farge G, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2001
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   GALLASTEGUI J, 1987, AM J CARDIOL, V60, P385, DOI 10.1016/0002-9149(87)90255-4
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano L, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.364
   Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Groto Y, 1990, NATURE, V348, P651
   Guda Purnima, 2007, GENOMICS PROTEOMICS & BIOINFORMATICS, V5, P166, DOI 10.1016/S1672-0229(08)60004-2
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HAYDAR NA, 1971, ANN INTERN MED, V74, P548, DOI 10.7326/0003-4819-74-4-548
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 1996, HANDBOOK OF MUSCLE DISEASE, V0, P479
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2012, J INHERIT METAB DIS, V35, P679, DOI 10.1007/s10545-011-9434-1
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   KASAMATSU H, 1974, ANNU REV BIOCHEM, V43, P695, DOI 10.1146/annurev.bi.43.070174.003403
   KAWAI H, 1995, MUSCLE NERVE, V18, P753, DOI 10.1002/mus.880180712
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   KOEHLER CM, 1991, GENETICS, V129, P247
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Koopman Werner J H, 2010, ANTIOXID REDOX SIGNAL, V12, P1431, DOI 10.1089/ars.2009.2743
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X
   Lehmann D, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000113
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435
   Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0
   Majamaa PG, 2012, COCHRANE LIB, V0, P0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McKelvie P, 2012, J CLIN NEUROSCI, V19, P195, DOI 10.1016/j.jocn.2011.09.009
   Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mordaunt DA, 2015, AM J MED GENET A, V167, P1330, DOI 10.1002/ajmg.a.36968
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Ng YS, 2016, J MED GENET, V53, P768, DOI 10.1136/jmedgenet-2016-103910
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   OBRIEN TW, 1971, J BIOL CHEM, V246, P3409
   Ojala D, 1981, NATURE, V290, P246
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   SHAPIRA Y, 1977, ISRAEL J MED SCI, V13, P161
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   SPIRO AJ, 1970, ARCH NEUROL-CHICAGO, V23, P103, DOI 10.1001/archneur.1970.00480260009002
   Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Swalwell H, 2011, EUROPEAN J HUMAN GEN, V19, P169
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284
   Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923
   Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528
   Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2001, THE METABOLIC AND MOLECULAR BASIS OF INHERITED DISEASE, V0, P2425
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe K, 2011, J NUCLEIC ACIDS, V2011, P0, DOI 10.4061/2011/623095
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, MITOCHONDRIAL CASE S, V0, P55
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
NR 218
TC 14
Z9 16
U1 0
U2 5
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2660
EI 
J9 ADV GENET
JI Adv. Genet.
PD JUN 15
PY 2017
VL 98
IS 
BP 63
EP 116
DI 10.1016/bs.adgen.2017.06.002
PG 54
WC Genetics & Heredity
SC Genetics & Heredity
GA BI7LS
UT WOS:000414415300003
PM 28942795
DA 2024-11-01
ER

PT J
AU Suzuki, J
   Iwata, M
   Moriyoshi, H
   Nishida, S
   Yasuda, T
   Ito, Y
AF Suzuki, Junichiro
   Iwata, Mai
   Moriyoshi, Hideyuki
   Nishida, Suguru
   Yasuda, Takeshi
   Ito, Yasuhiro
TI Familial Pernicious Chronic Intestinal Pseudo-obstruction with a Mitochondrial DNA A3243G Mutation
SO INTERNAL MEDICINE
LA English
DT Article
DE chronic intestinal pseudo-obstruction; mitochondrial DNA A3243G mutation; MELAS; familial occurrence
ID stroke-like episodes; lactic-acidosis; gastrointestinal-tract; prominent degeneration; melas; encephalomyopathy; encephalopathy; pathology; myopathy; diseases
AB We report the case of a mother and two children who shared a mitochondrial DNA A3243G mutation. The mother had diabetes mellitus, neurogenic bladder, bradykinesia, dystonia, and slowly progressive cerebellar ataxia. Her two daughters were diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes at adolescence. They all presented with gastrointestinal symptoms at an advanced clinical stage. They were diagnosed with chronic intestinal pseudo-obstruction, and they were resistant to therapy. The mother and her youngest daughter died from aspiration pneumonia because of vomiting. The determination of chronic intestinal pseudo-obstruction is an important prognostic factor in patients with the mitochondrial DNA A3243G variant.
C1 [Suzuki, Junichiro; Iwata, Mai; Moriyoshi, Hideyuki; Nishida, Suguru; Yasuda, Takeshi; Ito, Yasuhiro] TOYOTA Mem Hosp, Dept Neurol, Toyota, Japan.
RP Suzuki, J (corresponding author), TOYOTA Mem Hosp, Dept Neurol, Toyota, Japan.
EM junichiro_suzuki@mail.toyota.co.jp
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Chinnery PF, 2001, GUT, V48, P121, DOI 10.1136/gut.48.1.121
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Hara K, 1994, RINSHO SHINKEIGAKU, V34, P361
   HESS J, 1995, LANCET, V346, P189, DOI 10.1016/S0140-6736(95)91251-7
   Hiel JAP, 1998, NETH J MED, V53, P27, DOI 10.1016/S0300-2977(98)00018-7
   Hirano I, 2000, DIGEST DIS, V18, P83, DOI 10.1159/000016969
   Hom XB, 2004, MITOCHONDRION, V4, P601, DOI 10.1016/j.mito.2004.07.014
   KAGEYAMA Y, 1991, ACTA NEUROPATHOL, V83, P99, DOI 10.1007/BF00294438
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Kobayashi Z, 2005, INTERNAL MED, V44, P328, DOI 10.2169/internalmedicine.44.328
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Kuroiwa T, 1998, ACTA NEUROPATHOL, V96, P86, DOI 10.1007/s004010050863
   Lee YC, 2009, EUR J NEUROL, V16, P513, DOI 10.1111/j.1468-1331.2008.02524.x
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Ohkubo H, 2012, DIGESTION, V86, P12, DOI 10.1159/000337528
   Petruzzella V, 2004, CLIN GENET, V65, P64, DOI 10.1111/j..2004.00185.x
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
NR 26
TC 8
Z9 8
U1 0
U2 1
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PD JUN 15
PY 2017
VL 56
IS 9
BP 1089
EP 1093
DI 10.2169/internalmedicine.56.7753
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EU3JR
UT WOS:000400925800017
PM 28458318
DA 2024-11-01
ER

PT J
AU Limongelli, G
   Masarone, D
   Pacileo, G
AF Limongelli, Giuseppe
   Masarone, Daniele
   Pacileo, Giuseppe
TI Mitochondrial disease and the heart
SO HEART
LA English
DT Article
ID parkinson-white-syndrome; cardiac involvement; clinical spectrum; catheter ablation; dna mutations; diagnosis; adults; exercise; cardiomyopathy; myopathy
C1 [Limongelli, Giuseppe; Masarone, Daniele; Pacileo, Giuseppe] Univ Naples 2, AORN Colli, Osped Monaldi, Naples, Italy.
C3 Universita della Campania Vanvitelli
RP Limongelli, G (corresponding author), Seconda Univ Napoli, AO Colli, Osped Monaldi, Cardiol Riabilitat, I-80100 Naples, Italy.
EM limongelligiuseppe@libero.it
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Baik R, 2012, J PAEDIATR CHILD H, V48, P1016, DOI 10.1111/j.1440-1754.2012.02585.x
   Banner NR, 2011, HEART, V97, P1520, DOI 10.1136/heartjnl-2011-300048
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2
   Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248
   Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Florian A, 2015, J CARDIOVASC MAGN R, V17, P0, DOI 10.1186/s12968-015-0145-x
   Gersh BJ, 2011, J AM COLL CARDIOL, V58, PE212, DOI 10.1016/j.jacc.2011.06.011
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Jose T, 2011, INT J CARDIOL, V149, PE24, DOI 10.1016/j.ijcard.2009.03.057
   Kim JT, 2009, ACTA PAEDIATR, V98, P1825, DOI 10.1111/j.1651-2227.2009.01428.x
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI 10.2217/fca.11.79
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Montaigne David, 2015, CARD ELECTROPHYSIOL CLIN, V7, P293, DOI 10.1016/j.ccep.2015.03.008
   Muller-Hocker J, 1998, MODERN PATHOL, V11, P295
   Naviaux RK, 2000, EUR J PEDIATR, V159, PS219, DOI 10.1007/PL00014407
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Page RL, 2016, CIRCULATION, V133, PE471, DOI 10.1161/CIR.0000000000000310
   Pappone C, 2003, NEW ENGL J MED, V349, P1803, DOI 10.1056/NEJMoa035345
   Pappone C, 2014, CIRCULATION, V130, P811, DOI 10.1161/CIRCULATIONAHA.114.011154
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316
   Rapezzi C, 2013, EUR HEART J, V34, P1448, DOI 10.1093/eurheartj/ehs397
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Scaglia F, 2012, METHODS MOL BIOL, V837, P17, DOI 10.1007/978-1-61779-504-6_2
   Schmauss D, 2007, PEDIATR TRANSPLANT, V11, P560, DOI 10.1111/j.1399-3046.2007.00719.x
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stalder N, 2012, CIRC-HEART FAIL, V5, PE1, DOI 10.1161/CIRCHEARTFAILURE.111.963900
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Todd DM, 2003, J AM COLL CARDIOL, V41, P245, DOI 10.1016/S0735-1097(02)02707-9
   Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569
   TVESKOV C, 1990, NEUROLOGY, V40, P553
   Vaughan CJ, 2003, J CARDIOVASC ELECTR, V14, P263, DOI 10.1046/j.1540-8167.2003.02394.x
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Weisz SH, 2010, CONGENIT HEART DIS, V5, P384, DOI 10.1111/j.1747-0803.2010.00446.x
NR 70
TC 24
Z9 24
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD MAR 15
PY 2017
VL 103
IS 5
BP 392
EP 400
DI 10.1136/heartjnl-2015-308193
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EN0AE
UT WOS:000395671900014
PM 27821705
DA 2024-11-01
ER

PT J
AU Phillips, AF
   Millet, AR
   Tigano, M
   Dubois, SM
   Crimmins, H
   Babin, L
   Charpentier, M
   Piganeau, M
   Brunet, E
   Sfeir, A
AF Phillips, Aaron F.
   Millet, Armel R.
   Tigano, Marco
   Dubois, Sonia M.
   Crimmins, Hannah
   Babin, Loelia
   Charpentier, Marine
   Piganeau, Marion
   Brunet, Erika
   Sfeir, Agnel
TI Single-Molecule Analysis of mtDNA Replication Uncovers the Basis of the Common Deletion
SO MOLECULAR CELL
LA English
DT Article
ID human mitochondrial-dna; progressive external ophthalmoplegia; double-strand breaks; lagging-strand; direct repeats; ligase iii; saccharomyces-cerevisiae; mammalian mitochondria; oxidative stress; 4977-bp deletion
AB Mutations in mtDNA lead to muscular and neurological diseases and are linked to aging. The most frequent aberrancy is the "common deletion'' that involves a 4,977-bp region flanked by 13-bp repeats. To investigate the basis of this deletion, we developed a single-molecule mtDNA combing method. The analysis of replicating mtDNA molecules provided in vivo evidence in support of the asymmetric mode of replication. Furthermore, we observed frequent fork stalling at the junction of the common deletion, suggesting that impaired replication triggers the formation of this toxic lesion. In parallel experiments, we employed mito-TALENs to induce breaks in distinct loci of the mitochondrial genome and found that breaks adjacent to the 5' repeat trigger the common deletion. Interestingly, this process was mediated by the mitochondrial replisome independent of canonical DSB repair. Altogether, our data underscore a unique replication-dependent repair pathway that leads to the mitochondrial common deletion.
C1 [Phillips, Aaron F.; Tigano, Marco; Crimmins, Hannah; Sfeir, Agnel] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA.
   [Millet, Armel R.; Dubois, Sonia M.; Babin, Loelia; Charpentier, Marine; Piganeau, Marion; Brunet, Erika] Museum Natl Hist Nat, Struct & Instabilite Genomes, INSERM, CNRS,U1154,UMR 7196, F-75005 Paris, France.
   [Millet, Armel R.; Babin, Loelia; Brunet, Erika] Inst Imagine, INSERM, UMR 1163, Genome Dynam Immune Syst Lab, F-75015 Paris, France.
C3 New York University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Sfeir, A (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA.; Brunet, E (corresponding author), Museum Natl Hist Nat, Struct & Instabilite Genomes, INSERM, CNRS,U1154,UMR 7196, F-75005 Paris, France.; Brunet, E (corresponding author), Inst Imagine, INSERM, UMR 1163, Genome Dynam Immune Syst Lab, F-75015 Paris, France.
EM erika.brunet@inserm.fr; agnel.sfeir@med.nyu.edu
FU Human Frontier Science Program [HFSP RGY0088]; David and Lucile Packard Foundation; Damon Runyon-Rachleff innovator award; NIH [2T32GM007238-39]; Le Canceropole IdF; La Ligue Contre le Cancer; Fondation pour la Recherche Medicale [FDT20160435361]; Genome Technology Center (GTC); Perlmutter Cancer Center at NYU Langone Medical Center
CR Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, PR632, DOI 10.1152/ajpregu.00853.2010
   Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539
   Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hou JH, 1998, MUTAT RES-FUND MOL M, V403, P75, DOI 10.1016/S0027-5107(98)00054-2
   Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   KONG DC, 1994, J BACTERIOL, V176, P5904, DOI 10.1128/jb.176.19.5904-5911.1994
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kühl I, 2014, NATURE, V514, PE7, DOI 10.1038/nature13690
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, PW242, DOI 10.1093/nar/gkw290
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Murgha YE, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094752
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603
   Oh S, 2014, DNA REPAIR, V21, P97, DOI 10.1016/j.dnarep.2014.04.015
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077
   Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stein A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005664
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wu Y, 2014, BIOCHEM BIOPH RES CO, V446, P261, DOI 10.1016/j.bbrc.2014.02.099
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Yu M, 2001, J BACTERIOL, V183, P1862, DOI 10.1128/JB.183.6.1862-1869.2001
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
NR 70
TC 92
Z9 103
U1 1
U2 30
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD FEB 2
PY 2017
VL 65
IS 3
BP 527
EP +
DI 10.1016/j.molcel.2016.12.014
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EO1BA
UT WOS:000396431400016
PM 28111015
DA 2024-11-01
ER

PT J
AU Jedrak, P
   Sowa, N
   Baranska, S
   Wegrzyn, G
AF Jedrak, Paulina
   Sowa, Natalia
   Baranska, Sylwia
   Wegrzyn, Grzegorz
TI Characterization of conditions and determination of practical tips for mtDNA level estimation in various human cells
SO ACTA BIOCHIMICA POLONICA
LA English
DT Article
DE mtDNA level; leukocytes; fibroblasts; qPCR methodology; Huntington disease
ID mitochondrial-dna content; peripheral-blood; huntingtons-disease; skeletal-muscle; copy number; leukocytes; depletion; quantification; diagnosis; increase
AB Determination of mtDNA copy number in the cell is crucial to understand many cellular processes. Recently, the number of studies with the use of mitochondrial DNA (mtDNA) content as the determinant of mitochondrial abnormalities increased greatly and is still growing, therefore, optimization of technical conditions for this analysis is crucial. Despite using similar laboratory protocols, some results cannot be compared between research centers, thus causing discrepancies in the assessment of mtDNA content. The aim of this work was to test which conditions of biological sample collection and storage affect estimation of mtDNA level relative to the nuclear DNA (nDNA) in the blood samples and dermal fibroblasts. We found that the time and temperature of sample storage, as well as the type of the blood sample (whole blood or leukocytes) influence the estimate of mtDNA/nDNA ratio in the blood. In the case of dermal fibroblasts collected from healthy control and Huntington disease patients, our data indicate that the passage number of cells is essential to obtain reliable results.
C1 [Jedrak, Paulina; Sowa, Natalia; Baranska, Sylwia; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, Gdansk, Poland.
   [Sowa, Natalia] Univ Gdansk, Dept Med Biol & Genet, Wita Stwosza 59, PL-80308 Gdansk, Poland.
   [Baranska, Sylwia] Univ Gdansk, Dept Bacterial Mol Genet, Wita Stwosza 59, PL-80308 Gdansk, Poland.
C3 Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk
RP Jedrak, P (corresponding author), Univ Gdansk, Dept Mol Biol, Gdansk, Poland.
EM paulina.jedrak@biol.ug.edu.pl
FU National Science Center (Poland) [2015/17/N/NZ2/04267, 2011/03/B/NZ2/01422]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Battersby BJ, 1998, AM J PHYSIOL-REG I, V275, PR905, DOI 10.1152/ajpregu.1998.275.3.R905
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093
   Chen S, 2015, BMC PSYCHIATRY, V15, P0, DOI 10.1186/s12888-015-0432-y
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719
   Gonzalez-Hunt Claudia P, 2016, CURR PROTOC TOXICOL, V67, P0, DOI 10.1002/0471140856.tx2011s67
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Huang J, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000003323
   Jedrak P, 2017, METAB BRAIN DIS, V32, P1237, DOI 10.1007/s11011-017-0026-0
   KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Liu CS, 2008, J NEUROL SCI, V264, P18, DOI 10.1016/j.jns.2007.07.016
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Malik AN, 2009, DIABETES RES CLIN PR, V86, P22
   Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210
   Meissner C, 2000, FORENSIC SCI INT, V113, P109, DOI 10.1016/S0379-0738(00)00249-8
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Nicholls David, 2002, SCI AGING KNOWLEDGE ENVIRON, V2002, P0
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   Wojtczak L, 2008, DRUG-INDUCED MITOCHONDRIAL DYSFUNCTION, V0, P0
   Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6
   YMD LO, 2006, ANN NY ACAD SCI, V945, P1
   ZHANG H, 1994, MOL PHARMACOL, V46, P1063
NR 32
TC 4
Z9 5
U1 0
U2 2
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
EI 1734-154X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PD JUN 15
PY 2017
VL 64
IS 4
BP 699
EP 704
DI 10.18388/abp.2017_2303
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FQ2AJ
UT WOS:000418158700018
PM 29240846
DA 2024-11-01
ER

PT J
AU Ng, YS
   Taylor, RW
   Schaefer, AM
AF Ng, Yi Shiau
   Taylor, Robert W.
   Schaefer, Andrew M.
TI Diabetes Mellitus in Mitochondrial Disease
SO DIABETES ASSOCIATED WITH SINGLE GENE DEFECTS AND CHROMOSOMAL ABNORMALITIES
LA English
DT Article; Book Chapter
ID trna(leu(uur)) gene; m.3243a-greater-than-g mutation; clinical-features; dna mutation; mtdna mutation; point mutation; beta-cells; deafness; adults; spectrum
AB Mitochondrial diseases arise as a consequence of respiratory chain dysfunction caused by mutations in the mitochondrial genome (mtDNA) or nuclear-encoded mitochondrial genes. Multisystem involvement is a hallmark of many subtypes of mitochondrial disease in which energy-dependent organs including the brain, skeletal muscles, and heart are commonly affected. The most common mitochondrial genotype that causes diabetes mellitus is a single nucleotide substitution (m.3243A>G) in the mitochondrial tRNA(Leu(UUR)) gene which is linked to a distinctive clinical phenotype-maternally inherited diabetes and deafness. Diabetes mellitus often arises insidiously as part of the clinical presentation associated with mitochondrial disease; however, there are unique clinical features and associated complications compared to other diabetes subtypes. Overall, the treatment of patients with mitochondrial diabetes is similar to those with other causes of diabetes but with additional emphasis on the screening and subsequent management of additional multiorgan involvement. (C) 2017 S. Karger AG, Basel
C1 [Ng, Yi Shiau; Taylor, Robert W.; Schaefer, Andrew M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW; Schaefer, AM (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@newcastle.ac.uk; andrew.schaefer@nuth.nhs.uk
CR [Anonymous], 2013, QUAL OUTC FRAM ACH P, V0, P0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Brändle M, 2001, DIABETES CARE, V24, P1253, DOI 10.2337/diacare.24.7.1253
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Feigl B, 2013, CAN J OPHTHALMOL, V48, PE111, DOI 10.1016/j.jcjo.2013.02.013
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Holmes-Walker DJ, 1998, DIABETIC MED, V15, P946, DOI 10.1002/(SICI)1096-9136(1998110)15:11<946::AID-DIA707>3.0.CO;2-L
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Iwasaki N, 2001, J HUM GENET, V46, P330, DOI 10.1007/s100380170068
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Massin P, 2008, DIABETOLOGIA, V51, P1664, DOI 10.1007/s00125-008-1073-1
   Momiyama Y, 2002, DIABETES CARE, V25, P2308, DOI 10.2337/diacare.25.12.2308
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Otabe S, 1999, BIOCHEM BIOPH RES CO, V259, P149, DOI 10.1006/bbrc.1999.0650
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   Ueno H, 1999, JPN CIRC J, V63, P877, DOI 10.1253/jcj.63.877
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   WALKER M, 1995, DIABETES CARE, V18, P1507, DOI 10.2337/diacare.18.11.1507
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 49
TC 1
Z9 1
U1 0
U2 1
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 0251-5342
EI 
J9 FRONT DIABETES
JI Front.Diabetes
PD JUN 15
PY 2017
VL 25
IS 
BP 55
EP 68
DI 10.1159/000454701
PG 14
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI4YX
UT WOS:000412098300006
DA 2024-11-01
ER

PT J
AU Lin, DS
   Kao, SH
   Ho, CS
   Wei, YH
   Hung, PL
   Hsu, MH
   Wu, TY
   Wang, TJ
   Jian, YR
   Lee, TH
   Chiang, MF
AF Lin, Dar-Shong
   Kao, Shu-Huei
   Ho, Che-Sheng
   Wei, Yau-Huei
   Hung, Pi-Lien
   Hsu, Mei-Hsin
   Wu, Tsu-Yen
   Wang, Tuan-Jen
   Jian, Yuan-Ren
   Lee, Tsung-Han
   Chiang, Ming-Fu
TI Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial disease
SO ONCOTARGET
LA English
DT Article
DE mitochondrial diseases; oxidative phosphorylation; bioenergetics; AMPK; metabolic inflexibility; Autophagy
ID fatty-acid oxidation; pyruvate-dehydrogenase activity; mouse model; complex i; skeletal-muscle; energy-metabolism; lactic-acidosis; gene-expression; beta-oxidation; mutation
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is most commonly caused by the A3243G mutation of mitochondrial DNA. The capacity to utilize fatty acid or glucose as a fuel source and how such dynamic switches of metabolic fuel preferences and transcriptional modulation of adaptive mechanism in response to energy deficiency in MELAS syndrome have not been fully elucidated. The fibroblasts from patients with MELAS syndrome demonstrated a remarkable deficiency of electron transport chain complexes I and IV, an impaired cellular biogenesis under glucose deprivation, and a decreased ATP synthesis. In situ analysis of the bioenergetic properties of MELAS cells demonstrated an attenuated fatty acid oxidation that concomitantly occurred with impaired mitochondrial respiration, while energy production was mostly dependent on glycolysis. Furthermore, the transcriptional modulation was mediated by the AMP-activated protein kinase (AMPK) signaling pathway, which activated its downstream modulators leading to a subsequent increase in glycolytic flux through activation of pyruvate dehydrogenase. In contrast, the activities of carnitine palmitoyltransferase for fatty acid oxidation and acetyl-CoA carboxylase-1 for fatty acid synthesis were reduced and transcriptional regulation factors for biogenesis were not altered. These results provide novel information that MELAS cells lack the adaptive mechanism to switch fuel source from glucose to fatty acid, as glycolysis rates increase in response to energy deficiency. The aberrant secondary cellular responses to disrupted metabolic homeostasis mediated by AMPK signaling pathway may contribute to the development of the clinical phenotype.
C1 [Lin, Dar-Shong; Ho, Che-Sheng] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.
   [Lin, Dar-Shong; Wei, Yau-Huei] Mackay Med Coll, Inst Biomed Sci, Dept Med, New Taipei, Taiwan.
   [Kao, Shu-Huei] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.
   [Hung, Pi-Lien; Hsu, Mei-Hsin] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat Neurol, Kaohsiung, Taiwan.
   [Wu, Tsu-Yen; Jian, Yuan-Ren; Lee, Tsung-Han] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
   [Wang, Tuan-Jen] Mackay Mem Hosp, Dept Lab Med, Taipei, Taiwan.
   [Chiang, Ming-Fu] Mackay Mem Hosp, Dept Neurosurg, Taipei, Taiwan.
   [Chiang, Ming-Fu] Mackay Med Nursing & Management Coll, Taipei, Taiwan.
   [Chiang, Ming-Fu] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan.
   [Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua, Taiwan.
C3 Mackay Memorial Hospital; Mackay Medical College; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Changhua Christian Hospital
RP Lin, DS (corresponding author), Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.; Lin, DS (corresponding author), Mackay Med Coll, Inst Biomed Sci, Dept Med, New Taipei, Taiwan.; Chiang, MF (corresponding author), Mackay Mem Hosp, Dept Neurosurg, Taipei, Taiwan.; Chiang, MF (corresponding author), Mackay Med Nursing & Management Coll, Taipei, Taiwan.; Chiang, MF (corresponding author), Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan.
EM dslin@mmh.org.tw; chiang66@gmail.com
FU Ministry of Science and Technology [MOST-102-2314-B-195-005-MY3, MOST-105-2314-B-195-011-MY2]; Mackay Memorial Hospital [MMH-E-104-02, MMH-E-105-02, MMH-E-106-02, MMH-CT-10410, MMH-CT-10510, MMH-106-114]
CR Athéa Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187
   Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Das KC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073358
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475
   Francis BM, 2014, J ALZHEIMERS DIS, V39, P347, DOI 10.3233/JAD-131499
   Fukushima A, 2016, AM J PHYSIOL-HEART C, V311, PH347, DOI 10.1152/ajpheart.00900.2015
   Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, PE1009, DOI 10.1152/ajpendo.90558.2008
   Gargus JJ, 2003, J INHERIT METAB DIS, V26, P659, DOI 10.1023/B:BOLI.0000005659.52200.c1
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Huang Y, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128561
   Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203
   Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, PE1242, DOI 10.1152/ajpendo.00382.2007
   Kong XX, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011707
   Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007
   Kühn K, 2015, PLANT PHYSIOL, V168, P1537, DOI 10.1104/pp.15.00589
   Lanning NJ, 2014, CELL REP, V7, P907, DOI 10.1016/j.celrep.2014.03.065
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Liemburg-Apers DC, 2015, BIOPHYS J, V109, P1372, DOI 10.1016/j.bpj.2015.08.002
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Mende S, 2011, NEUROL RES, V33, P638, DOI 10.1179/1743132810Y.0000000016
   Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863
   Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Rato L, 2014, BBA-BIOENERGETICS, V1837, P335, DOI 10.1016/j.bbabio.2013.12.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074
   Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Touw CML, 2014, BBA-MOL BASIS DIS, V1842, P2021, DOI 10.1016/j.bbadis.2014.05.032
   Venizelos N, 1998, J INHERIT METAB DIS, V21, P409, DOI 10.1023/A:1005310809714
   Wang P, 2015, ONCOTARGET, V6, P3947, DOI 10.18632/oncotarget.2968
   Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang WX, 2015, NEUROCHEM RES, V40, P1576, DOI 10.1007/s11064-015-1630-1
   Zhang S, 2014, NUTR METAB, V11, P0, DOI 10.1186/1743-7075-11-10
   Zhang Z, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069282
NR 51
TC 19
Z9 20
U1 0
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD SEP 26
PY 2017
VL 8
IS 43
BP 73627
EP 73639
DI 10.18632/oncotarget.20617
PG 13
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA FI2HT
UT WOS:000411760400024
PM 29088732
DA 2024-11-01
ER

PT J
AU Szczepanowska, K
   Trifunovic, A
AF Szczepanowska, Karolina
   Trifunovic, Aleksandra
TI Origins of mtDNA mutations in ageing
SO BIOLOGICAL MECHANISMS OF AGEING
LA English
DT Review; Book Chapter
ID dna-polymerase-gamma; base excision-repair; mitochondrial deletion mutants; endogenous oxidative damage; antiretroviral therapy; clonal expansion; skeletal-muscle; life-span; in-vivo; accumulation
AB MtDNA mutations are one of the hallmarks of ageing and age-related diseases. It is well established that somatic point mutations accumulate in mtDNA of multiple organs and tissues with increasing age and heteroplasmy is universal in mammals. However, the origin of these mutations remains controversial. The long-lasting hypothesis stating that mtDNA mutations emanate from oxidative damage via a self-perpetuating mechanism has been extensively challenged in recent years. Contrary to this initial ascertainment, mtDNA appears to be well protected from action of reactive oxygen species (ROS) through robust protein coating and endomitochondrial microcompartmentalization. Extensive development of scrupulous high-throughput DNA sequencing methods suggests that an imperfect replication process, rather than oxidative lesions are the main sources of mtDNA point mutations, indicating that mtDNA polymerase. (POLG) might be responsible for the majority of mtDNA mutagenic events. Here, we summarize the recent knowledge in prevention and defence of mtDNA oxidative lesions and discuss the plausible mechanisms of mtDNA point mutation generation and fixation.
C1 [Szczepanowska, Karolina; Trifunovic, Aleksandra] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.
   [Szczepanowska, Karolina; Trifunovic, Aleksandra] Univ Cologne, Inst Mitochondrial Dis & Aging, Fac Med, D-50931 Cologne, Germany.
   [Trifunovic, Aleksandra] Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne
RP Trifunovic, A (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.; Trifunovic, A (corresponding author), Univ Cologne, Inst Mitochondrial Dis & Aging, Fac Med, D-50931 Cologne, Germany.; Trifunovic, A (corresponding author), Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
EM aleksandra.trifunovic@uk-koeln.de
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alexeyev M, 2013, COLD SPRING HARB PERSPECT BIOL, V5, P0, DOI 10.1101/CSHPERSPECT.A012641
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355
   Appelhans T, 2012, NANO LETT, V12, P610, DOI 10.1021/nl203343a
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chatterjee A, 2001, NUCLEIC ACIDS RES, V29, P4935, DOI 10.1093/nar/29.24.4935
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Dizdaroglu M, 2012, CANCER LETT, V327, P26, DOI 10.1016/j.canlet.2012.01.016
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.bi.60.070191.002401
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Foury F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027847
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garcia-Diaz M, 2007, CRIT REV PLANT SCI, V26, P105, DOI 10.1080/07352680701252817
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Guo WW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070718
   Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hashiguchi K, 2004, NUCLEIC ACIDS RES, V32, P5596, DOI 10.1093/nar/gkh863
   Hazkani-Covo E, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000834
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345
   Kachhap S, 2004, MOL CANCER, V3, P0, DOI 10.1186/1476-4598-3-32
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kauppila JHK, 2015, BBA-BIOENERGETICS, V1847, P1354, DOI 10.1016/j.bbabio.2015.06.001
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   KUNKEL TA, 1988, BIOCHIM BIOPHYS ACTA, V951, P1, DOI 10.1016/0167-4781(88)90020-6
   Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497
   KUNKEL TA, 1988, J BIOL CHEM, V263, P4450
   Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lim KS, 2005, ANN NY ACAD SCI, V1042, P210, DOI 10.1196/annals.1338.023
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nachman MW, 2000, GENETICS, V156, P297
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002
   Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657
   Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Popanda O, 2013, INT J CANCER, V132, P55, DOI 10.1002/ijc.27665
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schneider S, 1999, GENETICS, V152, P1079
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004670
   Stojkovic G, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep28942
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wang GJ, 1997, BIOCHEM PHARMACOL, V54, P181, DOI 10.1016/S0006-2952(97)00158-5
   Wiederholt CJ, 2002, BIOCHEMISTRY-US, V41, P15838, DOI 10.1021/bi025903e
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x
   Yasui M, 2014, DNA REPAIR, V15, P11, DOI 10.1016/j.dnarep.2014.01.003
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 120
TC 45
Z9 51
U1 0
U2 13
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0071-1365
EI 1744-1358
J9 ESSAYS BIOCHEM
JI Essays Biochem.
PD JUN 15
PY 2017
VL 61
IS 3
BP 325
EP 337
DI 10.1042/EBC20160090
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BL4SO
UT WOS:000450752900003
PM 28698307
DA 2024-11-01
ER

PT J
AU Berglund, AK
   Navarrete, C
   Engqvist, MKM
   Hoberg, E
   Szilagyi, Z
   Taylor, RW
   Gustafsson, CM
   Falkenberg, M
   Clausen, AR
AF Berglund, Anna-Karin
   Navarrete, Clara
   Engqvist, Martin K. M.
   Hoberg, Emily
   Szilagyi, Zsolt
   Taylor, Robert W.
   Gustafsson, Claes M.
   Falkenberg, Maria
   Clausen, Anders R.
TI Nucleotide pools dictate the identity and frequency of ribonucleotide incorporation in mitochondrial DNA
SO PLOS GENETICS
LA English
DT Article
ID impair mtdna replication; depletion myopathy; thymidine kinase; polymerase gamma; topoisomerase-i; strand dna; 7s dna; mutations; transcription; maintenance
AB Previous work has demonstrated the presence of ribonucleotides in human mitochondrial DNA (mtDNA) and in the present study we use a genome-wide approach to precisely map the location of these. We find that ribonucleotides are distributed evenly between the heavy- and light-strand of mtDNA. The relative levels of incorporated ribonucleotides reflect that DNA polymerase. discriminates the four ribonucleotides differentially during DNA synthesis. The observed pattern is also dependent on the mitochondrial deoxyribonucleotide (dNTP) pools and disease-causing mutations that change these pools alter both the absolute and relative levels of incorporated ribonucleotides. Our analyses strongly suggest that DNA polymerase.-dependent incorporation is the main source of ribonucleotides in mtDNA and argues against the existence of a mitochondrial ribonucleotide excision repair pathway in human cells. Furthermore, we clearly demonstrate that when dNTP pools are limiting, ribonucleotides serve as a source of building blocks to maintain DNA replication. Increased levels of embedded ribonucleotides in patient cells with disturbed nucleotide pools may contribute to a pathogenic mechanism that affects mtDNA stability and impair new rounds of mtDNA replication.
C1 [Berglund, Anna-Karin; Navarrete, Clara; Engqvist, Martin K. M.; Hoberg, Emily; Szilagyi, Zsolt; Gustafsson, Claes M.; Falkenberg, Maria; Clausen, Anders R.] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.
   [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondria! Res, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of Gothenburg; Newcastle University - UK
RP Falkenberg, M; Clausen, AR (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se; anders.clausen@gu.se
FU Swedish Research Council [2012-2583, 2013-3621, 2014-6466]; Swedish Cancer Foundation [CAN 2016/816, CAN 2013/855]; European Research Council; Swedish Foundation for Strategic Research [ICA14-0060]; Wellcome Trust [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised Rare Mitochondrial Disorders of Adults and Children Service in Newcastle upon Tyne; MRC [G0601943] Funding Source: UKRI; Swedish Foundation for Strategic Research (SSF) [ICA14-0060] Funding Source: Swedish Foundation for Strategic Research (SSF)
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Balakrishnan L, 2013, COLD SPRING HARB PER, V0, P5
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Clausen Anders R, 2015, METHODS MOL BIOL, V1300, P123, DOI 10.1007/978-1-4939-2596-4_9
   Clausen AR, 2015, NAT STRUCT MOL BIOL, V22, P185, DOI 10.1038/nsmb.2957
   Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1141
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460
   Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p
   Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Reijns MAM, 2012, CELL, V149, P0, DOI 10.1016/j.cell.2012.04.011
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007
   Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6
   Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sun R, 2014, BIOCHEMISTRY-US, V53, P6142, DOI 10.1021/bi5006877
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37
   Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021
   Williams JS, 2012, DNA REPAIR, V11, P649, DOI 10.1016/j.dnarep.2012.05.004
   WONGSTAAL F, 1973, BIOCHEM BIOPH RES CO, V53, P140, DOI 10.1016/0006-291X(73)91412-5
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048
NR 57
TC 47
Z9 50
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD FEB 15
PY 2017
VL 13
IS 2
BP 
EP 
DI 10.1371/journal.pgen.1006628
PG 18
WC Genetics & Heredity
SC Genetics & Heredity
GA EO0QN
UT WOS:000396403100019
PM 28207748
DA 2024-11-01
ER

PT J
AU Pyal, A
   Paramasivam, A
   Meena, AK
   Bhavana, VB
   Thangaraj, K
AF Pyal, Anjan
   Paramasivam, Arumugam
   Meena, Angamuthu Kannan
   Bhavana, Velpula Bhagya
   Thangaraj, Kumarasamy
TI <i>MPV17</i> hepatocerebral mitochondrial DNA depletion syndrome presenting as acute flaccid paralysis - A case report
SO MITOCHONDRION
LA English
DT Article
DE MPV17 mutation; Mitochondrial DNA; mtDNA maintenance, hepatocerebral disease
ID progressive external ophthalmoplegia; multiple mtdna deletions; mutations; gene; form
AB Mutations in human MPV17 have been reported in patients with severe mitochondrial DNA (mtDNA) depletion manifesting as early childhood onset failure to thrive, hypoglycemia, encephalopathy and progressive liver failure. We describe an 11 year old girl, born to consanguineous parents, who presented with rapidly progressive weakness of all 4 limbs with symmetrical proximal and distal weakness, gastrointestinal disease and leukoencephalopathy. Genetic analysis of the patient revealed a homozygous pathogenic mutation c.121C > T (p.R41W) in the MPV17 gene. Further, screening for this mutation in the parents revealed the presence of heterozygous mutation in both the parents, suggesting the recessive nature of the disease.
C1 [Pyal, Anjan; Meena, Angamuthu Kannan] Nizams Inst Med Sci, Dept Neurol, Hyderabad 500082, Andhra Prades, India.
   [Paramasivam, Arumugam; Bhavana, Velpula Bhagya; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Prades, India.
C3 Nizam's Institute of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)
RP Meena, AK (corresponding author), Nizams Inst Med Sci, Dept Neurol, Hyderabad 500082, Andhra Prades, India.
EM meenaak@hotmail.com
FU Council of Scientific and Industrial Research (CSIR), Government of India [BioAge-BSC0208]; Science and Engineering Research Board (SERB), Government of India [PDF/2016/000881]
CR Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Thangaraj K, 2002, J ANDROL, V23, P815
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
NR 18
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2017
VL 37
IS 
BP 41
EP 45
DI 10.1016/j.mito.2017.06.006
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA FN8SO
UT WOS:000416296000005
PM 28673863
DA 2024-11-01
ER

PT J
AU Orsucci, D
   Angelini, C
   Bertini, E
   Carelli, V
   Comi, G
   Federico, A
   Minetti, C
   Moggio, M
   Mongini, T
   Santorelli, F
   Servidei, S
   Tonin, P
   Ardissone, A
   Bello, L
   Bruno, C
   Ienco, E
   Diodato, D
   Filosto, M
   Lamperti, C
   Moroni, I
   Musumeci, O
   Pegoraro, E
   Primiano, G
   Ronchi, D
   Rubegni, A
   Salvatore, S
   Sciacco, M
   Valentino, M
   Vercelli, L
   Toscano, A
   Zeviani, M
   Siciliano, G
   Mancuso, M
AF Orsucci, D.
   Angelini, C.
   Bertini, E.
   Carelli, V.
   Comi, G. P.
   Federico, A.
   Minetti, C.
   Moggio, M.
   Mongini, T.
   Santorelli, F. M.
   Servidei, S.
   Tonin, P.
   Ardissone, A.
   Bello, L.
   Bruno, C.
   Ienco, E. Caldarazzo
   Diodato, D.
   Filosto, M.
   Lamperti, C.
   Moroni, I.
   Musumeci, O.
   Pegoraro, E.
   Primiano, G.
   Ronchi, D.
   Rubegni, A.
   Salvatore, S.
   Sciacco, M.
   Valentino, M. L.
   Vercelli, L.
   Toscano, A.
   Zeviani, M.
   Siciliano, G.
   Mancuso, M.
TI Revisiting mitochondrial ocular myopathies: a study from the Italian Network
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE CPEO; Mitochondrial disorders; Mitochondrial myopathy; mtDNA; PEO
ID external ophthalmoplegia
AB Ocular myopathy, typically manifesting as progressive external ophthalmoplegia (PEO), is among the most common mitochondrial phenotypes. The purpose of this study is to better define the clinical phenotypes associated with ocular myopathy. This is a retrospective study on a large cohort from the database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases". We distinguished patients with ocular myopathy as part of a multisystem mitochondrial encephalomyopathy (PEO-encephalomyopathy), and then PEO with isolated ocular myopathy from PEO-plus when PEO was associated with additional features of multisystemic involvement. Ocular myopathy was the most common feature in our cohort of mitochondrial patients. Among the 722 patients with a definite genetic diagnosis, ocular myopathy was observed in 399 subjects (55.3%) and was positively associated with mtDNA single deletions and POLG mutations. Ocular myopathy as manifestation of a multisystem mitochondrial encephalomyopathy (PEO-encephalomyopathy, n = 131) was linked to the m.3243A > G mutation, whereas the other "PEO" patients (n = 268) were associated with mtDNA single deletion and Twinkle mutations. Increased lactate was associated with central neurological involvement. We then defined, among the PEO group, as "pure PEO" the patients with isolated ocular myopathy and "PEO-plus" those with ocular myopathy and other features of neuromuscular and multisystem involvement, excluding central nervous system. The male proportion was significantly lower in pure PEO than PEO-plus. This study reinforces the need for research on the role of gender in mitochondrial diseases. The phenotype definitions here revisited may contribute to a more homogeneous patient categorization, useful in future studies and clinical trials.
C1 [Orsucci, D.; Ienco, E. Caldarazzo; Siciliano, G.; Mancuso, M.] Univ Pisa, Neurol Clin, Via Roma 67, I-56100 Pisa, Italy.
   [Orsucci, D.] San Luca Hosp, Neurol Unit, Lucca, Italy.
   [Angelini, C.] Osped S Camillo, Fdn IRCCS, Venice, Italy.
   [Bertini, E.; Diodato, D.] Bambino Gesu Hosp IRCCS, Unit Neuromuscular Dis, Mol Med Lab, Rome, Italy.
   [Carelli, V.; Valentino, M. L.] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Carelli, V.; Valentino, M. L.] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Comi, G. P.; Ronchi, D.] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit, Milan, Italy.
   [Federico, A.; Salvatore, S.] Univ Siena, UOC Clin Neurol & Malattie Neurometab, Dipartimento Sci Med Chirurg & Neurosci, Siena, Italy.
   [Minetti, C.; Bruno, C.] Univ Genoa, G Gaslini Inst, Neuropediat & Muscle Disorders Unit, Genoa, Italy.
   [Moggio, M.; Sciacco, M.] Univ Milan, Neuromuscular & Rare Dis Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, Milan, Italy.
   [Mongini, T.; Vercelli, L.] Univ Turin, Dept Neurosci, Turin, Italy.
   [Santorelli, F. M.; Rubegni, A.] IRCCS Stella Maris, Pisa, Italy.
   [Servidei, S.; Primiano, G.] Catholic Univ, Inst Neurol, Rome, Italy.
   [Tonin, P.] Univ Verona, Neurol Clin, Verona, Italy.
   [Ardissone, A.; Moroni, I.] Fdn Carlo Besta Inst Neurol IRCCS, Child Neurol Unit, Milan, Italy.
   [Filosto, M.] Univ Hosp Spedali Civili, Neurol Clin, Brescia, Italy.
   [Lamperti, C.; Zeviani, M.] Fdn Carlo Besta Inst Neurol IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Musumeci, O.; Toscano, A.] Univ Messina, Dept Clin & Expt Med, Messina, Italy.
   [Bello, L.; Pegoraro, E.] Univ Padua, Dept Neurosci, Neuromuscular Unit, Padua, Italy.
   [Zeviani, M.] Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge, England.
C3 University of Pisa; IRCCS Ospedale San Camillo; IRCCS Bambino Gesu; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Siena; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Turin; IRCCS Fondazione Stella Maris; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona; Fondazione IRCCS Istituto Neurologico Carlo Besta; Hospital Spedali Civili Brescia; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Messina; University of Padua; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Via Roma 67, I-56100 Pisa, Italy.
EM mancusomichelangelo@gmail.com
FU Telethon [GUP09004, GSP16001]; MITOCON
CR DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0
NR 15
TC 22
Z9 23
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD AUG 15
PY 2017
VL 264
IS 8
BP 1777
EP 1784
DI 10.1007/s00415-017-8567-z
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA FC2SO
UT WOS:000406688800021
PM 28695364
DA 2024-11-01
ER

PT J
AU Srivastava, S
AF Srivastava, Sarika
TI The Mitochondrial Basis of Aging and Age-Related Disorders
SO GENES
LA English
DT Review
DE mitochondria; mitochondrial dysfunction; aging; reactive oxygen species; mitochondrial dynamics; mitophagy; mitochondrial biogenesis; age-related disorders
ID skeletal-muscle mitochondrial; dynamin-related protein; human substantia-nigra; life-span; oxidative damage; mitofusin 2; dna mutations; insulin-resistance; metabolic-control; point mutations
AB Aging is a natural phenomenon characterized by progressive decline in tissue and organ function leading to increased risk of disease and mortality. Among diverse factors that contribute to human aging, the mitochondrial dysfunction has emerged as one of the key hallmarks of aging process and is linked to the development of numerous age-related pathologies including metabolic syndrome, neurodegenerative disorders, cardiovascular diseases and cancer. Mitochondria are central in the regulation of energy and metabolic homeostasis, and harbor a complex quality control system that limits mitochondrial damage to ensure mitochondrial integrity and function. The intricate regulatory network that balances the generation of new and removal of damaged mitochondria forms the basis of aging and longevity. Here, I will review our current understanding on how mitochondrial functional decline contributes to aging, including the role of somatic mitochondrial DNA (mtDNA) mutations, reactive oxygen species (ROS), mitochondrial dynamics and quality control pathways. I will further discuss the emerging evidence on how dysregulated mitochondrial dynamics, mitochondrial biogenesis and turnover mechanisms contribute to the pathogenesis of age-related disorders. Strategies aimed to enhance mitochondrial function by targeting mitochondrial dynamics, quality control, and mitohormesis pathways might promote healthy aging, protect against age-related diseases, and mediate longevity.
C1 [Srivastava, Sarika] Virginia Tech, Carilion Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.
C3 Virginia Polytechnic Institute & State University
RP Srivastava, S (corresponding author), Virginia Tech, Carilion Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.
EM Sarika_Srivastava@vtc.vt.edu
FU Virginia Tech open access subvention fund
CR Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11
   Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023
   Arnould T, 2015, INT J MOL SCI, V16, P18224, DOI 10.3390/ijms160818224
   Asensi M, 1999, METHOD ENZYMOL, V299, P267
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Baker MJ, 2014, BRIT J PHARMACOL, V171, P1870, DOI 10.1111/bph.12430
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108
   Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Burkewitz K, 2016, EXPERIENTIA SUPPL, V107, P227, DOI 10.1007/978-3-319-43589-3_10
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Cannavino J, 2015, J PHYSIOL-LONDON, V593, P1981, DOI 10.1113/jphysiol.2014.286740
   Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161
   Chen L, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.112.003012
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Cuervo AM, 2011, SCIENCE, V332, P1392, DOI 10.1126/science.1208607
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   DAmico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Disatnik MH, 2013, J AM HEART ASSOC, V2, P0, DOI 10.1161/JAHA.113.000461
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fang L, 2007, LIFE SCI, V80, P2154, DOI 10.1016/j.lfs.2007.04.003
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012
   Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911
   Hall AR, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.139
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047
   Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010
   Jazwinski SM, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00139
   Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Jovaisaite V, 2015, CURR OPIN CELL BIOL, V33, P74, DOI 10.1016/j.ceb.2014.12.003
   Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Khalil B, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2014.581
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kubli Dieter A, 2013, COMMUN INTEGR BIOL, V6, Pe24511, DOI 10.4161/cib.24511
   Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulkarni SS, 2016, DIABETES, V65, P3552, DOI 10.2337/db15-1725
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410
   LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee MS, 2015, ANN NY ACAD SCI, V1350, P61, DOI 10.1111/nyas.12822
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Lewis GD, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001006
   Li QOY, 2017, ADIPOCYTE, V6, P161, DOI 10.1080/21623945.2017.1297346
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Lim KS, 2005, ANN NY ACAD SCI, V1042, P210, DOI 10.1196/annals.1338.023
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Liu RH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092810
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Mahdaviani K, 2017, EMBO REP, V18, P1123, DOI 10.15252/embr.201643827
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   Marchi Saverio, 2012, J SIGNAL TRANSDUCT, V2012, P329635, DOI 10.1155/2012/329635
   Martin-Montalvo A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3192
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Marzetti E, 2016, EXP GERONTOL, V80, P1, DOI 10.1016/j.exger.2016.04.003
   Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961
   Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107
   Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017
   Moreira OC, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/2012798
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Murakawa T, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8527
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011
   Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032
   Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Palikaras K, 2017, PHARMACOL THERAPEUT, V178, P157, DOI 10.1016/j.pharmthera.2017.04.005
   Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pisano A, 2016, CARDIOVASC PATHOL, V25, P103, DOI 10.1016/j.carpath.2015.09.009
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Poole AC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010054
   Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844
   Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Rose G, 2017, MECH AGEING DEV, V165, P115, DOI 10.1016/j.mad.2016.12.002
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076
   Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003
   Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Shen Jie, 2009, DISCOV MED, V8, P223
   Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Smaili SS, 2013, CURR MOL MED, V13, P252
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Song WH, 2016, P NATL ACAD SCI USA, V113, PE5261, DOI 10.1073/pnas.1605844113
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   SOONG NW, 1992, NAT GENET, V2, P318
   Srivastava S, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0104-7
   Srivastava S, 2011, CURR PHARM DESIGN, V17, P3418, DOI 10.2174/138161211798072526
   Strappazzon F, 2015, CELL DEATH DIFFER, V22, P419, DOI 10.1038/cdd.2014.139
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Suwa Masataka, 2013, CURR AGING SCI, V6, P178
   Taylor RC, 2011, COLD SPRING HARB PER, V3, P0, DOI 10.1101/cshperspect.a004440
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tezil T, 2014, CURR PHARM DESIGN, V20, P3052, DOI 10.2174/13816128113196660702
   Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Ugarte N, 2010, ANTIOXID REDOX SIGN, V13, P539, DOI 10.1089/ars.2009.2998
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wai T, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aad0116
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Weimer S, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4563
   Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang CS, 2016, CELL METAB, V23, P399, DOI 10.1016/j.cmet.2016.02.017
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
   Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 226
TC 215
Z9 241
U1 5
U2 50
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD DEC 15
PY 2017
VL 8
IS 12
BP 
EP 
DI 10.3390/genes8120398
PG 23
WC Genetics & Heredity
SC Genetics & Heredity
GA FR6YC
UT WOS:000419212400059
PM 29257072
DA 2024-11-01
ER

PT J
AU Zheng, NN
   Wei, D
   Dai, B
   Zheng, LY
   Zhao, MY
   Xin, N
   Chi, ZH
   Zhao, YT
   Ma, TX
   Jahane, R
   Sun, LN
AF Zheng, Ningning
   Wei, Dan
   Dai, Bo
   Zheng, Lanyan
   Zhao, Mingyi
   Xin, Na
   Chi, Zhihong
   Zhao, Yiting
   Ma, Tingxian
   Jahane, Rabita
   Sun, Luning
TI Mitochondrial Genome Encoded Proteins Expression Disorder, the Possible Mechanism of the Heart Disease in Metabolic Syndrome
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Metabolic Syndrome; Heart Disease; Mitochondrion Encoded Protein; Mitochondrial Ribosomal Proteins
ID electron-transfer flavoprotein; oxidative stress; atp synthesis; dna mutation; transport; adults; chain; narp; proliferation; degradation
AB Background/Aims: The direct consequence of metabolic syndrome (MS) is the increased morbidity and mortality caused by the heart disease. We tried to explain why the heart is more severely damaged during MS from the point of mitochondria, the center of cellular metabolism. Methods: 1. The classic diet induced MS rat model was used to observe the morphological changes of mitochondria by transmission electron microscope (TEM); 2. The expression of mitochondrial DNA (mt-DNA) encoded proteins was observed by immunohistochemistry and Western blot; 3. The expression of mitochondrial ribosomal proteins (MRPs) was observed by real-time PCR. Results: 1. The mitochondrial volume increased but the number was normal in myocardial cells of the MS rats. But in the hepatocytes and skeletal muscle cells, the mitochondrial number decreased; 2. The mt-DNA encoded protein cytochrome b increased significantly in heart but decreased in liver and the ATPase6 increased in liver but decreased in heart of the MS rats; 3. The mRNA levels of MRPS23, MRPL27, MRPL45 and MRPL48 elevated in heart but down-regulated in liver of the MS rats. Conclusion: The morphologic and functional alterations of mitochondrion in MS were tissue specific. Heart displays a distinctive pattern of mitochondrial metabolic status compared with other tissues. (C) 2017 The Author(s) Published by S. Karger AG, Basel
C1 [Zheng, Ningning; Xin, Na; Chi, Zhihong; Ma, Tingxian; Sun, Luning] China Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Shenyang, Liaoning, Peoples R China.
   [Wei, Dan; Dai, Bo] China Med Univ, Grad Sch, Dept Pathophysiol, Shenyang, Liaoning, Peoples R China.
   [Zheng, Lanyan] China Med Univ, Coll Basic Med Sci, Dept Pathogen Biol, Shenyang, Liaoning, Peoples R China.
   [Zhao, Mingyi] Shenyang Pharmaceut Univ, Dept Clin Pharm, Shenyang, Liaoning, Peoples R China.
   [Zhao, Yiting] Chinese Acad Med Sci, Canc Hosp, PET CT Ctr, Beijing, Peoples R China.
   [Jahane, Rabita] China Med Univ, Int Educ Sch, Shenyang, Liaoning, Peoples R China.
C3 China Medical University; China Medical University; China Medical University; Shenyang Pharmaceutical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; China Medical University
RP Sun, LN (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Shenyang North New Area, 77 Puhe Rd, Shenyang, Liaoning, Peoples R China.
EM lnsun@cmu.edu.cn
FU National Natural Science Foundation of China [30900567]
CR Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Aral C, 2011, HORM-INT J ENDOCRINO, V10, P298, DOI 10.14310/horm.2002.1321
   BECKMANN JD, 1985, BIOCHEMISTRY-US, V24, P3913, DOI 10.1021/bi00336a016
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x
   Fung S, 2013, MOL BIOL CELL, V24, P184, DOI 10.1091/mbc.E12-09-0651
   Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779
   Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073
   Harada T, 2010, APOPTOSIS, V15, P1247, DOI 10.1007/s10495-010-0519-3
   Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937
   Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003
   Juo SHH, 2010, MITOCHONDRION, V10, P294, DOI 10.1016/j.mito.2010.01.001
   Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1
   Kwasniak M, 2013, PLANT CELL, V25, P1855, DOI 10.1105/tpc.113.111294
   Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918
   Lim SK, 2007, BIOCHEM J, V403, P119, DOI 10.1042/BJ20061272
   Mackenzie J, 2006, J BIOL CHEM, V281, P31012, DOI 10.1074/jbc.M603405200
   Mandavia CH, 2012, METABOLISM, V61, P1205, DOI 10.1016/j.metabol.2012.02.013
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Nichols TW, 2012, MED HYPOTHESES, V79, P287, DOI 10.1016/j.mehy.2012.05.006
   Palmieri VO, 2011, NUTRITION, V27, P773, DOI 10.1016/j.nut.2010.08.016
   Phung TL, 2015, CANCER RES, V75, P40, DOI 10.1158/0008-5472.CAN-13-2961
   Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149
   RAMSAY RR, 1987, BIOCHEM J, V241, P883, DOI 10.1042/bj2410883
   Raza H, 2015, CELL PHYSIOL BIOCHEM, V35, P1241, DOI 10.1159/000373947
   Roul D, 2015, ANTIOXID REDOX SIGN, V22, P1502, DOI 10.1089/ars.2015.6311
   RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440
   Schönfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005
   Schönfeld P, 2006, J BIOL CHEM, V281, P7136, DOI 10.1074/jbc.M513198200
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Suh I, 2010, ARCH SURG-CHICAGO, V145, P226, DOI 10.1001/archsurg.2009.292
   Sumner AD, 2012, J CLIN HYPERTENS, V14, P502, DOI 10.1111/j.1751-7176.2012.00647.x
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   Terman Alexei, 2006, MOLECULAR ASPECTS OF MEDICINE, V27, P471, DOI 10.1016/j.mam.2006.08.006
   Thyfault JP, 2011, J APPL PHYSIOL, V111, P1218, DOI 10.1152/japplphysiol.00478.2011
   Walder Ken, 2002, ENDOCR REGUL, V36, P1
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Ye W, 2013, MOL MED REP, V8, P1060, DOI 10.3892/mmr.2013.1616
   Zheng NN, 2015, CELL PHYSIOL BIOCHEM, V36, P1903, DOI 10.1159/000430159
NR 44
TC 8
Z9 10
U1 0
U2 7
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PD JUN 15
PY 2017
VL 43
IS 3
BP 959
EP 968
DI 10.1159/000481649
PG 10
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA FN7TI
UT WOS:000416221300008
PM 28957804
DA 2024-11-01
ER

PT J
AU Grosso, S
   Carluccio, MA
   Cardaioli, E
   Cerase, A
   Malandrini, A
   Romano, C
   Federico, A
   Dotti, MT
AF Grosso, Salvatore
   Carluccio, Maria Alessandra
   Cardaioli, Elena
   Cerase, Alfonso
   Malandrini, Alessandro
   Romano, Chiara
   Federico, Antonio
   Dotti, Maria Teresa
TI Complex I deficiency related to T10158C mutation ND3 gene: A further definition of the clinical spectrum
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Mitochondrial disorder; Epilepsia partialis continua; MELAS; Leigh syndrome
ID epilepsia-partialis-continua; leigh-syndrome; mitochondrial myopathy; lactic-acidosis; encephalopathy; features; episodes; children; melas
AB Background: Complex I deficiency is the most common energy generation disorder which may clinically present at any age with a wide spectrum of symptoms and signs. The T10158C mutation ND3 gene is rare and occurs in patients showing an early rapid neurological deterioration invariably leading to death after a few months. Case presentation: We report a 9 year-old boy with a mtDNA T10158C mutation showing a mild MELAS-like phenotype and brain MRI features congruent with both MELAS and Leigh syndrome. Epilepsia partialis continua also occurred in the clinical course and related to a mild cortical atrophy of the left perisylvian area. Discussion: The present case confirms that the clinical spectrum of Complex I deficiency related to T10158C mutation ND3 gene is wider than previously described. Our observation further suggests that testing mutation in the MT-ND3 gene should be included in the diagnostic work-up of patients presenting with epilepsia partialis continua accompanied by suspicion of mitochondrial disorder. (C) 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Grosso, Salvatore; Romano, Chiara] Univ Siena, Dept Mol Med & Dev, Pediat Neurol Sect, Pediat Clin, Siena, Italy.
   [Carluccio, Maria Alessandra; Cardaioli, Elena; Malandrini, Alessandro; Federico, Antonio; Dotti, Maria Teresa] Univ Siena, Dept Neurol Neurosurg & Behav Sci, Siena, Italy.
   [Cerase, Alfonso] Univ Siena, Dept Neurol & Sensorial Sci, Unit NINT Neuroimaging & Neurointervent, Siena, Italy.
C3 University of Siena; University of Siena; University of Siena
RP Grosso, S (corresponding author), Univ Siena, Dept Pediat, Neurol Immunol & Endocrinol Unit, Via M Bracci, I-53100 Siena, Italy.
EM salvatore.grosso@unisi.it
CR Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Cockerell OC, 1996, BRAIN, V119, P393, DOI 10.1093/brain/119.2.393
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Sinha S, 2007, EPILEPSY RES, V74, P55, DOI 10.1016/j.eplepsyres.2006.12.003
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
NR 21
TC 10
Z9 12
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD MAR 15
PY 2017
VL 39
IS 3
BP 261
EP 265
DI 10.1016/j.braindev.2016.09.013
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EP4QW
UT WOS:000397366000013
PM 27742419
DA 2024-11-01
ER

PT J
AU Zhou, ZD
   Saw, WT
   Tan, EK
AF Zhou, Zhi-Dong
   Saw, Wuan-Ting
   Tan, Eng-King
TI Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases
SO MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Apoptosis; Coiled-coil-helix-coiled-coil-helix domain proteins; Mitochondria; Mitochondrial cristae; Neurodegenerative disease
ID cytochrome-c-oxidase; amyotrophic-lateral-sclerosis; frontotemporal dementia; intermembrane space; ribosomal-proteins; oxidative stress; skeletal-muscle; gene; identification; mia40
AB The coiled-coil-helix-coiled-coil-helix domain (CHCHD)-containing proteins are evolutionarily conserved nucleus-encoded small mitochondrial proteins with important functions. So far, nine members have been identified in this protein family. All CHCHD proteins have at least one functional coiled-coil-helix-coiled-coil-helix (CHCH) domain, which is stabilized by two pairs of disulfide bonds between two helices. CHCHD proteins have various important pathophysiological roles in mitochondria and other key cellular processes. Mutations of CHCHD proteins have been associated with various human neurodegenerative diseases. Mutations of CHCHD10 are associated with amyotrophic lateral sclerosis (ALS) and/or frontotemporal lobe dementia (FTD), motor neuron disease, and late-onset spinal muscular atrophy and autosomal dominant mitochondrial myopathy. CHCHD10 stabilizes mitochondrial crista ultrastructure and maintains its integrity. In patients with CHCHD10 mutations, there are abnormal mitochondrial crista structure, deficiencies of respiratory chain complexes, impaired mitochondrial respiration, and multiple mitochondrial DNA (mtDNA) deletions. Recently, CHCHD2 mutations are linked with autosomal dominant and sporadic Parkinson's disease (PD). The CHCHD2 is a multifunctional protein and plays roles in regulation of mitochondrial metabolism, synthesis of respiratory chain components, and modulation of cell apoptosis. With a better understanding of the pathophysiologic roles of CHCHD proteins, they may be potential novel therapeutic targets for human neurodegenerative diseases.
C1 [Zhou, Zhi-Dong; Saw, Wuan-Ting; Tan, Eng-King] Natl Neurosci Inst Singapore, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
   [Zhou, Zhi-Dong; Tan, Eng-King] Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, 8 Coll Rd, Singapore 169857, Singapore.
   [Tan, Eng-King] Singapore Gen Hosp, Dept Neurol, Outram Rd, Singapore 169608, Singapore.
C3 Tan Tock Seng Hospital; National Neuroscience Institute (NNI); National University of Singapore; Singapore General Hospital
RP Zhou, ZD; Tan, EK (corresponding author), Natl Neurosci Inst Singapore, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.; Zhou, ZD; Tan, EK (corresponding author), Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, 8 Coll Rd, Singapore 169857, Singapore.; Tan, EK (corresponding author), Singapore Gen Hosp, Dept Neurol, Outram Rd, Singapore 169608, Singapore.
EM Zhidong_zhou@nni.com.sg; saw.wuan.ting@singhealth.com.sg; Tan.eng.king@sgh.com.sg
FU Singapore National Medical Research Council (NMRC); STaR award; clinical translational research programme in Parkinson's disease; Transition award
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103
   Aras S, 2015, MITOCHONDRION, V20, P43, DOI 10.1016/j.mito.2014.10.003
   Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454
   Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015
   Auranen M, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000003
   Banci L, 2012, J STRUCT BIOL, V180, P190, DOI 10.1016/j.jsb.2012.07.007
   Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107
   Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553
   Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Baughman JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000590
   Bestwick M, 2010, MOL CELL BIOL, V30, P4480, DOI 10.1128/MCB.00228-10
   Bode M, 2013, ANTIOXID REDOX SIGN, V18, P1597, DOI 10.1089/ars.2012.4685
   Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, PC817, DOI 10.1152/ajpcell.00139.2004
   Brzóska K, 2006, ACTA BIOCHIM POL, V53, P685
   Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b
   Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chaussenot A, 2014, NEUROBIOL, V0, P0
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chiò A, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2015.01.017
   CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Darshi M, 2010, FASEB J, V24, P0
   Darshi M, 2012, J BIOL CHEM, V287, P0, DOI 10.1074/jbc.M112.387696
   Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753
   Ding CL, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep16064
   Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895
   Dols-Icardo O, 2015, BRAIN, V138, PE400, DOI 10.1093/brain/awv175
   Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8
   Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Foo JN, 2015, LANCET NEUROL, V14, P681, DOI 10.1016/S1474-4422(15)00098-8
   Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1
   Friedman JR, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07739
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Gallego NE, 2015, BIOPHYS J, V108, P0
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828
   Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s
   Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064
   Jansen IE, 2015, LANCET NEUROL, V14, P678, DOI 10.1016/S1474-4422(15)00094-0
   Jiao B, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv367
   Jin C, 1997, CURR GENET, V31, P228, DOI 10.1007/s002940050199
   Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518
   Johnson JO, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu265
   Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002
   Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200
   Koc EC, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00183
   Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002
   Koschmidder E, 2016, NEUROLOGY, V86, P577, DOI 10.1212/WNL.0000000000002361
   Kurosaka Satoshi, 2008, BIRTH DEFECTS RESEARCH, V84, P102, DOI 10.1002/bdrc.20125
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu H-M, 2012, J NANOMATER, V2012, P0, DOI 10.1155/2012/510478
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Liu Y, 2015, CELL DEATH DIFFER, V22, P1035, DOI 10.1038/cdd.2014.194
   Liu Y, 2015, MOL CELL ONCOL, V2, P0, DOI 10.1080/23723556.2015.1004964
   Martherus RSRM, 2010, BIOCHEM BIOPH RES CO, V402, P203, DOI 10.1016/j.bbrc.2010.09.109
   Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004
   Müller K, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu227
   Murari A, 2015, BIOCHEM J, V471, P231, DOI 10.1042/BJ20150012
   MUTISYA EM, 1994, J NEUROCHEM, V63, P2179
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367
   Ogaki K, 2015, NEUROLOGY, V85, P2016, DOI 10.1212/WNL.0000000000002170
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Puschmann A, 2015, LANCET NEUROL, V14, P679, DOI 10.1016/S1474-4422(15)00095-2
   Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099
   Radad K, 2006, NEUROCHEM INT, V49, P379, DOI 10.1016/j.neuint.2006.02.003
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Schulz KL, 2012, MOL NEUROBIOL, V46, P205, DOI 10.1007/s12035-012-8308-3
   Seo M, 2010, FASEB J, V24, P464, DOI 10.1096/fj.09-137562
   Shi CH, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.040
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Spiller MP, 2013, BIOCHEM J, V455, P27, DOI 10.1042/BJ20130442
   Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200
   Sztolsztener ME, 2013, TRAFFIC, V14, P309, DOI 10.1111/tra.12030
   Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072
   Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248
   Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Wei YH, 2015, MOL CANCER RES, V13, P1119, DOI 10.1158/1541-7786.MCR-14-0165-T
   Westerman BA, 2004, GENOMICS, V83, P1094, DOI 10.1016/j.ygeno.2003.12.006
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105
   Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052
   Yang J, 2012, J CLIN INVEST, V122, P600, DOI 10.1172/JCI58780
   Yang XL, 2016, PARKINSONISM RELAT D, V29, P42, DOI 10.1016/j.parkreldis.2016.05.032
   Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004
   Zhang M, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.038
   Zhang M, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv082
   Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147
NR 110
TC 41
Z9 44
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD SEP 15
PY 2017
VL 54
IS 7
BP 5534
EP 5546
DI 10.1007/s12035-016-0099-5
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA FC0BO
UT WOS:000406503500057
PM 27631878
DA 2024-11-01
ER

PT J
AU Ishimoto, Y
   Inagi, R
   Yoshihara, D
   Kugita, M
   Nagao, S
   Shimizu, A
   Takeda, N
   Wake, M
   Honda, K
   Zhou, J
   Nangaku, M
AF Ishimoto, Yu
   Inagi, Reiko
   Yoshihara, Daisuke
   Kugita, Masanori
   Nagao, Shizuko
   Shimizu, Akira
   Takeda, Norihiko
   Wake, Masaki
   Honda, Kenjiro
   Zhou, Jing
   Nangaku, Masaomi
TI Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
DE mitochondrial metabolism; polycystic kidney disease
ID signal-regulated kinase; dna copy number; oxidative stress; protein-phosphorylation; epithelial-cells; molecular-basis; biogenesis; metabolism; skeletal; muscle
AB Autosomal dominant polycystic kidney disease (ADPKD) constitutes the most inherited kidney disease. Mutations in the PKD1 and PKD2 genes, encoding the polycystin 1 and polycystin 2 Ca2+ ion channels, respectively, result in tubular epithelial cell-derived renal cysts. Recent clinical studies demonstrate oxidative stress to be present early in ADPKD. Mitochondria comprise the primary reactive oxygen species source and also their main effector target; however, the pathophysiological role of mitochondria in ADPKD remains uncharacterized. To clarify this function, we examined the mitochondria of cyst-lining cells in ADPKD model mice (Ksp-Cre PKD1(flox/flox)) and rats (Han: SPRD Cy/+), demonstrating obvious tubular cell morphological abnormalities. Notably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) expression were decreased in ADPKD model animal kidneys, with PGC-1 alpha expression inversely correlated with oxidative stress levels. Consistent with these findings, human ADPKD cyst-derived cells with heterozygous and homozygous PKD1 mutation exhibited morphological and functional abnormalities, including increased mitochondrial superoxide. Furthermore, PGC-1 alpha expression was suppressed by decreased intracellular Ca2+ levels via calcineurin, p38 mitogen-activated protein kinase (MAPK), and nitric oxide synthase deactivation. Moreover, the mitochondrion-specific antioxidant MitoQuinone (MitoQ) reduced intracellular superoxide and inhibited cyst epithelial cell proliferation through extracellular signal-related kinase/MAPK inactivation. Collectively, these results indicate that mitochondrial abnormalities facilitate cyst formation in ADPKD.
C1 [Ishimoto, Yu; Inagi, Reiko; Honda, Kenjiro; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo, Japan.
   [Ishimoto, Yu; Inagi, Reiko] Univ Tokyo, Grad Sch Med, Div CKD Pathophysiol, Tokyo, Japan.
   [Yoshihara, Daisuke; Kugita, Masanori; Nagao, Shizuko] Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan.
   [Shimizu, Akira] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo, Japan.
   [Takeda, Norihiko; Wake, Masaki] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.
   [Zhou, Jing] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Ctr Polycyst Kidney Dis,Res & Renal Div, Boston, MA USA.
C3 University of Tokyo; University of Tokyo; Fujita Health University; Nippon Medical School; University of Tokyo; Harvard University; Harvard Medical School; Brigham & Women's Hospital
RP Inagi, R; Nangaku, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo, Japan.; Inagi, R (corresponding author), Univ Tokyo, Grad Sch Med, Div CKD Pathophysiol, Tokyo, Japan.
EM inagi-npr@umin.ac.jp; mnangaku-tky@umin.ac.jp
FU Japan Society for the Promotion of Science [25461207, 15KT0088, 16K15465, 24390213, 16K15464]; Japanese Association of Dialysis Physicians (JADP) [2012-05]; Kyowa Hakko Kirin Co. Ltd.; U.S. National Institutes of Health [RO1DK099532, R37DK51050]; U.S. Department of Defense [PR152162]; Grants-in-Aid for Scientific Research [26111003, 16K15464, 15K09247, 15KT0088, 16K15465] Funding Source: KAKEN
CR Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024
   Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   Ahrabi AK, 2010, NEPHROL DIAL TRANSPL, V25, P1067, DOI 10.1093/ndt/gfp611
   Akabane S, 2016, MOL CELL, V62, P371, DOI 10.1016/j.molcel.2016.03.037
   BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75
   Baumann K, 2010, NAT REV MOL CELL BIO, V11, P392, DOI 10.1038/nrm2910
   Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147
   Burbulla LF, 2012, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/4228
   Calvet JP, 2015, POLYCYSTIC KIDNEY DISEASE, V0, P169
   Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cho YM, 2007, DIABETES RES CLIN PR, V77, PS172, DOI 10.1016/j.diabres.2007.01.052
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y
   Hajarnis S, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14395
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Harris PC, 2002, CURR OPIN NEPHROL HY, V11, P309, DOI 10.1097/00041552-200205000-00007
   Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3
   HEGG O, 1966, J PATHOL BACTERIOL, V91, P311, DOI 10.1002/path.1700910204
   Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045
   KASPAREITRITTINGHAUSEN J, 1989, VET PATHOL, V26, P195, DOI 10.1177/030098588902600302
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Klawitter J, 2014, AM J PHYSIOL-RENAL, V307, PF1198, DOI 10.1152/ajprenal.00327.2014
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, PF397, DOI 10.1152/ajprenal.00310.2002
   Luciano RL, 2014, NEPHROL DIAL TRANSPL, V29, P247, DOI 10.1093/ndt/gft437
   Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027
   Menon V, 2011, CLIN J AM SOC NEPHRO, V6, P7, DOI 10.2215/CJN.04140510
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x
   Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477
   Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com
   Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027
   Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6
   Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190
   Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rossman TG, 1998, MUTAT RES-FUND MOL M, V402, P103, DOI 10.1016/S0027-5107(97)00287-X
   Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sullivan LB, 2014, CANCER METAB, V2, P0, DOI 10.1186/2049-3002-2-17
   Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511
   Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Wang W, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aac7410
   Weber KH, 2008, AM J PHYSIOL-RENAL, V294, PF1279, DOI 10.1152/ajprenal.00348.2007
   Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107
   Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x
   Yu TM, 2016, LANCET ONCOL, V17, P1419, DOI 10.1016/S1470-2045(16)30250-9
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
NR 62
TC 101
Z9 110
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD DEC 15
PY 2017
VL 37
IS 24
BP 
EP 
DI 10.1128/MCB.00337-17
PG 23
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FN9SU
UT WOS:000416383100004
PM 28993480
DA 2024-11-01
ER

PT J
AU Ding, Y
   Xia, BH
   Zhang, CJ
   Zhuo, GC
AF Ding, Yu
   Xia, Bo-Hou
   Zhang, Cai-Juan
   Zhuo, Guang-Chao
TI Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE Mitochondrial tRNA; mutation; oxidative stress; mitochondrial dysfunction; PCOS-IR
ID a3302g mutation; oxidative stress; skeletal-muscle; dna mutations; dysfunction; expression; obesity; system; risk; fibroblasts
AB Polycystic ovary syndrome (PCOS) is a very common endocrine disorder affecting women of reproductive age. Insulin resistance (IR), a central component of this disease, occurs in 30%-40% of women with PCOS. To date, the molecular mechanism underlying PCOS-IR remains largely unknown. Most recently, increasing evidence has shown that mitochondrial dysfunction caused by mitochondrial DNA (mtDNA) mutations plays important roles in the pathogenesis of PCOS-IR. To identify the contribution of mitochondrial tRNA (mt-tRNA) mutations in this disease, we screened 80 women with PCOS-IR and 50 healthy control participants for mt-tRNA mutations. After genetic amplification and direct sequencing, we identified nine mt-tRNA mutations that were potentially associated with PCOS-IR: mt-tRNA(Leu(UUR)) A3302G and C3275A mutations, mt-tRNA(Gln) T4363C and T4395C mutations, mt-tRNA(Ser(UCN)) C7492T mutation, mt-tRNA(Asp) A7543G mutation, mt-tRNA(Lys) A8343G mutation, mt-tRNA(Arg) T10454C mutation and mt-tRNA(Glu) A14693G mutation. These mutations were localized at evolutionarily conserved nucleotides and altered the secondary structure of mt-tRNAs, thus resulting in failure of mt-tRNA metabolism. Moreover, molecular and biochemical analysis revealed that levels of 8-OHdG, malondialdehyde and reactive oxygen species were increased in patients with PCOS-IR carrying these mt-tRNA mutations compared with in healthy control participants, whereas superoxide dismutase levels, mitochondrial copy number, membrane potential and ATP levels were significantly reduced. Taken together, our data indicate that mt-tRNAs are key locations for pathogenic mutations associated with PCOS-IR. Mitochondrial dysfunction caused by mt-tRNA mutations may be involved in the pathogenesis of PCOS-IR. Thus, our findings provide novel insight into the pathophysiology of this disorder.
C1 [Ding, Yu; Zhuo, Guang-Chao] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Cent Lab, Hangzhou 310006, Zhejiang, Peoples R China.
   [Zhang, Cai-Juan] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Gynecol & Obstet, Hangzhou, Zhejiang, Peoples R China.
   [Xia, Bo-Hou] Hunan Univ Chinese Med, Dept Pharm, Changsha, Hunan, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Hunan University of Chinese Medicine
RP Ding, Y (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Cent Lab, Hangzhou 310006, Zhejiang, Peoples R China.
EM dingyu.zj@gmail.com
FU Ministry of Public Health from Zhejiang Province [2013KYA158]; Hangzhou Bureau of Science and Technology [20150633B16]; Natural Science Foundation of Zhejiang Province [LY14H270008, LY15H280007]
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004
   Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059
   Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005
   Ding LL, 2016, FERTIL STERIL, V105, P1330, DOI 10.1016/j.fertnstert.2016.01.020
   Ding Y, 2016, MOL MED REP, V13, P3169, DOI 10.3892/mmr.2016.4916
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Ding Y, 2013, BIOCHEM GENET, V51, P588, DOI 10.1007/s10528-013-9589-6
   Dunaif A, 2013, J CLIN ENDOCR METAB, V98, P4325, DOI 10.1210/jc.2013-2040
   Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Garcia-Lozano J R, 2000, HUM MUTAT, V15, P120, DOI 10.1002/(SICI)1098-1004(200001)15:1<120::AID-HUMU33>3.0.CO;2-8
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greenwood EA, 2015, FERTIL STERIL, V104, P707, DOI 10.1016/j.fertnstert.2015.05.019
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Jaksch M, 2001, J MED GENET, V38, P665, DOI 10.1136/jmg.38.10.665
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Juan CC, 2015, FERTIL STERIL, V104, P200, DOI 10.1016/j.fertnstert.2015.03.027
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165
   Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193
   Li M, 2002, J CLIN ENDOCR METAB, V87, P4088, DOI 10.1210/jc.2002-020363
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007
   Luther JM, 2011, TRENDS PHARMACOL SCI, V32, P734, DOI 10.1016/j.tips.2011.07.006
   Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087
   MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Nie HR, 2016, MITOCHONDRION, V26, P104, DOI 10.1016/j.mito.2015.12.001
   Papalou O, 2016, CURR PHARM DESIGN, V22, P2709, DOI 10.2174/1381612822666160216151852
   Prieto D, 2014, CURR VASC PHARMACOL, V12, P412, DOI 10.2174/1570161112666140423221008
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Serra D, 2013, ANTIOXID REDOX SIGN, V19, P269, DOI 10.1089/ars.2012.4875
   Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Victor VM, 2009, J CLIN ENDOCR METAB, V94, P3505, DOI 10.1210/jc.2009-0466
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zhu HY, 2009, CLIN CHIM ACTA, V410, P64, DOI 10.1016/j.cca.2009.09.023
   Zhuo GC, 2012, ARCH GYNECOL OBSTET, V286, P653, DOI 10.1007/s00404-012-2358-7
NR 50
TC 50
Z9 52
U1 0
U2 6
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
EI 
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PD JUN 15
PY 2017
VL 9
IS 6
BP 2984
EP 2996
DI 
PG 13
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA EZ2OJ
UT WOS:000404548300027
PM 28670386
DA 2024-11-01
ER

PT J
AU Di Nottia, M
   Montanari, A
   Verrigni, D
   Oliva, R
   Torraco, A
   Fernandez-Vizarra, E
   Diodato, D
   Rizza, T
   Bianchi, M
   Catteruccia, M
   Zeviani, M
   Dionisi-Vici, C
   Francisci, S
   Bertini, E
   Carrozzo, R
AF Di Nottia, Michela
   Montanari, Arianna
   Verrigni, Daniela
   Oliva, Romina
   Torraco, Alessandra
   Fernandez-Vizarra, Erika
   Diodato, Daria
   Rizza, Teresa
   Bianchi, Marzia
   Catteruccia, Michela
   Zeviani, Massimo
   Dionisi-Vici, Carlo
   Francisci, Silvia
   Bertini, Enrico
   Carrozzo, Rosalba
TI Novel mutation in mitochondrial Elongation Factor EF-Tu associated to dysplastic leukoencephalopathy and defective mitochondrial DNA translation
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE TUFM; Mitochondrial translation; Leukodystrophy; OXPHOS defects
AB The mitochondrial Elongation Factor Tu (EF-Tu), encoded by the TUFM gene, is a highly conserved GTPase, which is part of the mitochondrial protein translation machinery. In its activated form it delivers the aminoacyl-tRNAs to the A site of the mitochondrial ribosome. We report here on a baby girl with severe infantile macrocystic leukodystrophy with micropolygyria and a combined defect of complexes I and IV in muscle biopsy, caused by a novel mutation identified in TUFM. Using human mutant cells and the yeast model, we demonstrate the pathological role of the novel variant. Moreover, results of a molecular modeling study suggest that the mutant is inactive in mitochondrial polypeptide chain elongation, probably as a consequence of its reduced ability to bind mitochondrial aa-tRNAs. Four patients have so far been described with mutations in TUFM, and, following the first description of the disease in a single patient, we describe similar clinical and neuroradiological features in an additional patient. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
EM rosalba.carrozzo@opbg.net
FU Telethon Grant [GGP11011]; Italian Ministry of Health [GR2010-2316392]; Pasteur Institute - Cenci Bolognetti Foundation [40]
CR Akama K, 2010, BBA-MOL BASIS DIS, V1802, P692, DOI 10.1016/j.bbadis.2010.04.003
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   BOSCH L, 1983, PROG NUCLEIC ACID RE, V30, P91
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chomyn A, 1996, METHODS ENZYMOL, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Christian BE, 1819, BIOCHIM BIOPHYS ACTA, V2012, P1035
   Chrzanowska-Lightowlers Z M A, 2011, NEUROMUSCUL DISORD, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Fernández-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Montanari A, 2013, GENE, V527, P1, DOI 10.1016/j.gene.2013.05.042
   MULERO JJ, 1993, MOL BIOL CELL, V4, P1327, DOI 10.1091/mbc.4.12.1327
   Nagao Asuteka, 2007, NUCLEIC ACIDS SYMP SER (OXF), V0, P41
   Rizza T, 2009, BIOCHEM BIOPH RES CO, V383, P58, DOI 10.1016/j.bbrc.2009.03.121
   Rotig A, 1807, BIOCHIM BIOPHYS ACTA, V2011, P1198
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valente L, 2009, BBA-MOL BASIS DIS, V1792, P791, DOI 10.1016/j.bbadis.2009.06.002
   Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 27
TC 16
Z9 17
U1 1
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD APR 15
PY 2017
VL 1863
IS 4
BP 961
EP 967
DI 10.1016/j.bbadis.2017.01.022
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EP4PC
UT WOS:000397361400012
PM 28132884
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Newman, NJ
AF Yu-Wai-Man, Patrick
   Newman, Nancy J.
TI Inherited eye-related disorders due to mitochondrial dysfunction
SO HUMAN MOLECULAR GENETICS
LA English
DT Review
ID hereditary optic neuropathy; progressive external ophthalmoplegia; pluripotent stem-cells; wolfram-syndrome; opa1 mutations; dna mutation; mtdna-maintenance; retinal dystrophy; spindle transfer; disease
AB Genetic disorders due to mitochondrial dysfunction are not uncommon and the majority of these patients will have eye-related manifestations, including visual loss from the optic nerve and retinal disease, visual field loss from retrochiasmal visual pathway damage, and ptosis and ocular dysmotility from extraocular muscle involvement. Defects in both the nuclear and mitochondrial genomes cause mitochondrial dysfunction via several mechanisms, including impaired mitochondrial energy production, oxidative stress, mitochondrial DNA instability, abnormalities in the regulation of mitochondrial dynamics and mitochondrial quality control, and disturbed cellular interorganellar communication. Advances in our understanding of the molecular genetic basis of mitochondrial disease have not only improved genetic diagnosis, but they have provided important insights into the pathophysiologic basis of these disorders and potential therapeutic targets. In parallel, more sophisticated techniques for genetic manipulation are facilitating the development of animal and in vitro models that should prove powerful and versatile tools for disease modelling and therapeutic experimentation. Effective therapies for mitochondrial disorders are beginning to translate from bench to bedside along the paths of neuroprotection, gene replacement and stem cell-based regenerative paradigms. Additionally, preventing the transmission of pathogenic mtDNA mutations from mother to child is now a reality with in vitro fertilization mitochondrial replacement techniques.
C1 [Yu-Wai-Man, Patrick] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London, England.
   [Yu-Wai-Man, Patrick] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol Surg, Atlanta, GA USA.
C3 University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Newcastle University - UK; Emory University; Emory University; Emory University
RP Newman, NJ (corresponding author), Neuroophthalmol Unit, 1365-B Clifton Rd NE, Atlanta, GA 30322 USA.
EM ophtnjn@emory.edu
FU Medical Research Council (UK); Fight for Sight (UK); UK National Institute of Health Research (NIHR) as part of the Rare Diseases Translational Research Collaboration; NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Department of Ophthalmology, Emory University School of Medicine from Research to Prevent Blindness, Inc. (New York, N.Y.); NIH/NEI (Department of Ophthalmology, Emory University School of Medicine) [P30-EY06360]; MRC [G1002570, G0701386] Funding Source: UKRI
CR Alikani M, 2017, REPROD BIOMED ONLINE, V34, P333, DOI 10.1016/j.rbmo.2017.02.004
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Craven L, 2011, HUM MOL GENET, V20, PR168, DOI 10.1093/hmg/ddr373
   de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Flachsbarth K, 2014, INVEST OPHTH VIS SCI, V55, P7029, DOI 10.1167/iovs.14-15266
   Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Herbert M, 2017, NEW ENGL J MED, V376, P171, DOI 10.1056/NEJMcibr1615669
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Johnson TV, 2013, CURR OPIN PHARMACOL, V13, P78, DOI 10.1016/j.coph.2012.08.003
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Landes T, 2010, SEMIN CELL DEV BIOL, V21, P593, DOI 10.1016/j.semcdb.2009.12.012
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Lu SM, 2014, P NATL ACAD SCI USA, V111, PE5292, DOI 10.1073/pnas.1421055111
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nishino I, 2000, ANN NEUROL, V47, P792
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Rigoli L, 2012, CURR OPIN PEDIATR, V24, P512, DOI 10.1097/MOP.0b013e328354ccdf
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Rouzier C, 2017, HUM MOL GENET, V26, P1599, DOI 10.1093/hmg/ddx060
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245
   Shoubridge EA, 2016, NATURE, V540, P210, DOI 10.1038/nature20483
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429
   Xie BB, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0112175
   Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2017, MITOCHONDRION, V0, P0
   Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
   Yu-Wai-Man P, 2011, OPHTHALMOLOGY, V118, P558, DOI 10.1016/j.ophtha.2010.07.029
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhong XF, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5047
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 80
TC 41
Z9 43
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 1
PY 2017
VL 26
IS R1
BP R12
EP R20
DI 10.1093/hmg/ddx182
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FC4EW
UT WOS:000406792500003
PM 28481993
DA 2024-11-01
ER

PT J
AU Greenfield, A
   Braude, P
   Flinter, F
   Lovell-Badge, R
   Ogilvie, C
   Perry, ACF
AF Greenfield, Andy
   Braude, Peter
   Flinter, Frances
   Lovell-Badge, Robin
   Ogilvie, Caroline
   Perry, Anthony C. F.
TI Assisted reproductive technologies to prevent human mitochondrial disease transmission
SO NATURE BIOTECHNOLOGY
LA English
DT Review
ID preimplantation genetic diagnosis; replacement techniques; polar body; pronuclear transfer; spindle transfer; embryonic-development; pluripotent cells; dna segregation; genome transfer; in-vitro
AB Mitochondria are essential cytoplasmic organelles that generate energy (ATP) by oxidative phosphorylation and mediate key cellular processes such as apoptosis. They are maternally inherited and in humans contain a 16,569-base-pair circular genome (mtDNA) encoding 37 genes required for oxidative phosphorylation. Mutations in mtDNA cause a range of pathologies, commonly affecting energy-demanding tissues such as muscle and brain. Because mitochondrial diseases are incurable, attention has focused on limiting the inheritance of pathogenic mtDNA by mitochondrial replacement therapy (MRT). MRT aims to avoid pathogenic mtDNA transmission between generations by maternal spindle transfer, pronuclear transfer or polar body transfer: all involve the transfer of nuclear DNA from an egg or zygote containing defective mitochondria to a corresponding egg or zygote with normal mitochondria. Here we review recent developments in animal and human models of MRT and the underlying biology. These have led to potential clinical applications; we identify challenges to their technical refinement.
C1 [Greenfield, Andy] MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Harwell, Oxon, England.
   [Braude, Peter] Kings Coll London, Div Womens Hlth, London, England.
   [Flinter, Frances] Guys Hosp, Clin Genet Dept, London, England.
   [Lovell-Badge, Robin] Francis Crick Inst, London, England.
   [Ogilvie, Caroline] Guys & St Thomas NHS Fdn Trust, Genet Dept, London, England.
   [Ogilvie, Caroline] Kings Coll London, Div Womens Hlth, London, England.
   [Perry, Anthony C. F.] Univ Bath, Dept Biol & Biochem, Lab Mammalian Mol Embryol, Bath, Avon, England.
C3 MRC Harwell; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Francis Crick Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Bath
RP Greenfield, A (corresponding author), MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Harwell, Oxon, England.
EM a.greenfield@har.mrc.ac.uk
FU Medical Research Council, UK [MR/N000080/1, MR/N020294/1]; MRC [MR/N020294/1, MC_U117562207, MR/N000080/1, MC_U142684167] Funding Source: UKRI
CR Akman G, 2016, P NATL ACAD SCI USA, V113, PE4276, DOI 10.1073/pnas.1600537113
   Alikani M, 2017, REPROD BIOMED ONLINE, V34, P333, DOI 10.1016/j.rbmo.2017.02.004
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Appleby JB, 2017, BIOETHICS, V31, P2, DOI 10.1111/bioe.12313
   Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044
   Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   Boudoures AL, 2017, DEV BIOL, V426, P126, DOI 10.1016/j.ydbio.2017.04.005
   Bredenoord AL, 2017, CELL STEM CELL, V21, P301, DOI 10.1016/j.stem.2017.08.009
   Bredenoord AL, 2017, EMBO MOL MED, V9, P396, DOI 10.15252/emmm.201607291
   Cao LQ, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000756
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   CHA KY, 1991, FERTIL STERIL, V55, P109
   Chaigne A, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms10253
   Chinnery PF, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004315
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Cohen IG, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aag2959
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Cross P C, 1970, BIOL REPROD, V3, P298
   Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744
   Deglincerti A, 2016, CURR TOP DEV BIOL, V116, P99, DOI 10.1016/bs.ctdb.2015.11.010
   Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898
   Eyre-Walker A, 2017, GENETICS, V205, P1365, DOI 10.1534/genetics.116.196436
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gleicher N, 2017, REPROD BIOMED ONLINE, V0, P0
   Hayashi JI, 2016, CURR OPIN GENET DEV, V38, P63, DOI 10.1016/j.gde.2016.03.004
   Heindryckx B, 2014, MITOCHONDRION, V18, P12, DOI 10.1016/j.mito.2014.08.005
   Hikabe O, 2016, NATURE, V539, P299, DOI 10.1038/nature20104
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishii T, 2014, REPROD BIOMED ONLINE, V29, P150, DOI 10.1016/j.rbmo.2014.04.001
   Jo A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/305716
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Katayama M, 2006, DEV BIOL, V299, P206, DOI 10.1016/j.ydbio.2006.07.022
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   KIMURA Y, 1995, BIOL REPROD, V53, P855, DOI 10.1095/biolreprod53.4.855
   Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85
   Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Ledford H, 2016, NATURE, V532, P427, DOI 10.1038/nature.2016.19797
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Liao SM, 2017, BIOETHICS, V31, P20, DOI 10.1111/bioe.12308
   Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002
   Luo SM, 2013, P NATL ACAD SCI USA, V110, P13038, DOI 10.1073/pnas.1303231110
   Ma H, 2017, CELL STEM CELL, V20, P112, DOI 10.1016/j.stem.2016.10.001
   Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mitalipov S, 2014, CELL REP, V7, P935, DOI 10.1016/j.celrep.2014.05.004
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Nakada K, 2001, SEMIN CELL DEV BIOL, V12, P459, DOI 10.1006/scdb.2001.0283
   Newson AJ, 2017, BIOETHICS, V31, P55, DOI 10.1111/bioe.12312
   Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D, V0, P0
   Otten ABC, 2015, HUM REPROD UPDATE, V21, P671, DOI 10.1093/humupd/dmv024
   Palacios-González C, 2017, J LAW BIOSCI, V4, P50, DOI 10.1093/jlb/lsw065
   Palacios-González C, 2016, MONASH BIOETH REV, V34, P37, DOI 10.1007/s40592-016-0059-x
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Rishishwar L, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-3539-3
   Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347
   Shitara H, 2000, GENETICS, V156, P1277
   Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953
   Song WH, 2016, P NATL ACAD SCI USA, V113, PE5261, DOI 10.1073/pnas.1605844113
   Song WH, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/981867
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Steffann J, 2014, CELL REP, V7, P933, DOI 10.1016/j.celrep.2014.05.005
   Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Thorburn DR, 2009, MOL GENET METAB, V98, P5
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615
   Wakayama T, 1997, J REPROD FERTIL, V110, P263, DOI 10.1530/jrf.0.1100263
   Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang MK, 2001, ZYGOTE, V9, P9, DOI 10.1017/S0967199401001022
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Wolf DP, 2017, EMBO J, V36, P2659, DOI 10.15252/embj.201797843
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001
   Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287
   Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhang J, 2016, REPROD BIOMED ONLINE, V33, P529, DOI 10.1016/j.rbmo.2016.07.008
NR 98
TC 79
Z9 83
U1 0
U2 52
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD NOV 15
PY 2017
VL 35
IS 11
BP 1059
EP 1068
DI 10.1038/nbt.3997
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA FM2UM
UT WOS:000414856200022
PM 29121011
DA 2024-11-01
ER

PT J
AU Legati, A
   Reyes, A
   Berti, CC
   Stehling, O
   Marchet, S
   Lamperti, C
   Ferrari, A
   Robinson, AJ
   Mühlenhoff, U
   Lill, R
   Zeviani, M
   Goffrini, P
   Ghezzi, D
AF Legati, Andrea
   Reyes, Aurelio
   Berti, Camilla Ceccatelli
   Stehling, Oliver
   Marchet, Silvia
   Lamperti, Costanza
   Ferrari, Alberto
   Robinson, Alan J.
   Muhlenhoff, Ulrich
   Lill, Roland
   Zeviani, Massimo
   Goffrini, Paola
   Ghezzi, Daniele
TI A novel de novo dominant mutation in <i>ISCU</i> associated with mitochondrial myopathy
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID iron-sulfur clusters; protein biogenesis; metabolism; reconstitution; architecture; ferredoxins; involvement; reveals; family; leads
AB Background Hereditary myopathy with lactic acidosis and myopathy with deficiency of succinate dehydrogenase and aconitase are variants of a recessive disorder characterised by childhood-onset early fatigue, dyspnoea and palpitations on trivial exercise. The disease is non-progressive, but life-threatening episodes of widespread weakness, metabolic acidosis and rhabdomyolysis may occur. So far, this disease has been molecularly defined only in Swedish patients, all homozygous for a deep intronic splicing affecting mutation in ISCU encoding a scaffold protein for the assembly of iron-sulfur (Fe-S) clusters. A single Scandinavian family was identified with a different mutation, a missense change in compound heterozygosity with the common intronic mutation. The aim of the study was to identify the genetic defect in our proband. Methods A next-generation sequencing (NGS) approach was carried out on an Italian male who presented in childhood with ptosis, severe muscle weakness and exercise intolerance. His disease was slowly progressive, with partial recovery between episodes. Patient's specimens and yeast models were investigated. Results Histochemical and biochemical analyses on muscle biopsy showed multiple defects affecting mitochondrial respiratory chain complexes. We identified a single heterozygous mutation p. Gly96Val in ISCU, which was absent in DNA from his parents indicating a possible de novo dominant effect in the patient. Patient fibroblasts showed normal levels of ISCU protein and a few variably affected Fe-S cluster-dependent enzymes. Yeast studies confirmed both pathogenicity and dominance of the identified missense mutation. Conclusion We describe the first heterozygous dominant mutation in ISCU which results in a phenotype reminiscent of the recessive disease previously reported.
C1 [Legati, Andrea; Marchet, Silvia; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Neurol Inst Besta, Mol Neurogenet Unit, Milan, Italy.
   [Reyes, Aurelio; Robinson, Alan J.; Zeviani, Massimo] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
   [Berti, Camilla Ceccatelli; Ferrari, Alberto; Goffrini, Paola] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.
   [Stehling, Oliver; Muhlenhoff, Ulrich; Lill, Roland] Philipps Univ, Inst Zytobiol & Zytopathol, Dept Med, Marburg, Germany.
   [Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, Unit Metab, Marburg, Germany.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Parma; Philipps University Marburg
RP Goffrini, P (corresponding author), Univ Parma, Dept Chem, Life Sci & Environm Sustainabil, Viale Sci 11-A, I-43124 Parma, Italy.; Ghezzi, D (corresponding author), Ist Nazl Neurol Carlo Besta, Mol Neurogenet, I-20126 Milan, Italy.
EM paola.goffrini@unipr.it; daniele.ghezzi@istituto-besta.it
FU TelethonItaly [GGP15041]; Pierfranco and Luisa Mariani Foundation; MRC7QQR [201572020]; ERC advanced grant [FP77322424]; NRJ Foundation7Institut de France; E7Rare project GENOMIT; Deutsche Forschungsgemeinschaft [SFB 987, SPP 1927]; LOEWE program of state Hessen; MRC [MC_U105674181, MC_UP_1002/1, MC_UU_00015/5] Funding Source: UKRI
CR Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604
   Barrientos Antoni, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1903s63
   Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Brachmann CB, 1998, YEAST, V14, P115
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Cory SA, 2017, P NATL ACAD SCI USA, V114, PE5325, DOI 10.1073/pnas.1702849114
   Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889
   DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003
   Freibert SA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms13932
   Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542
   Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294
   Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07
   Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004
   Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Holmes-Hampton GP, 2016, HUM MOL GENET, V25, P5178, DOI 10.1093/hmg/ddw338
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Maio N, 2017, CELL METAB, V25, P945, DOI 10.1016/j.cmet.2017.03.010
   Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0
   Mühlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446
   Nachbauer W, 2012, J NEUROPATH EXP NEUR, V71, P708, DOI 10.1097/NEN.0b013e31825fed76
   Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665
   Sambrook J, 1990, COLD SPRING HARBOR LABORATORIES, V186, P182
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206
   Schmucker S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016199
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772
   Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107
   Shi R, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000354
   Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002
   Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002
   Stehling O, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011312
   Stevens A, 1990, THEORY PRACTICE HIST, V0, P245
   Stiban J, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1066, DOI 10.1134/S0006297916100059
   Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001
   UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708
   Webert H, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6013
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
NR 51
TC 25
Z9 28
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD DEC 15
PY 2017
VL 54
IS 12
BP 815
EP 824
DI 10.1136/jmedgenet-2017-104822
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA FN6SU
UT WOS:000416147100005
PM 29079705
DA 2024-11-01
ER

PT J
AU Mukai, M
   Nagata, E
   Mizuma, A
   Yamano, M
   Sugaya, K
   Nishino, I
   Goto, Y
   Takizawa, S
AF Mukai, Masako
   Nagata, Eiichiro
   Mizuma, Atsushi
   Yamano, Mitsuhiko
   Sugaya, Keizo
   Nishino, Ichizo
   Goto, Yu-ichi
   Takizawa, Shunya
TI Adult-onset Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke (MELAS)-like Encephalopathy Diagnosed Based on the Complete Sequencing of Mitochondrial DNA Extracted from Biopsied Muscle without any Myopathic Changes
SO INTERNAL MEDICINE
LA English
DT Article
DE MELAS; stroke-like episodes; MT-ND3; adult onset; m.10158T > C mutation
ID nd3 gene; leigh-syndrome; i deficiency; mutation; episodes; mt-nd3; melas
AB The clinical features of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) are not uniform. We herein report a male patient with unusual MELAS-like encephalopathy who had been experiencing isolated recurrent stroke-like episodes since he was 33 years old without any particular family history. Despite an extensive investigation, he had no other signs suggestive of MELAS. Although the muscle pathology showed a normal appearance, a mitochondrial genome sequence analysis of the biopsied muscle revealed a heteroplasmic m. 10158T>C mutation in the mitochondrial complex I subunit gene, MT-ND3. To prevented further deterioration of the higher brain function, the early diagnosis and treatment of mitochondrial stroke-like episodes is important.
C1 [Mukai, Masako; Nagata, Eiichiro; Mizuma, Atsushi; Yamano, Mitsuhiko; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Hiratsuka, Kanagawa 25912, Japan.
   [Sugaya, Keizo] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Kodaira, Tokyo, Japan.
C3 Tokai University; Tokyo Metropolitan Institute for Neuroscience; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Mukai, M (corresponding author), Tokai Univ, Sch Med, Dept Neurol, Hiratsuka, Kanagawa 25912, Japan.
EM mmukai@tokai.ac.jp
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Levy RJ, 2014, J CHILD NEUROL, V29, PNP105, DOI 10.1177/0883073813506783
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mukai M, 2015, NEUROL CLIN NEUROSCI, V3, P153, DOI 10.1111/ncn3.173
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
NR 12
TC 11
Z9 15
U1 0
U2 4
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PD JUN 15
PY 2017
VL 56
IS 1
BP 95
EP 99
DI 10.2169/internalmedicine.56.7301
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EI4AS
UT WOS:000392435400015
PM 28050007
DA 2024-11-01
ER

PT J
AU Giannoccaro, MP
   La Morgia, C
   Rizzo, G
   Carelli, V
AF Giannoccaro, Maria Pia
   La Morgia, Chiara
   Rizzo, Giovanni
   Carelli, Valerio
TI Mitochondrial DNA and Primary Mitochondrial Dysfunction in Parkinson's Disease
SO MOVEMENT DISORDERS
LA English
DT Review
DE Parkinson disease; parkinsonism; mitochondrial DNA; mtDNA; quality control; mitophagy
ID progressive external ophthalmoplegia; hereditary optic neuropathy; respiratory-chain activity; multiple mtdna deletions; complex i deficiency; loss-of-function; alpha-synuclein; polymerase-gamma; substantia-nigra; skeletal-muscle
AB In 1979, it was observed that parkinsonism could be induced by a toxin inhibiting mitochondrial respiratory complex I. This initiated the long- standing hypothesis that mitochondrial dysfunction may play a key role in the pathogenesis of Parkinson's disease (PD). This hypothesis evolved, with accumulating evidence pointing to complex I dysfunction, which could be caused by environmental or genetic factors. Attention was focused on the mitochondrial DNA, considering the occurrence of mutations, polymorphic haplogroupspecific variants, and defective mitochondrial DNA maintenance with the accumulation of multiple deletions and a reduction of copy number. Genetically determined diseases of mitochondrial DNA maintenance frequently manifest with parkinsonism, but the age-related accumulation of somatic mitochondrial DNA errors also represents a major driving mechanism for PD. Recently, the discovery of the genetic cause of rare inherited forms of PD highlighted an extremely complex homeostatic control over mitochondria, involving their dynamic fission/fusion cycle, the balancing of mitobiogenesis and mitophagy, and consequently the quality control surveillance that corrects faulty mitochondrial DNA maintenance. Many genes came into play, including the PINK1/parkin axis, but also OPA1, as pieces of the same puzzle, together with mitochondrial DNA damage, complex I deficiency and increased oxidative stress. The search for answers will drive future research to reach the understanding necessary to provide therapeutic options directed not only at limiting the clinical evolution of symptoms but also finally addressing the pathogenic mechanisms of neurodegeneration in PD. (C) 2017 International Parkinson and Movement Disorder Society
C1 [Giannoccaro, Maria Pia; La Morgia, Chiara; Rizzo, Giovanni; Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Giannoccaro, Maria Pia; La Morgia, Chiara; Rizzo, Giovanni; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Giannoccaro, Maria Pia] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of Bologna; University of Oxford
RP Carelli, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Osped Bellaria, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
FU Italian Ministry of Health; Italian Ministries of Health and of Research; Emilia Romagna Region; Telethon-Italy; e-RARE
CR Ahlskog JE, 2009, PARKINSONISM RELAT D, V15, P721, DOI 10.1016/j.parkreldis.2009.09.010
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amboni M, 2009, MOVEMENT DISORD, V24, P303, DOI 10.1002/mds.22342
   Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104
   [Anonymous], 2012, ANN SAUDI MED, V0, P0
   Enríquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   CHECCARELLI N, 1994, J NEUROL SCI, V123, P74, DOI 10.1016/0022-510X(94)90206-2
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   De Rosa P, 2015, CLIN CHIM ACTA, V449, P68, DOI 10.1016/j.cca.2015.04.042
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948
   Di Maio R, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf3634
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DIMAURO S, 1993, NEUROLOGY, V43, P2170, DOI 10.1212/WNL.43.11.2170
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Erro R, 2015, MOVEMENT DISORD, V30, P780, DOI 10.1002/mds.26209
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI 10.1089/ars.2008.2247
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fato R, 2008, NEUROCHEM RES, V33, P2487, DOI 10.1007/s11064-008-9747-0
   Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016
   Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grenier K, 2013, FRONT NEUROL, V4, P0, DOI 10.3389/fneur.2013.00100
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012962
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Guarás A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009
   Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213
   Heo JY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032629
   HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307
   Höglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173
   Jenner P, 2001, TRENDS NEUROSCI, V24, P245, DOI 10.1016/S0166-2236(00)01789-6
   Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223
   Kapsa RMI, 1996, J NEUROL SCI, V144, P204, DOI 10.1016/S0022-510X(96)00247-X
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   KOLATA G, 1983, SCIENCE, V220, P705, DOI 10.1126/science.6403987
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krüger R, 2011, NEUROBIOL AGING, V32, P0, DOI 10.1016/j.neurobiolaging.2009.11.021
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   Mehta SH, 2016, PARKINSONISM RELAT D, V30, P83, DOI 10.1016/j.parkreldis.2016.06.013
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538
   Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Niu JW, 2012, J NEUROCHEM, V122, P650, DOI 10.1111/j.1471-4159.2012.07809.x
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Pogson JH, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004815
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424
   Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Ramonet D, 2013, CELL DEATH DIFFER, V20, P77, DOI 10.1038/cdd.2012.95
   RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89
   Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350
   Rodriguez M, 2015, AGING CELL, V14, P293, DOI 10.1111/acel.12312
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Rostovtseva TK, 2015, J BIOL CHEM, V290, P18467, DOI 10.1074/jbc.M115.641746
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   SCHAPIRA AHV, 1993, ADV NEUROL, V60, P288
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202
   SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406
   Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3
   Schon EA, 1998, NEUROLOGY, V51, P326, DOI 10.1212/WNL.51.1.326
   Sherer TB, 2002, J NEUROSCI, V22, P7006
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627
   Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685
   Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P993, DOI 10.1016/j.freeradbiomed.2012.05.024
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Subramaniam SR, 2013, MITOCHONDRIAL DYSFUN, V107, P17, DOI 10.1016/J.PNEUR0BI0.2013.04.004
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trimmer PA, 2009, EXP NEUROL, V218, P320, DOI 10.1016/j.expneurol.2009.03.016
   Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   UHL GR, 1985, LANCET, V1, P956
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740
   Vilain S, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002456
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655
   Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y
   WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X
   Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211
   Zheng B, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001059
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
NR 263
TC 105
Z9 115
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD MAR 15
PY 2017
VL 32
IS 3
BP 346
EP 363
DI 10.1002/mds.26966
PG 18
WC Clinical Neurology
SC Neurosciences & Neurology
GA EQ4QS
UT WOS:000398063600006
PM 28251677
DA 2024-11-01
ER

PT J
AU Fragaki, K
   Chaussenot, A
   Boutron, A
   Bannwarth, S
   Cochaud, C
   Richelme, C
   Sacconi, S
   Paquis-Flucklinger, V
AF Fragaki, Konstantina
   Chaussenot, Annabelle
   Boutron, Audrey
   Bannwarth, Sylvie
   Cochaud, Charlotte
   Richelme, Christian
   Sacconi, Sabrina
   Paquis-Flucklinger, Veronique
TI SEVERE DEFECT IN MITOCHONDRIAL COMPLEX I ASSEMBLY WITH MITOCHONDRIAL DNA DELETIONS IN <i>ACAD9</i>-DEFICIENT MILD MYOPATHY
SO MUSCLE & NERVE
LA English
DT Article
DE ACAD9 mutation; complex I deficiency; complex I disassembly; exercise intolerance; mitochondrial myopathy; mtDNA deletions
ID acad9; deficiency; mutation
AB Introduction: Acyl-coenzyme A dehydrogenase 9 (ACAD9) has a role in mitochondrial complex I (CI) assembly. Only a few patients who carry ACAD9 mutations have been reported. They mainly present with severe hypertrophic cardiomyopathy, although a minority have only mild isolated myopathy. Although the secondary factors influencing disease severity have not been elucidated, conservation of CI assembly and residual enzymatic activity have been suggested as explanations for the mild phenotypes associated with ACAD9 mutations. Methods: We report a novel homozygous ACAD9 mutation (c.1240C>T; p.Arg414Cys) in a 34-year-old woman who presented with non-progressive myopathy. Results: We show that this ACAD9 mutation led to a severe defect in CI assembly in the patient's muscle. Furthermore, the impact of CI deficiency is confirmed by accumulation of mitochondrial DNA deletions. Conclusion: Our data suggest that a major defect of CI assembly is not responsible for a severe phenotype.
C1 [Fragaki, Konstantina; Chaussenot, Annabelle; Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Nice Sophia Antipolis Univ, Inst Res Canc & Aging IRCAN, CNRS, INSERM,UMR 7284, 28 Ave Valombrose, F-06107 Nice 2, France.
   [Fragaki, Konstantina; Chaussenot, Annabelle; Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Sch Med, U1081, 28 Ave Valombrose, F-06107 Nice 2, France.
   [Fragaki, Konstantina; Chaussenot, Annabelle; Bannwarth, Sylvie; Cochaud, Charlotte; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, Nice, France.
   [Boutron, Audrey] Paris Sud Teaching Hosp, Bicetre Hosp, AP HP, Dept Biochem, Paris, France.
   [Richelme, Christian] Nice Teaching Hosp, Dept Pediat, Nice, France.
   [Sacconi, Sabrina] Nice Teaching Hosp, Natl Ctr Neuromuscular Disorders, Nice, France.
C3 Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Universite Cote d'Azur; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CHU Nice; CHU Nice
RP Paquis-Flucklinger, V (corresponding author), Nice Sophia Antipolis Univ, Inst Res Canc & Aging IRCAN, CNRS, INSERM,UMR 7284, 28 Ave Valombrose, F-06107 Nice 2, France.; Paquis-Flucklinger, V (corresponding author), Sch Med, U1081, 28 Ave Valombrose, F-06107 Nice 2, France.; Paquis-Flucklinger, V (corresponding author), Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, Nice, France.
EM paquis@hermes.unice.fr
CR Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Collet M, 2016, EUR J HUM GENET, V24, P1112, DOI 10.1038/ejhg.2015.264
   Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Moraes C, 1989, NEW ENGL J MED, V18, P1293
   Nouws J, 2014, JIMD REP, V12, P37, DOI 10.1007/8904_2013_242
   Paul R, 1996, TRENDS GENET, V12, P131
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074
NR 12
TC 4
Z9 4
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JUN 15
PY 2017
VL 55
IS 6
BP 919
EP 922
DI 10.1002/mus.25262
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EY5TA
UT WOS:000404041600027
PM 27438479
DA 2024-11-01
ER

PT J
AU Nivison, MP
   Ericson, NG
   Green, VM
   Bielas, JH
   Campbell, JS
   Horner, PJ
AF Nivison, Mary P.
   Ericson, Nolan G.
   Green, Virginia M.
   Bielas, Jason H.
   Campbell, Jean S.
   Horner, Philip J.
TI Age-related accumulation of phosphorylated mitofusin 2 protein in retinal ganglion cells correlates with glaucoma progression
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Mitofusin; Mitochondria; Phosphorylation; Axon transport; Neurodegeneration; Mutation frequency
ID dba/2j mouse model; mitochondrial fusion; pink1/parkin pathway; oxidative stress; skeletal-muscle; dysfunction; mutations; quantification; transport; atrophy
AB Dysregulation of axonal bioenergetics is likely a key mechanism in the initiation and progression of age-related neurodegenerative diseases. Glaucoma is a quintessential neurodegenerative disorder characterized by progressive deterioration of the optic nerve (ON) and eventual death of retinal ganglion cells (RGCs). Age and elevation of intraocular pressure are key risk factors in glaucoma, but the common early hallmarks of decreased axonal transport and increased bioenergetic vulnerability likely underlie disease initiation. We examined the correlation between bioenergetics and axonal transport with mitochondrial mutation frequency and post-translational modifications of mitofusin 2 (Mfn2) in RGCs during glaucoma progression. No increase in the frequency of mtDNA mutations was detected, but we observed significant shifts in mitochondrial protein species. Mfn2 is a fusion protein that functions in mitochondrial biogenesis, maintenance, and mitochondrial transport. We demonstrate that Mfn2 accumulates selectively in RGCs during glaucomatous degeneration, that two novel states of Mfn2 exist in retina and ON, and identify a phosphorylated form that selectively accumulates in RGCs, but is absent in ON. Phosphorylation of Mfn2 is correlated with higher ubiquitination, and failure of the protein to reach the ON. Together, these data suggest that post-translational modification of Mfn2 is associated with its dysregulation during a window of metabolic vulnerability that precedes glaucomatous degeneration. Future work to either manipulate expression of Mfn2 or to prevent its degradation could have therapeutic value in the treatment of neurodegenerative diseases where long-tract axons are vulnerable. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Nivison, Mary P.; Bielas, Jason H.; Campbell, Jean S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA.
   [Green, Virginia M.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA.
   [Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.
   [Campbell, Jean S.] Fred Hutchinson Canc Res Ctr, Program Immunol, Div Clin Res, Seattle, WA 98109 USA.
   [Horner, Philip J.] Houston Methodist Res Inst, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.
C3 University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Benaroya Research Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Houston Methodist Hospital
RP Horner, PJ (corresponding author), Houston Methodist Res Inst, Dept Neurol Surg, Ctr Regenerat & Restorat Neurosurg, Ctr Neuroregenerat Med, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.; Horner, PJ (corresponding author), Houston Methodist Res Inst, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.
EM pjhorner@houstonmethodist.org
FU Glaucoma Research Foundation Catalyst for a Cure Initiative; Melza M. and Frank Theodore Barr Foundation; Ellison Medical Foundation New Scholar award [AG-NS-0577-09]; Outstanding New Environmental Scientist Award (ONES) from the National Institute of Environmental Health Sciences [ES019319]; Congressionally Directed Medical Research Programs/U.S. Department of Defense [W81XWH-10-1-0563]
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794
   Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337
   Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008
   Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001
   Calkins DJ, 2012, INVEST OPHTH VIS SCI, V53, P2482, DOI 10.1167/iovs.12-9483i
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2
   Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cooper ML, 2016, EXP EYE RES, V150, P22, DOI 10.1016/j.exer.2015.11.016
   Corazao-Rozas P, 2016, ONCOTARGET, V7, P39473, DOI 10.18632/oncotarget.7790
   Coughlin L, 2015, INVEST OPHTH VIS SCI, V56, P1437, DOI 10.1167/iovs.14-16126
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002
   Eschenbacher WH, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044296
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Frogne T, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035233
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Gong GH, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aad2459
   Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181
   Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002
   Huang PS, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024109
   Inman DM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065389
   Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925
   Jarrett Stuart G, 2013, METHODS MOL BIOL, V935, P227, DOI 10.1007/978-1-62703-080-9_16
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Lambert W, 2008, INVEST OPHTHALMOL VI, V49, P5498
   Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015
   Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130
   Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Nguyen D, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.117
   ONeill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103
   Park J, 2015, J NEUROCHEM, V132, P687, DOI 10.1111/jnc.12984
   Peng KG, 2017, MOL NEUROBIOL, V54, P3783, DOI 10.1007/s12035-016-9944-9
   Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poole AC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010054
   Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042
   Shen HW, 2008, BRAIN STRUCT FUNCT, V213, P149, DOI 10.1007/s00429-008-0184-2
   Shiba-Fukushima K, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004391
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tanwar M, 2010, MOL VIS, V16, P518
   Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yue W, 2014, CELL RES, V24, P482, DOI 10.1038/cr.2014.20
   Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101
NR 68
TC 13
Z9 14
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD OCT 15
PY 2017
VL 296
IS 
BP 49
EP 61
DI 10.1016/j.expneurol.2017.07.001
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA FE6CC
UT WOS:000408296600006
PM 28684211
DA 2024-11-01
ER

PT J
AU Scholimann, G
   Picker-Minh, S
   Schwarz, JM
   Gill, E
   Rodenburg, RJT
   Stenzel, W
   Kaindl, AM
   Schuelke, M
AF Scholimann, Gudrun
   Picker-Minh, Sylvie
   Schwarz, Jana Marie
   Gill, Esther
   Rodenburg, Richard J. T.
   Stenzel, Werner
   Kaindl, Angela M.
   Schuelke, Markus
TI Recessive mutation in <i>EXOSC3</i> associates with mitochondrial dysfunction and pontocerebellar hypoplasia
SO MITOCHONDRION
LA English
DT Article
DE Pontocerebellar hypoplasia type 1; Human RNA exosome complex; Pyruvate dehydrogenase deficiency; Complex I deficiency; Mitochondrial disease; Whole exome sequencing; Transcriptome analysis; mtDNA copy numbers
ID eukaryotic rna exosome; intellectual disability; protein; gene; muscle; type-1; degradation; expression; phenotype; framework
AB Recessive mutations in EXOSC3, encoding a subunit of the human RNA exosome complex, cause pontocerebellar hypoplasia type 1b (PCH1B). We report a boy with severe muscular hypotonia, psychomotor retardation, progressive microcephaly, and cerebellar atrophy. Biochemical abnormalities comprised mitochondrial complex I and pyruvate dehydrogenase complex (PDHc) deficiency. Whole exome sequencing uncovered a known EXOSC3 mutation p.(D132A) as the underlying cause. In patient fibroblasts, a large portion of the EXOSC3 protein was trapped in the cytosol. MtDNA copy numbers in muscle were reduced to 35%, but mutations in the mtDNA and in nuclear mitochondrial genes were ruled out. RNA-Seq of patient muscle showed highly increased mRNA copy numbers, especially for genes encoding structural subunits of OXPHOS complexes I, III, and W, possibly due to reduced degradation by a dysfunctional exosome complex. This is the first case of mitochondrial dysfunction associated with an EXOSC3 mutation, which expands the phenotypic spectrum of PCH1B. We discuss the links between exosome and mitochondrial dysfunction.
C1 [Scholimann, Gudrun; Schwarz, Jana Marie; Gill, Esther; Schuelke, Markus] Charite, NCRC, Berlin, Germany.
   [Scholimann, Gudrun; Picker-Minh, Sylvie; Schwarz, Jana Marie; Gill, Esther; Stenzel, Werner; Kaindl, Angela M.; Schuelke, Markus] Humboldt Univ, Freie Univ Berlin, Berlin, Germany.
   [Scholimann, Gudrun; Picker-Minh, Sylvie; Schwarz, Jana Marie; Gill, Esther; Stenzel, Werner; Kaindl, Angela M.; Schuelke, Markus] Berlin Inst Hlth, Berlin, Germany.
   [Scholimann, Gudrun; Picker-Minh, Sylvie; Kaindl, Angela M.; Schuelke, Markus] Charite, Dept Neuropediat, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Picker-Minh, Sylvie; Kaindl, Angela M.] Charite, Ctr Chronically Sick Children, Berlin, Germany.
   [Picker-Minh, Sylvie; Kaindl, Angela M.] Charite, Inst Cell Biol & Neurobiol, Berlin, Germany.
   [Rodenburg, Richard J. T.] Radboud Ctr Mitochondrial Disorders, Dept Pediat, Translat Metab Lab, Radboudumc, Nijmegen, Netherlands.
   [Stenzel, Werner] Charite, Inst Neuropathol, Berlin, Germany.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Kaindl, AM; Schuelke, M (corresponding author), Charite, Dept Neuropediat, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM angela.kaindl@charite.de; markus.schuelke@charite.de
FU Deutsche Forschungsgemeinschaft [SFB 665]; Berlin Institute of Health (BIH); NeuroCure Center of Excellence [Exc 257]; Charite-Universitatsmedizin Berlin; Berlin Institute of Health
CR [Anonymous], 1900, DOI 10.48550/ARXIV.1303.3997, V0, P0
   Biancheri R, 2013, J NEUROL, V260, P1866, DOI 10.1007/s00415-013-6896-0
   Boczonadi V, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5287
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5
   Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200
   Di Donato N, 2016, J MED GENET, V53, P419, DOI 10.1136/jmedgenet-2015-103511
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Eggens VRC, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-23
   Ferdinandusse S, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-188
   Gillespie A, 2017, RNA, V23, P466, DOI 10.1261/rna.060004.116
   Giunta M, 2016, HUM MOL GENET, V25, P2985, DOI 10.1093/hmg/ddw149
   Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018
   Haack TB, 2013, J INHERIT METAB DIS, V36, P55, DOI 10.1007/s10545-012-9489-7
   Halevy A, 2014, J NEUROL, V261, P2165, DOI 10.1007/s00415-014-7457-x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Januszyk K, 2014, CURR OPIN STRUC BIOL, V24, P132, DOI 10.1016/j.sbi.2014.01.011
   Lal D, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0146040
   Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020
   Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Namavar Y, 2011, ORPHANET J RARE DIS, V6, P0, DOI 10.1186/1750-1172-6-50
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rudnik-Schöneborn S, 2013, NEUROLOGY, V80, P438, DOI 10.1212/WNL.0b013e31827f0f66
   Schottmann G, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000032
   Schuelke M, 1998, BIOCHEM BIOPH RES CO, V245, P599, DOI 10.1006/bbrc.1998.8486
   Schwabova J, 2013, J NEUROGENET, V27, P163, DOI 10.3109/01677063.2013.814651
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Seelow D, 2012, NUCLEIC ACIDS RES, V40, PW516, DOI 10.1093/nar/gks487
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254
   Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019
   Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251
   Zanni G, 2013, NEUROGENETICS, V14, P247, DOI 10.1007/s10048-013-0371-z
NR 44
TC 23
Z9 25
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2017
VL 37
IS 
BP 46
EP 54
DI 10.1016/j.mito.2017.06.007
PG 9
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA FN8SO
UT WOS:000416296000006
PM 28687512
DA 2024-11-01
ER

PT J
AU Shabalina, IG
   Vyssokikh, MY
   Gibanova, N
   Csikasz, RI
   Edgar, D
   Hallden-Waldemarson, A
   Rozhdestvenskaya, Z
   Bakeeva, LE
   Vays, VB
   Pustovidko, AV
   Skulachev, MV
   Cannon, B
   Skulachev, VP
   Nedergaard, J
AF Shabalina, Irina G.
   Vyssokikh, Mikhail Yu.
   Gibanova, Natalia
   Csikasz, Robert I.
   Edgar, Daniel
   Hallden-Waldemarson, Anne
   Rozhdestvenskaya, Zinaida
   Bakeeva, Lora E.
   Vays, Valeria B.
   Pustovidko, Antonina V.
   Skulachev, Maxim V.
   Cannon, Barbara
   Skulachev, Vladimir P.
   Nedergaard, Jan
TI Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1
SO AGING-US
LA English
DT Article
DE reactive oxygen species; oxidative stress; mitochondria; cardiolipin; thermogenesis; brown adipose tissue; longevity
ID oxidative stress; adipose-tissue; dna mutations; fatty-acid; assay; age; generation; prevention; phenotypes; muscle
AB MtDNA mutator mice exhibit marked features of premature aging. We find that these mice treated from age of approximate to 100 days with the mitochondria-targeted antioxidant SkQ1 showed a delayed appearance of traits of aging such as kyphosis, alopecia, lowering of body temperature, body weight loss, as well as ameliorated heart, kidney and liver pathologies. These effects of SkQ1 are suggested to be related to an alleviation of the effects of an enhanced reactive oxygen species (ROS) level in mtDNA mutator mice: the increased mitochondrial ROS released due to mitochondrial mutations probably interact with polyunsaturated fatty acids in cardiolipin, releasing malondialdehyde and 4-hydroxynonenal that form protein adducts and thus diminishes mitochondrial functions. SkQ1 counteracts this as it scavenges mitochondrial ROS. As the results, the normal mitochondrial ultrastructure is preserved in liver and heart; the phosphorylation capacity of skeletal muscle mitochondria as well as the thermogenic capacity of brown adipose tissue is also improved. The SkQ1-treated mice live significantly longer (335 versus 290 days). These data may be relevant in relation to treatment of mitochondrial diseases particularly and the process of aging in general.
C1 [Shabalina, Irina G.; Gibanova, Natalia; Csikasz, Robert I.; Edgar, Daniel; Hallden-Waldemarson, Anne; Rozhdestvenskaya, Zinaida; Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.
   [Vyssokikh, Mikhail Yu.; Bakeeva, Lora E.; Vays, Valeria B.; Pustovidko, Antonina V.; Skulachev, Vladimir P.] Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119992, Russia.
   [Bakeeva, Lora E.; Skulachev, Maxim V.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Inst Mitoengineering, Moscow 119992, Russia.
   [Edgar, Daniel] Buck Inst Res aging, Novato, CA 94945 USA.
C3 Stockholm University; Lomonosov Moscow State University; Lomonosov Moscow State University; Buck Institute for Research on Aging
RP Nedergaard, J (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.; Skulachev, VP (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119992, Russia.
EM skulach@belozersky.msu.ru; jan@metabol.su.se
FU Mitotech; Russian Scientific Foundation [14-24-00107, 14-50-00029]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Russian Science Foundation [17-24-00014] Funding Source: Russian Science Foundation
CR Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Anisimov VN, 2011, AGING-US, V3, P1110, DOI 10.18632/aging.100404
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/360438
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cottrell D A, 2000, CURR OPIN CLIN NUTR METAB CARE, V3, P473, DOI 10.1097/00075197-200011000-00009
   Currais A, 2015, AGEING RES REV, V21, P30, DOI 10.1016/j.arr.2015.02.001
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fischer AW, 2016, AM J PHYSIOL-ENDOC M, V311, PE202, DOI 10.1152/ajpendo.00093.2016
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Kanyicska B, 2003, ENDOCRINE, V20, P53, DOI 10.1385/ENDO:20:1-2:53
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004385
   Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Lokhmatikov AV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1081, DOI 10.1134/S0006297914100101
   Manskikh VN, 2015, HISTOL HISTOPATHOL, V30, P353, DOI 10.14670/HH-30.353
   Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0
   Nacarelli T, 2016, HEALTHY AGEING LONG, V4, P169, DOI 10.1007/978-3-319-26239-0_10
   Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200
   Shabalina IG, 2014, BBA-BIOENERGETICS, V1837, P2017, DOI 10.1016/j.bbabio.2014.04.005
   Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044
   Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305
   Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033
   Skulachev VP, 2010, BBA-BIOENERGETICS, V1797, P878, DOI 10.1016/j.bbabio.2010.03.015
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   Thompson LV, 2006, EXP GERONTOL, V41, P1220, DOI 10.1016/j.exger.2006.10.018
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   Vyssokikh Mikhail Y, 2015, METHODS MOL BIOL, V1265, P149, DOI 10.1007/978-1-4939-2288-8_12
   Wallace D C, 2001, NOVARTIS FOUND SYMP, V235, P247
   Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Wiswedel I, 2010, FREE RADICAL RES, V44, P135, DOI 10.3109/10715760903352841
   Yagi K, 1998, METHODS MOL BIOL, V108, P101
NR 55
TC 72
Z9 80
U1 3
U2 14
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
EI 
J9 AGING-US
JI Aging-US
PD FEB 15
PY 2017
VL 9
IS 2
BP 315
EP 339
DI 10.18632/aging.101174
PG 25
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA EO7TH
UT WOS:000396892500005
PM 28209927
DA 2024-11-01
ER

PT J
AU Borgia, D
   Malena, A
   Spinazzi, M
   Desbats, MA
   Salviati, L
   Russell, AP
   Miotto, G
   Tosatto, L
   Pegoraro, E
   Sorarù, G
   Pennuto, M
   Vergani, L
AF Borgia, Doriana
   Malena, Adriana
   Spinazzi, Marco
   Desbats, Maria Andrea
   Salviati, Leonardo
   Russell, Aaron P.
   Miotto, Giovanni
   Tosatto, Laura
   Pegoraro, Elena
   Soraru, Gianni
   Pennuto, Maria
   Vergani, Lodovica
TI Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID human androgen receptor; transgenic mouse model; respiratory-chain supercomplexes; nucleocytoplasmic transport; mitochondrial dysfunction; intranuclear inclusions; polyglutamine disease; nuclear-localization; repeat expansion; lipid extraction
AB Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by polyglutamine expansion in the androgen receptor (AR) and characterized by the loss of lower motor neurons. Here we investigated pathological processes occurring in muscle biopsy specimens derived from SBMA patients and, as controls, age-matched healthy subjects and patients suffering from amyotrophic lateral sclerosis (ALS) and neurogenic atrophy. We detected atrophic fibers in the muscle of SBMA, ALS and neurogenic atrophy patients. In addition, SBMA muscle was characterized by the presence of a large number of hypertrophic fibers, with oxidative fibers having a larger size compared with glycolytic fibers. Polyglutamine- expanded AR expression was decreased in whole muscle, yet enriched in the nucleus, and localized to mitochondria. Ultrastructural analysis revealed myofibrillar disorganization and streaming in zones lacking mitochondria and degenerating mitochondria. Using molecular (mtDNA copy number), biochemical (citrate synthase and respiratory chain enzymes) and morphological (dark blue area in nicotinamide adenine dinucleotide-stained muscle cross-sections) analyses, we found a depletion of the mitochondria associated with enhanced mitophagy. Mass spectrometry analysis revealed an increase of phosphatidylethanolamines and phosphatidylserines in mitochondria isolated from SBMA muscles, as well as a 50% depletion of cardiolipin associated with decreased expression of the cardiolipin synthase gene. These observations suggest a causative link between nuclear polyglutamine- expanded AR accumulation, depletion of mitochondrial mass, increased mitophagy and altered mitochondrial membrane composition in SBMA muscle patients. Given the central role of mitochondria in cell bioenergetics, therapeutic approaches toward improving the mitochondrial network are worth considering to support SBMA patients.
C1 [Borgia, Doriana; Malena, Adriana; Pegoraro, Elena; Soraru, Gianni; Vergani, Lodovica] Univ Padua, Dept Neurosci, Padua, Italy.
   [Spinazzi, Marco] KU Leuven Ctr Human Genet, VIB Ctr Biol Dis, Leuven, Belgium.
   [Desbats, Maria Andrea; Salviati, Leonardo] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, Padua, Italy.
   [Desbats, Maria Andrea; Salviati, Leonardo] IRP Citta Speranza, Padua, Italy.
   [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Burwood, Australia.
   [Miotto, Giovanni] Univ Padua, Dept Mol Med, Padua, Italy.
   [Miotto, Giovanni] Univ Padua, Prote Ctr, VIMM, Padua, Italy.
   [Miotto, Giovanni] Padova Univ Hosp, Padua, Italy.
   [Tosatto, Laura; Pennuto, Maria] Univ Trento, Ctr Integrat Biol, Dulbecco Telethon Inst, Trento, Italy.
C3 University of Padua; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Padua; Fondazione Citta della Speranza; Deakin University; University of Padua; Veneto Institute Molecular Medicine; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Trento
RP Vergani, L (corresponding author), Ctr Biomed Pietro DAbano, Via Orus 2B, I-35129 Padua, Italy.; Pennuto, M (corresponding author), Univ Trento, Ctr Integrat Biol CIBIO, Lab Neurodegenerat Dis, Dulbecco Telethon Inst, Via Sommarive 9, I-38123 Trento, Italy.
EM mpennuto@dti.telethon.it; lodovica.vergani@unipd.it
FU Telethon-Italy and Provincia Autonoma di Trento [TCP12013]; Italian Ministry of Health [RF-2011-02350097]; Bando Progetti Strategici di Ateneo-University of Trento; Association Francaise contre les Myopathies [18722]; Telethon-Italy [GGP13222]; Fondazione CARIPARO; Dulbecco Telethon Institute International Postdoctoral Programme; Akira Arimura Foundation; Fondazione Telethon
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Beauchemin AMJ, 2001, BRAIN RES BULL, V56, P285, DOI 10.1016/S0361-9230(01)00583-4
   Bernardi P, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011387
   Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Böttinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001
   Bott LC, 2016, HUM MOL GENET, V25, P1979, DOI 10.1093/hmg/ddw073
   Cequier-Sánchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e
   Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Chua JP, 2014, HUM MOL GENET, V23, P1376, DOI 10.1093/hmg/ddt527
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Cortes CJ, 2014, NAT NEUROSCI, V17, P1180, DOI 10.1038/nn.3787
   Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001
   Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103
   DePrimo SE, 2002, GENOME BIOL, V3, P0
   DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Fernández-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5
   Finsterer J, 2016, AMYOTROPH LAT SCL FR, V17, P112, DOI 10.3109/21678421.2015.1089910
   Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974
   Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607
   Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035
   Giorgetti E, 2016, CELL REP, V17, P125, DOI 10.1016/j.celrep.2016.08.084
   Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012
   Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a
   HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012
   Havel LS, 2009, MOL BRAIN, V2, P0, DOI 10.1186/1756-6606-2-21
   Herzog R, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029851
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167
   Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878
   Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6
   Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4
   KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671
   Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   LECOCQ J, 1964, BIOCHEMISTRY-US, V3, P976, DOI 10.1021/bi00895a023
   Lee HJ, 2006, LIPIDS HEALTH DIS, V5, P0, DOI 10.1186/1476-511X-5-2
   Lieberman AP, 2014, CELL REP, V7, P774, DOI 10.1016/j.celrep.2014.02.008
   Lo Verso F, 2014, AUTOPHAGY, V10, P1883, DOI 10.4161/auto.32154
   Malena A, 2013, ACTA NEUROPATHOL, V126, P109, DOI 10.1007/s00401-013-1122-9
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Milan G, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7670
   Mitsuhashi S, 2011, AUTOPHAGY, V7, P1559, DOI 10.4161/auto.7.12.17925
   Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104
   Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115
   Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407
   Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042
   Orsucci D, 2014, CURR MOL MED, V14, P598, DOI 10.2174/1566524014666140603100131
   Ostojic O, 2013, J APPL PHYSIOL, V114, P444, DOI 10.1152/japplphysiol.01312.2012
   Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109
   Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019
   Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11
   Pennuto M, 2016, J MOL NEUROSCI, V58, P365, DOI 10.1007/s12031-015-0677-4
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Pronsato L, 2013, ARCH BIOCHEM BIOPHYS, V530, P13, DOI 10.1016/j.abb.2012.12.011
   Querin G, 2016, J NEUROL NEUROSUR PS, V87, P810, DOI 10.1136/jnnp-2015-311305
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001
   Rocchi A, 2016, ACTA NEUROPATHOL, V132, P127, DOI 10.1007/s00401-016-1550-4
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015
   Rusmini P, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15174
   Rusmini P, 2010, NEUROBIOL DIS, V40, P361, DOI 10.1016/j.nbd.2010.06.016
   Sambataro F, 2012, PROG NEUROBIOL, V97, P152, DOI 10.1016/j.pneurobio.2011.10.003
   Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Sorarù G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348
   Su SL, 2010, CLIN CHIM ACTA, V411, P626, DOI 10.1016/j.cca.2009.12.007
   Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9
   Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, PC575, DOI 10.1152/ajpcell.00119.2011
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   WICKS KL, 1991, AM J PHYSIOL, V260, PC841, DOI 10.1152/ajpcell.1991.260.4.C841
   Wong YC, 2014, P NATL ACAD SCI USA, V111, PE4439, DOI 10.1073/pnas.1405752111
   Yang JW, 2013, J CLIN NEUROL, V9, P125, DOI 10.3988/jcn.2013.9.2.125
   Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773
   Yu ZG, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002321
   Yun JN, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01958
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
   Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973
NR 100
TC 43
Z9 52
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2017
VL 26
IS 6
BP 1087
EP 1103
DI 10.1093/hmg/ddx019
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EU3EI
UT WOS:000400911000006
PM 28087734
DA 2024-11-01
ER

PT J
AU Coutelier, M
   Coarelli, G
   Monin, ML
   Konop, J
   Davoine, CS
   Tesson, C
   Valter, R
   Anheim, M
   Behin, A
   Castelnovo, G
   Charles, P
   David, A
   Ewenczyk, C
   Fradin, M
   Goizet, C
   Hannequin, D
   Labauge, P
   Riant, F
   Sarda, P
   Sznajer, Y
   Tison, F
   Ullmann, U
   Van Maldergem, L
   Mochel, F
   Brice, A
   Stevanin, G
   Durr, A
AF Coutelier, Marie
   Coarelli, Giulia
   Monin, Marie-Lorraine
   Konop, Juliette
   Davoine, Claire-Sophie
   Tesson, Christelle
   Valter, Remi
   Anheim, Mathieu
   Behin, Anthony
   Castelnovo, Giovanni
   Charles, Perrine
   David, Albert
   Ewenczyk, Claire
   Fradin, Melanie
   Goizet, Cyril
   Hannequin, Didier
   Labauge, Pierre
   Riant, Florence
   Sarda, Pierre
   Sznajer, Yves
   Tison, Francois
   Ullmann, Urielle
   Van Maldergem, Lionel
   Mochel, Fanny
   Brice, Alexis
   Stevanin, Giovanni
   Durr, Alexandra
TI A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies
SO BRAIN
LA English
DT Article
DE cerebellar ataxia; channelopathies; CACNA1A; SPG7
ID progressive external ophthalmoplegia; mitochondrial-dna polymerase; hereditary spastic paraplegia; cag trinucleotide repeat; spinocerebellar ataxia; autosomal-dominant; episodic ataxia; calcium-channel; mutations cause; polyglutamine expansions
AB Autosomal dominant cerebellar ataxias have a marked heterogeneous genetic background, with mutations in 34 genes identified so far. This large amount of implicated genes accounts for heterogeneous clinical presentations, making genotype-phenotype correlations a major challenge in the field. While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias. After exclusion of CAG/polyglutamine expansions in spinocerebellar ataxia genes in 412 index cases with dominantly inherited cerebellar ataxias, we aimed to establish the relative frequencies of mutations in other genes, with an approach combining panel sequencing and TaqMan (R) polymerase chain reaction assay. We found relevant genetic variants in 59 patients (14.3%). The most frequently mutated were channel genes [CACNA1A (n = 16), KCND3 (n = 4), KCNC3 (n = 2) and KCNA1 (n = 2)]. Deletions in ITPR1 (n = 11) were followed by biallelic variants in SPG7 (n = 9). Variants in AFG3L2 (n = 7) came next in frequency, and variants were rarely found in STBN2 (n = 2), ELOVL5, FGF14, STUB1 and TTBK2 (n = 1 each). Interestingly, possible risk factor variants were detected in SPG7 and POLG. Clinical comparisons showed that ataxias due to channelopathies had a significantly earlier age at onset with an average of 24.6 years, versus 40.9 years for polyglutamine expansion spinocerebellar ataxias and 37.8 years for SPG7-related forms (P = 0.001). In contrast, disease duration was significantly longer in the former (20.5 years versus 9.3 and 13.7, P= 0.001), though for similar functional stages, indicating slower progression of the disease. Of interest, intellectual deficiency was more frequent in channel spinocerebellar ataxias, while cognitive impairment in adulthood was similar among the three groups. Similar differences were found among a single gene group, comparing 23 patients with CACNA1A expansions (spinocerebellar ataxia 6) to 22 patients with CACNA1A point mutations, which had lower average age at onset (25.2 versus 47.3 years) with longer disease duration (18.7 versus 10.9), but lower severity indexes (0.39 versus 0.44), indicating slower progression of the disease. In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes. We could delineate firm genotype-phenotype correlations that are important for genetic counselling and of possible prognostic value.
C1 [Coutelier, Marie; Coarelli, Giulia; Konop, Juliette; Davoine, Claire-Sophie; Tesson, Christelle; Mochel, Fanny; Brice, Alexis; Stevanin, Giovanni; Durr, Alexandra] INSERM, U 1127, F-75013 Paris, France.
   [Coutelier, Marie; Coarelli, Giulia; Konop, Juliette; Davoine, Claire-Sophie; Tesson, Christelle; Valter, Remi; Mochel, Fanny; Brice, Alexis; Stevanin, Giovanni; Durr, Alexandra] CNRS, UMR 7225, F-75013 Paris, France.
   [Coutelier, Marie; Coarelli, Giulia; Konop, Juliette; Davoine, Claire-Sophie; Tesson, Christelle; Valter, Remi; Mochel, Fanny; Brice, Alexis; Stevanin, Giovanni; Durr, Alexandra] Univ Pierre & Marie Curie Paris 06, Sorbonne Univ, UMRS 1127, F-75013 Paris, France.
   [Coutelier, Marie; Coarelli, Giulia; Konop, Juliette; Davoine, Claire-Sophie; Tesson, Christelle; Valter, Remi; Mochel, Fanny; Brice, Alexis; Stevanin, Giovanni; Durr, Alexandra] Inst Cerveau & Moelle Epiniere, F-75013 Paris, France.
   [Coutelier, Marie] Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium.
   [Coutelier, Marie; Konop, Juliette; Tesson, Christelle; Valter, Remi; Stevanin, Giovanni] PSL Res Univ, Ecole Prat Hautes Etud, F-75014 Paris, France.
   [Coarelli, Giulia; Charles, Perrine; Ewenczyk, Claire; Mochel, Fanny; Brice, Alexis; Stevanin, Giovanni; Durr, Alexandra] Hop la Pitie Salpetriere, AP HP, Ctr Reference Neurogenet, F-75013 Paris, France.
   [Anheim, Mathieu] Univ Strasbourg, FMTS, F-67200 Strasbourg, France.
   [Anheim, Mathieu] CHU Strasbourg, Hop Hautepierre, Dept Neurol, F-67100 Strasbourg, France.
   [Anheim, Mathieu] Univ Strasbourg, CNRS UMR7104, INSERM U964, IGBMC, F-67400 Illkirch Graffenstaden, France.
   [Behin, Anthony] GHU Pitie Salpetriere, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, AP HP, F-75013 Paris, France.
   [Castelnovo, Giovanni] Ctr Hosp Univ Caremeau, Serv Neurol, F-30900 Nimes, France.
   [David, Albert] CHU Nantes, Serv Genet Med, F-44093 Nantes, France.
   [Fradin, Melanie] CHU Rennes, Serv Genet Med, F-35033 Rennes, France.
   [Fradin, Melanie] Ctr Hosp St Brieuc, Serv Genet Med, F-22000 St Brieuc, France.
   [Goizet, Cyril] Univ Bordeaux, INSERM U1211, Lab Malad Rares Genet & Metab, F-33000 Bordeaux, France.
   [Goizet, Cyril] CHU Bordeaux, Serv Genet Med, F-33000 Bordeaux, France.
   [Hannequin, Didier] Rouen Univ Hosp, Inserm U1079, Serv Neurol, Serv Genet, F-76031 Rouen, France.
   [Labauge, Pierre] CHU Montpellier, Hop Gui de Chauliac, Serv Neurol, F-34295 Montpellier 5, France.
   [Riant, Florence] Grp Hosp Lariboisiere Fernand, AP HP, Lab Genet, F-75010 Paris, France.
   [Labauge, Pierre] CHU Montpellier, Hop Arnaud Villeneuve, Dept Genet Med, F-34295 Montpellier, France.
   [Sznajer, Yves] Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium.
   [Tison, Francois] Univ Bordeaux, CHU Bordeaux, Inst Malad Neurodegenerat, CNRS UMR 5293, F-33076 Bordeaux, France.
   [Ullmann, Urielle] Inst Pathol & Genet, Ctr Genet Humaine, B-6041 Gosselies, Belgium.
   [Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, F-25000 Besancon, France.
   [Van Maldergem, Lionel] Univ Liege, Ctr Reference Malad Metab, B-4000 Liege, Belgium.
   [Mochel, Fanny] Univ Paris 06, Neurometab Res Grp, F-75013 Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Sorbonne Universite; Sorbonne Universite; Universite Catholique Louvain; Universite PSL; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite de Montpellier; CHU de Nimes; Nantes Universite; CHU de Nantes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bordeaux; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Universite de Montpellier; CHU de Montpellier; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; CHU Bordeaux; CNRS - National Institute for Biology (INSB); Universite de Franche-Comte; University of Liege; Sorbonne Universite
RP Durr, A (corresponding author), Pitie Salpetriere Hop, CNRS UMR7225, UPMC U1127, Inst Cerveau & Moelle Epiniere,INSERM, 47 Bd Hop, F-75013 Paris, France.
EM giovanni.stevanin@upmc.fr
FU Fond National de la Recherche Scientifique (aspirant Fonds National de la Recherche Scientifique); French Ministry for Research through the Doctoral School [472-EPHE]; French National Agency for Research (ANR); French Ministry of Health PHRC program [AOM 09178]; European Union; Verum Foundation; Fondation Roger de Spoelberch; French patient association 'Connaitre les Syndromes Cerebelleux'; program Investissements d'Avenir [ANR-10-IAIHU-06]
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bourassa CV, 2012, AM J HUM GENET, V91, P548, DOI 10.1016/j.ajhg.2012.07.018
   Brkanac Z, 2009, AM J HUM GENET, V84, P692, DOI 10.1016/j.ajhg.2009.04.008
   BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136
   Burusnukul P, 2009, J CHILD NEUROL, V24, P482, DOI 10.1177/0883073808324539
   Cadieux-Dion M, 2014, JAMA NEUROL, V71, P470, DOI 10.1001/jamaneurol.2013.6337
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883
   Chinnery PF, 2004, NEUROLOGY, V63, P710, DOI 10.1212/01.WNL.0000135346.63675.3E
   Coutelier M, 2015, AM J HUM GENET, V97, P726, DOI 10.1016/j.ajhg.2015.09.007
   Coutelier M, 2015, J NEUROL, V262, P2382, DOI 10.1007/s00415-015-7725-4
   Coutelier M, 2015, NEUROLOGY, V84, P1751, DOI 10.1212/WNL.0000000000001524
   David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65
   Delplanque J, 2014, BRAIN, V137, P2657, DOI 10.1093/brain/awu202
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Di Gregorio E, 2014, AM J HUM GENET, V95, P209, DOI 10.1016/j.ajhg.2014.07.001
   Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909
   Fogel BL, 2015, MOVEMENT DISORD, V30, P284, DOI 10.1002/mds.26096
   Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944
   Gomez CM, 2014, JAMA NEUROL, V71, P1215, DOI 10.1001/jamaneurol.2014.2015
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hekman KE, 2012, HUM MOL GENET, V21, P5472, DOI 10.1093/hmg/dds392
   Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728
   Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a
   Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221
   Keogh MJ, 2015, J NEUROL, V262, P1822, DOI 10.1007/s00415-015-7772-x
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015
   Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047
   KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9
   Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Marelli C, 2011, REV NEUROL-FRANCE, V167, P385, DOI 10.1016/j.neurol.2011.01.015
   Marelli C, 2011, ARCH NEUROL-CHICAGO, V68, P637, DOI 10.1001/archneurol.2011.81
   Matsuura T, 2004, AM J HUM GENET, V74, P1216, DOI 10.1086/421526
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Monin ML, 2015, ANN CLIN TRANSL NEUR, V2, P202, DOI 10.1002/acn3.156
   Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827
   Nemeth AH, 2013, BRAIN, V136, P3106, DOI 10.1093/brain/awt236
   Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363
   Obayashi M, 2012, J HUM GENET, V57, P202, DOI 10.1038/jhg.2012.5
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2
   ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269
   Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Roxburgh RH, 2013, J NEUROL, V260, P1286, DOI 10.1007/s00415-012-6792-z
   Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801
   Russell JF, 2012, ANN NEUROL, V72, P175, DOI 10.1002/ana.23666
   Sánchez-Ferrero E, 2013, CLIN GENET, V83, P257, DOI 10.1111/j.1399-0004.2012.01896.x
   Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019
   Sawyer SL, 2014, HUM MUTAT, V35, P45, DOI 10.1002/humu.22451
   Schöls L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Shi Y, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081884
   Stevanin G, 2000, NAT GENET, V24, P213, DOI 10.1038/73408
   Tsoi H, 2014, J MED GENET, V51, P590, DOI 10.1136/jmedgenet-2014-102333
   van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488
   Vidal R, 1999, NATURE, V399, P776
   Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
   Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758
   Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035
   Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411
   Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613
   Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62
   Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361
NR 85
TC 85
Z9 89
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JUN 15
PY 2017
VL 140
IS 
BP 1579
EP 1594
DI 10.1093/brain/awx081
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EW7VX
UT WOS:000402726600014
PM 28444220
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
TI Management of epilepsy in MERRF syndrome
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Review
DE mtDNA; MERRF; m.8344A > G; Seizures; Stroke-like episode; Gene; Mitochondrial disorder; Epilepsy
ID ragged-red fibers; progressive myoclonus epilepsy; stroke-like episodes; mitochondrial-dna; a8344g mutation; astatic epilepsy; antiepileptic drugs; greater-than; disorders; patient
AB Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is a rare syndromic mitochondrial disorder (MID) with a broad phenotypic but narrow genotypic heterogeneity. One of the predominant phenotypic features in addition to myopathy is epilepsy. The most frequent seizure type in MERRF is generalised myoclonic seizure but also focal myoclonic, focal atonic, generalised tonic-clonic, generalised atonic, generalised myoclonic-atonic, typical absences, or tonic-clonic seizures of unknown onset have been reported. There are no guidelines available for the management of epilepsy in MERRF syndrome but several expert opinions and general recommendations for the treatment of mitochondria] epilepsy have been published. According to these recommendations the antiepileptic drugs (AEDs) of choice are levetiracetam, topiramate, zonisamide, piracetam, and benzodiazepines. Perampanel has not been applied in MERRF patients but is promising in non-mitochondrial myoclonic epilepsy. Mitochondrion toxic agents, including mitochondrion-toxic AEDs, such as valproate, carbamazepine, phenytoin, and barbiturates, should be avoided as well as AEDs potentially enhancing the frequency of myoclonus, such as phenytoin, carbamazepine, lamotrigine, vigabatrin, tiagabine, gabapentin, pregabalin, and oxcarbazepine. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Univ Tunis El Manar, Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Afra P, 2012, SEIZURE-EUR J EPILEP, V21, P202, DOI 10.1016/j.seizure.2011.12.010
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   [Anonymous], 2010, NEURO ENDOCRINOL LET, V31, P336
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biancheri R, 2010, AJNR AM J NEURORADIOL, V31, PE78, DOI 10.3174/ajnr.A2182
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chen ST, 2008, J CHILD NEUROL, V23, P1447, DOI 10.1177/0883073808318541
   Crest C, 2004, NEUROLOGY, V62, P640, DOI 10.1212/01.WNL.0000110193.78872.DD
   Delgado-Escueta AV, 2001, AM J MED GENET, V106, P129, DOI 10.1002/ajmg.1575
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S, 2003, GENEREVIEWS, V0, P0
   Fan PC, 2014, J FORMOS MED ASSOC, V113, P258, DOI 10.1016/j.jfma.2013.02.008
   Fedi M, 2001, ARCH NEUROL-CHICAGO, V58, P781, DOI 10.1001/archneur.58.5.781
   Finsterer J, 2013, ACTA NEUROL SCAND, V128, P141, DOI 10.1111/ane.12122
   Finsterer J, 2017, IRAN J NEUR IN PRESS, V0, P0
   Finsterer J, 2016, EUR J PAEDIATR NEURO, V20, P824, DOI 10.1016/j.ejpn.2016.08.002
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Frye RE, 2015, EPILEPSY BEHAV, V47, P147, DOI 10.1016/j.yebeh.2014.08.134
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Iwanga K, 1992, RINSHO SHINKEIGAKU, V32, P870
   Kilaru S, 2007, EPILEPSIA, V48, P1703, DOI 10.1111/j.1528-1167.2007.01186.x
   Lamperti C, 2016, EPILEPTIC DISORD, V18, P0
   Lee HN, 2016, PEDIATR NEUROL, V0, P0
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mantoan L, 2011, CURR TREAT OPTION NE, V13, P355, DOI 10.1007/s11940-011-0131-z
   Michelucci R, 2016, EPILEPTIC DISORD, V18, PS145, DOI 10.1684/epd.2016.0861
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Nomura T, 1993, RINSHO SHINKEIGAKU, V33, P1198
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   PRANZATELLI MR, 1995, EPILEPSIA, V36, P783, DOI 10.1111/j.1528-1157.1995.tb01615.x
   Santamarina E, 2015, EPILEPSY BEHAV CASE, V4, P56, DOI 10.1016/j.ebcr.2015.06.007
   Santos NAG, 2008, TOXICOL IN VITRO, V22, P1143, DOI 10.1016/j.tiv.2008.03.004
   Scalais E, 2007, EUR J NEUROL, V14, Pe3, DOI 10.1111/j.1468-1331.2007.01926.x
   Scalais E, 2013, EUR J PAEDIATR NEURO, V17, P625, DOI 10.1016/j.ejpn.2013.05.013
   Sitburana Oraporn, 2001, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V84, P1051
   Steele HE, 2015, SEMIN NEUROL, V35, P300, DOI 10.1055/s-0035-1552624
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
   von Stülpnagel C, 2012, EUR J PAEDIATR NEURO, V16, P459, DOI 10.1016/j.ejpn.2011.12.012
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Yang Hecheng, 2014, PEDIATR NEUROL, V51, Pe19, DOI 10.1016/j.pediatrneurol.2014.08.020
   Zaganas I, 2009, J NEUROL, V256, P271, DOI 10.1007/s00415-009-0921-3
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
   Zupanc ML, 2010, PEDIATR NEUROL, V42, P396, DOI 10.1016/j.pediatrneurol.2010.02.013
NR 64
TC 14
Z9 19
U1 0
U2 7
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD AUG 15
PY 2017
VL 50
IS 
BP 166
EP 170
DI 10.1016/j.seizure.2017.06.010
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF3HR
UT WOS:000408786600029
PM 28686997
DA 2024-11-01
ER

PT J
AU Wang, W
   Zhuang, QQ
   Ji, KQ
   Wen, B
   Lin, PF
   Zhao, YY
   Li, W
   Yan, CZ
AF Wang, Wei
   Zhuang, Qianqian
   Ji, Kunqian
   Wen, Bing
   Lin, Pengfei
   Zhao, Yuying
   Li, Wei
   Yan, Chuanzhu
TI Identification of miRNA, lncRNA and mRNA-associated ceRNA networks and potential biomarker for MELAS with mitochondrial DNA A3243G mutation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID long noncoding rna; micrornas; apoptosis; cardiomyocytes; activation; complexity; autophagy; nuclear; pathway; disease
AB Researchers in the field of mitochondrial biology are increasingly unveiling of the complex mechanisms between mitochondrial dysfunction and noncoding RNAs (ncRNAs). However, roles of ncRNAs underlying mitochondrial myopathy remain unexplored. The aim of this study was to elucidate the regulating networks of dysregulated ncRNAs in Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) with mitochondrial DNA (mtDNA) A3243G mutation, which might make contributions to the unveiling of the complex mechanisms underlying mitochondrial myopathy and, possibly, new tools applicable to clinical practice. Through high-throughput technology followed by quantitative real-time polymerase chain reaction (qRT-PCR) and bioinformatics analyses, for the first time, we found that the dysregulated muscle miRNAs and lncRNAs between 20 MELAS patients with mtDNA A3243G mutation and 20 controls formed complex regulation networks and participated in immune system, signal transduction, translation, muscle contraction and other pathways in discovery and training phase. Then, selected ncRNAs were validated in muscle and serum in independent validation cohorts by qRT-PCR. Finally, ROC curve analysis indicated reduced serum miR-27b-3p had the better diagnosis value than lactate and might serve as a novel, noninvasive biomarker for MELAS. Follow-up investigation is warranted to better understand roles of ncRNAs in mitochondrial myopathy pathogenesis.
C1 [Wang, Wei; Ji, Kunqian; Wen, Bing; Lin, Pengfei; Zhao, Yuying; Li, Wei; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan, Peoples R China.
   [Wang, Wei; Ji, Kunqian; Wen, Bing; Lin, Pengfei; Zhao, Yuying; Li, Wei; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan, Peoples R China.
   [Zhuang, Qianqian] Qilu Univ Technol, Sch Bioengn, Jinan, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Key Lab Expt Teratol, Minist Educ,Brain Sci Res Inst,Dept Neurol, Jinan, Peoples R China.
C3 Shandong University; Shandong University; Qilu University of Technology; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, Jinan, Peoples R China.
EM chuanzhuyan@163.com
FU National Natural Science Foundation of China [81300983, 81301071, 81671235]
CR Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327
   Bi R, 2015, BIOCHEM BIOPH RES CO, V460, P469, DOI 10.1016/j.bbrc.2015.03.057
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bucha S, 2015, BIOCHEM BIOPH RES CO, V465, P797, DOI 10.1016/j.bbrc.2015.08.090
   Cha MJ, 2013, BIOCHEM BIOPH RES CO, V435, P720, DOI 10.1016/j.bbrc.2013.05.050
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157
   Duarte FV, 2015, ADV EXP MED BIOL, V888, P123, DOI 10.1007/978-3-319-22671-2_8
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Friedländer MR, 2014, GENOME BIOL, V15, P0, DOI 10.1186/gb-2014-15-4-r57
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Hangauer MJ, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003569
   Hu Y, 2015, INT J MOL SCI, V16, P24895, DOI 10.3390/ijms161024895
   Huang SY, 2015, AUTOPHAGY, V11, P2172, DOI 10.1080/15548627.2015.1106663
   Johnson SC, 2017, HUM GENET, V136, P55, DOI 10.1007/s00439-016-1736-9
   Kim J, 2016, MOL NEURODEGENER, V11, P0, DOI 10.1186/s13024-016-0121-4
   Lambertini Luca, 2016, CURR ENVIRON HEALTH REP, V3, P214, DOI 10.1007/s40572-016-0103-2
   Lang A, 2016, AGING-US, V8, P484, DOI 10.18632/aging.100905
   Lee YE, 2015, INT J BIOL SCI, V11, P246, DOI 10.7150/ijbs.11138
   Li HJ, 2015, JPN J CLIN ONCOL, V45, P1055, DOI 10.1093/jjco/hyv132
   Li RW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029392
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liu F, 2016, ONCOTARGET, V7, P19666, DOI 10.18632/oncotarget.7531
   Maass PG, 2014, J MOL MED, V92, P337, DOI 10.1007/s00109-014-1131-8
   Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722
   Nie Y, 2016, FASEB J OFFICIAL PUB, V0, P0
   Niyazov DM, 1900, V7, V0, P122
   Noh JH, 2016, GENE DEV, V30, P1224, DOI 10.1101/gad.276022.115
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Rastogi N, 2014, FREE RADICAL BIO MED, V68, P288, DOI 10.1016/j.freeradbiomed.2013.12.016
   Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240
   Sripada L, 2012, MITOCHONDRION, V12, P593, DOI 10.1016/j.mito.2012.10.009
   Stadler PF, 2014, METHODS MOL BIOL, V1097, P199, DOI 10.1007/978-1-62703-709-9_10
   Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986
   Tomasetti M, 2014, BBA-GEN SUBJECTS, V1840, P1441, DOI 10.1016/j.bbagen.2013.09.002
   van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wang K, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004467
   Wang K, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4596
   Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018
   Yao DH, 2016, CELL PROLIFERAT, V49, P541, DOI 10.1111/cpr.12277
   Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010
   Zeng XC, 2016, MOL MED REP, V14, P129, DOI 10.3892/mmr.2016.5208
   Zhang Z, 2014, METHODS, V69, P315, DOI 10.1016/j.ymeth.2014.06.003
   Zhang Z, 2014, INT J BIOCHEM CELL B, V50, P106, DOI 10.1016/j.biocel.2014.02.012
   Zhang Z, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069282
   Zhao XM, 2016, PEERJ, V4, P0, DOI 10.7717/peerj.1635
   Zhou XH, 2015, J PHYSIOL BIOCHEM, V71, P753, DOI 10.1007/s13105-015-0439-3
   Zhu Qi, 2007, V382, V0, PP287, DOI 10.1007/978-1-59745-304-2_19
NR 50
TC 34
Z9 36
U1 0
U2 19
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD JAN 31
PY 2017
VL 7
IS 
BP 
EP 
DI 10.1038/srep41639
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EJ3EL
UT WOS:000393095300002
PM 28139706
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
TI Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
SO NEUROPSYCHIATRIC DISEASE AND TREATMENT
LA English
DT Article
DE multisystem disease; mitochondrial cytopathy; multiorgan; mitochondriopathy; cardiomyopathy; encephalomyopathy
ID progressive external ophthalmoplegia; stroke-like episodes; dna a3243g mutation; of-the-literature; pearson-syndrome; lactic-acidosis; point mutation; melas syndrome; adult patients; transfer-rna
AB Objectives: Mitochondrial disorders (MIDs) frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or evolve into MIMODS during the course. This study aimed to find which organs and/or tissues are most frequently affected by MIMODS, which are the most frequent abnormalities within an affected organ, whether there are typical MIMODS patterns, and to generate an MIMODS score to assess the diagnostic probability for an MID. Methods: This is a retrospective evaluation of clinical, biochemical, and genetic investigations of adult patients with definite MIDs. A total of 36 definite MID patients, 19 men and 17 women, aged 29-82 years were included in this study. The diagnosis was based on genetic testing (n=21), on biochemical investigations (n=17), or on both (n=2). Results: The number of organs most frequently affected was 4 ranging from 1 to 9. MIMODS was diagnosed in 97% of patients. The organs most frequently affected were the muscle (97%), central nervous system (CNS; 72%), endocrine glands (69%), heart (58%), intestines (55%), and peripheral nerves (50%). The most frequent CNS abnormalities were leukoencephalopathy, prolonged visually evoked potentials, and atrophy. The most frequent endocrine abnormalities included thyroid dysfunction, short stature, and diabetes. The most frequent cardiac abnormalities included arrhythmias, systolic dysfunction, and hypertrophic cardiomyopathy. The most frequent MIMODS patterns were encephalomyopathy, encephalomyo-endocrinopathy, and encepalo-myo-endocrino-cardiopathy. The mean +/- 2SD MIMODS score was 35.97 +/- 27.6 (range = 11-71). An MIMODS score >10 was regarded as indicative of an MID. Conclusion: Adult MIDs manifest as MIMODS in the vast majority of the cases. The organs most frequently affected in MIMODS are muscles, CNS, endocrine glands, and heart. An MIMODS score >10 suggests an MID.
C1 [Finsterer, Josef] Municipal Hosp Rudolfstiftung, Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fipaps@yahoo.de
CR Anglin RE, 2012, J CLIN PSYCHIAT, V73, P506, DOI 10.4088/JCP.11r07237
   BARRIENTOS A, 1995, MED CLIN-BARCELONA, V105, P180
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Brunetti-Pierri N, 2011, MOL GENET METAB, V103, P167, DOI 10.1016/j.ymgme.2011.02.007
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Cardaioli E, 2010, NEUROL SCI, V31, P491, DOI 10.1007/s10072-010-0225-5
   Carmi E, 2001, ANN DERMATOL VENER, V128, P1031
   Cassandrini D, 2006, J CHILD NEUROL, V21, P983, DOI 10.1177/08830738060210111001
   Chang MC, 2005, OSTEOARTHR CARTILAGE, V13, P1004, DOI 10.1016/j.joca.2005.06.011
   Coomans H, 2011, REV NEUROL-FRANCE, V167, P847, DOI 10.1016/j.neurol.2011.01.013
   DAco KE, 2013, PEDIATR NEPHROL, V28, P515, DOI 10.1007/s00467-012-2354-y
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Danpure CJ, 2003, BBA-PROTEINS PROTEOM, V1647, P70, DOI 10.1016/S1570-9639(03)00055-4
   de Keyzer Y, 2009, PEDIATR RES, V66, P91, DOI 10.1203/PDR.0b013e3181a7c270
   Demarest ST, 2014, J CHILD NEUROL, V29, P1249, DOI 10.1177/0883073814538511
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Desguerre I, 2014, REV NEUROL-FRANCE, V170, P375, DOI 10.1016/j.neurol.2014.03.010
   Devaux-Bricout M, 2014, REV NEUROL-FRANCE, V170, P381, DOI 10.1016/j.neurol.2014.03.006
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Doss S, 2014, J NEUROL, V261, P207, DOI 10.1007/s00415-013-7177-7
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Ezgu F, 2013, GENE, V528, P364, DOI 10.1016/j.gene.2013.07.007
   Finsterer J, 2000, EUR NEUROL, V44, P37, DOI 10.1159/000008190
   Finsterer J, 2005, ACTA OPHTHALMOL SCAN, V83, P628, DOI 10.1111/j.1600-0420.2005.00518.x
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2013, ACTA NEUROL SCAND, V128, P141, DOI 10.1111/ane.12122
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Finsterer J, 2017, IRAN J NEUROL, V16, P45
   Finsterer J, 2015, SINGAP MED J, V56, P412, DOI 10.11622/smedj.2015112
   Finsterer Josef, 2015, OPEN NEUROL J, V9, P28, DOI 10.2174/1874205X01509010028
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gdynia HJ, 2006, EUR J MED RES, V11, P545
   Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111
   Guo H, 2012, BBA-MOL BASIS DIS, V1822, P1535, DOI 10.1016/j.bbadis.2012.06.010
   Gurgey A, 1996, PEDIATR NEPHROL, V10, P637
   Gurrieri C, 2011, CAN J ANESTH, V58, P751, DOI 10.1007/s12630-011-9528-0
   Haas RH, 2014, SEMIN NEUROL, V34, P321, DOI 10.1055/s-0034-1386770
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Harty LC, 2012, ANN RHEUM DIS, V71, P582, DOI 10.1136/annrheumdis-2011-200245
   Hiraki N, 2010, J LARYNGOL OTOL, V124, P1007, DOI 10.1017/S0022215110001477
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Hung PC, 2012, BRAIN DEV-JPN, V34, P866, DOI 10.1016/j.braindev.2012.02.011
   Inczedy-Farkas G, 2014, ARCH CLIN NEUROPSYCH, V29, P315, DOI 10.1093/arclin/acu016
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Kalashnikova LA, 2010, ZH NEVROL PSIKHIATR, V110, P3
   Kleefstra T, 2011, EUR J HUM GENET, V19, P138, DOI 10.1038/ejhg.2010.171
   La Morgia C, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-116
   Lehmann D, 2015, NEUROMUSCULAR DISORD, V25, P81, DOI 10.1016/j.nmd.2014.09.008
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Liu HM, 2012, PEDIATR NEONATOL, V53, P264, DOI 10.1016/j.pedneo.2011.08.013
   Lohi O, 2005, J INHERIT METAB DIS, V28, P1165, DOI 10.1007/s10545-005-0075-0
   Lovan Alyson, 2013, BMJ CASE REP, V2013, P0, DOI 10.1136/bcr-2013-010343
   Low E, 2008, PEDIATR NEUROL, V39, P368, DOI 10.1016/j.pediatrneurol.2008.07.023
   Lu Hong-bin, 2006, ZHONG NAN DA XUE XUE BAO YI XUE BAN, V31, P640
   Mahjoub SZ, 2011, CARDIOLOGY, V118, P153, DOI 10.1159/000328002
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   McKelvie P, 2012, NEUROMUSCULAR DISORD, V22, P401, DOI 10.1016/j.nmd.2011.10.017
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mulliez E, 2000, BULL SOC BELGE OPHTALMOL, V0, P35
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Naghizadeh F, 2014, IDEGGYOGY SZEMLE, V67, P335
   Nucci C, 2013, INT OPHTHALMOL, V33, P75, DOI 10.1007/s10792-012-9623-4
   Oláhová M, 2015, EUR J HUM GENET, V23, P935, DOI 10.1038/ejhg.2014.214
   Park J, 2015, MOL MED REP, V11, P3741, DOI 10.3892/mmr.2014.3127
   Perez-Atayde AR, 1998, AM J SURG PATHOL, V22, P1141, DOI 10.1097/00000478-199809000-00014
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Pronicki Maciej, 2002, MED SCI MONIT, V8, P0
   Ranjbar SH, 2008, J PEDIATR ENDOCR MET, V21, P1185
   Rivera H, 2013, BMC NEPHROL, V14, P0, DOI 10.1186/1471-2369-14-195
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rubegni A, 2014, J NEUROL SCI, V338, P232, DOI 10.1016/j.jns.2014.01.010
   Ryther RCC, 2011, J NEUROL, V258, P912, DOI 10.1007/s00415-010-5818-7
   Sakharova AV, 2012, ARKHIV PATOLOGII, V74, P51
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schmidt H, 2014, J CRIT CARE, V29, P367, DOI 10.1016/j.jcrc.2013.12.015
   Cardena MMSG, 2013, MITOCHONDR DNA, V24, P46, DOI 10.3109/19401736.2012.717933
   Sobenin IA, 2012, CLIN DEV IMMUNOL, V0, P0, DOI DOI 10.1155/2012/832464
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Takahashi Y, 2008, ENDOCR J, V55, P509, DOI 10.1507/endocrj.K07E-091
   Tanigawa J, 2012, BRAIN DEV-JPN, V34, P861, DOI 10.1016/j.braindev.2012.02.007
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026
   Varanasi SS, 1999, OSTEOPOROSIS INT, V10, P143, DOI 10.1007/s001980050209
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Williams TB, 2012, MOL GENET METAB, V106, P104, DOI 10.1016/j.ymgme.2012.01.018
   Yang G, 2014, CHINESE MED J-PEKING, V127, P1989, DOI 10.3760/cma.j.issn.0366-6999.20132876
   Zhao DH, 2013, CLIN NEUROL NEUROSUR, V115, P1490, DOI 10.1016/j.clineuro.2012.11.011
   Zhuo GC, 2010, BIOCHEM GENET, V48, P157, DOI 10.1007/s10528-009-9308-5
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
NR 100
TC 19
Z9 19
U1 0
U2 7
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2021
EI 
J9 NEUROPSYCH DIS TREAT
JI Neuropsychiatr. Dis. Treat.
PD JUN 15
PY 2017
VL 13
IS 
BP 2569
EP 2579
DI 10.2147/NDT.S149067
PG 11
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FJ1YL
UT WOS:000412517100001
PM 29062232
DA 2024-11-01
ER

PT J
AU Kauppila, TES
   Kauppila, JHK
   Larsson, NG
AF Kauppila, Timo E. S.
   Kauppila, Johanna H. K.
   Larsson, Nils-Goeran
TI Mammalian Mitochondria and Aging: An Update
SO CELL METABOLISM
LA English
DT Review
ID dna-deletion mutations; somatic mtdna mutations; human skeletal-muscle; oxidative damage; mouse model; polymerase-gamma; point mutations; life-span; deoxyribonucleic-acid; protein acetylation
AB Mitochondria were first postulated to contribute to aging more than 40 years ago. During the following decades, multiple lines of evidence in model organisms and humans showed that impaired mitochondrial function can contribute to age-associated disease phenotypes and aging. However, in contrast to the original theory favoring oxidative damage as a cause for mtDNA mutations, there are now strong data arguing that most mammalian mtDNA mutations originate as replication errors made by the mtDNA polymerase. Currently, a substantial amount of mitochondrial research is focused on finding ways to either remove or counteract the effects of mtDNA mutations with the hope of extending the human health-and lifespan. This review summarizes the current knowledge regarding the formation of mtDNA mutations and their impact on mitochondrial function. We also critically discuss proposed pathways interlinked withmammalian mtDNA mutations and suggest future research strategies to elucidate the role of mtDNA mutations in aging.
C1 [Kauppila, Timo E. S.; Kauppila, Johanna H. K.; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.
   [Larsson, Nils-Goeran] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
C3 Max Planck Society; Karolinska Institutet
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.; Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
EM larsson@age.mpg.de
FU Max Planck Society; Swedish Research Council [2015-00418]; Knut and Alice Wallenberg Foundation; Swedish Research Council [2015-00418] Funding Source: Swedish Research Council
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   [Anonymous], 2017, CELL METABOLISM, V0, P0
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198
   Baens M, 2006, PLOS ONE, V1, P0, DOI 10.1371/journal.pone.0000054
   Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Bjelakovic G, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD007176
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6
   Chalkiadaki A, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004490
   Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177
   Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618
   CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349
   Cochemé HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003
   Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Dumont M, 2014, FASEB J, V28, P1745, DOI 10.1096/fj.13-236331
   DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225
   Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109
   Finley LWS, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023295
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje
   Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, PC572, DOI 10.1152/ajpcell.00481.2009
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080
   HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y
   HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6
   Halsne R, 2012, DNA REPAIR, V11, P278, DOI 10.1016/j.dnarep.2011.12.001
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herranz D, 2010, NAT COMMUN, V1, P0, DOI 10.1038/ncomms1001
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659
   Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2013, TRENDS CELL BIOL, V23, P457, DOI 10.1016/j.tcb.2013.04.009
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, PE463, DOI 10.1152/ajpendo.00666.2007
   Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   NOVIKOFF ALEX B, 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P179, DOI 10.1083/jcb.2.4.179
   Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   Padman BS, 2013, AUTOPHAGY, V9, P1862, DOI 10.4161/auto.26557
   Parihar P, 2015, EXP GERONTOL, V61, P130, DOI 10.1016/j.exger.2014.12.004
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pereira L, 2012, BMC CANCER, V12, P0, DOI 10.1186/1471-2407-12-53
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Roberts LJ, 2001, BIOCHEM BIOPH RES CO, V287, P254, DOI 10.1006/bbrc.2001.5583
   Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023
   Rowe GC, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0041817
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   SAKUMI K, 1993, J BIOL CHEM, V268, P23524
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999
   Sohl CD, 2015, P NATL ACAD SCI USA, V112, P8596, DOI 10.1073/pnas.1421733112
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004670
   Stojkovic G, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep28942
   Stram AR, 2016, CELL MOL LIFE SCI, V73, P4063, DOI 10.1007/s00018-016-2280-4
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Vaitkus JA, 2015, INT J MOL SCI, V16, P16158, DOI 10.3390/ijms160716158
   Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420
   Velarde Michael C, 2014, LONGEV HEALTHSPAN, V3, P2, DOI 10.1186/2046-2395-3-2
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271
   Weinert BT, 2014, MOL SYST BIOL, V10, P0, DOI 10.1002/msb.134766
   Weinert BT, 2011, SCI SIGNAL, V4, P0, DOI 10.1126/scisignal.2001902
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
   Zhao W, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-51
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 220
TC 418
Z9 460
U1 6
U2 183
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JAN 10
PY 2017
VL 25
IS 1
BP 57
EP 71
DI 10.1016/j.cmet.2016.09.017
PG 15
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA EI9RC
UT WOS:000392845500009
PM 28094012
DA 2024-11-01
ER

PT J
AU Fayssoil, A
   Laforêt, P
   Bougouin, W
   Jardel, C
   Lombès, A
   Bécane, HM
   Berber, N
   Stojkovic, T
   Béhin, A
   Eymard, B
   Duboc, D
   Wahbi, K
AF Fayssoil, A.
   Laforet, P.
   Bougouin, W.
   Jardel, C.
   Lombes, A.
   Becane, H. M.
   Berber, N.
   Stojkovic, T.
   Behin, A.
   Eymard, B.
   Duboc, D.
   Wahbi, K.
TI Prediction of long-term prognosis by heteroplasmy levels of the m.3243A&gt;G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE death; lactic acidosis and stroke-like episodes; mitochondrial diseases; mitochondrial encephalomyopathy; mutation load; prognosis
ID a3243g mutation; dna; melas; load; 3243a-greater-than-g; diagnosis; myopathy; tissue; cells
AB Background and purposeOur aim was to determine the prognostic value of urine and blood heteroplasmy in patients with the m.3243A>G mutation. MethodsAdults with the m.3243A>G mutation referred to our institution between January 2000 and May 2014 were retrospectively included. The relationship between their baseline clinical characteristics, their mutation load in urine and blood, and major adverse events (MAEs) during follow-up, defined as medical complications requiring a hospitalization or complicated by death, was studied. ResultsOf the 43 patients (age 45.6 13.3 years) included in the study, 36 patients were symptomatic, including nine with evidence of focal brain involvement, and seven were asymptomatic. Over a 5.5 4.0 year mean follow-up duration, 14 patients (33%) developed MAEs. Patients with MAEs had a higher mutation load than others in urine (60.1% +/- 13.8% vs. 40.6% +/- 26.2%, P = 0.01) and in blood (26.9% +/- 18.4% vs. 16.0% +/- 12.1%, P = 0.03). Optimal cutoff values for the prediction of MAEs were 45% for urine and 35% for blood. In multivariate analysis, mutation load in urine 45% [odds ratio 25.3; 95% confidence interval (CI) 1.1-567.8; P = 0.04], left ventricular hypertrophy (odds ratio 16.7; 95% CI 1.3- 222.5; P = 0.03) and seizures (odds ratio 48.3; 95% CI 2.5-933; P = 0.01) were associated with MAEs. ConclusionsPatients with the m.3243A>G mutation are at high risk of MAEs, which can be independently predicted by mutation load in urine 45%, a personal history of seizures, and left ventricular hypertrophy. Click to view the accompanying paper in this issue.
C1 [Fayssoil, A.; Laforet, P.; Becane, H. M.; Berber, N.; Stojkovic, T.; Behin, A.; Eymard, B.; Duboc, D.; Wahbi, K.] Hop La Pitie Salpetriere, AP HP, Reference Ctr Muscle Dis Paris Est, Myol Inst, Paris, France.
   [Fayssoil, A.] Versailles St Quentin Yvelines Univ, Raymond Poincare Hosp, AP HP, Garches, France.
   [Laforet, P.; Eymard, B.] Pierre & Marie Curie Paris 6 Univ, Pitie Salpetriere Hosp, Myol Inst, Paris, France.
   [Bougouin, W.] Paris Cardiovasc Res Ctr PARCC, INSERM, Unit 970, Paris, France.
   [Bougouin, W.; Lombes, A.; Duboc, D.; Wahbi, K.] Sorbonne Paris Cite Univ, Paris Descartes, Paris, France.
   [Bougouin, W.] Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France.
   [Jardel, C.] Hop La Pitie Salpetriere, AP HP, Dept Biochem, Paris, France.
   [Jardel, C.; Lombes, A.] Inst Cochin, CNRS, INSERM, U1016,UMR 8104, Paris, France.
   [Duboc, D.; Wahbi, K.] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Cardiol, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP
RP Wahbi, K (corresponding author), Cochin Hosp, Dept Cardiol, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France.
EM karim.wahbi@aphp.fr
FU AFM-Telethon (Association Francaise contre les Myopathies, French Alliance against Myopathies)
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   SCHUMANN GB, 1981, ACTA CYTOL, V25, P147
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 17
TC 39
Z9 40
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD FEB 15
PY 2017
VL 24
IS 2
BP 255
EP 261
DI 10.1111/ene.13176
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EI9CG
UT WOS:000392804300009
PM 27869334
DA 2024-11-01
ER

PT J
AU Balasubramaniam, S
   Lewis, B
   Mock, DM
   Said, HM
   Tarailo-Graovac, M
   Mattman, A
   van Karnebeek, CD
   Thorburn, DR
   Rodenburg, RJ
   Christodoulou, J
AF Balasubramaniam, Shanti
   Lewis, B.
   Mock, D. M.
   Said, H. M.
   Tarailo-Graovac, M.
   Mattman, A.
   van Karnebeek, C. D.
   Thorburn, D. R.
   Rodenburg, R. J.
   Christodoulou, J.
TI Leigh-Like Syndrome Due to Homoplasmic m.8993T&gt; Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD)
SO JIMD REPORTS, VOL 33
LA English
DT Article; Book Chapter
ID mitochondrial-dna mutations; clinical-features; biotin transport; nucleotide 8993; citrulline; marker; disease; acid; hyperammonemia; abnormality
AB Leigh syndrome (LS), or subacute necrotizing encephalomyelopathy, is a genetically heterogeneous, relentlessly progressive, devastating neurodegenerative disorder that usually presents in infancy or early childhood. A diagnosis of Leigh-like syndrome may be considered in individuals who do not fulfil the stringent diagnostic criteria but have features resembling Leigh syndrome. We describe a unique presentation of Leigh-like syndrome in a 3-year-old boy with elevated 3-hydroxyisovalerylcarnitine (C5-OH) on newborn screening (NBS). Subsequent persistent plasma elevations of C5-OH and propionylcarnitine (C3) as well as fluctuating urinary markers were suggestive of multiple carboxylase deficiency (MCD). Normal enzymology and mutational analysis of genes encoding holocarboxylase synthetase (HLCS) and biotinidase (BTD) excluded MCD. Biotin uptake studies were normal excluding biotin transporter deficiency. His clinical features at 13 months of age comprised psychomotor delay, central hypotonia, myopathy, failure to thrive, hypocitrullinemia, recurrent episodes of decompensation with metabolic keto-lactic acidosis and an episode of hyperammonemia. Biotin treatment from 13 months of age was associated with increased patient activity, alertness, and attainment of new developmental milestones, despite lack of biochemical improvements. Whole exome sequencing (WES) analysis failed to identify any other variants which could likely contribute to the observed phenotype, apart from the homoplasmic (100%) m.8993T>G variant initially detected by mitochondrial DNA (mtDNA) sequencing. Hypocitrullinemia has been reported in patients with the m.8993T>G variant and other mitochondrial disorders. However, persistent plasma elevations of C3 and C5-OH have previously only been reported in one other patient with this homoplasmic mutation. We suggest considering the m.8993T>G variant early in the diagnostic evaluation of MCD-like biochemical disturbances, particularly when associated with hypocitrullinemia on NBS and subsequent confirmatory tests. An oral biotin trial is also warranted.
C1 [Balasubramaniam, Shanti] Princess Margaret Hosp, Metab Unit, Dept Rheumatol & Metab Med, Perth, WA, Australia.
   [Balasubramaniam, Shanti] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia.
   [Balasubramaniam, Shanti] Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW, Australia.
   [Lewis, B.] Princess Margaret Hosp, PathWest Labs WA, Perth, WA, Australia.
   [Mock, D. M.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.
   [Said, H. M.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA.
   [Tarailo-Graovac, M.] Univ British Columbia, Ctr Mol Med, Dept Med Genet, Child & Family Res Inst, Vancouver, BC, Canada.
   [Mattman, A.] Univ British Columbia, Adult Metab Dis Clin, Div Endocrinol & Metab, Vancouver, BC, Canada.
   [van Karnebeek, C. D.] Univ British Columbia, Ctr Mol Med, Dept Pediat, Child & Family Res Inst, Vancouver, BC, Canada.
   [Thorburn, D. R.; Christodoulou, J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, D. R.; Christodoulou, J.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, D. R.; Christodoulou, J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Rodenburg, R. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
C3 Princess Margaret Hospital for Children; University of Western Australia; University of Western Australia; NSW Health; The Children's Hospital at Westmead; Sydney Childrens Hospitals Network; University of Sydney; University of Western Australia; Princess Margaret Hospital for Children; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Irvine; University of British Columbia; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; University of Melbourne; Radboud University Nijmegen
RP Balasubramaniam, S (corresponding author), Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW, Australia.
EM saras329@hotmail.com
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853
   Bindoff L, 2006, MITOCHONDRIAL MEDICINE, V0, P143
   Blijlevens NMA, 2004, BONE MARROW TRANSPL, V34, P193, DOI 10.1038/sj.bmt.1704563
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227
   Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Debray FG, 2010, J CHILD NEUROL, V25, P1000, DOI 10.1177/0883073809351983
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   ELLIOTT KRF, 1974, BIOCHEM J, V141, P817, DOI 10.1042/bj1410817
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Hauser N, 2014, 64 ANN M AM SOC HUM, V0, P0
   Henriques M, 2012, J CHILD NEUROL, V27, P1059, DOI 10.1177/0883073811431015
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7
   Ishiyama N, 2001, J STRUCT BIOL, V136, P30, DOI 10.1006/jsbi.2001.4421
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Kumakura A, 2009, PEDIATR NEUROL, V41, P309, DOI 10.1016/j.pediatrneurol.2009.04.028
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lutgens LCHW, 2003, INT J RADIAT ONCOL, V57, P1067, DOI 10.1016/S0360-3016(03)00781-8
   MOCK DM, 1997, METHOD ENZYMOL, V0, P265
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   MORIN C, 1993, AM J HUM GENET, V53, P488
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   SAID HM, 1988, GASTROENTEROLOGY, V94, P68, DOI 10.1016/0016-5085(88)90611-7
   Said HM, 1998, AM J PHYSIOL-CELL PH, V275, PC1365, DOI 10.1152/ajpcell.1998.275.5.C1365
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   SPECTOR R, 1988, NEUROCHEM RES, V13, P213, DOI 10.1007/BF00971535
   SPECTOR R, 1987, J NEUROCHEM, V48, P400, DOI 10.1111/j.1471-4159.1987.tb04107.x
   Thorburn DR, 2014, GENEREVIEWS, V0, P1993
   van Karnebeek CD, 2014, AM J HUM GENET, V94, P453, DOI 10.1016/j.ajhg.2014.01.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 42
TC 12
Z9 14
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2017
VL 33
IS 
BP 99
EP 107
DI 10.1007/8904_2016_559
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RW
UT WOS:000405120800014
PM 27450367
DA 2024-11-01
ER

PT J
AU Someya, S
   Kujoth, GC
   Kim, MJ
   Hacker, TA
   Vermulst, M
   Weindruch, R
   Prolla, TA
AF Someya, Shinichi
   Kujoth, Gregory C.
   Kim, Mi-Jung
   Hacker, Timothy A.
   Vermulst, Marc
   Weindruch, Richard
   Prolla, Tomas A.
TI Effects of calorie restriction on the lifespan and healthspan of POLG mitochondrial mutator mice
SO PLOS ONE
LA English
DT Article
ID oxidative damage; dna polymerase; aged rat; mutations; overexpression; muscle; replication; phenotypes; stress; brain
AB Mitochondrial DNA (mtDNA) mutations are thought to have a causative role in age-related pathologies. We have shown previously that mitochondrial mutator mice (Polg(D257A/D257A)), harboring a proofreading-deficient version of the mtDNA polymerase gamma (POLG), accumulate mtDNA mutations in multiple tissues and display several features of accelerated aging. Calorie restriction (CR) is known to delay the onset of age-related diseases and to extend the lifespan of a variety of species, including rodents. In the current study we investigated the effects of CR on the lifespan and healthspan of mitochondrial mutator mice. Longterm CR did not increase the median or maximum lifespan of Polg(D257A/D257A) mice. Furthermore, CR did not reduce mtDNA deletions in the heart and muscle, accelerated sarcopenia, testicular atrophy, nor improve the alterations in cardiac parameters that are present in aged mitochondrial mutator mice. Therefore, our findings suggest that accumulation of mtDNA mutations may interfere with the beneficial action of CR in aging retardation.
C1 [Someya, Shinichi; Kim, Mi-Jung] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Kujoth, Gregory C.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA.
   [Hacker, Timothy A.] Univ Wisconsin, Dept Med, Madison, WI USA.
   [Vermulst, Marc] Univ Penn, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Weindruch, Richard] Univ Wisconsin, Geriatr Res Educ & Clin Ctr, Vet Adm Hosp, Madison, WI USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison
RP Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.; Prolla, TA (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
EM taprolla@wisc.edu
FU NIH [RO1 AG021905, RO1 DC012552, R01 DC014437, R03 DC011840]; American Federation for Aging Research Grant; NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   Alderman JM, 2010, GERONTOLOGY, V56, P404, DOI 10.1159/000235720
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barger JL, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002264
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Diderich K, 2011, DNA REPAIR, V10, P772, DOI 10.1016/j.dnarep.2011.04.025
   FINDLAY WA, 1995, BIOCHEMISTRY-US, V34, P2087, DOI 10.1021/bi00007a001
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Hamilton R, 2016, J NEUROL SCI, V370, P47, DOI 10.1016/j.jns.2016.09.021
   Han C, 2013, EXP GERONTOL, V48, P1091, DOI 10.1016/j.exger.2013.02.014
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lezza AMS, 2008, NEUROCHEM RES, V33, P2609, DOI 10.1007/s11064-008-9866-7
   Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024
   McKiernan SH, 2011, EXP GERONTOL, V46, P23, DOI 10.1016/j.exger.2010.09.011
   Muller FL, 2007, AM J PHYSL REGUL INT, V293, P0
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   Safdar A, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0075-9
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
NR 36
TC 15
Z9 16
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2017
VL 12
IS 2
BP 
EP 
DI 10.1371/journal.pone.0171159
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DG
UT WOS:000396161700034
PM 28158260
DA 2024-11-01
ER

PT J
AU Houston, BA
   Judge, DP
   Brown, E
   Halushka, M
   Barouch, LA
AF Houston, Brian A.
   Judge, Daniel P.
   Brown, Emily
   Halushka, Marc
   Barouch, Lili A.
TI Giant Ring Mitochondria in a Patient With Heart Failure and Cerebral White Matter Disease Resulting From an <i>MT-TL1</i> Mitochondrial Gene Mutation
SO JOURNAL OF CARDIAC FAILURE
LA English
DT Article
DE Cardiomyopathy; mitochondrial disease; mitochondrial genetics; ring mitochondria
ID dna; disorders
AB Background: The presence of giant ring mitochondria on endomyocardial biopsy is rarely reported and does not have a well-defined differential diagnosis. Methods: We report the case of a 54-year-old man with heart failure and preserved ejection fraction and left ventricular hypertrophy, initially thought to have an infiltrative cardiomyopathy. Results: The patient was found to have extensive vacuolization caused by giant ring mitochondria on endomyocardial biopsy. Mitochondrial genetic testing revealed an A3243G mutation in the MT-TL1 gene, which is a mitochondrial encoded transfer RNA-leucine molecule. Conclusions: Mitochondrial disease should be considered in patients presenting with unexplained cardiomyopathy and skeletal muscle, cerebral, or metabolic abnormalities. In this case, the presence of unexpected extensive cardiomyocyte vacuolization and giant, ring-shaped mitochondria on endomyocardial biopsy prompted mitochondrial genetic testing, which ultimately resulted in the correct diagnosis and treatment.
C1 [Houston, Brian A.] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA.
   [Judge, Daniel P.; Brown, Emily; Barouch, Lili A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.
   [Halushka, Marc] Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA.
C3 Medical University of South Carolina; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine
RP Houston, BA (corresponding author), MUSC, Cardiol, 114 Doughty St,MSC 592,BM222, Charleston, SC 29425 USA.
EM houstobr@musc.edu
CR Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BINAK K, 1967, BRIT HEART J, V29, P422
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Taylor GP, 2004, PEDIATR DEVEL PATHOL, V7, P620, DOI 10.1007/s10024-004-5050-5
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wallace DC, 2010, GENE DEV, V24, P1571, DOI 10.1101/gad.1960210
NR 15
TC 3
Z9 3
U1 0
U2 0
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 1071-9164
EI 1532-8414
J9 J CARD FAIL
JI J. Card. Fail.
PD AUG 15
PY 2017
VL 23
IS 8
BP 652
EP 655
DI 10.1016/j.cardfail.2017.06.001
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE7QW
UT WOS:000408403000010
PM 28624653
DA 2024-11-01
ER

PT J
AU Yang, SK
   Han, YC
   Liu, J
   Song, PN
   Xu, XX
   Zhao, L
   Hu, C
   Xiao, L
   Liu, FY
   Zhang, H
   Sun, L
AF Yang, Shikun
   Han, Yachun
   Liu, Jun
   Song, Panai
   Xu, Xiaoxuan
   Zhao, Li
   Hu, Chun
   Xiao, Li
   Liu, Fuyou
   Zhang, Hao
   Sun, Lin
TI Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Mitochondria; Renal injury; Diabetic nephropathy; microvascular complications; mitochondrial dysfuction; mitophagy
ID nlrp3 inflammasome activation; mediates high-glucose; renal tubular injury; oxidative stress; protein-kinase; cell-death; myoinositol oxygenase; induced apoptosis; skeletal-muscle; dna mutations
AB Background: Diabetic nephropathy (DN) is an important diabetic microvascular complication, and it is becoming the leading cause of end-stage renal disease worldwide. Unfortunately, there are no effective therapies to treat established DN. Therefore, new therapeutic targets are urgently required. Accumulating studies indicate that mitochondrial dysfunction is central to the pathogenesis of DN, and therapies targeted mitochondria might effectively delay the progression of DN. Methods: A structured search of previously research literature about mitochondrial structure and function, mitochondrial DNA, mitochondrial biogenesis, mitochondrial dynamics change, mitophagy, mitochondrial ROS, mitochondrial apoptosis and therapies targeted mitochondria has been performed in several databases. Results: 176 papers were included in this review, the results from these papers indicated that mitochondrial dysfunction is a pivotal issue for the development of DN, such as elevated oxidative stress induced by disorders of the mitochondrial respiratory chain complex and mitochondrial dynamic disorders, mutation of mitochondrial DNA, mitochondrial abnormal biogenesis, mitochondrial excessive fission, mitochondrial ROS overproduction. In addition, several therapeutic agents targeting the mitochondria (e.g. mitochondrial ROS modulators, mitochondrial fragmentation inhibitors and mitochondrial biogenesis activators) have shown perfect therapeutic effect and security for DN. Conclusion: The finding of this review has further confirmed the vital role of mitochondrial dysfunction in the progression of DN, management strategies for recovering the normal mitochondrial function will offer potential novel therapeutic targets for DN.
C1 [Yang, Shikun; Han, Yachun; Song, Panai; Xu, Xiaoxuan; Zhao, Li; Hu, Chun; Xiao, Li; Liu, Fuyou; Sun, Lin] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.
   [Yang, Shikun; Liu, Jun; Zhang, Hao] Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha 410011, Hunan, Peoples R China.
C3 Central South University; Central South University
RP Sun, L (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Nephrol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.
EM zndxsunlinll@l63.com
FU National Natural Sciences Foundation of China [81470960, 81500558]; National Basic Research Program of China [2016YFC1305501]; New Xiangya Talent Project of the Third xiangya hospital of Central South University [JY201521]
CR Achilli A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021029
   Adema AY, 2016, NETH J MED, V74, P455
   Akhmedov AT, 2015, MOL CELL BIOCHEM, V409, P283, DOI 10.1007/s11010-015-2532-x
   Al-Kafaji G, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/754946
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014
   Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aparicio-Trejo OE, 2017, BIOFACTORS, V43, P293, DOI 10.1002/biof.1338
   Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096
   Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367
   Bandiera S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020746
   Bao L, 2014, FOOD FUNCT, V5, P1872, DOI 10.1039/c4fo00340c
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brenneman J, 2016, BIOORG MED CHEM LETT, V26, P4394, DOI 10.1016/j.bmcl.2016.07.079
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   Buemi M, 1997, NEPHRON, V76, P249, DOI 10.1159/000190188
   Cerqueira FM, 2016, FEBS J, V283, P822, DOI 10.1111/febs.13632
   Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   Connor TM, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006620
   Coughlan MT, 2016, KIDNEY INT, V90, P272, DOI 10.1016/j.kint.2016.02.043
   Coughlan MT, 2016, CLIN SCI, V130, P711, DOI 10.1042/CS20150838
   Cucchiari D, 2016, ACTA DIABETOL, V53, P551, DOI 10.1007/s00592-016-0836-2
   Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200
   Cui L, 2017, VASC PHARMACOL, V88, P21, DOI 10.1016/j.vph.2016.11.006
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002
   DSouza GGM, 2004, CURR GENE THER, V4, P317
   Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732
   de Arriba G, 2013, TOXICOL LETT, V218, P30, DOI 10.1016/j.toxlet.2013.01.007
   Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179
   Djordjevic VB, 2004, INT REV CYTOL, V237, P57, DOI 10.1016/S0074-7696(04)37002-6
   Du K, 2016, TOXICOL SCI, V154, P214, DOI 10.1093/toxsci/kfw158
   Duffield Jeremy S, 2013, DRUG DISCOV TODAY DIS MODELS, V10, P0
   El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, P0, DOI 10.3389/fcvm.2016.00025
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Fang L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072344
   Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fukuda M, 1999, J DIABETES COMPLICAT, V13, P277, DOI 10.1016/S1056-8727(99)00060-4
   Funk JA, 2012, AM J PHYSIOL-RENAL, V302, PF853, DOI 10.1152/ajprenal.00035.2011
   Galimov ER, 2010, ACTA NATURAE, V2, P44, DOI 10.32607/20758251-2010-2-4-44-51
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Gonzalez AS, 2014, FREE RADICAL RES, V48, P769, DOI 10.3109/10715762.2014.906592
   Granata S, 2015, NUTR METAB, V12, P0, DOI 10.1186/s12986-015-0044-z
   Guo KF, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125176
   György H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   HA H, 1995, KIDNEY INT, V48, P0
   Hagiwara S, 2010, BIOMED RES-TOKYO, V31, P263, DOI 10.2220/biomedres.31.263
   Hakim FA, 2010, MED SCI MONITOR, V16, P0
   He T, 2016, J MOL MED, V94, P1359, DOI 10.1007/s00109-016-1451-y
   Hickey FB, 2014, DIABETES, V63, P4314, DOI 10.2337/db13-1256
   Higgins GC, 2014, BRIT J PHARMACOL, V171, P1917, DOI 10.1111/bph.12503
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Holmström KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hou YJ, 2016, AM J PHYSIOL-RENAL, V310, PF547, DOI 10.1152/ajprenal.00574.2014
   Huang CY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033657
   Huang CL, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep29196
   Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758
   Hur KY, 2015, J DIABETES INVEST, V6, P600, DOI 10.1111/jdi.12328
   Ishimoto Y, 2016, NEPHROL DIAL TRANSPL, V31, P1062, DOI 10.1093/ndt/gfv317
   Iwasaki N, 2001, J HUM GENET, V46, P330, DOI 10.1007/s100380170068
   Jefferson JA, 2011, AM J KIDNEY DIS, V58, P835, DOI 10.1053/j.ajkd.2011.03.033
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588
   Kanauchi M, 2002, NEPHRON, V91, P327, DOI 10.1159/000058412
   Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150
   Karaa A, 2015, PEDIATR DIABETES, V16, P1, DOI 10.1111/pedi.12223
   Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581
   Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2
   Kitada M, 2016, DIABETOLOGIA, V59, P1307, DOI 10.1007/s00125-016-3925-4
   Kitada M, 2011, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2011/908185
   Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386
   Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980
   Koh ES, 2015, J TRANSL MED, V13, P0, DOI 10.1186/s12967-015-0563-4
   Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376
   Kuwagata S, 2016, KIDNEY INT, V90, P1211, DOI 10.1016/j.kint.2016.06.036
   Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lee HB, 2003, J AM SOC NEPHROL, V14, PS241, DOI 10.1097/01.ASN.0000077410.66390.0F
   Li AY, 2016, MOL CELL ENDOCRINOL, V434, P36, DOI 10.1016/j.mce.2016.06.008
   Cavoli G, 2011, AM J EMERG MED, V29, P568, DOI 10.1016/j.ajem.2011.02.024
   Li PF, 2012, J CELL BIOCHEM, V113, P1104, DOI 10.1002/jcb.24004
   Li P, 2016, J DIABETES RES, V2016, P0, DOI 10.1155/2016/1802036
   Li W, 2016, BIOCHEM BIOPH RES CO, V478, P612, DOI 10.1016/j.bbrc.2016.07.115
   LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0
   Liu HW, 2016, FOOD FUNCT, V7, P1941, DOI 10.1039/c6fo00078a
   Ma LQ, 2016, PATHOL RES PRACT, V212, P310, DOI 10.1016/j.prp.2016.02.001
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Maimaitijiang A, 2016, BIOCHEM BIOPH RES CO, V471, P474, DOI 10.1016/j.bbrc.2016.02.051
   Malik AN, 2015, CLIN PRACT, V110, P257
   Martikainen MH, 2015, DIABETES VASC DIS RE, V12, P302, DOI 10.1177/1479164115579007
   Martínez-Castelao A, 2015, J CLIN MED, V4, P1207, DOI 10.3390/jcm4061207
   Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017
   Massin P, 2008, DIABETOLOGIA, V51, P1664, DOI 10.1007/s00125-008-1073-1
   Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031
   Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632
   Müller-Deile J, 2014, FRONT ENDOCRINOL, V5, P0, DOI 10.3389/fendo.2014.00209
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472
   Nakamura S, 1999, DIABETES RES CLIN PR, V44, P183, DOI 10.1016/S0168-8227(99)00051-0
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011
   Pichler R, 2017, AM J PHYSIOL-RENAL, V312, PF716, DOI 10.1152/ajprenal.00314.2016
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380
   Pitts KR, 2004, J BIOL CHEM, V279, P50286, DOI 10.1074/jbc.M405531200
   Ralto KM, 2016, SEMIN NEPHROL, V36, P8, DOI 10.1016/j.semnephrol.2016.01.005
   Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031
   Ravindran S, 2017, J CELL PHYSIOL, V232, P731, DOI 10.1002/jcp.25598
   Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020
   Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Sesaki H, 2014, BBA-MOL BASIS DIS, V1842, P1179, DOI 10.1016/j.bbadis.2013.11.024
   Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271
   Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Singh SP, 2016, PROSTAG OTH LIPID M, V125, P8, DOI 10.1016/j.prostaglandins.2016.07.004
   Smith MA, 2012, ARCH BIOCHEM BIOPHYS, V523, P161, DOI 10.1016/j.abb.2012.04.020
   Song PN, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/746531
   Su M, 2013, AM J PHYSIOL-RENAL, V305, PF520, DOI 10.1152/ajprenal.00570.2012
   Sun L, 2016, J BIOL CHEM, V291, P5688, DOI 10.1074/jbc.M115.669952
   Sun L, 2010, AM J PHYSIOL-RENAL, V299, PF1014, DOI 10.1152/ajprenal.00414.2010
   Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336
   Suzuki S, 1999, DIABETES RES CLIN PR, V45, P161, DOI 10.1016/S0168-8227(99)00046-7
   Taneda S, 2010, AM J PHYSIOL-RENAL, V299, PF1451, DOI 10.1152/ajprenal.00637.2009
   Tang WX, 2012, ENDOCRINE, V41, P236, DOI 10.1007/s12020-011-9555-1
   Thomas MC, 2016, NAT REV NEPHROL, V12, P73, DOI 10.1038/nrneph.2015.173
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011
   Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175
   Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009
   Wang Y, 2015, METABOLISM, V64, P677, DOI 10.1016/j.metabol.2015.02.004
   Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x
   Wu WH, 2015, GENET MOL RES, V14, P4593, DOI 10.4238/2015.May.4.18
   Wu YQ, 2016, YONSEI MED J, V57, P1252, DOI 10.3349/ymj.2016.57.5.1252
   Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412
   Xu XX, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep29302
   Xu Y, 2015, J DIABETES COMPLICAT, V29, P976, DOI 10.1016/j.jdiacomp.2015.07.021
   Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080
   Yang SK, 2014, RENAL FAILURE, V36, P313, DOI 10.3109/0886022X.2013.846867
   Yao F, 2016, ACTA PHARM SIN B, V6, P20, DOI 10.1016/j.apsb.2015.07.009
   Yiu WH, 2016, KIDNEY INT, V89, P386, DOI 10.1038/ki.2015.331
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025
   Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457
   Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441
   Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16
   Zhang LM, 2015, RENAL FAILURE, V37, P903, DOI 10.3109/0886022X.2015.1034607
   Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148
   Zhao X, 2015, INT J MOL MED, V35, P684, DOI 10.3892/ijmm.2014.2052
   Zheng SF, 2014, J DIABETES, V6, P132, DOI 10.1111/1753-0407.12105
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zhuang YB, 2015, AM J PHYSIOL-RENAL, V308, PF857, DOI 10.1152/ajprenal.00203.2014
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 175
TC 58
Z9 65
U1 3
U2 48
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD JUN 15
PY 2017
VL 24
IS 29
BP 3185
EP 3202
DI 10.2174/0919867314666170509111003
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA FJ4DX
UT WOS:000412686800004
PM 28486920
DA 2024-11-01
ER

PT J
AU Lu, YY
   Zhao, DH
   Yao, S
   Wu, SW
   Hong, DJ
   Wang, QQ
   Liu, J
   Smeitink, JAM
   Yuan, Y
   Wang, ZX
AF Lu, Yuanyuan
   Zhao, Danhua
   Yao, Sheng
   Wu, Shiwen
   Hong, Daojun
   Wang, Qingqing
   Liu, Jing
   Smeitink, Jan A. M.
   Yuan, Yun
   Wang, Zhaoxia
TI Mitochondrial tRNA genes are hotspots for mutations in a cohort of patients with exercise intolerance and mitochondrial myopathy
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial myopathy; Exercise intolerance; Mitochondrial DNA; tRNA gene
ID complex-i; a3243g mutation; lactic-acidosis; encephalopathy; disease; dna; involvement; diagnosis; deafness
AB Objective: Mitochondrial myopathy (MM) is a relatively rare type of mitochondrial disorder characterized by predominant skeletal muscle involvement. Both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) mutations have been reported as the genetic causes of this disease. Here, we described the clinical and genetic features of a cohort of patients with MM. Methods: We conducted a retrospective, single center study enrolling 22 patients with clinically and myopathologically diagnosed MM. The clinical records and results of laboratory examinations were collected and analyzed. The follow-up was conducted by telephone interview in 12 patients. Muscle biopsy and gene analysis was performed in all patients. MtDNA mutation load was quantified in all available tissues. Results: Muscle biopsy revealed ragged red fibers and/or cytochrome c oxidase deficient fibers in all patients. Mitochondrial DNA analysis identified pathogenic mutations in 11 patients, including four previously reported mutations (mt-tRNA(Leb(UUR)) m.3243A>G in five patients, mt-tRNA(LYs) m.8344A>G in four patients, mt-tRNA(Leu(UUR)) m.3302A>G in one patient, and mt-tRNA(Leu(UUR)) m.3250T>C in one patient) and a novel possible pathogenic variant (MTND1 m.3437G>A) in one patient The mtDNA mutation load was consistently higher in muscles than in blood. In the remaining 10 patients, there was no pathogenic mutation found either by the Sanger sequencing of entire mitochondrial genome or by the targeted next-generation sequencing which included 238 nuclear genes related to mitochondrial diseases. Clinically, the onset age of these 22 MM patients ranged from 1 to 51 years (mean = 21.1 +/- 14.3 years), and the disease duration was between 3 and 44 years (mean = 14.1 +/- 9.4 years). Proximal limb weakness with or without exercise intolerance was present in 21 patients, and one patient showed only exercise intolerance. Out of these 22 patients, dysphagia/dysarthria, neck flexor muscle weakness, dyspnea, cardiomyopathy and exercise induced myalgia were observed in five, two, four, one and four patients, respectively. Neither central nervous system manifestation nor brain MRI abnormality was present in these patients. Notably, three of the four patients carrying the m.8344A>G mutation presented with dysarthria. The follow-up of 12 patients revealed symptom improvements in four cases, stable conditions in two cases, and worsened conditions in five cases. The case with the m.3302A>G mutation died of respiratory failure. Conclusions: Mitochondrial tRNA genes, as hotspots for mutations, accounted for 50% of MM in this cohort of patients. Patients associated with the m.8344A>G mutation were prone to laryngopharyngeal muscle involvement. The prognosis in our patients is relatively benign except one patient with the m.3302A>G mutation. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Lu, Yuanyuan; Wang, Qingqing; Liu, Jing; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, Beijing, Peoples R China.
   [Zhao, Danhua] China Aerosp Corp, Cent Hosp, Dept Neurol, Beijing, Peoples R China.
   [Yao, Sheng] PLA Navy Gen Hosp, Dept Neurol, Beijing, Peoples R China.
   [Wu, Shiwen] Chinese Armed Police Force, Dept Neurol, Gen Hosp, Beijing, Peoples R China.
   [Hong, Daojun] Nanchang Univ, Dept Neurol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.
   [Smeitink, Jan A. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Pediat, Nijmegen, Netherlands.
C3 Peking University; Sixth Medical Center of Chinese PLA General Hospital; Nanchang University; Radboud University Nijmegen
RP Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, Beijing, Peoples R China.
EM drwangzx@163.com
FU Ministry of Science and Technology of China [2011ZX09307-001-07]; Beijing Municipal Science and Technology Commission [Z151100003915126]
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Angelini C, 2009, ACTA MYOL, V28, P16
   Beresford MW, 2006, NEUROMUSCULAR DISORD, V16, P613, DOI 10.1016/j.nmd.2006.07.003
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Delmiro A, 2013, HUM MUTAT, V34, P1623, DOI 10.1002/humu.22445
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1999, ITAL J NEUROL SCI, V20, P387
   Gal Aniko, 2008, ORVOSI HETILAP, V149, P1593, DOI 10.1556/OH.2008.28398
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   HARTLEY C, 1994, J LARYNGOL OTOL, V108, P685, DOI 10.1017/S0022215100127835
   Hirata K, 1999, J HUM GENET, V44, P210, DOI 10.1007/s100380050145
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Kelly EA, 2013, ANN OTO RHINOL LARYN, V122, P177, DOI 10.1177/000348941312200306
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Miller DK, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0104879
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   MITOMAP, 2008, HUM MIT GEN DAT, V0, P0
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pfeffer G, 2012, COCHRANE DB SYST REV, V18, P4
   Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5
   SHIBASAKI H, 1973, J NEUROL SCI, V18, P301, DOI 10.1016/0022-510X(73)90078-6
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Yang CC, 1998, J FORMOS MED ASSOC, V97, P715
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 42
TC 17
Z9 17
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2017
VL 379
IS 
BP 137
EP 143
DI 10.1016/j.jns.2017.05.056
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FC9TR
UT WOS:000407184500033
PM 28716227
DA 2024-11-01
ER

PT J
AU Phadke, R
AF Phadke, Rahul
TI Myopathology of Adult and Paediatric Mitochondrial Diseases
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE mitochondrial; muscle biopsy; ragged red; COX-negative; subsarcolemmal; immunohistochemistry
ID cytochrome-c-oxidase; progressive external ophthalmoplegia; ragged-red fibers; of-function mutations; skeletal-muscle; complex-ii; dna deletions; succinate-dehydrogenase; recurrent myoglobinuria; diagnostic-criteria
AB Mitochondria are dynamic organelles ubiquitously present in nucleated eukaryotic cells, subserving multiple metabolic functions, including cellular ATP generation by oxidative phosphorylation (OXPHOS). The OXPHOS machinery comprises five transmembrane respiratory chain enzyme complexes (RC). Defective OXPHOS gives rise to mitochondrial diseases (mtD). The incredible phenotypic and genetic diversity of mtD can be attributed at least in part to the RC dual genetic control (nuclear DNA (nDNA) and mitochondrial DNA (mtDNA)) and the complex interaction between the two genomes. Despite the increasing use of next-generation-sequencing (NGS) and various omics platforms in unravelling novel mtD genes and pathomechanisms, current clinical practice for investigating mtD essentially involves a multipronged approach including clinical assessment, metabolic screening, imaging, pathological, biochemical and functional testing to guide molecular genetic analysis. This review addresses the broad muscle pathology landscape including genotype-phenotype correlations in adult and paediatric mtD, the role of immunodiagnostics in understanding some of the pathomechanisms underpinning the canonical features of mtD, and recent diagnostic advances in the field.
C1 [Phadke, Rahul] UCLH NHS Fdn Trust, Div Neuropathol, UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Phadke, Rahul] Great Ormond St Hosp Children NHS Fdn Trust, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
C3 University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Phadke, R (corresponding author), UCLH NHS Fdn Trust, Div Neuropathol, UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.; Phadke, R (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
EM r.phadke@ucl.ac.uk
CR Alfadhel M, 2011, AM J MED GENET A, V155A, P840, DOI 10.1002/ajmg.a.33881
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
   BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468
   Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2015, INT J BIOCHEM CELL B, V63, P32, DOI 10.1016/j.biocel.2015.01.025
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BOURGERON T, 1993, J BIOL CHEM, V268, P19369
   BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802
   Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Carry M R, 1989, BULL SOC BELGE OPHTALMOL, V237, P303
   Chaturvedi S, 2005, MED SCI MONITOR, V11, P0
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   COQUET M, 1990, ANN PATHOL, V10, P181
   Cotta A, 2014, ARQ NEURO-PSIQUIAT, V72, P721, DOI 10.1590/0004-282X20140110
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI 10.1177/000271623618500112
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2001, ACTA MED AUST, V28, P152, DOI 10.1046/j.1563-2571.2001.01036.x
   Finsterer J, 2016, WORLD J CARDIOL, V8, P333, DOI 10.4330/wjc.v8.i5.333
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gal A, 2017, EMBO MOL MED, V0, P0
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Gonzalez-Lima F, 1998, CYTOCHROME OXIDASE IN NEURONAL METABOLISM AND ALZHEIMERS DISEASE, V0, P0
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   HASEGAWA H, 1993, ACTA NEUROPATHOL, V85, P280
   Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kalra AA, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Köller H, 1998, J NEUROL NEUROSUR PS, V64, P407, DOI 10.1136/jnnp.64.3.407
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Laforêt P, 2010, NEUROMUSCULAR DISORD, V20, P693, DOI 10.1016/j.nmd.2010.06.018
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Machado PM, 2014, CURR OPIN NEUROL, V27, P591, DOI 10.1097/WCO.0000000000000129
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Marín-García J, 2003, PEDIATR NEUROL, V29, P26, DOI 10.1016/S0887-8994(03)00013-4
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Mastaglia FL, 2012, CURR NEUROL NEUROSCI, V12, P54, DOI 10.1007/s11910-011-0232-9
   MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   Miles L, 2006, HUM PATHOL, V37, P173, DOI 10.1016/j.humpath.2005.10.008
   Miles L, 2012, HUM PATHOL, V43, P1249, DOI 10.1016/j.humpath.2011.09.016
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Montero R, 2016, PLOS ONE, V11, P0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Moslemi AR, 2000, CARDIOLOGY, V94, P68, DOI 10.1159/000007049
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MULLERHOCKER J, 1986, VIRCHOWS ARCH B, V52, P353, DOI 10.1007/BF02889977
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nance JR, 2015, MUSCLE NERVE, V51, P793, DOI 10.1002/mus.24606
   Nasca A, 2017, HUM MUTAT, V0, P0
   Nascimento A, 2016, SEMIN PEDIATR NEUROL, V23, P290, DOI 10.1016/j.spen.2016.11.004
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Patterson K, 2004, PEDIATR DEVEL PATHOL, V7, P629, DOI 10.1007/s10024-004-5051-4
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sacconi S, 2006, NEUROLOGY, V67, P1464, DOI 10.1212/01.wnl.0000240071.62540.6f
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Simon NG, 2016, J CLIN NEUROSCI, V33, P1, DOI 10.1016/j.jocn.2016.01.041
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   SMEITINK JAM, 2004, MED INTELL UNIT, V0, P0
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   SPARACO M, 1995, BRAIN PATHOL, V5, P125, DOI 10.1111/j.1750-3639.1995.tb00586.x
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Teraoka M, 1999, HUM GENET, V105, P560, DOI 10.1007/s004390051145
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Vladutiu GD, 2000, ARCH PATHOL LAB MED, V124, P1755
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Weber K, 1997, AM J HUM GENET, V60, P373
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong L-JC, 2013, BIOCH MOL METHODS ST, V0, P27
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   YAMAMOTO M, 1988, ACTA NEUROPATHOL, V76, P558, DOI 10.1007/BF00689593
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   YONEDA M, 1995, MUSCLE NERVE, V0, PS95
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 192
TC 28
Z9 28
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
EI 
J9 J CLIN MED
JI J. Clin. Med.
PD JUL 15
PY 2017
VL 6
IS 7
BP 
EP 
DI 10.3390/jcm6070064
PG 24
WC Medicine, General & Internal
SC General & Internal Medicine
GA FD2AH
UT WOS:000407337300002
PM 28677615
DA 2024-11-01
ER

PT J
AU Garone, C
   Gurgel-Giannetti, J
   Sanna-Cherchi, S
   Krishna, S
   Naini, A
   Quinzii, CM
   Hirano, M
AF Garone, Caterina
   Gurgel-Giannetti, Juliana
   Sanna-Cherchi, Simone
   Krishna, Sindu
   Naini, Ali
   Quinzii, Catarina M.
   Hirano, Michio
TI A Novel <i>SUCLA2</i> Mutation Presenting as a Complex Childhood Movement Disorder
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE SUCLA2; coenzyme Q10; movement disorders; brain MRI
ID mitochondrial-dna depletion; encephalomyopathy; replication; deficiency; defects; subunit; disease
AB SUCLA2 defects have been associated with mitochondrial DNA (mtDNA) depletion and the triad of hypotonia, dystonia/ Leighlike syndrome, and deafness. A 9-year-old Brazilian boy of consanguineous parents presented with psychomotor delay, deafness, myopathy, ataxia, and chorea. Despite the prominent movement disorder, brain magnetic resonance imaging (MRI) was normal while 1 H-magnetic resonance spectroscopy (MRS) showed lactate peaks in the cerebral cortex and lateral ventricles. Decreased biochemical activities of mitochondrial respiratory chain enzymes containing mtDNA-encoded subunits and mtDNA depletion were observed in muscle and fibroblasts. A novel homozygous mutation in SUCLA2, the first one in the ligase coenzyme A (CoA) domain of the protein, was identified. Escalating doses of CoQ10 up to 2000 mg daily were associated with improvement of muscle weakness and stabilization of the disease course. The findings indicate the importance of screening for mitochondrial dysfunction in patients with complex movement disorders without brain MRI lesions and further investigation for potential secondary CoQ10 deficiency in patients with SUCLA2 mutations.
C1 [Garone, Caterina; Krishna, Sindu; Quinzii, Catarina M.; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Garone, Caterina] Univ Turin, Turin, Italy.
   [Garone, Caterina] Univ Bologna, Turin, Italy.
   [Gurgel-Giannetti, Juliana] Univ Fed Minas Gerais, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Sanna-Cherchi, Simone] Columbia Univ, Med Ctr, Dept Med, New York, NY USA.
   [Naini, Ali] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA.
C3 Columbia University; University of Turin; University of Bologna; Universidade Federal de Minas Gerais; Columbia University; Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, 630 168th St, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NIH [U54 NS078059, P01 HD080642]; MDA; Marriott Mitochondrial Disease Clinical Research Fund (MMDCRF); Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23 HD065871]
CR Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Jaberi E, 2013, J HUM GENET, V58, P526, DOI 10.1038/jhg.2013.45
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lamperti C, 2012, MOL GENET METAB, V107, P403, DOI 10.1016/j.ymgme.2012.08.020
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
NR 12
TC 10
Z9 12
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB 15
PY 2017
VL 32
IS 2
BP 246
EP 250
DI 10.1177/0883073816666221
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EP2LC
UT WOS:000397213600015
PM 27651038
DA 2024-11-01
ER

PT J
AU Golla, S
   Ren, JM
   Malloy, CR
   Pascual, JM
AF Golla, Sailaja
   Ren, Jimin
   Malloy, Craig R.
   Pascual, Juan M.
TI Intramyocellular lipid excess in the mitochondrial disorder MELAS MRS determination at 7T
SO NEUROLOGY-GENETICS
LA English
DT Article
ID magnetic-resonance spectroscopy; skeletal-muscle; insulin sensitivity; soleus muscle; body-fat
AB Objective: There is a paucity of objective, quantifiable indicators of mitochondrial disease available for clinical and scientific investigation. Methods: To this end, we explore intramyocellular lipid (IMCL) accumulation noninvasively by 7T magnetic resonance spectroscopy (MRS) as a reporter of metabolic dysfunction in MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes). We reasoned that mitochondrial dysfunction may impair muscle fat metabolism, resulting in lipid deposition (as is sometimes observed in biopsies), and that MRS is well suited to quantify these lipids. Results: In 10 MELAS participants and relatives, IMCL abundance correlates with percent mitochondrial DNA mutation abundance and with disease severity. Conclusions: These results indicate that IMCL accumulation is a novel potential disease hallmark in MELAS.
C1 [Golla, Sailaja; Pascual, Juan M.] Univ Texas Southwestern Med Ctr Dallas, Rare Brain Disorders Program, Dallas, TX 75390 USA.
   [Golla, Sailaja; Pascual, Juan M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.
   [Ren, Jimin; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA.
   [Ren, Jimin; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.
   [Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.
   [Pascual, Juan M.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.
   [Pascual, Juan M.] Univ Texas Southwestern Med Ctr Dallas, Ctr Human Genet, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.
C3 University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas
RP Pascual, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Rare Brain Disorders Program, Dallas, TX 75390 USA.; Pascual, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.; Pascual, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Pascual, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Human Genet, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.
EM Juan.Pascual@UTSouthwestern.edu
FU pilot grant under NIH grant [UL1TR001105]; Hegi Foundation; NIH grants [NS077015, NS078059, EB015908, RR024982]
CR Cree-Green M, 2015, DIABETES, V64, P383, DOI 10.2337/db14-0765
   Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004
   Misra A, 2003, DIABETIC MED, V20, P361, DOI 10.1046/j.1464-5491.2003.00932.x
   Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233
   Ren JM, 2010, MAGN RESON MED, V64, P662, DOI 10.1002/mrm.22345
   Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
NR 9
TC 6
Z9 8
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD JUN 15
PY 2017
VL 3
IS 3
BP 
EP 
DI 10.1212/NXG.0000000000000160
PG 4
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA FW1BM
UT WOS:000425030300014
PM 28589178
DA 2024-11-01
ER

PT J
AU Sissler, M
   González-Serrano, LE
   Westhof, E
AF Sissler, Marie
   Gonzalez-Serrano, Ligia Elena
   Westhof, Eric
TI Recent Advances in Mitochondrial Aminoacyl-tRNA Synthetases and Disease
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID spinal-cord involvement; unfolded protein response; lactate elevation; brain-stem; mutation; translation; dna; gene; leukoencephalopathy; myopathy
AB Dysfunctions in mitochondria - the powerhouses of the cell - lead to several human pathologies. Because mitochondria integrate nuclear and mitochondrial genetic systems, they are richly intertwined with cellular activities. The nucleus-encoded mitochondrial aminoacyl-tRNA synthetases (mt-aaRSs) are key components of the mitochondrial translation apparatus. Mutations in these enzymes predominantly affect the central nervous system (CNS) but also target other organs. Comparable mutations in mt-aaRSs can lead to vastly diverse diseases, occurring at different stages in life, and within different tissues; this represents a confounding issue. With newer information available, we propose that the pleiotropy and tissue-specificity of mt-aaRS-associated diseases result from the molecular integration of mitochondrial translation events within the cell; namely, through specific crosstalk between the cellular program and the energy demands of the cell. We place particular focus on neuronal cells.
C1 [Sissler, Marie; Gonzalez-Serrano, Ligia Elena; Westhof, Eric] Univ Strasbourg, CNRS, Unite Propre Rech 9002, Architecture & Reactivite ARN, F-67084 Strasbourg, France.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg
RP Sissler, M (corresponding author), Univ Strasbourg, CNRS, Unite Propre Rech 9002, Architecture & Reactivite ARN, F-67084 Strasbourg, France.
EM m.sissler@ibmc-cnrs.unistra.fr
FU CNRS; Universite de Strasbourg (UNISTRA); French National Program Investissement d'Avenir (Labex MitoCross and Labex NetRNA) [ANR-11-LABX-0057_MITOCROSS, ANR-10-LABX-0036_NETRNA]; LabEx MitoCross
CR Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Carapito C, 2017, METHODS, V113, P111, DOI 10.1016/j.ymeth.2016.10.012
   Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040
   Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0
   Delano WL, 2002, PROTEINS STRUCT FUNC, V30, P442
   DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Echevarría L, 2014, BIOCHEM J, V460, P91, DOI 10.1042/BJ20131107
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Engelhard J, 2011, FREE RADICAL BIO MED, V50, P1234, DOI 10.1016/j.freeradbiomed.2011.01.035
   ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Giegé R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187
   Godin JD, 2016, TRENDS NEUROSCI, V39, P394, DOI 10.1016/j.tins.2016.04.002
   Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956
   Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105
   Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044
   Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498
   Jovaisaite V, 2015, CURR OPIN CELL BIOL, V33, P74, DOI 10.1016/j.ceb.2014.12.003
   Karadimas C, 2001, J CHILD NEUROL, V16, P531, DOI 10.1177/088307380101600715
   Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124
   Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020
   Klipcan L, 2012, J MOL BIOL, V415, P527, DOI 10.1016/j.jmb.2011.11.029
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096
   Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943
   Messmer M, 2011, BIOCHEM J, V433, P441, DOI 10.1042/BJ20101902
   Monaghan RM, 2015, TRENDS BIOCHEM SCI, V40, P728, DOI 10.1016/j.tibs.2015.10.003
   Moulinier L, 2017, HUM MUTAT, V0, P0
   Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9
   Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nouws J, 2016, J BIOL CHEM, V291, P989, DOI 10.1074/jbc.M115.689299
   Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013
   Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rath VL, 1998, STRUCT FOLD DES, V6, P439, DOI 10.1016/S0969-2126(98)00046-X
   Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Santamaría-Gómez J, 2016, FRONT MICROBIOL, V7, P0, DOI 10.3389/fmcb.2016.00857
   Sauter C, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17332
   Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schwenzer H, 2014, TOP CURR CHEM, V344, P247, DOI 10.1007/128_2013_457
   Schwenzer H, 2014, BIOCHIMIE, V100, P18, DOI 10.1016/j.biochi.2013.09.027
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123
   SHIBA K, 1994, J BIOL CHEM, V269, P30049
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Storkebaum E, 2016, BIOESSAYS, V38, P818, DOI 10.1002/bies.201600052
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200
   van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026
   van Berge L, 2013, BIOCHEM J, V450, P345, DOI 10.1042/BJ20121564
   van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang M, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12061
   Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041
   Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373
   ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6
NR 83
TC 131
Z9 148
U1 2
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD AUG 15
PY 2017
VL 23
IS 8
BP 693
EP 708
DI 10.1016/j.molmed.2017.06.002
PG 16
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine
GA FC0QZ
UT WOS:000406545100004
PM 28716624
DA 2024-11-01
ER

PT J
AU Kytövuori, L
   Kärppä, M
   Tuominen, H
   Uusimaa, J
   Saari, M
   Hinttala, R
   Majamaa, K
AF Kytovuori, Laura
   Karppa, Mikko
   Tuominen, Hannu
   Uusimaa, Johanna
   Saari, Markku
   Hinttala, Reetta
   Majamaa, Kari
TI Case report: a novel frameshift mutation in the <i>mitochondrial</i> <i>cytochrome c oxidase II</i> gene causing mitochondrial disorder
SO BMC NEUROLOGY
LA English
DT Article
DE Neuromuscular disorders; Mitochondrial diseases; Cytochrome c oxidase deficiency; Case report
ID subunit-ii; lactic-acidosis; human mtdna; complex iv; encephalomyopathy; deficiency; dna; myopathy; disease; cox6b1
AB Background: Mitochondrial cytochrome c oxidase 2, MT-CO2, encodes one of the three subunits, which form the catalytic core of cytochrome c oxidase (COX), complex IV. Mutations in MT-CO2 are rare and the associated phenotypes are variable including nonsyndromic and syndromic forms of mitochondrial diseases. Case presentation: We describe a 30-year-old man with cognitive decline, epilepsy, psychosis, exercise intolerance, sensorineural hearing impairment, retinitis pigmentosa, cataract and lactic acidosis. COX-deficient fibers and ragged red fibers were abundant in the muscle. Sequencing of mitochondrial DNA (mtDNA) revealed a novel frameshift mutation m.8156delG that was predicted to cause altered C-terminal amino acid sequence and to lead to truncation of the COX subunit 2. The deletion was heteroplasmic being present in 26% of the mtDNA in blood, 33% in buccal mucosa and 95% in muscle. Deletion heteroplasmy correlated with COX-deficiency in muscle histochemistry. The mother and the siblings of the proband did not harbor the deletion. Conclusions: The clinical features and muscle histology of the proband suggested a mitochondrial disorder. The m.8156delG deletion is a new addition to the short list of pathogenic mutations in the mtDNA-encoded subunits of COX. This case illustrates the importance of mtDNA sequence analysis in patients with an evident mitochondrial disorder.
C1 [Kytovuori, Laura; Karppa, Mikko; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, POB 5000, FI-90014 Oulu, Finland.
   [Kytovuori, Laura; Karppa, Mikko; Uusimaa, Johanna; Hinttala, Reetta; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Kytovuori, Laura; Karppa, Mikko; Uusimaa, Johanna; Hinttala, Reetta; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Kytovuori, Laura; Karppa, Mikko; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, POB 20OYS, FI-90029 Oulu, Finland.
   [Tuominen, Hannu] Univ Oulu, Dept Pathol, Canc & Translat Med Res Unit, Oulu, Finland.
   [Tuominen, Hannu] Oulu Univ Hosp, Dept Pathol, Oulu, Finland.
   [Uusimaa, Johanna; Hinttala, Reetta] Univ Oulu, PEDEGO Res Unit, POB 5000, FI-90014 Oulu, Finland.
   [Uusimaa, Johanna; Hinttala, Reetta] Oulu Univ Hosp, Div Pediat Neurol, Dept Children & Adolescents, Oulu, Finland.
   [Uusimaa, Johanna; Hinttala, Reetta] Univ Oulu, Bioctr Oulu, POB 5000, FI-90014 Oulu, Finland.
   [Saari, Markku] Univ Turku, Turku Ctr Biotechnol, Cell Imaging Core, FI-20520 Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Turku
RP Kytövuori, L (corresponding author), Univ Oulu, Res Unit Clin Neurosci, POB 5000, FI-90014 Oulu, Finland.; Kytövuori, L (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.; Kytövuori, L (corresponding author), Univ Oulu, Oulu, Finland.; Kytövuori, L (corresponding author), Oulu Univ Hosp, Dept Neurol, POB 20OYS, FI-90029 Oulu, Finland.
EM laura.kytovuori@oulu.fi
FU Sigrid Juselius Foundation; Medical Research Center; Oulu University Hospital and Oulu University Hospital; Academy of Finland [266,498, 273,790]
CR Abdulhag UN, 2015, EUR J HUM GENET, V23, P159, DOI 10.1038/ejhg.2014.85
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Hallmann K, 2016, BRAIN, V139, P338, DOI 10.1093/brain/awv357
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Shoubridge E A, 1996, METHODS ENZYMOL, V264, P465, DOI 10.1016/S0076-6879(96)64042-7
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 21
TC 8
Z9 8
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
EI 
J9 BMC NEUROL
JI BMC Neurol.
PD MAY 18
PY 2017
VL 17
IS 
BP 
EP 
DI 10.1186/s12883-017-0883-5
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA EV4LF
UT WOS:000401730600001
PM 28521807
DA 2024-11-01
ER

PT J
AU Morén, C
   González-Casacuberta, I
   Navarro-Otano, J
   Juárez-Flores, D
   Vilas, D
   Garrabou, G
   Milisenda, JC
   Pont-Sunyer, C
   Catalán-García, M
   Guitart-Mampel, M
   Tobías, E
   Cardellach, F
   Valldeoriola, F
   Iranzo, A
   Tolosa, E
AF Moren, C.
   Gonzalez-Casacuberta, I.
   Navarro-Otano, J.
   Juarez-Flores, D.
   Vilas, D.
   Garrabou, G.
   Milisenda, J. C.
   Pont-Sunyer, C.
   Catalan-Garcia, M.
   Guitart-Mampel, M.
   Tobias, E.
   Cardellach, F.
   Valldeoriola, F.
   Iranzo, A.
   Tolosa, E.
TI Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder
SO PARKINSONS DISEASE
LA English
DT Article
ID enteric nervous-system; complex-i deficiency; alpha-synuclein; respiratory-chain; skeletal-muscle; premotor stage; wake changes; dysfunction; progression; pathology
AB Objective. To determine potential mitochondrial and oxidative alterations in colon biopsies from idiopathic REM sleep behavior disorder (iRBD) and Parkinson's disease (PD) subjects. Methods. Colonic biopsies from 7 iRBD subjects, 9 subjects with clinically diagnosed PD, and 9 healthy controls were homogenized in 5% w/v mannitol. Citrate synthase (CS) and complex I (CI) were analyzed spectrophotometrically. Oxidative damage was assessed either by lipid peroxidation, through malondialdehyde and hydroxyalkenal content by spectrophotometry, or through antioxidant enzyme levels of superoxide dismutase-2 (SOD2), glutathione peroxidase-1 (Gpx1), and catalase (CAT) by western blot. The presence of mitochondrial DNA (mtDNA) deletions was assessed by long PCR and electrophoresis. Results. Nonsignificant trends to CI decrease in both iRBD (45.69 +/- 18.15; 23% decrease) and PD patients (37.57 +/- 12.41; 37% decrease) were found compared to controls (59.51 +/- 12.52, p: NS). Lipid peroxidation was maintained among groups (iRBD: 27.46 +/- 3.04, PD: 37.2 +/- 3.92, and controls: 31.71 +/- 3.94; p: NS). Antioxidant enzymes SOD2 (iRBD: 2.30 +/- 0.92, PD: 1.48 +/- 0.39, and controls: 1.09 +/- 0.318) and Gpx1 (iRBD 0.29 +/- 0.12, PD: 0.56 +/- 0.33, and controls: 0.38 +/- 0.16) did not show significant differences between groups. CAT was only detected in 2 controls and 1 iRBD subject. One iRBD patient presented a single mtDNA deletion.
C1 [Moren, C.; Gonzalez-Casacuberta, I.; Juarez-Flores, D.; Garrabou, G.; Milisenda, J. C.; Catalan-Garcia, M.; Guitart-Mampel, M.; Tobias, E.; Cardellach, F.] Univ Barcelona, Internal Med Dept, Fac Med & Hlth Sci,Hosp Clin Barcelona,CIBERER U7, Muscle Res & Mitochondrial Funct Lab,Cellex IDIBA, Barcelona, Spain.
   [Navarro-Otano, J.; Iranzo, A.] Hosp Clin Barcelona, IDIBAPS, CIBERNED, Neurol Serv, Barcelona, Spain.
   [Vilas, D.; Pont-Sunyer, C.; Valldeoriola, F.; Tolosa, E.] Hosp Clin Barcelona, IDIBAPS, CIBERNED, Movement Disorder Unit,Neurol Serv, Barcelona, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED
RP González-Casacuberta, I (corresponding author), Univ Barcelona, Internal Med Dept, Fac Med & Hlth Sci,Hosp Clin Barcelona,CIBERER U7, Muscle Res & Mitochondrial Funct Lab,Cellex IDIBA, Barcelona, Spain.
EM ingrid@clinic.ub.es
FU Fundacio Privada Cellex; Fondo de Investigacion Sanitaria [PI00462/11, PI13/01455, PI13/01738, PI15/00903, PI15/00817]; ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF); Grups de Recerca de la Generalitat de Catalunya [SGR 2014/376]; InterCiber [PIE1400061]; Spanish Ministry (Ministerio de Educacion, Cultura y Deporte) [CAS15/00140]; CIBER de Enfermedades Raras (CIBERER, an initiative of ISCIII)
CR Antunes L, 2016, MOVEMENT DISORD, V31, P1567, DOI 10.1002/mds.26702
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Braidy N, 2014, NEUROTOX RES, V25, P170, DOI 10.1007/s12640-013-9420-5
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Corbillé AG, 2016, NEUROGASTROENT MOTIL, V28, P966, DOI 10.1111/nmo.12797
   Corbillé AG, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0305-8
   Cuervo AM, 2010, MOVEMENT DISORD, V25, PS49, DOI 10.1002/mds.22718
   de Farias CC, 2016, NEUROSCI LETT, V617, P66, DOI 10.1016/j.neulet.2016.02.011
   Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Fedorova TD, 2017, NEUROLOGY, V88, P775, DOI 10.1212/WNL.0000000000003633
   Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x
   Gatt AP, 2016, MOVEMENT DISORD, V31, P352, DOI 10.1002/mds.26513
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Iranzo A, 2013, CURR NEUROL NEUROSCI, V13, P0, DOI 10.1007/s11910-013-0373-0
   Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049
   Keane PC, 2011, PARKINSONS DIS-US, V2011, P0, DOI 10.4061/2011/716871
   Knudsen K, 2017, J PARKINSON DIS, V7, P359, DOI 10.3233/JPD-161050
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Mortiboys H, 2015, NEUROLOGY, V85, P846, DOI 10.1212/WNL.0000000000001905
   Mrabet S, 2016, J CLIN GASTROENTEROL, V50, PE85, DOI 10.1097/MCG.0000000000000606
   Müller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016
   Pan-Montojo F, 2012, SCI REP-UK, V2, P0, DOI 10.1038/srep00898
   Pan-Montojo F, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0008762
   Postuma RB, 2012, NEUROBIOL DIS, V46, P553, DOI 10.1016/j.nbd.2011.10.003
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52
   Schneider SA, 2016, EUR J NEUROL, V23, P247, DOI 10.1111/ene.12753
   Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838
   Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004
   Sprenger FS, 2015, NEUROLOGY, V85, P1761, DOI 10.1212/WNL.0000000000002126
   Stokholm MG, 2016, ANN NEUROL, V79, P940, DOI 10.1002/ana.24648
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   Trudler D, 2015, J NEURAL TRANSM, V122, P1409, DOI 10.1007/s00702-015-1399-z
   Visanji Naomi P, 2013, ACTA NEUROPATHOL COMMUN, V1, P2, DOI 10.1186/2051-5960-1-2
NR 41
TC 3
Z9 3
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8083
EI 2042-0080
J9 PARKINSONS DIS-US
JI Parkinsons Dis.
PD JUN 15
PY 2017
VL 2017
IS 
BP 
EP 
DI 10.1155/2017/9816095
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA EY2KH
UT WOS:000403796600001
PM 28660090
DA 2024-11-01
ER

PT J
AU Feichtinger, RG
   Oláhová, M
   Kishita, Y
   Garone, C
   Kremer, LS
   Yagi, M
   Uchiumi, T
   Jourdain, AA
   Thompson, K
   D'Souza, AR
   Kopajtich, R
   Alston, CL
   Koch, J
   Sperl, W
   Mastantuono, E
   Strom, TM
   Wortmann, SB
   Meitinger, T
   Pierre, G
   Chinnery, PF
   Chrzanowska-Lightowlers, ZM
   Lightowlers, RN
   DiMauro, S
   Calvo, SE
   Mootha, VK
   Moggio, M
   Sciacco, M
   Comi, GP
   Ronchi, D
   Murayama, K
   Ohtake, A
   Rebelo-Guiomar, P
   Kohda, M
   Kang, D
   Mayr, JA
   Taylor, RW
   Okazaki, Y
   Minczuk, M
   Prokisch, H
AF Feichtinger, Rene G.
   Olahova, Monika
   Kishita, Yoshihito
   Garone, Caterina
   Kremer, Laura S.
   Yagi, Mikako
   Uchiumi, Takeshi
   Jourdain, Alexis A.
   Thompson, Kyle
   D'Souza, Aaron R.
   Kopajtich, Robert
   Alston, Charlotte L.
   Koch, Johannes
   Sperl, Wolfgang
   Mastantuono, Elisa
   Strom, Tim M.
   Wortmann, Saskia B.
   Meitinger, Thomas
   Pierre, Germaine
   Chinnery, Patrick F.
   Chrzanowska-Lightowlers, Zofia M.
   Lightowlers, Robert N.
   DiMauro, Salvatore
   Calvo, Sarah E.
   Mootha, Vamsi K.
   Moggio, Maurizio
   Sciacco, Monica
   Comi, Giacomo P.
   Ronchi, Dario
   Murayama, Kei
   Ohtake, Akira
   Rebelo-Guiomar, Pedro
   Kohda, Masakazu
   Kang, Dongchon
   Mayr, Johannes A.
   Taylor, Robert W.
   Okazaki, Yasushi
   Minczuk, Michal
   Prokisch, Holger
TI Biallelic <i>C1QBP</i> Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID mitochondrial-dna deletions; p-32 protein; matrix; maintenance; p32/gc1qr; disorder; spectrum; receptor
AB Complement component 1 Q subcomponent-binding protein (C1QBP; also known as p32) is a multi-compartmental protein whose precise function remains unknown. It is an evolutionary conserved multifunctional protein localized primarily in the mitochondrial matrix and has roles in inflammation and infection processes, mitochondrial ribosome biogenesis, and regulation of apoptosis and nuclear transcription. It has an N-terminal mitochondrial targeting peptide that is proteolytically processed after import into the mitochondrial matrix, where it forms a homotrimeric complex organized in a doughnut-shaped structure. Although C1QBP has been reported to exert pleiotropic effects on many cellular processes, we report here four individuals from unrelated families where biallelic mutations in C1QBP cause a defect in mitochondrial energy metabolism. Infants presented with cardiomyopathy accompanied by multisystemic involvement (liver, kidney, and brain), and children and adults presented with myopathy and progressive external ophthalmoplegia. Multiple mitochondrial respiratory-chain defects, associated with the accumulation of multiple deletions of mitochondrial DNA in the later-onset myopathic cases, were identified in all affected individuals. Steady-state C1QBP levels were decreased in all individuals' samples, leading to combined respiratory-chain enzyme deficiency of complexes I, III, and IV. C1qbp(-/-) mouse embryonic fibroblasts (MEFs) resembled the human disease phenotype by showing multiple defects in oxidative phosphorylation (OXPHOS). Complementation with wild-type, but not mutagenized, C1qbp restored OXPHOS protein levels and mitochondrial enzyme activities in C1qbp(-/-) MEFs. C1QBP deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio) myopathy and late-onset progressive external ophthalmoplegia.
C1 [Feichtinger, Rene G.; Koch, Johannes; Sperl, Wolfgang; Wortmann, Saskia B.; Mayr, Johannes A.] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Olahova, Monika; Thompson, Kyle; Alston, Charlotte L.; Chrzanowska-Lightowlers, Zofia M.; Lightowlers, Robert N.; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Olahova, Monika; Thompson, Kyle; Alston, Charlotte L.; Chrzanowska-Lightowlers, Zofia M.; Lightowlers, Robert N.; Taylor, Robert W.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Kishita, Yoshihito; Kohda, Masakazu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Saitama 3501241, Japan.
   [Kishita, Yoshihito; Kohda, Masakazu; Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Diagnost & Therapeut Intractable Dis, Intractable Dis Res Ctr, Tokyo 1138421, Japan.
   [Garone, Caterina; D'Souza, Aaron R.; Chinnery, Patrick F.; Rebelo-Guiomar, Pedro; Minczuk, Michal] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Wellcome Trust, MRC Bldg, Cambridge CB2 0XY, England.
   [Kremer, Laura S.; Kopajtich, Robert; Mastantuono, Elisa; Strom, Tim M.; Wortmann, Saskia B.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Kremer, Laura S.; Mastantuono, Elisa; Strom, Tim M.; Wortmann, Saskia B.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
   [Yagi, Mikako; Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
   [Jourdain, Alexis A.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Genome Med, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA.
   [Jourdain, Alexis A.; Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany.
   [Pierre, Germaine] Bristol Royal Hosp Children, South West Reg Metab Dept, Bristol BS1 3NU, Avon, England.
   [DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Moggio, Maurizio; Sciacco, Monica] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Neuromuscular Unit, I-20122 Milan, Italy.
   [Comi, Giacomo P.; Ronchi, Dario] Univ Milan, IRCCS, Fdn Ca Granda,Osped Maggiore Policlin, Neurosci Sect,Dept Pathophysiol & Transplantat,Di, I-20122 Milan, Italy.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan.
   [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Saitama 3500495, Japan.
   [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4099002 Oporto, Portugal.
C3 Paracelsus Private Medical University; Newcastle University - UK; Newcastle University - UK; Saitama Medical University; Juntendo University; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Wellcome Trust Sanger Institute; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kyushu University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Munich Heart Alliance; German Centre for Cardiovascular Research; Bristol Royal Hospital For Children; Columbia University; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Chiba Children's Hospital; Saitama Medical University; Universidade do Porto
RP Prokisch, H (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.; Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
EM prokisch@helmholtz-muenchen.de
FU Horizon through E-Rare project GENOMIT [01GM1603, 01GM1207, FWF-I2741-B26]; Vereinigung zur Forderung Padiatrischer Forschung Salzburg; EU FP7 MEET Project [317433]; Horizon Project SOUND [633974]; Marie Sklodowska-Curie Actions Reintegration Fellowship [Mitobiopath-705560]; UK NHS Highly Specialised Mitochondrial Service; Wellcome Centre for Mitochondrial Research [203105/Z/16]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NIHR fellowship [NIHR-HCS-D12-03-04]; Wellcome Senior Fellowship [101876/Z/13/Z]; UK NIHR award; MRC Mitochondrial Biology Unit [MC_UP_1501/2]; NIH [R01 GM0077465, R35 GM122455]; EMBO fellowship [ALTF554-2015]; UK MRC core funding for the Mitochondrial Biology Unit of the University of Cambridge [MC_U105697135]; Portuguese Fundacao para a Ciencia e a Tecnologia [PD/BD/105750/2014]; Italian Telethon [GSP16001]; Fondazione Cariplo [2014-1010]; Strategic Research Center in Private Universities from MEXT; Practical Research Project for Rare/Intractable Diseases from AMED; German BMBF; Fundação para a Ciência e a Tecnologia [PD/BD/105750/2014] Funding Source: FCT; MRC [MC_U105697135, MC_UU_00015/4] Funding Source: UKRI; Grants-in-Aid for Scientific Research [17H01550, 16K09973, 15H04764] Funding Source: KAKEN; Austrian Science Fund (FWF) [I2741] Funding Source: Austrian Science Fund (FWF)
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802
   CALVO SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1093/BIOINFORMATICS/BTP324
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0
   Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621
   FEICHTINGER RG, 2010, BMC CANCER, V10, P0, DOI 10.1002/GLIA.22621
   Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033
   Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09
   Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002
   Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kremer LS, 2016, AM J HUM GENET, V99, P894, DOI 10.1016/j.ajhg.2016.07.018
   Kremer LS, 2016, J HEPATOL, V65, P377, DOI 10.1016/j.jhep.2016.04.017
   Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677
   Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245
   Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Rahman S, 2016, INBORN METABOLIC DIS, V0, P223
   Rubinstein DB, 2004, INT J CANCER, V110, P741, DOI 10.1002/ijc.20105
   Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Seytter T, 1998, YEAST, V14, P303, DOI 10.1002/(SICI)1097-0061(19980315)14:4<303::AID-YEA217>3.0.CO;2-N
   Soltys BJ, 2000, HISTOCHEM CELL BIOL, V114, P245
   Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200
   Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418
   SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3
   Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   van Leeuwen HC, 2001, J CELL SCI, V114, P2115
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 40
TC 51
Z9 55
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT 5
PY 2017
VL 101
IS 4
BP 525
EP 538
DI 10.1016/j.ajhg.2017.08.015
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA FI8UJ
UT WOS:000412277300004
PM 28942965
DA 2024-11-01
ER

PT J
AU Mordel, P
   Schaeffer, S
   Dupas, Q
   Laville, MA
   Gérard, M
   Chapon, F
   Allouche, S
AF Mordel, Patrick
   Schaeffer, Stephane
   Dupas, Quentin
   Laville, Marie-Alice
   Gerard, Marion
   Chapon, Francoise
   Allouche, S.
TI A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrorne
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial disease; Complex V deficiency; Next generation sequencing; ATP6 deletion; NARP syndrome
ID complex-v deficiency; mutation; synthase; cardiomyopathy; dna
AB Mitochondrial (mt) DNA-associated NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) syndrome is due to mutation in the MT-ATP6 gene. We report the case of a 18-year-old man who presented with deafness, a myoclonic epilepsy, muscle weakness since the age of 10 and further developed a retinitis pigmentosa and ataxia. The whole mtDNA analysis by next-generation sequencing revealed the presence of the 2 bp microdeletion m.9127-9128 del AT in the ATP6 gene at 82% heteroplasmy in muscle and to a lower load in blood (10-20%) and fibroblasts (50%). Using the patient's fibroblasts, we demonstrated a 60% reduction of the oligomycinsensitive ATPase hydrolytic activity, a 40% decrease in the ATP synthesis and determination of the mitochondrial membrane potential using the fluorescent probe tetramethylrhodamine, ethyl ester indicated a significant reduction in oligomycin sensitivity. In conclusion, we demonstrated that this novel AT deletion in the ATP6 gene is pathogenic and responsible for the NARP syndrome. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Mordel, Patrick; Dupas, Quentin; Allouche, S.] Normandie Univ, UNICAEN, CHU Caen, Signalisat Electrophysiol & Imagerie Les Ischemie, F-14032 Caen, France.
   [Schaeffer, Stephane; Chapon, Francoise] CHU Caen, Neuromuscular Competence Ctr, F-14032 Caen, France.
   [Laville, Marie-Alice] CHU Caen, Dept Ophthalmol, F-14032 Caen, France.
   [Gerard, Marion] CHU Caen, Dept Med Genet, F-14032 Caen, France.
   [Chapon, Francoise] CHU Caen, Dept Pathol, F-14032 Caen, France.
   [Allouche, S.] CHU Caen, Dept Biochem, Ave Cote Nacre,CS 30001, F-14032 Caen 9, France.
C3 Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE
RP Allouche, S (corresponding author), CHU Caen, Dept Biochem, Ave Cote Nacre,CS 30001, F-14032 Caen 9, France.
EM allouche-s@chu-caen.fr
CR Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Habersetzer J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075429
   Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037
   Hao XS, 2015, NEUROREPORT, V26, P588, DOI 10.1097/WNR.0000000000000392
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Houstek J, 1999, HUM MOL GENET, V8, P1967
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Martin J, 2015, J BIOL CHEM, V290, P10717, DOI 10.1074/jbc.M115.646430
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Rühle T, 2015, BBA-BIOENERGETICS, V1847, P849, DOI 10.1016/j.bbabio.2015.02.005
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109
   Zhou AN, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.10180
   ziel G, 1900, V3, V0, P6
NR 31
TC 16
Z9 16
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 9
PY 2017
VL 494
IS 1-2
BP 133
EP 137
DI 10.1016/j.bbrc.2017.10.066
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FO2NF
UT WOS:000416615300022
PM 29054413
DA 2024-11-01
ER

PT J
AU Han, SJ
   Noh, MR
   Jung, JM
   Ishii, I
   Yoo, J
   Kim, JI
   Park, KM
AF Han, Sang Jun
   Noh, Mi Ra
   Jung, Jung-Min
   Ishii, Isao
   Yoo, Jeongsoo
   Kim, Jee In
   Park, Kwon Moo
TI Hydrogen sulfide-producing cystathionine γ-lyase is critical in the progression of kidney fibrosis
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Chronic kidney disease; Cystathionine gamma-lyase; Reactive oxygen species; Kidney fibrosis; Hydrogen sulfide
ID methionine sulfoxide reductase; oxidative stress; renal ischemia/reperfusion; transsulfuration pathway; diabetic-nephropathy; n-acetylcysteine; ischemic-injury; deficient mice; glutathione; cysteine
AB Cystathionine gamma-lyase (CSE), the last key enzyme of the transsulfuration pathway, is involved in the production of hydrogen sulfide (H2S) and glutathione (GSH), which regulate redox balance and act as important antioxidant molecules. Impairment of the H2S- and GSH-mediated antioxidant system is associated with the progression of chronic kidney disease (CKD), characterized by kidney fibrosis and dysfunction. Here, we evaluated the role of CSE in the progression of kidney fibrosis after unilateral ureteral obstruction (UUO) using mice deficient in the Cse gene. UUO of wild-type mice reduced the expression of H2S-producing enzymes, CSE, cystathionine beta-synthase, and 3-mercaptopyruvate sulfurtransferase in the obstructed kidneys, resulting in decreased H2S and GSH levels. Cse gene deletion lowered H2S and GSH levels in the kidneys. Deleting the Cse gene exacerbated the decrease in H2S and GSH levels and increase in superoxide formation and oxidative damage to proteins, lipids, and DNA in the kidneys after UUO, which were accompanied by greater kidney fibrosis, deposition of extracellular matrixes, expression of a-smooth muscle actin, tubular damage, and infiltration of inflammatory cells. Furthermore, Cse gene deletion exacerbated mitochondrial fragmentation and apoptosis of renal tubule cells after UUO. The data provided herein constitute in vivo evidence that Cse deficiency impairs renal the H2S- and GSH-producing activity and exacerbates UUO-induced kidney fibrosis. These data propose a novel therapeutic approach against CKD by regulating CSE and the transsulfuration pathway.
C1 [Han, Sang Jun; Noh, Mi Ra; Park, Kwon Moo] Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Dept Anat, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Han, Sang Jun; Noh, Mi Ra; Park, Kwon Moo] Kyungpook Natl Univ, Sch Med, Plus BK21, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Jung, Jung-Min; Yoo, Jeongsoo] Kyungpook Natl Univ, Plus BK21, Dept Mol Med, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Ishii, Isao] Showa Pharmaceut Univ, Lab Hlth Chem, Machida, Tokyo 1948543, Japan.
   [Kim, Jee In] Keimyung Univ, Coll Med, Dept Mol Med, 1095 Dalgubeol Daero 250 Gil, Daegu 42601, South Korea.
   [Kim, Jee In] Keimyung Univ, Coll Med, MRC, 1095 Dalgubeol Daero 250 Gil, Daegu 42601, South Korea.
C3 Kyungpook National University (KNU); Kyungpook National University (KNU); Kyungpook National University (KNU); Showa Pharmaceutical University; Keimyung University; Keimyung University
RP Park, KM (corresponding author), Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Dept Anat, 680 Gukchaebosang Ro, Daegu 41944, South Korea.; Park, KM (corresponding author), Kyungpook Natl Univ, Sch Med, Plus BK21, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
EM kmpark@knu.ac.kr
FU National Research Foundation of Korea (NRF) [2015R1A2A1A15052400]; Minister of Health & Welfare by the Korean government [HI14C2011]; Grants-in-Aid for Scientific Research [16K15194] Funding Source: KAKEN
CR Akerboom T P, 1981, METHODS ENZYMOL, V77, P373
   Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560
   ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
   Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   CeballosPicot I, 1996, FREE RADICAL BIO MED, V21, P845, DOI 10.1016/0891-5849(96)00233-X
   Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86
   Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, PF4, DOI 10.1152/ajprenal.00045.2005
   El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7
   Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109
   Han SJ, 2016, J AM SOC NEPHROL, V0, P0
   Han SJ, 2015, NEPHROL DIAL TRANSPL, V30, P1497, DOI 10.1093/ndt/gfv226
   Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111
   Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439
   Jang HS, 2008, TRANSPLANTATION, V85, P447, DOI 10.1097/TP.0b013e318160f0d1
   Jang HS, 2012, NEPHROL DIAL TRANSPL, V27, P3762, DOI 10.1093/ndt/gfs097
   Jiang DP, 2014, NEUROUROL URODYNAM, V33, P538, DOI 10.1002/nau.22450
   Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015
   Kim JI, 2015, FREE RADICAL BIO MED, V89, P201, DOI 10.1016/j.freeradbiomed.2015.07.018
   Kim JI, 2013, ANTIOXID REDOX SIGN, V18, P2241, DOI 10.1089/ars.2012.4598
   Kim J, 2009, AM J PHYSIOL-RENAL, V297, PF461, DOI 10.1152/ajprenal.90735.2008
   Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x
   Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282
   LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218
   Lee ES, 2016, NEPHROL DIAL TRANSPL, V31, P391, DOI 10.1093/ndt/gfv377
   Lee ZW, 2014, BIOCHEM J, V460, P425, DOI 10.1042/BJ20131434
   Li Y, 2017, RENAL FAILURE, V39, P265, DOI 10.1080/0886022X.2016.1257433
   Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI 10.1089/ars.2009.2695
   McBean GJ, 2012, AMINO ACIDS, V42, P199, DOI 10.1007/s00726-011-0864-8
   Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200
   Otunctemur A, 2014, RENAL FAILURE, V36, P925, DOI 10.3109/0886022X.2014.900599
   Perna AF, 2012, NEPHROL DIAL TRANSPL, V27, P486, DOI 10.1093/ndt/gfr737
   Perna AF, 2009, NEPHROL DIAL TRANSPL, V24, P3756, DOI 10.1093/ndt/gfp378
   Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200
   Renga Barbara, 2011, INFLAMMATION & ALLERGY DRUG TARGETS, V10, P85
   Rushworth GF, 2014, PHARMACOL THERAPEUT, V141, P150, DOI 10.1016/j.pharmthera.2013.09.006
   Shen Y, 2016, ACTA PHARMACOL SIN, V37, P637, DOI 10.1038/aps.2016.12
   Song K, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/458720
   Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449
   Stallons LJ, 2013, CURR PATHOBIOL REP, V1, P0
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   Wang P, 2014, PHYSL REP, V2, P12
   Wu DD, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/2715718
   Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142
   Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667
   Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749
   Zhang S, 2015, OXID MED CELL LONGEV, V2015, P12
   Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593
NR 49
TC 42
Z9 45
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV 15
PY 2017
VL 112
IS 
BP 423
EP 432
DI 10.1016/j.freeradbiomed.2017.08.017
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA FI3BD
UT WOS:000411829300037
PM 28842346
DA 2024-11-01
ER

PT J
AU Chang, JC
   Hoel, F
   Liu, KH
   Wei, YH
   Cheng, FC
   Kuo, SJ
   Tronstad, KJ
   Liu, CS
AF Chang, Jui-Chih
   Hoel, Fredrik
   Liu, Ko-Hung
   Wei, Yau-Huei
   Cheng, Fu-Chou
   Kuo, Shou-Jen
   Tronstad, Karl Johan
   Liu, Chin-San
TI Peptide-mediated delivery of donor mitochondria improves mitochondrial function and cell viability in human cybrid cells with the MELAS A3243G mutation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID penetrating peptides; membrane interactions; complex i; fission; rescue; pep-1; opa1; transplantation; translocation; dynamics
AB The cell penetrating peptide, Pep-1, has been shown to facilitate cellular uptake of foreign mitochondria but further research is required to evaluate the use of Pep-1-mediated mitochondrial delivery (PMD) in treating mitochondrial defects. Presently, we sought to determine whether mitochondrial transplantation rescue mitochondrial function in a cybrid cell model of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) disease. Following PMD, recipient cells had internalized donor mitochondria after 1 h, and expressed higher levels of normal mitochondrial DNA, particularly at the end of the treatment and 11 days later. After 4 days, mitochondrial respiratory function had recovered and biogenesis was evident in the Pep-1 and PMD groups, compared to the untreated MELAS group. However, only PMD was able to reverse the fusion-to-fission ratio of mitochondrial morphology, and mitochondria shaping proteins resembled the normal pattern seen in the control group. Cell survival following hydrogen peroxide-induced oxidative stress was also improved in the PMD group. Finally, we observed that PMD partially normalized cytokine expression, including that of interleukin (IL)-7, granulocyte macrophage-colony-stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF), in the MELAS cells. Presently, our data further confirm the protective effects of PMD as well in MELAS disease.
C1 [Chang, Jui-Chih; Liu, Ko-Hung; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.
   [Hoel, Fredrik; Tronstad, Karl Johan] Univ Bergen, Dept Biomed, Bergen, Norway.
   [Wei, Yau-Huei] Natl Yang Ming Univ, Sch Life Sci, Dept Biochem & Mol Biol, Taipei, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei, Taiwan.
   [Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, Changhua, Taiwan.
   [Kuo, Shou-Jen] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan.
   [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.
C3 Changhua Christian Hospital; University of Bergen; National Yang Ming Chiao Tung University; Mackay Medical College; Taichung Veterans General Hospital; Changhua Christian Hospital; Changhua Christian Hospital
RP Liu, CS (corresponding author), Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.; Liu, CS (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.
EM 26602@cch.org.tw
FU Changhua Christian Hospital [104-CCH-IST-005]; National Science Council [MOST 103-2320-B-371 -001-, MOST 104-2314-B-371 -001 -MY2]
CR Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Buhlman L, 2014, BBA-MOL CELL RES, V1843, P2012, DOI 10.1016/j.bbamcr.2014.05.012
   Cavalli G, 2015, RHEUMATOLOGY, V54, P2134, DOI 10.1093/rheumatology/kev269
   Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chang JC, 2013, CYTOTHERAPY, V15, P1580, DOI 10.1016/j.jcyt.2013.06.008
   Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981
   Cho YM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032778
   Cselenyák A, 2010, BMC CELL BIOL, V11, P0, DOI 10.1186/1471-2121-11-29
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Henriques ST, 2008, J PEPT SCI, V14, P482, DOI 10.1002/psc.1003
   Henriques ST, 2004, BIOCHEMISTRY-US, V43, P9716, DOI 10.1021/bi036325k
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, PC1440, DOI 10.1152/ajpcell.00607.2004
   Lin BY, 2015, ANN NY ACAD SCI, V1350, P17, DOI 10.1111/nyas.12858
   Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   MacVicar TDB, 2014, J CELL SCI, V127, P2313, DOI 10.1242/jcs.144337
   Margus H, 2012, MOL THER, V20, P525, DOI 10.1038/mt.2011.284
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011
   Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173
   Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nikolaisen J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0101365
   Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478
   Pasquier J, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-94
   Peng JY, 2011, PLOS COMPUT BIOL, V7, P0, DOI 10.1371/journal.pcbi.1002212
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2013, J APPL PHYSIOL, V115, P1562, DOI 10.1152/japplphysiol.00819.2013
   Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004
   RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X
   Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Suarez-Rivero Juan M, 2016, DISEASES, V5, P0, DOI 10.3390/diseases5010001
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Tronstad KJ, 2014, CURR PHARM DESIGN, V20, P5634, DOI 10.2174/1381612820666140305230546
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Walker MA, 2014, J IMMUNOL RES, V2014, P0, DOI 10.1155/2014/164309
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 53
TC 47
Z9 48
U1 2
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD SEP 6
PY 2017
VL 7
IS 
BP 
EP 
DI 10.1038/s41598-017-10870-5
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG0MI
UT WOS:000409439900128
PM 28878349
DA 2024-11-01
ER

